<SEC-DOCUMENT>0001104659-24-096442.txt : 20240903
<SEC-HEADER>0001104659-24-096442.hdr.sgml : 20240903
<ACCEPTANCE-DATETIME>20240903171457
ACCESSION NUMBER:		0001104659-24-096442
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20240903
DATE AS OF CHANGE:		20240903

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ares Dynamic Credit Allocation Fund, Inc.
		CENTRAL INDEX KEY:			0001515324
		ORGANIZATION NAME:           	
		IRS NUMBER:				454969053
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-279977
		FILM NUMBER:		241275026

	BUSINESS ADDRESS:	
		STREET 1:		1800 AVENUE OF THE STARS
		STREET 2:		SUITE 1400
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067
		BUSINESS PHONE:		(310) 201-4200

	MAIL ADDRESS:	
		STREET 1:		1800 AVENUE OF THE STARS
		STREET 2:		SUITE 1400
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ares Senior Credit Strategies Fund, Inc.
		DATE OF NAME CHANGE:	20110314
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>tm2416373d6_424b2.htm
<DESCRIPTION>424B2
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--INTEGIX by Ez-XBRL-->
<!-- Assembled by CompSci Transform  (tm) - http://www.compsciresources.com - version 1.2 -->
<!-- Created: Tue Sep 03 20:31:08 UTC 2024 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:ck0001515324="http://www.www.arespublicfunds.com/20240830" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2023">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
  <title>Ares Dynamic Credit Allocation Fund, Inc. - 1515324 - 2024</title>
</head>
<body><!-- BannerFile="tm2416373d6_inlinepackage.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-6/tm2416373-6_424b2seq1" -->

<div style="display:none">
<ix:header>
  <ix:hidden>
    <ix:footnote id="FN20240830180412881" xml:lang="en-US">The percentage reflects estimated offering expenses of approximately $250,000 for the estimated duration of this offering and assumes we sell all $150,000,000 of common shares under this Prospectus Supplement and the accompanying Prospectus. There is no guarantee that there will be any sales of our common shares pursuant to this Prospectus Supplement and the accompanying Prospectus. Actual sales of the Fund's common shares under this Prospectus Supplement and the accompanying Prospectus, if any, may be less than as set forth under &#8220;Capitalization&#8221; below. In addition, the price per share of any such sale may be greater than or less than the price set forth under &#8220;Capitalization&#8221; below, depending on market price of the Fund's common shares at the time of any such sale.</ix:footnote>
    <ix:footnote id="FN20240830180423289" xml:lang="en-US">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</ix:footnote>
    <ix:footnote id="FN20240830180433673" xml:lang="en-US">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable to common shares than if the Fund did not use leverage. The advisory fee shown in the table assumes an amount of leverage of 36% of the Fund&#8217;s Managed Assets. Based on the same assumptions, leverage would equal 56% of the Fund&#8217;s net assets.</ix:footnote>
    <ix:footnote id="FN20240830180443793" xml:lang="en-US">&#8220;Interest payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for the six months ended June 30, 2024. We had outstanding borrowings of approximately $190 million (with a carrying value of approximately $189) as of June 30, 2024. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at leverage of 36% of the Fund&#8217;s Managed Assets and 56% of the Fund&#8217;s net assets) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s and the Board of Directors of the Fund's assessment of market and other factors at the time of any proposed borrowing.</ix:footnote>
    <ix:footnote id="FN20240830180453153" xml:lang="en-US">&#8220;Other Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on estimated amounts for the current fiscal year.</ix:footnote>
    <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20240830to20240830" id="Fdei_EntityCentralIndexKey20240830100824006">0001515324</ix:nonNumeric>
    <ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20240830to20240830" id="Fdei_AmendmentFlag20240830100847280">false</ix:nonNumeric>
    <ix:nonNumeric name="dei:DocumentType" contextRef="C_20240830to20240830" id="Fdei_DocumentType20240830111654741">424B2</ix:nonNumeric>
    </ix:hidden>
  <ix:references> <link:schemaRef xlink:type="simple" xlink:href="ck0001515324-20240830.xsd"/>
    </ix:references>
  <ix:resources>
    <xbrli:context id="C_20240830to20240830">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-30</xbrli:startDate>
        <xbrli:endDate>2024-08-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240401to20240630">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240101to20240331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20231001to20231231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230701to20230930">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230401to20230630">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20230101to20230331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20221001to20221231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220701to20220930">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220401to20220630">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240823">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2024-08-23</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240823to20240823">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-23</xbrli:startDate>
        <xbrli:endDate>2024-08-23</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20240826to20240826">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001515324</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-26</xbrli:startDate>
        <xbrli:endDate>2024-08-26</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:unit id="Percentage">
      <xbrli:measure>xbrli:pure</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="Usd_per_Share"><xbrli:divide>
      <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator>
      <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide>
      </xbrli:unit>
    <ix:relationship fromRefs="Fxbrl_20240830180159779" toRefs="FN20240830180412881"/>
    <ix:relationship fromRefs="Fxbrl_20240830180202468" toRefs="FN20240830180423289"/>
    <ix:relationship fromRefs="Fxbrl_20240830180256967" toRefs="FN20240830180433673"/>
    <ix:relationship fromRefs="Fxbrl_20240830180259813" toRefs="FN20240830180443793"/>
    <ix:relationship fromRefs="Fxbrl_20240830180302941" toRefs="FN20240830180453153"/>
    </ix:resources>
  </ix:header></div>


<div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font-size:10pt;margin:0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">PROSPECTUS SUPPLEMENT</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">(To Prospectus dated August&#160;26, 2024)</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right"><span style="font-size:10pt">Filed Pursuant to Rule&#160;424(b)(2)</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:right"><span style="font-size:10pt">Registration Statement No.&#160;333-279977</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong><ix:nonNumeric id="Fxbrl_20240830101439415" name="dei:EntityRegistrantName" contextRef="C_20240830to20240830">ARES
DYNAMIC CREDIT ALLOCATION FUND, INC.</ix:nonNumeric></strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Up to $150,000,000
of Common Stock</strong></span></p>


<p style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="padding-top:5pt;font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Ares Dynamic
Credit Allocation Fund,&#160;Inc. (the &#8220;Fund,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is offering for sale
up to $150,000,000 of our common stock, par value $0.001 per share (&#8220;common shares&#8221;). Our common shares are listed on the
New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;ARDC.&#8221; As of the close of business on August&#160;30, 2024,
the last reported net asset value (&#8220;NAV&#8221;) per share of our common shares was $14.71 and the last reported sales price per
share of our common shares on the NYSE was $15.37.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
Fund is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended, </span><span style="font-size:10pt">together
with the rules&#160;and regulations promulgated thereunder (the &#8220;Investment Company Act&#8221;). The Fund&#8217;s investment objective
is to seek an attractive risk-adjusted level of total return, primarily through current income and, secondarily, through capital appreciation.
The Fund is externally managed by its investment adviser, Ares Capital Management II LLC (the &#8220;Adviser&#8221;), a subsidiary of
Ares Management Corporation, a publicly traded, leading global alternative investment manager.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
Fund has entered into a distribution agreement dated September 3, 2024</span><span style="font-size:10pt"> (the &#8220;Distribution
Agreement&#8221;) with Ares Management Capital Markets LLC (the &#8220;Distributor&#8221;), an affiliate of the Adviser, to provide for
distribution of the Fund&#8217;s common shares. The Distributor has entered into a sub-placement agent agreement dated September 3, 2024 (the &#8220;Sub-Placement Agent Agreement&#8221;) with UBS Securities LLC (the &#8220;Sub-Placement Agent&#8221;) with respect to
the Fund relating to the common shares offered by this Prospectus Supplement and the accompanying prospectus dated August&#160;26, 2024
(the &#8220;Prospectus&#8221;). In accordance with the terms of the Sub-Placement Agent Agreement, the Fund may offer and sell its common
shares from time to time through the Sub-Placement Agent as sub-placement agent for the offer and sale of its common shares. Under the
Investment Company Act, the Fund may not sell any common shares at a price below the current NAV of such common shares, exclusive of any
distributing commission or discount.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Sales of our common shares,
if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or transactions that are
deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The Fund will compensate
the Distributor with respect to sales of common shares at a commission rate of 1.00% of the gross proceeds of the sale of the Fund&#8217;s
common shares. Out of this commission, the Distributor will compensate the Sub-Placement Agent at a rate of up to 0.80% of the gross sales
proceeds of the sale of the Fund&#8217;s common shares sold by the Sub-Placement Agent. The Adviser may agree to waive a portion of its
advisory fee from time to time corresponding to the amount of commission received by the Distributor and not paid to the Sub-Placement
Agent. In connection with the sale of the common shares on the Fund&#8217;s behalf, the Distributor may be deemed to be an &#8220;underwriter&#8221;
within the meaning of the Securities Act and the compensation of the Distributor may be deemed to be underwriting commissions or discounts.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt"><strong>Investing in the
Fund&#8217;s common shares involves certain risks that are described in the &#8220;Risks&#8221; section beginning on page&#160;25 of the
accompanying Prospectus.</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt"><strong>NEITHER THE SECURITIES
AND EXCHANGE COMMISSION (&#8220;SEC&#8221;) NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED
IF THIS PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</strong></span><span style="font-size:10pt">&#160;</span><span style="font-size:10pt"></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="margin:0pt">&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">This Prospectus Supplement,
together with the accompanying Prospectus, sets forth concisely the information about the Fund that a prospective investor should know
before investing. You should read this Prospectus Supplement and the accompanying Prospectus, which contain important information, before
deciding whether to invest in the common shares. You should retain the accompanying Prospectus and this Prospectus Supplement for future
reference. A Statement of Additional Information, dated August&#160;26, 2024 (&#8220;SAI&#8221;), containing additional information about
the Fund, has been filed with the SEC and, as amended from time to time, is incorporated by reference in its entirety into this Prospectus
Supplement and the accompanying Prospectus. This Prospectus Supplement, the accompanying Prospectus and the SAI are part of a &#8220;shelf&#8221;
registration statement filed with the SEC. This Prospectus Supplement describes the specific details regarding this offering, including
the method of distribution. If information in this Prospectus Supplement is inconsistent with the accompanying Prospectus or the SAI,
you should rely on this Prospectus Supplement. You may call (888) 818-5298, visit the Fund&#8217;s website (www.arespublicfunds.com) or
write to the Fund to obtain, free of charge, copies of the SAI, the Fund&#8217;s proxy voting record and the Fund&#8217;s semi-annual
and annual reports, as well as to obtain other information about the Fund or to make shareholder inquiries. The SAI, as well as the Fund&#8217;s
semi-annual and annual reports, are also available for free on the SEC&#8217;s website (http://www.sec.gov). You may also e-mail requests
for these documents to publicinfo@sec.gov. Information contained in, or that can be accessed through, the Fund&#8217;s website is not
part of this Prospectus Supplement or the accompanying Prospectus.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">You should not construe
the contents of this Prospectus Supplement and the accompanying Prospectus as legal, tax or financial advice. You should consult with
your own professional advisers as to the legal, tax, financial or other matters relevant to the suitability of an investment in the Fund.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt"><strong>The Fund&#8217;s
common shares do not represent a deposit or an obligation of, and are not guaranteed or endorsed by, any bank or other insured depository
institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government
agency.</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt">September 3, 2024</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt"><strong>You should rely
only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus. Neither
the Fund nor the underwriter have authorized anyone to provide you with different information. The Fund is not making an offer to sell
these securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in
this Prospectus Supplement and the accompanying Prospectus is accurate as of any date other than the date of this Prospectus Supplement
and the accompanying Prospectus, respectively. Our business, financial condition, results of operations and prospects may have changed
since those dates. In this Prospectus Supplement and in the accompanying Prospectus, unless otherwise indicated, &#8220;Fund,&#8221; &#8220;us,&#8221;
&#8220;our&#8221; and &#8220;we&#8221; refer to Ares Dynamic Credit Allocation Fund,&#160;Inc.</strong></span><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">S-2</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><strong>TABLE
OF CONTENTS</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><strong>Prospectus
Supplement</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:90%"><a href="#PS1_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CAUTIONARY NOTICE
        REGARDING FORWARD-LOOKING STATEMENTS</span></a></td>
    <td style="width:10%;text-align:right"><a href="#PS1_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">S-4</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#PS2_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PROSPECTUS SUPPLEMENT SUMMARY</span></a></td>
    <td style="text-align:right"><a href="#PS2_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">S-4</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#PS3_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUMMARY OF FUND EXPENSES</span></a></td>
    <td style="text-align:right"><a href="#PS3_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">S-5</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#PS4_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">USE OF PROCEEDS</span></a></td>
    <td style="text-align:right"><a href="#PS4_integixAnchor">S-<span style="font-family:Times New Roman, Times, Serif;font-size:10pt">6</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#PS5_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CAPITALIZATION</span></a></td>
    <td style="text-align:right"><a href="#PS5_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">S-7</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#PS6_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PRICE RANGE OF COMMON SHARES</span></a></td>
    <td style="text-align:right"><a href="#PS6_integixAnchor">S-<span style="font-family:Times New Roman, Times, Serif;font-size:10pt">7</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#PS7_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PLAN OF DISTRIBUTION</span></a></td>
    <td style="text-align:right"><a href="#PS7_integixAnchor">S-<span style="font-family:Times New Roman, Times, Serif;font-size:10pt">8</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#PS8_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">LEGAL MATTERS</span></a></td>
    <td style="text-align:right"><a href="#PS8_integixAnchor">S-<span style="font-family:Times New Roman, Times, Serif;font-size:10pt">9</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#PS9_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">ADDITIONAL INFORMATION</span></a></td>
    <td style="text-align:right"><a href="#PS9_integixAnchor">S-<span style="font-family:Times New Roman, Times, Serif;font-size:10pt">9</span></a></td>
        </tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span>&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Prospectus</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:90%"><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PROSPECTUS SUMMARY</span></a></td>
    <td style="width:10%;text-align:right"><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">5</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUMMARY OF FUND EXPENSES</span></a></td>
    <td style="text-align:right"><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">9</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">FINANCIAL HIGHLIGHTS</span></a></td>
    <td style="text-align:right"><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">11</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">USE OF PROCEEDS</span></a></td>
    <td style="text-align:right"><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND</span></a></td>
    <td style="text-align:right"><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DESCRIPTION OF SHARES</span></a></td>
    <td style="text-align:right"><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND&#8217;S INVESTMENTS</span></a></td>
    <td style="text-align:right"><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">14</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">LEVERAGE</span></a></td>
    <td style="text-align:right"><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">21</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RISKS</span></a></td>
    <td style="text-align:right"><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">24</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">HOW THE FUND MANAGES RISK</span></a></td>
    <td style="text-align:right"><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">MANAGEMENT OF THE FUND</span></a></td>
    <td style="text-align:right"><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">NET ASSET VALUE</span></a></td>
    <td style="text-align:right"><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">27</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DISTRIBUTIONS</span></a></td>
    <td style="text-align:right"><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">29</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DIVIDEND REINVESTMENT PLAN</span></a></td>
    <td style="text-align:right"><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RIGHTS OFFERINGS</span></a></td>
    <td style="text-align:right"><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAX MATTERS</span></a></td>
    <td style="text-align:right"><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">31</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAXATION OF HOLDERS OF RIGHTS</span></a></td>
    <td style="text-align:right"><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">37</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CERTAIN PROVISIONS IN THE CHARTER
        AND BYLAWS</span></a></td>
    <td style="text-align:right"><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">38</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CLOSED-END FUND STRUCTURE</span></a></td>
    <td style="text-align:right"><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">41</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">REPURCHASE OF COMMON SHARES</span></a></td>
    <td style="text-align:right"><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PLAN OF DISTRIBUTION</span></a></td>
    <td style="text-align:right"><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td>
        </tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">INCORPORATION BY REFERENCE</span></a></td>
    <td style="text-align:right"><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td>
        </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PRIVACY PRINCIPLES OF THE FUND</span></a></td>
    <td style="text-align:right"><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td>
        </tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;<span style="font-size:10pt">&#160;&#160;</span></p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">S-3</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="PS1_integixAnchor"></span><span style="font-size:10pt"><strong>CAUTIONARY
NOTICE REGARDING FORWARD-LOOKING STATEMENTS</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">This Prospectus Supplement,
the accompanying Prospectus and the SAI contain &#8220;forward-looking statements.&#8221; Forward-looking statements can be identified
by the words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221;
&#8220;continue,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; and similar terms and the negative of such terms. Such forward-looking
statements may be contained in this Prospectus Supplement, as well as in the accompanying Prospectus. By their nature, all forward-looking
statements involve risks and uncertainties, and actual results could differ materially from those contemplated by the forward-looking
statements. Several factors that could materially affect our actual results are the performance of the portfolio of securities we hold,
the price at which our shares will trade in the public markets and other factors discussed in our periodic filings with the SEC.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Although we believe that
the expectations expressed in our forward-looking statements are reasonable, actual results could differ materially from those projected
or assumed in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking
statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risks&#8221;
section of the accompanying Prospectus. All forward-looking statements contained or incorporated by reference in this Prospectus Supplement
or the accompanying Prospectus are made as of the date of this Prospectus Supplement or the accompanying Prospectus, as the case may be.
Except for our ongoing obligations under the federal securities laws, we do not intend, and we undertake no obligation, to update any
forward-looking statement. The forward-looking statements contained in this Prospectus Supplement, the accompanying Prospectus and the
SAI are excluded from the safe harbor protection provided by Section&#160;27A of the Securities Act.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Currently known risk factors
that could cause actual results to differ materially from our expectations include, but are not limited to, the factors described in the
&#8220;Risks&#8221; section of the accompanying Prospectus. We urge you to review carefully those sections for a more detailed discussion
of the risks of an investment in our common shares.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong><span id="PS2_integixAnchor"></span>PROSPECTUS
SUPPLEMENT SUMMARY</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The following summary
is qualified in its entirety by reference to the more detailed information included elsewhere in this Prospectus Supplement and in the
accompanying Prospectus and in the SAI.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"><strong>The Fund</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The Fund is a diversified,
closed-end management investment company. The Fund&#8217;s investment objective is to seek an attractive risk-adjusted level of total
return, primarily through current income and, secondarily, through capital appreciation. The Fund is not intended as, and you should not
construe it to be, a complete investment program. There can be no assurance that the Fund&#8217;s investment objective will be achieved
or that the Fund&#8217;s investment program will be successful. The Fund&#8217;s common shares are listed for trading on the NYSE under
the symbol &#8220;ARDC.&#8221;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"><strong>Investment Adviser</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Ares Capital Management
II LLC (previously defined as the &#8220;Adviser&#8221;) is the Fund&#8217;s investment adviser. The Adviser receives a management fee
at an annual rate of 1.00% of the average daily value of the Fund's total assets (including any assets attributable to any preferred shares
or to indebtedness) minus the Fund's liabilities other than liabilities relating to indebtedness (&#8220;Managed Assets&#8221;).</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"><strong>The Offering</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The Fund has entered into
the Distribution Agreement with the Distributor to provide for distribution of the Fund&#8217;s common shares. The Distributor has entered
into the Sub-Placement Agent Agreement with the Sub-Placement Agent with respect to the Fund relating to the common shares offered by
this Prospectus Supplement and the accompanying Prospectus. In accordance with the terms of the Sub-Placement Agent Agreement, the Fund
may offer and sell its common shares from time to time through the Sub-Placement Agent as sub-placement agent for the offer and sale of
its common shares. The Fund will compensate the Distributor with respect to sales of common shares at a commission rate of 1.00% of the
gross proceeds of the sale of the Fund&#8217;s common shares. Out of this commission, the Distributor will compensate the Sub-Placement
Agent at a rate of up to 0.80% of the gross sales proceeds of the sale of the Fund&#8217;s common shares sold by the Sub-Placement Agent.
The Adviser may agree to waive a portion of its advisory fee from time to time corresponding to the amount of commission received by the
Distributor and not paid to the Sub-Placement Agent.</span><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">S-4</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The provisions of the
Investment Company Act generally require that the public offering price of common shares (less any underwriting commissions and discounts)
must equal or exceed the NAV per share of a company&#8217;s common shares (calculated within 48 hours of pricing).</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Sales of our common shares,
if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or transactions that are
deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act, including sales made directly on the NYSE
or sales made to or through a market maker other than on an exchange.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"><strong>Use of Proceeds</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">We
currently anticipate that we will be able to invest all of the net proceeds of any sales of common shares pursuant to this Prospectus
Supplement in accordance with our investment objective and policies as described in the accompanying Prospectus under &#8220;The Fund&#8217;s
Investments&#8221; within approximately three months of the receipt of such proceeds</span><span style="font-size:10pt">; however, the
identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market conditions could
result in the Fund&#8217;s anticipated investment period extending to as long as six months. Pending such investment, it is anticipated
that the proceeds will be invested in short-term investment grade securities or in high quality, short-term money market instruments.
Depending on market conditions and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering,
may be used to pay distributions in accordance with the Fund&#8217;s distribution policy and may be a return of capital.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong><span id="PS3_integixAnchor"></span>SUMMARY
OF FUND EXPENSES</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p> <ix:nonNumeric id="Fxbrl_20240830180654210" name="cef:PurposeOfFeeTableNoteTextBlock" contextRef="C_20240830to20240830" escape="true">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The following table and
example are intended to assist you in understanding the various costs and expenses directly or indirectly associated with investing in
our common shares.</span></p> </ix:nonNumeric>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p> <ix:nonNumeric id="Fxbrl_20240830175521162" name="cef:ShareholderTransactionExpensesTableTextBlock" contextRef="C_20240830to20240830" continuedAt="F20240830180631532" escape="true">


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:bold 10pt Times New Roman, Times, Serif">Shareholder Transaction Expenses</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;width:88%;text-align:left">Sales load paid by you (<ix:nonNumeric id="Fxbrl_20240830180724459" name="cef:BasisOfTransactionFeesNoteTextBlock" contextRef="C_20240830to20240830" escape="true"><span style="font-size:10pt;font-family:Times New Roman">as
        a percentage of offering price</span></ix:nonNumeric>)</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"><ix:nonFraction id="Fxbrl_20240830180153949" name="cef:SalesLoadPercent" contextRef="C_20240830to20240830" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.00</ix:nonFraction></td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Offering expenses borne by the Fund (as a percentage
        of offering price) (1)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240830180159779" name="cef:OtherTransactionExpensesPercent" contextRef="C_20240830to20240830" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.17</ix:nonFraction></td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Dividend reinvestment plan fees(2)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><ix:nonFraction id="Fxbrl_20240830180202468" name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="C_20240830to20240830" unitRef="USD" scale="0" decimals="0" format="ixt-sec:numwordsen">None</ix:nonFraction></span></td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td> </tr>
  </table> </ix:nonNumeric>


<div style="display:none"> <ix:continuation id="F20240830180631532" continuedAt="F20240830175552954">


<div>&#160;</div> </ix:continuation> </div> <ix:nonNumeric id="Fxbrl_20240830175537024" name="cef:AnnualExpensesTableTextBlock" contextRef="C_20240830to20240830" continuedAt="F20240830183912994" escape="true">


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:bold 10pt Times New Roman, Times, serif;text-align:left;width:88%">Annual Expenses (as a percentage of net assets attributable
        to common shares)</td>
    <td style="font-size:10pt;width:1%">&#160;</td>
    <td style="font-size:10pt;text-align:right;width:10%">&#160;</td>
    <td style="font-size:10pt;text-align:left;width:1%">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Advisory Fees(3)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240830180256967" name="cef:ManagementFeesPercent" contextRef="C_20240830to20240830" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.67</ix:nonFraction></td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Interest payments on borrowed funds(4)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240830180259813" name="cef:InterestExpensesOnBorrowingsPercent" contextRef="C_20240830to20240830" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.56</ix:nonFraction></td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Other Expenses(5)</td>
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240830180302941" name="cef:OtherAnnualExpensesPercent" contextRef="C_20240830to20240830" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.76</ix:nonFraction></td>
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Total Annual Fund Operating Expenses</td>
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
    <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240830180306076" name="cef:TotalAnnualExpensesPercent" contextRef="C_20240830to20240830" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.99</ix:nonFraction></td>
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1.5pt;text-align:left">%</td> </tr>
  </table> </ix:nonNumeric>


<p style="margin-top:0;margin-bottom:0">&#160;</p>


<div style="margin-top:3pt;margin-bottom:3pt;width:25%">


<div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div> </div> <ix:continuation id="F20240830175552954">


<div>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;width:4%;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td>
    <td style="font-size:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The percentage reflects
        estimated offering expenses of approximately $250,000 for the estimated duration of this offering and assumes we sell all $150,000,000
        of common shares under this Prospectus Supplement and the accompanying Prospectus. There is no guarantee that there will be any sales
        of our common shares pursuant to this Prospectus Supplement and the accompanying Prospectus. Actual sales of the Fund's common shares
        under this Prospectus Supplement and the accompanying Prospectus, if any, may be less than as set forth under &#8220;Capitalization&#8221;
        below. In addition, the price per share of any such sale may be greater than or less than the price set forth under &#8220;Capitalization&#8221;
        below, depending on market price of the Fund's common shares at the time of any such sale.</span></td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify">&#160;</td>
    <td style="font-size:10pt;text-align:justify">&#160;</td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td>
    <td style="font-size:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The plan administrator's
        service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders
        with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or
        in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's
        open-market purchases in connection with the reinvestment of dividends and distributions.</span></td> </tr>
  </table> </div> </ix:continuation> <ix:continuation id="F20240830183912994">


<table cellpadding="0" cellspacing="0" style="width:100%">
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%">&#160;</td>
    <td style="font-size:10pt;text-align:justify;width:96%">&#160;</td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(3)</span></td>
    <td style="font-size:10pt;text-align:justify;width:96%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund currently
        pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders
        bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable
        to common shares than if the Fund did not use leverage.&#160;&#160;The advisory fee shown in the table assumes an <span>amount of leverage
        of </span>36<span>% of the Fund&#8217;s Managed Assets.&#160;&#160;Based on the same assumptions, leverage would equal </span>56<span>%
        of the Fund&#8217;s net assets.</span></span></td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%">&#160;</td>
    <td style="font-size:10pt;text-align:justify;width:96%">&#160;</td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(4)</span></td>
    <td style="font-size:10pt;text-align:justify;width:96%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Interest
        payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for the six months ended June&#160;30,
        2024.&#160;&#160;We had outstanding borrowings of approximately $190 million (with a carrying value of approximately $189) as of June&#160;30,
        2024. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at
        leverage of 36% of the Fund&#8217;s Managed Assets <span>and </span>56<span>% of the Fund&#8217;s net assets</span>) to those prior to
        such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s
        and the Board of Directors of the Fund's assessment of market and other factors at the time of any proposed borrowing. </span></td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%">&#160;</td>
    <td style="font-size:10pt;text-align:justify;width:96%">&#160;</td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(5)</span></td>
    <td style="font-size:10pt;text-align:justify;width:96%"> <ix:nonNumeric id="Fxbrl_20240830181905930" name="cef:OtherExpensesNoteTextBlock" contextRef="C_20240830to20240830" escape="true"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Other
        Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred
        by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221;
        are based on estimated amounts for the current fiscal year.</span></ix:nonNumeric> </td> </tr>
  </table> </ix:continuation>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">S-5</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;&#160;</span></p> <ix:nonNumeric id="Fxbrl_20240830175850525" name="cef:ExpenseExampleTableTextBlock" contextRef="C_20240830to20240830" escape="true">


<div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-size:10pt">The
following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (i)&#160;total annual
expenses of 4.99% of net assets attributable to common shares in 2024 and thereafter, and (ii)&#160;a 5% annual return:</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in">
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">One&#160;Year</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Three&#160;Years</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Five&#160;Years</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Ten&#160;Years</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Total expenses incurred</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240830180528618" name="cef:ExpenseExampleYear01" contextRef="C_20240830to20240830" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">62</ix:nonFraction></td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240830180534041" name="cef:ExpenseExampleYears1to3" contextRef="C_20240830to20240830" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">163</ix:nonFraction></td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240830180549809" name="cef:ExpenseExampleYears1to5" contextRef="C_20240830to20240830" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">264</ix:nonFraction></td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"><ix:nonFraction id="Fxbrl_20240830180553938" name="cef:ExpenseExampleYears1to10" contextRef="C_20240830to20240830" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">515</ix:nonFraction></td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td> </tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt"><strong>The example should
not be considered a representation of future expenses. The example assumes that the estimated &#8220;Other expenses&#8221; set forth in
the Estimated Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be
greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return
shown in the example.</strong></span></p> </div> </ix:nonNumeric>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong><span id="PS4_integixAnchor"></span>USE
OF PROCEEDS</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Sales of our common shares,
if any, under this Prospectus Supplement and the accompanying Prospectus may be made in negotiated transactions or transactions that are
deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act, including sales made directly on the NYSE
or sales made to or through a market maker other than on an exchange. There is no guarantee that there will be any sales of our common
shares pursuant to this Prospectus Supplement and the accompanying Prospectus. Assuming the sale of all of the common shares offered under
this Prospectus Supplement and the accompanying Prospectus, we estimate that the net proceeds of this offering will be approximately $148
million after deducting the estimated sales load and the estimated offering expenses payable by the Fund, if any. This amount does not
reflect any waiver or reimbursement of the sales load received by the Distributor.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
net proceeds from the issuance of common shares hereunder will be invested in accordance with the Fund&#8217;s investment objective and
policies as set forth in this Prospectus Supplement and the accompanying Prospectus. We currently anticipate that we will be able to invest
all of the net proceeds in accordance with our investment objective and policies within approximately three months of the receipt of such
proceeds</span><span style="font-size:10pt">; however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s
investment style or changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long as
six months. Pending such investment, it is anticipated that the proceeds will be invested in short-term investment grade securities or
in high quality, short-term money market instruments. Depending on market conditions and operations, a portion of the cash held by the
Fund, including any proceeds raised from the offering, may be used to pay distributions in accordance with the Fund&#8217;s distribution
policy and may be a return of capital. A return of capital is a return to investors of a portion of their original investment in the Fund.
In general terms, a return of capital would involve a situation in which the Fund distribution (or a portion thereof) represents a return
of a portion of a shareholder&#8217;s investment in the Fund, rather than making a distribution that is funded from the Fund&#8217;s earned
income or other profits. Although return of capital distributions may not be currently taxable, such distributions would decrease the
basis of a shareholder&#8217;s shares, and therefore, may increase a shareholder&#8217;s tax liability for capital gains upon a sale of
shares, even if sold at a loss to the shareholder&#8217;s original investments.</span><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">S-6</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong><span id="PS5_integixAnchor"></span>CAPITALIZATION</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
Fund may offer and sell up to $150,000,000 of common shares, $0.001 par value per share, from time to time through the&#160;Sub-Placement&#160;Agent
as&#160;sub-placement&#160;agent under this Prospectus Supplement and the accompanying Prospectus. There is no guarantee that there will
be any sales of the Fund&#8217;s common shares pursuant to this Prospectus Supplement and the accompanying Prospectus. The table below
assumes that the Fund will sell $150,000,000 of common shares at a price of $</span><span style="font-size:10pt">15.29 per share (the
last reported price per share of the Fund&#8217;s common shares on the NYSE on August&#160;23, 2024). Actual sales, if any, of our common
shares under this Prospectus Supplement and the accompanying Prospectus may be less than as set forth below in this paragraph. In addition,
the price per share of any such sale may be greater or less than the price set forth in this paragraph, depending on the market price
of our common shares at the time of any such sale. As a result, the actual net proceeds we receive may be more or less than the amount
of net proceeds estimated in this Prospectus Supplement.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The Fund and the Distributor
will determine whether any sales of the Fund&#8217;s common shares will be authorized on a particular day; the Fund and the Distributor,
however, will not authorize sales of the Fund&#8217;s common shares if the per share price of the shares is less than the current NAV
per share plus the per share amount of the commission to be paid to the Distributor (the &#8220;Minimum Price&#8221;). The Fund and the
Distributor may also not authorize sales of the Fund&#8217;s common shares on a particular day even if the per share price of the shares
is equal to or greater than the Minimum Price, or may only authorize a fixed number of shares to be sold on any particular day. The Fund
and the Distributor will have full discretion regarding whether sales of Fund common shares will be authorized on a particular day and,
if so, in what amounts.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
following table sets forth the Fund&#8217;s capitalization (1)&#160;on a historical basis as of June&#160;30, 2024 (unaudited); and (2)&#160;on
a pro forma basis as adjusted to reflect the assumed sale of $150,000,000 of common shares at $</span><span style="font-size:10pt">15.29
per share (the last reported price per share of the Fund&#8217;s common shares on the NYSE on August&#160;23, 2024), in an offering under
this Prospectus Supplement and the accompanying Prospectus, after deducting the assumed commission of $1,500,000 (representing an estimated
commission to the Distributor of 1.00% of the gross proceeds of the sale of Fund common shares, out of which the Distributor will compensate
the&#160;Sub-Placement&#160;Agent at a rate of up to 0.80% of the gross sales proceeds of the sale of the Fund&#8217;s common shares sold
by the&#160;Sub-Placement&#160;Agent).</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p>


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in">
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">As&#160;of&#160;June
        30, 2024<br/>(unaudited)<br/>(in thousands)</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">As adjusted&#160;for<br/>offering<br/>(unaudited)<br/>(in
        thousands)</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;font-weight:bold;text-indent:-12pt;padding-left:12pt">Debt</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="width:68%;font-size:10pt;text-align:left;text-indent:-12pt;padding-left:12pt">Mandatory Redeemable Preferred Shares</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:13%;font-size:10pt;text-align:right">100,000</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:13%;font-size:10pt;text-align:right">100,000</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;padding-bottom:1pt;text-indent:-12pt;padding-left:12pt">Debt</td>
    <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
    <td style="border-bottom:Black 1pt solid;font-size:10pt;text-align:left">$</td>
    <td style="border-bottom:Black 1pt solid;font-size:10pt;text-align:right">89,604</td>
    <td style="padding-bottom:1pt;font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
    <td style="border-bottom:Black 1pt solid;font-size:10pt;text-align:left">$</td>
    <td style="border-bottom:Black 1pt solid;font-size:10pt;text-align:right">89,604</td>
    <td style="padding-bottom:1pt;font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-align:left;text-indent:-12pt;padding-left:12pt">Total Debt</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">189,604</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">189,604</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-12pt;padding-left:12pt">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;font-weight:bold;text-align:left;text-indent:-12pt;padding-left:12pt">Net Assets</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-align:left;text-indent:-12pt;padding-left:12pt">Paid in Capital</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">439,773</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">588,013</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-align:left;padding-bottom:1pt;text-indent:-12pt;padding-left:12pt">Accumulated Overdistributed Earnings</td>
    <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
    <td style="border-bottom:Black 1pt solid;font-size:10pt;text-align:left">$</td>
    <td style="border-bottom:Black 1pt solid;font-size:10pt;text-align:right">(102,653</td>
    <td style="padding-bottom:1pt;font-size:10pt;text-align:left">)</td>
    <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
    <td style="border-bottom:Black 1pt solid;font-size:10pt;text-align:left">$</td>
    <td style="border-bottom:Black 1pt solid;font-size:10pt;text-align:right">(102,653</td>
    <td style="padding-bottom:1pt;font-size:10pt;text-align:left">)</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-align:left;text-indent:-12pt;padding-left:12pt">Net Assets</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">337,120</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">485,360</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-12pt;padding-left:12pt">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-align:left;text-indent:-12pt;padding-left:12pt">Total Capitalization</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">526,724</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">674,964</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-12pt;padding-left:12pt">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-12pt;padding-left:12pt">Shares Outstanding</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">22,915</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">32,725</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-12pt;padding-left:12pt">NAV per common share</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.71</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.83</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span>&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span id="PS6_integixAnchor"></span><strong>PRICE
RANGE OF COMMON SHARES</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-size:10pt">The
following table sets forth, for the quarters indicated, the highest and lowest daily closing prices on the NYSE per common share, and
the NAV per common share and the premium to or discount from NAV, on the date of each of the high and low market prices. The table also
sets forth the number of common shares traded on the NYSE during the respective quarters.</span><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">S-7</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p> <ix:nonNumeric id="Fxbrl_20240830180020628" name="cef:SharePriceTableTextBlock" contextRef="C_20240830to20240830" escape="true">


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">
  <tr style="vertical-align:bottom">
    <td style="padding-bottom:1pt;vertical-align:bottom;font:10pt Times New Roman, Times, Serif;text-align:left">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>&#160;</strong></p> </td>
    <td style="padding-bottom:1pt">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">NYSE&#160;Market&#160;Price<br/>Per&#160;Common
        Share</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">NAV per Common<br/>Share on&#160;Date&#160;of<br/>Market&#160;Price</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="border-bottom:Black 1pt solid;padding-bottom:1pt;font-size:10pt;font-weight:bold;text-align:center">Premium/(Discount)&#160;on<br/>Date&#160;of<br/>Market&#160;Price</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font-size:10pt;font-weight:bold;text-align:center">Trading</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="padding-bottom:1pt;font-size:10pt"><strong>During Quarter Ended</strong></td>
    <td style="padding-bottom:1pt">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Volume</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:15%;font-size:10pt;text-indent:-10pt;padding-left:10pt">June 30, 2024</td>
    <td style="width:1%">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:9%;font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181013582" name="cef:HighestPriceOrBid" contextRef="C_20240401to20240630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.89</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:9%;font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181022795" name="cef:LowestPriceOrBid" contextRef="C_20240401to20240630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.79</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:9%;font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181026051" name="cef:HighestPriceOrBidNav" contextRef="C_20240401to20240630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.81</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:9%;font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181029025" name="cef:LowestPriceOrBidNav" contextRef="C_20240401to20240630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.50</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:9%;font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181032041" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240401to20240630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.54</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">%</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:9%;font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181035961" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240401to20240630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">4.90</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">)%</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:9%;font-size:10pt;text-align:right">5,985,800</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">March 31, 2024</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_4_3" name="cef:HighestPriceOrBid" contextRef="C_20240101to20240331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.29</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_8_3" name="cef:LowestPriceOrBid" contextRef="C_20240101to20240331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.41</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_12_3" name="cef:HighestPriceOrBidNav" contextRef="C_20240101to20240331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.69</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_16_3" name="cef:LowestPriceOrBidNav" contextRef="C_20240101to20240331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.46</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_20_3" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240101to20240331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">2.72</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_24_3" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240101to20240331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">7.26</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,951,700</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">December&#160;31, 2023</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_4_4" name="cef:HighestPriceOrBid" contextRef="C_20231001to20231231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.86</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_8_4" name="cef:LowestPriceOrBid" contextRef="C_20231001to20231231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.88</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_12_4" name="cef:HighestPriceOrBidNav" contextRef="C_20231001to20231231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.51</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_16_4" name="cef:LowestPriceOrBidNav" contextRef="C_20231001to20231231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.76</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_20_4" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20231001to20231231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">4.48</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_24_4" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20231001to20231231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">13.66</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,020,500</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">September&#160;30, 2023</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_4_5" name="cef:HighestPriceOrBid" contextRef="C_20230701to20230930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.93</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_8_5" name="cef:LowestPriceOrBid" contextRef="C_20230701to20230930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.10</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_12_5" name="cef:HighestPriceOrBidNav" contextRef="C_20230701to20230930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.25</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_16_5" name="cef:LowestPriceOrBidNav" contextRef="C_20230701to20230930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.75</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_20_5" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230701to20230930" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">9.26</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_24_5" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230701to20230930" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.00</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,500,400</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">June&#160;30, 2023</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_4_6" name="cef:HighestPriceOrBid" contextRef="C_20230401to20230630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.33</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_8_6" name="cef:LowestPriceOrBid" contextRef="C_20230401to20230630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.61</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_12_6" name="cef:HighestPriceOrBidNav" contextRef="C_20230401to20230630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.87</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_16_6" name="cef:LowestPriceOrBidNav" contextRef="C_20230401to20230630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.58</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_20_6" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230401to20230630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">11.10</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_24_6" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230401to20230630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">14.51</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,473,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">March&#160;31, 2023</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_4_7" name="cef:HighestPriceOrBid" contextRef="C_20230101to20230331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.85</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_8_7" name="cef:LowestPriceOrBid" contextRef="C_20230101to20230331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.42</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_12_7" name="cef:HighestPriceOrBidNav" contextRef="C_20230101to20230331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.12</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_16_7" name="cef:LowestPriceOrBidNav" contextRef="C_20230101to20230331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.37</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_20_7" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230101to20230331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">8.99</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_24_7" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230101to20230331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">14.58</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">7,627,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">December&#160;31, 2022</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_4_8" name="cef:HighestPriceOrBid" contextRef="C_20221001to20221231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.31</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_8_8" name="cef:LowestPriceOrBid" contextRef="C_20221001to20221231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.27</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_12_8" name="cef:HighestPriceOrBidNav" contextRef="C_20221001to20221231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.73</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_16_8" name="cef:LowestPriceOrBidNav" contextRef="C_20221001to20221231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.17</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_20_8" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20221001to20221231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">10.34</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_24_8" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20221001to20221231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">14.43</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,699,200</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">September&#160;30, 2022</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_4_9" name="cef:HighestPriceOrBid" contextRef="C_20220701to20220930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.45</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_8_9" name="cef:LowestPriceOrBid" contextRef="C_20220701to20220930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.65</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_12_9" name="cef:HighestPriceOrBidNav" contextRef="C_20220701to20220930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.77</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_16_9" name="cef:LowestPriceOrBidNav" contextRef="C_20220701to20220930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.33</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_20_9" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220701to20220930" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">8.94</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_24_9" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220701to20220930" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.60</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">4,773,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">June&#160;30, 2022</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_4_10" name="cef:HighestPriceOrBid" contextRef="C_20220401to20220630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.82</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_8_10" name="cef:LowestPriceOrBid" contextRef="C_20220401to20220630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.89</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_12_10" name="cef:HighestPriceOrBidNav" contextRef="C_20220401to20220630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">15.96</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_16_10" name="cef:LowestPriceOrBidNav" contextRef="C_20220401to20220630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.75</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_20_10" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220401to20220630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">7.14</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_24_10" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220401to20220630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">13.53</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,461,400</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">March&#160;31, 2022</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_4_11" name="cef:HighestPriceOrBid" contextRef="C_20220101to20220331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">16.37</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_8_11" name="cef:LowestPriceOrBid" contextRef="C_20220101to20220331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.61</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_12_11" name="cef:HighestPriceOrBidNav" contextRef="C_20220101to20220331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">16.71</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830181153539_16_11" name="cef:LowestPriceOrBidNav" contextRef="C_20220101to20220331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">15.56</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830181153539_20_11" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220101to20220331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">2.03</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<span style="font-size:10pt;font-family:Times New Roman"><ix:nonFraction id="Fxbrl_20240830181153539_24_11" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220101to20220331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.53</ix:nonFraction></span></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,201,000</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  </table> </ix:nonNumeric>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">As
of August&#160;</span><span style="font-size:10pt">23, 2024, the NAV per common share of the Fund was $<ix:nonFraction id="Fxbrl_20240830184026160" name="us-gaap:NetAssetValuePerShare" contextRef="C_20240823" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.72</ix:nonFraction>
and the market price per common share was $<ix:nonFraction id="Fxbrl_20240830184032957" name="us-gaap:SharePrice" contextRef="C_20240823" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">15.29</ix:nonFraction>,
representing a premium to NAV of <ix:nonFraction id="Fxbrl_20240830184048799" name="cef:LatestPremiumDiscountToNavPercent" contextRef="C_20240823to20240823" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.87</ix:nonFraction>%.
Common shares of the Fund have periodically traded at a premium and discount to NAV.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">As
of </span><span style="font-size:10pt">August&#160;23, 2024, the Fund had outstanding 22,915,000 common shares.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong><span id="PS7_integixAnchor"></span>PLAN
OF DISTRIBUTION</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Under the&#160;Sub-Placement&#160;Agent
Agreement, upon instructions from the Distributor, the&#160;Sub-Placement&#160;Agent will use its reasonable best efforts to sell, as&#160;sub-placement&#160;agent,
common shares under the terms and subject to the conditions set forth in the&#160;Sub-Placement&#160;Agent Agreement. The Distributor
will instruct the&#160;Sub-Placement&#160;Agent as to the amount of Fund common shares authorized for sale by the&#160;Sub-Placement&#160;Agent
on any particular day that the NYSE is open for trading. The Distributor will also instruct the&#160;Sub-Placement&#160;Agent not to sell
Fund common shares if the sales cannot be effected at or above a price designated by the Distributor, which price will at least be equal
to the Minimum Price and which price, may, in the discretion of the Distributor and the Fund, be above the Minimum Price. The Distributor
and the Fund may, in their discretion, determine not to authorize sales of the Fund&#8217;s common shares on a particular day even if
the per share price of the common shares is equal to or greater than the Minimum Price. The Fund and the Distributor will have full discretion
regarding whether sales of common shares will be authorized on a particular day and, if so, in what amounts. The Fund, the Distributor
or the&#160;Sub-Placement&#160;Agent may suspend a previously authorized offering of common shares upon proper notice and subject to other
conditions.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The&#160;Sub-Placement&#160;Agent
will provide written confirmation to the Distributor following the close of trading on a day on which common shares are sold under the&#160;Sub-Placement&#160;Agent
Agreement. Each confirmation will include the number of shares sold, the net proceeds to the Fund and the compensation the&#160;Sub-Placement&#160;Agent
is owed in connection with the sales.</span><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">S-8</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The Fund will compensate
the Distributor with respect to sales of common shares at a commission rate of 1.00% of the gross proceeds of the sale of the common shares.
Out of this commission, the Distributor will compensate the&#160;Sub-Placement&#160;Agent at a rate of up to 0.80% of the gross sales
proceeds of the sale of the common shares sold by the&#160;Sub-Placement&#160;Agent. There is no guarantee that there will be any sales
of the common shares pursuant to this Prospectus Supplement and the accompanying Prospectus. Actual sales, if any, of the common shares
under this Prospectus Supplement and the accompanying Prospectus may be greater or less than the most recent market price set forth in
this Prospectus Supplement, depending on the market price of the common shares at the time of any such sale; provided, however, that sales
will not be made at less than the Minimum Price.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Settlements of sales of
common shares are expected to occur on the next business day following the date on which any such sales are made, in return for payment
of the net proceeds to the Fund. There is no arrangement for funds to be deposited in escrow, trust or similar arrangement.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">In
connection with the sale of common shares on behalf of the Fund, the Distributor may be deemed to be an underwriter within the meaning
of the Securities Act, and the compensation of the Distributor may be deemed to be underwriting commissions or discounts. The Adviser
may agree to waive a portion of its advisory fee from time to time corresponding to the amount of commission received by the Distributor
and not paid to the Sub-Placement Agent.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The offering of the Fund&#8217;s
common shares pursuant to the Distribution Agreement will terminate upon the earlier of (i)&#160;the sale of all common shares subject
thereto or (ii)&#160;termination of the Distribution Agreement. The Fund and the Distributor each have the right to terminate the Distribution
Agreement in its discretion upon advance notice to the other party.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The Fund has agreed to
indemnify the Distributor and hold the Distributor harmless against certain liabilities, including certain liabilities under the Securities
Act, except for any liability to the Fund or its investors to which the Distributor would otherwise be subject by reason of willful misfeasance,
bad faith or gross negligence in the performance of its duties or by its reckless disregard of its obligations and duties under its agreement
with the Fund.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">The common shares may
not be sold through the Distributor or the Sub-Placement Agent without delivery or deemed delivery of this Prospectus Supplement and the
accompanying Prospectus describing the method and terms of the offering of the common shares.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">The Sub-Placement Agent,
its affiliates or their respective employees hold or may hold in the future, directly or indirectly, investment interests in the Fund.
The interests held by the Sub-Placement Agent, its affiliates or their respective employees are not attributable to, and no investment
discretion is held by, the Sub-Placement Agent, its affiliates or their respective affiliates.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">The principal business
address of Ares Management Capital Markets LLC is 1800 Avenue of the Stars, Suite 1400, Los Angeles, California 90067. The principal business
address of UBS Securities LLC is 1285 Avenue of the Americas, New York, New York 10019.&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><span id="PS8_integixAnchor"></span><strong>LEGAL
MATTERS</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">Certain legal matters
in connection with the common shares will be passed upon for the Fund by Willkie Farr&#160;&amp; Gallagher LLP, New York, New York, counsel
to the Fund. Willkie Farr&#160;&amp; Gallagher LLP may rely as to certain matters of Maryland law on the opinion of Venable LLP, Baltimore,
Maryland.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><span id="PS9_integixAnchor"></span><strong>ADDITIONAL
INFORMATION</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">This Prospectus Supplement
and the accompanying Prospectus constitute part of a Registration Statement filed by the Fund with the SEC under the Securities Act and
the Investment Company Act. This Prospectus Supplement and the accompanying Prospectus omit certain of the information contained in the
Registration Statement, and reference is hereby made to the Registration Statement and related exhibits for further information with respect
to the Fund and the common shares offered hereby. Any statements contained herein concerning the provisions of any document are not necessarily
complete, and, in each instance, reference is made to the copy of such document filed as an exhibit to the Registration Statement or otherwise
filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration Statement may be obtained
from the SEC upon payment of the fee prescribed by its rules&#160;and regulations or free of charge through the SEC&#8217;s website (<span style="text-decoration:underline">http://www.sec.gov</span>).</span><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt"></span></p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">S-9</p> </div> </div>


<div style="font:10pt Times New Roman, Times, Serif">



<div style="Page-Break-Before:Always"></div> </div>
<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong><span style="font-size:10pt"><span style="text-decoration:underline">BASE
PROSPECTUS</span></span></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Up to $500,000,000
of Common Stock</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Ares Dynamic Credit
Allocation Fund,&#160;Inc.</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Common Shares</strong>&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Rights to Purchase
Common Shares</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-size:10pt">Ares
Dynamic Credit Allocation Fund,&#160;Inc. (the &#8220;Fund,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is a diversified,
closed-end management investment company. The Fund&#8217;s investment objective is to seek an attractive risk-adjusted level of total
return, primarily through current income and, secondarily, through capital appreciation.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-size:10pt">We may
offer, from time to time, in one or more offerings, up</span> to $500,000,000 of our common stock, par value $0.001 per share (&#8220;common
shares&#8221; and the holders thereof, &#8220;common shareholders&#8221;). We may also offer subscription rights to purchase our common
shares. Common shares may be offered at prices and on terms to be set forth in one or more supplements to this Prospectus (each, a &#8220;Prospectus
Supplement&#8221;). You should read this Prospectus and the applicable Prospectus Supplement carefully before you invest in our common
shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Our common shares may be offered
directly to one or more purchasers, including through a rights offering, through agents designated from time to time by us, or to or through
underwriters or dealers. The Prospectus Supplement relating to the offering will identify any agents or underwriters involved in the sale
of our common shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between us and our agents
or underwriters, or among our underwriters, or the basis upon which such amount may be calculated. The Prospectus Supplement relating
to any offering of rights will set forth the number of common shares issuable upon the exercise of each right (or number of rights) and
the other terms of such rights offering. We may not sell any of our common shares through agents, underwriters or dealers without delivery
of a Prospectus Supplement describing the method and terms of the particular offering of our common shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Our common shares are listed on the
New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;ARDC.&#8221; The last reported sale price of our common shares, as
reported by the NYSE on August 6, 2024, was $15.09 per common share. The net asset value of our common shares at the close of business
on August 6, 2024 was $14.65 per common share. Rights issued by the Fund may also be listed on a securities exchange.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>Investing in the Fund&#8217;s
common shares involves certain risks that are described in the &#8220;Risks&#8221; section beginning on page&#160;25 of this Prospectus.</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>Shares of closed-end management
investment companies frequently trade at a discount to their net asset value. The Fund&#8217;s common shares have traded at a discount
to net asset value, including during recent periods. If the Fund&#8217;s common shares trade at a discount to its net asset value, the
risk of loss may increase for purchasers in a public offering.</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>Neither the Securities and
Exchange Commission (&#8220;SEC&#8221;) nor any state securities commission has approved or disapproved these securities or passed upon
the adequacy of this Prospectus. Any representation to the contrary is a criminal offense.</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">This Prospectus, together with any
Prospectus Supplement, sets forth concisely the information about the Fund that a prospective investor should know before investing. You
should read this Prospectus and applicable Prospectus Supplement, which contain important information, before deciding whether to invest
in the common shares. You should retain the Prospectus and Prospectus Supplement for future reference. A Statement of Additional Information
(&#8220;SAI&#8221;), dated August 26, 2024, containing additional information about the Fund, has been filed with the SEC and, as amended
from time to time, is incorporated by reference in its entirety into this Prospectus. You may call (888) 818-5298, visit the Fund&#8217;s
website (www.arespublicfunds.com) or write to the Fund to obtain, free of charge, copies of the SAI, the Fund&#8217;s proxy voting record
and the Fund&#8217;s semi-annual and annual reports, as well as to obtain other information about the Fund or to make shareholder inquiries.
The SAI, as well as the Fund&#8217;s semi-annual and annual reports, are also available for free on the SEC&#8217;s website (http://www.sec.gov).
You may also e-mail requests for these documents to publicinfo@sec.gov. Information contained in, or that can be accessed through, the
Fund&#8217;s website is not part of this Prospectus.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">2&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">You should not construe the contents
of this Prospectus as legal, tax or financial advice. You should consult with your own professional advisers as to the legal, tax, financial
or other matters relevant to the suitability of an investment in the Fund.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>The Fund&#8217;s common shares
do not represent a deposit or an obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution,
and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Prospectus dated August 26, 2024</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">3&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>TABLE OF CONTENTS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:90%"><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PROSPECTUS SUMMARY</span></a></td>
    <td style="width:10%;text-align:right"><a href="#a_001_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">5</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">SUMMARY OF FUND EXPENSES</span></a></td>
    <td style="text-align:right"><a href="#a_003_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">9</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">FINANCIAL HIGHLIGHTS</span></a></td>
    <td style="text-align:right"><a href="#a_004_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">11</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">USE OF PROCEEDS</span></a></td>
    <td style="text-align:right"><a href="#a_005_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND</span></a></td>
    <td style="text-align:right"><a href="#a_006_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DESCRIPTION OF SHARES</span></a></td>
    <td style="text-align:right"><a href="#a_007_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">12</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">THE FUND&#8217;S INVESTMENTS</span></a></td>
    <td style="text-align:right"><a href="#a_008_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">14</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">LEVERAGE</span></a></td>
    <td style="text-align:right"><a href="#a_009_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">21</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RISKS</span></a></td>
    <td style="text-align:right"><a href="#a_010_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">24</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">HOW THE FUND MANAGES RISK</span></a></td>
    <td style="text-align:right"><a href="#a_011_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">MANAGEMENT OF THE FUND</span></a></td>
    <td style="text-align:right"><a href="#a_012_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">25</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">NET ASSET VALUE</span></a></td>
    <td style="text-align:right"><a href="#a_013_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">27</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DISTRIBUTIONS</span></a></td>
    <td style="text-align:right"><a href="#a_014_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">29</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">DIVIDEND REINVESTMENT PLAN</span></a></td>
    <td style="text-align:right"><a href="#a_015_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">RIGHTS OFFERINGS</span></a></td>
    <td style="text-align:right"><a href="#a_016_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">30</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAX MATTERS</span></a></td>
    <td style="text-align:right"><a href="#a_017_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">31</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">TAXATION OF HOLDERS OF RIGHTS</span></a></td>
    <td style="text-align:right"><a href="#a_018_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">37</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CERTAIN PROVISIONS IN THE CHARTER
        AND BYLAWS</span></a></td>
    <td style="text-align:right"><a href="#a_019_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">38</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">CLOSED-END FUND STRUCTURE</span></a></td>
    <td style="text-align:right"><a href="#a_020_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">41</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">REPURCHASE OF COMMON SHARES</span></a></td>
    <td style="text-align:right"><a href="#a_021_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PLAN OF DISTRIBUTION</span></a></td>
    <td style="text-align:right"><a href="#a_022_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">42</span></a></td></tr>
  <tr style="vertical-align:bottom">
    <td><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">INCORPORATION BY REFERENCE</span></a></td>
    <td style="text-align:right"><a href="#a_023_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">PRIVACY PRINCIPLES OF THE FUND</span></a></td>
    <td style="text-align:right"><a href="#a_024_integixAnchor"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">44</span></a></td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>You should rely only on the information contained
in, or incorporated by reference into, this Prospectus and any related Prospectus Supplement in making your investment decisions. The
Fund has not authorized any person to provide you with different information. If anyone provides you with different or inconsistent information,
you should not rely on it. The Fund is not making an offer to sell the common shares in any jurisdiction where the offer or sale is not
permitted. You should assume that the information in this Prospectus and any Prospectus Supplement is accurate only as of the dates on
their covers. The Fund&#8217;s business, financial condition and prospects may have changed since the date of its description in this
Prospectus or the date of its description in any Prospectus Supplement.</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">4&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="padding-right:10pt;padding-left:10pt;border:Black 1pt solid">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_001_integixAnchor"></span><strong>PROSPECTUS
SUMMARY</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><i>This is only a summary of certain
information relating to Ares Dynamic Credit Allocation Fund,&#160;Inc. This summary may not contain all of the information that you should
consider before investing in our common shares. You should consider the more detailed information contained in the Prospectus and in any
related Prospectus Supplement and in the Statement of Additional Information (&#8220;SAI&#8221;) before purchasing common shares.</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse">
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;width:25%;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>The
        Fund</strong></span></td>
    <td style="padding-bottom:10pt;width:75%;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Ares
        Dynamic Credit Allocation Fund,&#160;Inc. is a diversified, closed-end management investment company. Throughout this Prospectus, we refer
        to Ares Dynamic Credit Allocation Fund,&#160;Inc. simply as the &#8220;Fund&#8221; or as &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our.&#8221;
        See &#8220;The Fund.&#8221;</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
        Fund&#8217;s common shares are listed for trading on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;ARDC.&#8221;
        As of August 6, 2024 the net assets of the Fund were $335,600,000, the total assets of the Fund were $561,700,000 and the Fund had outstanding
        22,915,000 common shares. The last reported sale price of the Fund&#8217;s common shares, as reported by the NYSE on August 6, 2024 was
        $15.09 per common share. The net asset value (&#8220;NAV&#8221;) of the Fund&#8217;s common shares at the close of business on August
        6, 2024 was $14.65 per common share. See &#8220;Description of Shares.&#8221; Rights issued by the Fund may also be listed on a securities
        exchange.</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>The
        Offering</strong></span></td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">We
        may offer, from time to time, in one or more offerings, up to $500,000,000 of our common shares on terms to be determined at the time
        of the offering. We may also offer subscription rights to purchase our common shares. The common shares may be offered at prices and on
        terms to be set forth in one or more Prospectus Supplements. You should read this Prospectus and the applicable Prospectus Supplement
        carefully before you invest in our common shares. Our common shares may be offered directly to one or more purchasers, through agents
        designated from time to time by us, or to or through underwriters or dealers. The offering price per common share will not be less than
        the NAV per common share at the time we make the offering, exclusive of any underwriting commissions or discounts, provided that rights
        offerings that meet certain conditions may offer common shares at a price below the then current NAV. See &#8220;Rights Offerings.&#8221;
        The Prospectus Supplement relating to the offering will identify any agents, underwriters or dealers involved in the sale of our common
        shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between us and our agents or underwriters,
        or among our underwriters, or the basis upon which such amount may be calculated. See &#8220;Plan of Distribution.&#8221; The Prospectus
        Supplement relating to any offering of rights will set forth the number of common shares issuable upon the exercise of each right (or
        number of rights) and the other terms of such rights offering. </span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Use
        of Proceeds</strong></span></td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
        net proceeds from the issuance of common shares hereunder will be invested in accordance with our investment objective and policies as
        appropriate investment opportunities are identified, which is expected to be substantially completed in approximately three months from
        the date on which the proceeds from an offering are received by the Fund; however, the identification of appropriate investment opportunities
        pursuant to the Fund&#8217;s investment style or changes in market conditions could result in the Fund&#8217;s anticipated investment
        period extending to as long as six months. See &#8220;Use of Proceeds.&#8221;</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Investment
        Objective and Policies</strong></span></td>
    <td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please
        refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section
        of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective,
        Policies and Risks,&#8221;</a></span> <span>which is incorporated by reference herein, for a discussion of the Fund&#8217;s investment
        objective and policies.</span></td></tr>
  </table>


<p style="margin:0">&#160;</p></div>


<p style="margin:0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">5&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="margin:0">&#160;</p>


<div style="padding-right:10pt;padding-left:10pt;border:Black 1pt solid">


<p style="margin:0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse">
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:25%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Leverage</strong></span></td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify;width:75%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
        Fund is authorized to utilize leverage to the maximum extent permitted by law for investment and other general corporate purposes. The
        Fund currently utilizes leverage through the issuance of its preferred stock, par value $0.001 per share (the &#8220;preferred shares&#8221;),
        and bank borrowings and may obtain additional leverage in the future by issuing preferred shares and/or notes and borrowing funds from
        banks and other financial institutions. The Fund may also gain leverage synthetically through swaps and other derivatives. The use of
        leverage to purchase additional securities creates an opportunity for increased common share dividends, but also creates risks for the
        common shareholders, including increased variability of the Fund&#8217;s net income, distributions, net asset value and/or market price
        of its common shares in relation to market changes. Leverage is a speculative technique that exposes the Fund to greater risk and increased
        costs than if it were not implemented. Increases and decreases in the value of the Fund&#8217;s portfolio will be magnified through the
        use of leverage. The Fund pays dividends on its preferred shares and interest on borrowings, which increases expenses and may reduce the
        Fund&#8217;s return. These dividend payments and interest expenses (which are borne entirely by common shareholders) may be greater than
        the Fund&#8217;s return on the underlying investments. </span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund will pay (and common shareholders will bear)
        all costs and expenses relating to the issuance and ongoing maintenance of preferred shares and other forms of indebtedness issued by
        the Fund, including higher advisory fees. As a result, the Fund cannot assure you that the issuance of preferred shares and/or notes or
        other forms of indebtedness will provide a higher yield or return to the holders of the common shares. The costs of any new offers and/or
        issuances of preferred shares and/or notes or other forms of indebtedness will be borne immediately by the common shareholders and result
        in a reduction of the net asset value of the common shares.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">So long as the Fund&#8217;s portfolio provides a higher
        rate of return, net of expenses, than the interest or dividend rate on borrowed money, the leverage may cause common shareholders to receive
        a higher current rate of return than if the Fund were not leveraged. If, however, long-term and/or short-term rates rise, the interest
        rate on borrowed money could exceed the rate of return on securities held by the Fund, reducing returns to common shareholders. Developments
        in the credit markets may adversely affect the ability of the Fund to borrow for investment purposes and may increase the costs of such
        borrowings, which would reduce returns to common shareholders.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">There is no assurance that a leveraging strategy will
        be successful. Leverage involves risks and special considerations for common shareholders.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
        preferred shares and indebtedness incurred by the Fund impose covenants and other restrictions imposed by its lenders are in addition
        to, and in certain cases more stringent than, those imposed by the </span>Investment Company Act of 1940, as amended, together with the
        rules&#160;and regulations promulgated thereunder (the &#8220;Investment Company Act&#8221;). Certain types of borrowings by the Fund
        may result in the Fund being subject to covenants relating to asset coverage and portfolio composition requirements. These covenants and
        restrictions may negatively affect the Fund&#8217;s ability to achieve its investment objective. See &#8220;Leverage.&#8221;</p></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Preferred
        Shares</strong></span></td>
    <td style="padding-right:5.4pt;padding-left:5.4pt">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Fund has authorized and issued 800,000 shares of
        Series&#160;A Mandatory Redeemable Preferred Stock, $0.001 par value per share (the &#8220;Series&#160;A MRP Shares&#8221;), for gross
        proceeds of $20 million, 1,200,000 shares of Series&#160;B Mandatory Redeemable Preferred Stock, $0.001 par value per share (the &#8220;Series&#160;B
        MRP Shares&#8221;), for gross proceeds of $30 million and 2,000,000 shares of Series&#160;C Mandatory Redeemable Preferred Stock, $0.001
        par value per share (the &#8220;Series&#160;C MRP Shares&#8221; and, together with the Series&#160;A MRP Shares and Series&#160;B MRP
        Shares, the &#8220;MRP Shares&#8221;), for gross proceeds of $50 million. Each of the MRP Shares has a liquidation preference of $25.00
        per share. The aggregate redemption amount of the MRP Shares is $100 million.</p></td></tr>
  </table>


<p style="margin:0">&#160;</p></div>


<p style="margin:0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">6&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="margin:0">&#160;</p>


<div style="padding-right:10pt;padding-left:10pt;border:Black 1pt solid">


<p style="margin:0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse">
  <tr style="vertical-align:top">
    <td style="width:25%">&#160;</td>
    <td style="padding-right:5.4pt;padding-left:5.4pt;width:75%">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The redemption dates for the Series&#160;A MRP Shares,
        Series&#160;B MRP Shares and Series&#160;C MRP Shares are July&#160;15, 2026, September&#160;15, 2026 and September&#160;15, 2028, respectively.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The Series&#160;A MRP Shares and the Series&#160;B
        MRP Shares have a dividend rate of 2.58% per annum, payable quarterly, with a redemption date of five years from issuance. The Series&#160;C
        MRP Shares have a dividend rate of 3.03% per annum, payable quarterly, with a redemption date of seven years from issuance. The MRP Shares
        are subject to optional and mandatory redemption in certain circumstances. The Fund may be obligated to redeem certain of the MRP Shares
        if the Fund fails to maintain an asset coverage ratio, calculated in accordance with the Investment Company Act, greater than or equal
        to 225%. The Fund is subject to certain restrictions relating to the preferred shares such as maintaining certain asset coverage ratio
        requirements. Failure to comply with these restrictions could preclude the Fund from declaring any dividend to common shareholders and
        could trigger the mandatory redemption of the MRP Shares. As of the date of this Prospectus, the Fund was in compliance in all material
        respects with the terms of the MRP Shares.</p></td></tr>
  </table>


<p style="margin:0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse">
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:25%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Credit
        Facility</strong></span></td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:75%">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span>Under the Investment Company Act, the Fund is
        permitted to incur indebtedness, including through the issuance of debt securities or borrowings from a bank, if immediately thereafter
        the Fund has asset coverage of at least 300%. In general, the term &#8220;asset coverage&#8221; for this purpose means the ratio which
        the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities, bears to the aggregate
        amount of senior securities representing indebtedness of the Fund.</span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span>&#160;</span></p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
        Fund is a party to a senior secured revolving credit facility (as amended, the &#8220;Credit Facility&#8221;), that allows the Fund to
        borrow up to $212 million at any one time outstanding. The Credit Facility is scheduled to terminate in 2026 unless extended. Under the
        Credit Facility, the Fund is required to comply with various covenants, reporting requirements and other customary requirements for similar
        revolving credit facilities, including, without limitation, covenants related to: (a)&#160;limitations on the incurrence of additional
        indebtedness, including additional mandatory redeemable preferred shares, and liens, (b)&#160;limitations on certain investments, (c)&#160;limitations
        on certain restricted payments, and (d)&#160;maintaining a ratio of total assets (less total liabilities other than senior securities
        representing indebtedness) to senior securities representing indebtedness plus the involuntary liquidation preference of the mandatory
        redeemable preferred shares of the Fund (subject to certain exceptions) of not less than 2:1.0. These covenants are subject to important
        limitations and exceptions that are described in the documents governing the Credit Facility. As of the date of this Prospectus, </span><span style="font-size:10pt">t</span>he
        Fund was in compliance in all material respects with the terms of the Credit Facility. See &#8220;Credit Facility.&#8221;</p></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Investment
        Adviser</strong></span></td>
    <td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
        Fund is externally managed by Ares Capital Management II LLC (the &#8220;Adviser&#8221;), a subsidiary of Ares Management Corporation
        (NYSE: ARES) (&#8220;Ares&#8221;), pursuant to an investment advisory and management agreement. The Adviser receives an annual fee of
        1.00% of the average daily value of the Fund&#8217;s total assets (including any assets attributable to any preferred shares or to indebtedness)
        minus the Fund&#8217;s liabilities other than liabilities relating to indebtedness (&#8220;Managed Assets&#8221;). See &#8220;Management
        of the Fund&#8212;Investment Adviser.&#8221;</span></td></tr>
  </table>


<p style="margin:0">&#160;</p></div>


<p style="margin:0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">7&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="margin:0">&#160;</p>


<div style="border:Black 1pt solid;padding-right:10pt;padding-left:10pt">


<p style="margin:0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="width:100%;font:10pt Times New Roman, Times, Serif;border-collapse:collapse">
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;width:25%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Distributions</strong></span></td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify;width:75%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
        Fund expects to distribute monthly all or a portion of its net investment income to common shareholders.</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
        Fund intends to pay common shareholders at least annually all or substantially all of its net investment income after the payment of dividends
        and interest, if any, owed with respect to any outstanding preferred shares and/or notes or other forms of leverage utilized by the Fund.
        The Fund intends to pay any capital gains distributions at least annually. If the Fund makes a long-term capital gain distribution, it
        will be required to allocate such gain between the common shares and any preferred shares issued by the Fund in proportion to the total
        dividends paid to each class for the year in which the income is realized. The U.S. federal income tax treatment and characterization
        of the Fund&#8217;s distributions may vary from time to time because of the varied nature of the Fund&#8217;s investments. Various factors
        will affect the level of the Fund&#8217;s income, including the asset mix, the average maturity of the Fund&#8217;s portfolio and default
        rates, the amount of leverage utilized by the Fund, if any, and any use of hedging activities by the Fund.</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">&#160;</td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The distributions for any full or partial year might
        not be made in equal amounts, and any one distribution may be larger than the other. The Fund will make a distribution only if authorized
        by the Board of Directors of the Fund (the &#8220;Board&#8221; and each member thereof, a &#8220;Director&#8221;) or by the officers of
        the Fund pursuant to delegated authority granted by the Board, and declared by the Fund out of assets legally available for these distributions.
        The Fund may pay a special distribution at the end of each fiscal year if necessary to maintain the Fund&#8217;s tax treatment as a registered
        investment company (&#8220;RIC&#8221;) and/or avoid the imposition of tax on the Fund. This distribution policy may, under certain circumstances,
        have certain adverse consequences to the Fund and its shareholders because it may result in a return of capital to shareholders, which
        would reduce the Fund&#8217;s net asset value and, over time, potentially increase the Fund&#8217;s expense ratio. If a distribution constitutes
        a return of capital, it means that the Fund is returning to shareholders a portion of their investment rather than making a distribution
        that is funded from the Fund&#8217;s earned income or other profits. The Board may elect to change the Fund&#8217;s distribution policy
        at any time.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Section&#160;19(b)&#160;of the Investment Company Act
        and Rule&#160;19b-1 thereunder generally limit the Fund to one long-term capital gain distribution per year, subject to certain exceptions.</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">&#160;</p>
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">Shareholders will automatically have all dividends
        and distributions reinvested in common shares of the Fund in accordance with the Fund&#8217;s dividend reinvestment plan, unless an election
        is made to receive cash by contacting the plan administrator, at (877) 272-8164. See &#8220;Dividend Reinvestment Plan.&#8221;</p></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Listing</strong></span></td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
        Fund&#8217;s common shares are listed on the NYSE under the symbol &#8220;ARDC.&#8221; See &#8220;Description of Shares&#8212;Common Shares.&#8221;</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Administrator,
        Custodian and Transfer Agent and Other Services</strong></span></td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">State
        Street Bank and Trust Company (&#8220;State Street&#8221;) serves as the Fund&#8217;s administrator and fund accountant, custodian and
        transfer agent. Destra Capital Advisors LLC (&#8220;Destra&#8221;) provides investor support services in connection with the ongoing operations
        of the Fund.</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Market
        Price of Shares</strong></span></td>
    <td style="padding-bottom:10pt;padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Common
        shares of closed-end investment companies frequently trade at prices lower than their NAV. The Fund cannot assure you that its common
        shares will trade at a price higher than or equal to NAV. See &#8220;Use of Proceeds.&#8221; The Fund&#8217;s common shares trade in the
        open market at market prices that are a function of several direct and indirect factors, including dividend levels (which are in turn
        affected by expenses), NAV, call protection for portfolio securities, portfolio credit quality, liquidity, dividend stability, relative
        demand for and supply of the common shares in the market, general market and economic conditions and other factors. See &#8220;Leverage,&#8221;
        &#8220;Risks,&#8221; &#8220;Description of Shares&#8221; and &#8220;Repurchase of Common Shares.&#8221; The common shares are designed
        primarily for long-term investors and you should not purchase common shares of the Fund if you intend to sell them shortly after purchase.</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-right:5.4pt;padding-left:5.4pt"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><strong>Special
        Risk Considerations</strong></span></td>
    <td style="padding-right:5.4pt;padding-left:5.4pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">An
        investment in common shares of the Fund involves risk. Please refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section
        of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective,
        Policies and Risks,&#8221;</a></span> <span>which is incorporated by reference herein, for a discussion of the risks of investing in the
        Fund. You should carefully consider those risks, which are described in more detail under &#8220;Risks&#8221; beginning on page&#160;</span>25
        <span>of this Prospectus.</span></td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">8&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify">The following table is intended to assist you in understanding
the costs and expenses that an investor in our common shares will bear, directly or indirectly, based on the assumptions set forth below.
We caution you that some of the percentages indicated in the table below are estimates and may vary. The table reflects the use of leverage
in the form of borrowings in an amount equal to 36% of the Fund&#8217;s Managed Assets (after the leverage is incurred), and shows Fund
expenses as a percentage of net assets attributable to common shares. The extent of the Fund&#8217;s assets attributable to leverage following
an offering, and the Fund&#8217;s associated expenses, are likely to vary (perhaps significantly) from these assumptions.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_003_integixAnchor"></span><strong>SUMMARY
OF FUND EXPENSES</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:bold 10pt Times New Roman, Times, Serif">Shareholder Transaction Expenses</td>
    <td style="font-size:10pt">&#160;</td>
    <td colspan="2" style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt">&#160;</td></tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Sales load paid by you (as a percentage of offering price)(1)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right">None</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Offering expenses borne by the Fund (as a percentage of offering price)(2)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right">None</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in">Dividend reinvestment plan fees(3)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font:10pt Times New Roman, Times, Serif;text-align:right">None</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:bold 10pt Times New Roman, Times, Serif">Annual Expenses (as a percentage of net assets attributable to common shares)</td>
    <td style="font-size:10pt;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font-size:10pt;text-align:right">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt">&#160;</td></tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;width:87%;padding-left:0.25in">Advisory Fees(4)</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">1.74</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:0.25in">Interest payments on borrowed funds(5)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">2.42</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;padding-left:0.25in">Other Expenses(6)</td>
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">0.80</td>
    <td style="padding-bottom:1pt;font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:0.375in">Total Annual Fund Operating Expenses</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="border-bottom:Black medium double;font:10pt Times New Roman, Times, Serif;text-align:right">4.96</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:3pt;margin-bottom:3pt;width:25%">


<div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div></div>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;width:4%;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td>
    <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">In the event that
        the securities to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose
        the applicable sales load (underwriting discount or commission). Purchases of common shares on the secondary market are not subject to
        sales charges but may be subject to brokerage commissions or other charges. The table does not include any sales load that shareholders
        may have paid in connection with their purchase of common shares. </span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td>
    <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The related prospectus
        supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by the Fund as
        a percentage of the offering price.</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(3)</span></td>
    <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The plan administrator&#8217;s
        service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders
        with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or
        in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator&#8217;s
        open-market purchases in connection with the reinvestment of dividends and distributions.</span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(4)</span></td>
    <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund currently
        pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund&#8217;s Managed Assets. Common shareholders
        bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable
        to common shares than if the Fund did not use leverage.&#160;&#160;The advisory fee shown in the table assumes an <span>amount of leverage
        of </span>36<span>% of the Fund&#8217;s Managed Assets.&#160;&#160;Based on the same assumptions, leverage would equal 55% of the Fund&#8217;s
        net assets. </span></span></td></tr>
  <tr style="vertical-align:top">
    <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(5)</span></td>
    <td style="padding-bottom:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Interest
        payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for fiscal year ended 2023.&#160;&#160;We
        had outstanding borrowings of approximately $163 million (with a carrying value of approximately $163 million) as of December&#160;31,
        2023. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at
        leverage of 36% of the Fund&#8217;s Managed Assets <span>and 55% of the Fund&#8217;s net assets</span>) to those prior to such offering.
        The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s and the
        Board&#8217;s assessment of market and other factors at the time of any proposed borrowing. See &#8220;Credit Facility.&#8221;</span></td></tr>
  <tr style="vertical-align:top">
    <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(6)</span></td>
    <td style="text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Other Expenses&#8221; includes
        our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC
        in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on
        estimated amounts for the current fiscal year.</span></td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (i)&#160;total annual
expenses of </span>4.96% of net assets attributable to common shares in 2023 and thereafter, and (ii)&#160;a 5% annual return:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">9&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">One&#160;Year</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Three&#160;Years</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Five&#160;Years</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Ten&#160;Years</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Total expenses incurred</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">51</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">152</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">254</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">506</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>The example should not be
considered a representation of future expenses. The example assumes that the estimated &#8220;Other expenses&#8221; set forth in the Estimated
Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be greater or less
than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the
example.</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">10&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_004_integixAnchor"></span><strong>FINANCIAL
HIGHLIGHTS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
audited financial statements and financial highlights included in the <span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">Annual
Report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 2023</a></span></span>, together with the report of
Ernst&#160;&amp; Young LLP for the Fund&#8217;s Annual Report are incorporated herein by reference.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">11&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_005_integixAnchor"></span></p></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>USE OF PROCEEDS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
net proceeds from the issuance of common shares hereunder will be invested in accordance with the Fund&#8217;s investment objective and
policies as stated below. We currently anticipate that we will be able to invest all of the net proceeds in accordance with our investment
objective and policies within approximately three months from the date on which the proceeds from an offering are received by the Fund</span>;
however, the identification of appropriate investment opportunities pursuant to the Fund&#8217;s investment style or changes in market
conditions could result in the Fund&#8217;s anticipated investment period extending to as long as six months. Pending such investment,
it is anticipated that the proceeds will be invested in short-term investment grade securities or in high quality, short-term money market
instruments<span>.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_006_integixAnchor"></span><strong>THE FUND</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is a diversified, closed-end
management investment company registered under the Investment Company Act. The Fund was organized as a Maryland corporation on March&#160;14,
2011, pursuant to its charter (the &#8220;Charter&#8221;) and is governed by the laws of the State of Maryland. The Fund&#8217;s principal
office is located at 1800 Avenue of the Stars, Suite 1400, Los Angeles, CA 90067, and its telephone number is (888) 818-5298.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_007_integixAnchor"></span><strong>DESCRIPTION
OF SHARES</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Common Shares</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Shareholders are entitled to share
pro rata in the net assets of the Fund available for distribution to shareholders upon liquidation of the Fund. Shareholders are entitled
to one vote for each share held. Shareholders do not have preemptive, conversion or subscription rights and the Fund&#8217;s common shares
are not redeemable. Common shares, when issued and outstanding, will be fully paid and non-assessable.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund intends to hold annual meetings
of shareholders so long as the common shares are listed on a national securities exchange and such meetings are required as a condition
to such listing. The Fund will send unaudited reports at least semi-annually and audited annual financial statements to all of its shareholders.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Unlike open-end funds, closed-end
funds like the Fund do not continuously offer shares and do not provide daily redemptions. Rather, if a shareholder determines to buy
additional common shares or sell shares already held, the shareholder may do so by trading through a broker on the NYSE or otherwise.
Shares of closed-end investment companies frequently trade on an exchange at prices lower than NAV. Shares of closed-end investment companies
like the Fund have during some periods traded at prices higher than NAV and during other periods have traded at prices lower than NAV.
Because the market value of the common shares may be influenced by such direct and indirect factors as dividend levels (which are in turn
affected by expenses), call protection on its portfolio securities, dividend stability, portfolio credit quality, the Fund&#8217;s NAV,
relative demand for and supply of such shares in the market, general market and economic conditions and other factors beyond the control
of the Fund, the Fund cannot assure you that its common shares will trade at a price equal to or higher than NAV in the future. The common
shares are designed primarily for long-term investors and you should not purchase the common shares if you intend to sell them soon after
purchase. See &#8220;Repurchase of Common Shares&#8221; below and &#8220;Repurchase of Common Shares&#8221; in the SAI.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund&#8217;s outstanding common
shares are, and when issued, the common shares offered by this Prospectus will be, publicly held and listed and traded on the NYSE under
the symbol &#8220;ARDC.&#8221; The Fund determines its NAV on a daily basis. The following table sets forth, for the quarters indicated,
the highest and lowest daily closing prices on the NYSE per common share, and the NAV per common share and the premium to or discount
from NAV, on the date of each of the high and low market prices. The table also sets forth the number of common shares traded on the NYSE
during the respective quarters.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">12&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p> <ix:nonNumeric id="Fxbrl_20240830184741228" name="cef:SharePriceTableTextBlock" contextRef="C_20240826to20240826" escape="true">


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, serif;border-bottom:1pt solid black">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>During Quarter Ended</strong></p> </td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="font-size:10pt;font-weight:bold;text-align:center;border-bottom:Black 1pt solid">NYSE&#160;Market&#160;Price<br/>Per&#160;Common
        Share</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="font-size:10pt;font-weight:bold;text-align:center;border-bottom:Black 1pt solid">NAV per<br/>Common<br/>Share on&#160;Date&#160;of<br/>Market&#160;Price</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="font-size:10pt;font-weight:bold;text-align:center;border-bottom:Black 1pt solid">Premium/(Discount)&#160;on<br/>Date&#160;of<br/>Market&#160;Price</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font-size:10pt;font-weight:bold;text-align:center">Trading</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Volume</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:30%;font-size:10pt">March 31, 2024</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:7%;font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104255668" name="cef:HighestPriceOrBid" contextRef="C_20240101to20240331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.29</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:7%;font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104407642" name="cef:LowestPriceOrBid" contextRef="C_20240101to20240331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.41</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:7%;font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104411837" name="cef:HighestPriceOrBidNav" contextRef="C_20240101to20240331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.69</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:7%;font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104415673" name="cef:LowestPriceOrBidNav" contextRef="C_20240101to20240331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.46</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:7%;font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104419888" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240101to20240331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">2.72</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">)%</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:7%;font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104423280" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20240101to20240331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">7.26</ix:nonFraction></td>
    <td style="width:1%;font-size:10pt;text-align:left">)%</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:7%;font-size:10pt;text-align:right">6,951,700</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">December&#160;31, 2023</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104646811_xbrl_20240830104255668" name="cef:HighestPriceOrBid" contextRef="C_20231001to20231231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.86</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104646811_xbrl_20240830104407642" name="cef:LowestPriceOrBid" contextRef="C_20231001to20231231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.88</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104646811_xbrl_20240830104411837" name="cef:HighestPriceOrBidNav" contextRef="C_20231001to20231231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.51</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104646811_xbrl_20240830104415673" name="cef:LowestPriceOrBidNav" contextRef="C_20231001to20231231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.76</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104646811_xbrl_20240830104419888" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20231001to20231231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">4.48</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104646811_xbrl_20240830104423280" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20231001to20231231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">13.66</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,020,500</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt">September&#160;30, 2023</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104649011_xbrl_20240830104255668" name="cef:HighestPriceOrBid" contextRef="C_20230701to20230930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.93</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104649011_xbrl_20240830104407642" name="cef:LowestPriceOrBid" contextRef="C_20230701to20230930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.10</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104649011_xbrl_20240830104411837" name="cef:HighestPriceOrBidNav" contextRef="C_20230701to20230930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.25</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104649011_xbrl_20240830104415673" name="cef:LowestPriceOrBidNav" contextRef="C_20230701to20230930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.75</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104649011_xbrl_20240830104419888" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230701to20230930" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">9.26</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104649011_xbrl_20240830104423280" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230701to20230930" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.00</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,500,400</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">June&#160;30, 2023</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104651851_xbrl_20240830104255668" name="cef:HighestPriceOrBid" contextRef="C_20230401to20230630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.33</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104651851_xbrl_20240830104407642" name="cef:LowestPriceOrBid" contextRef="C_20230401to20230630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.61</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104651851_xbrl_20240830104411837" name="cef:HighestPriceOrBidNav" contextRef="C_20230401to20230630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.87</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104651851_xbrl_20240830104415673" name="cef:LowestPriceOrBidNav" contextRef="C_20230401to20230630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.58</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104651851_xbrl_20240830104419888" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230401to20230630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">11.10</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104651851_xbrl_20240830104423280" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230401to20230630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">14.51</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,473,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt">March&#160;31, 2023</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104654339_xbrl_20240830104255668" name="cef:HighestPriceOrBid" contextRef="C_20230101to20230331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.85</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104654339_xbrl_20240830104407642" name="cef:LowestPriceOrBid" contextRef="C_20230101to20230331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.42</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104654339_xbrl_20240830104411837" name="cef:HighestPriceOrBidNav" contextRef="C_20230101to20230331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.12</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104654339_xbrl_20240830104415673" name="cef:LowestPriceOrBidNav" contextRef="C_20230101to20230331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.37</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104654339_xbrl_20240830104419888" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230101to20230331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">8.99</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104654339_xbrl_20240830104423280" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20230101to20230331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">14.58</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">7,627,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">December&#160;31, 2022</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104656723_xbrl_20240830104255668" name="cef:HighestPriceOrBid" contextRef="C_20221001to20221231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.31</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104656723_xbrl_20240830104407642" name="cef:LowestPriceOrBid" contextRef="C_20221001to20221231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.27</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104656723_xbrl_20240830104411837" name="cef:HighestPriceOrBidNav" contextRef="C_20221001to20221231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.73</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104656723_xbrl_20240830104415673" name="cef:LowestPriceOrBidNav" contextRef="C_20221001to20221231" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.17</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104656723_xbrl_20240830104419888" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20221001to20221231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">10.34</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104656723_xbrl_20240830104423280" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20221001to20221231" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">14.43</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,699,200</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt">September&#160;30, 2022</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104658658_xbrl_20240830104255668" name="cef:HighestPriceOrBid" contextRef="C_20220701to20220930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.45</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104658658_xbrl_20240830104407642" name="cef:LowestPriceOrBid" contextRef="C_20220701to20220930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.65</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104658658_xbrl_20240830104411837" name="cef:HighestPriceOrBidNav" contextRef="C_20220701to20220930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.77</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104658658_xbrl_20240830104415673" name="cef:LowestPriceOrBidNav" contextRef="C_20220701to20220930" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.33</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104658658_xbrl_20240830104419888" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220701to20220930" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">8.94</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104658658_xbrl_20240830104423280" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220701to20220930" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.60</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">4,773,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">June&#160;30, 2022</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104701506_xbrl_20240830104255668" name="cef:HighestPriceOrBid" contextRef="C_20220401to20220630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.82</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104701506_xbrl_20240830104407642" name="cef:LowestPriceOrBid" contextRef="C_20220401to20220630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">11.89</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104701506_xbrl_20240830104411837" name="cef:HighestPriceOrBidNav" contextRef="C_20220401to20220630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">15.96</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104701506_xbrl_20240830104415673" name="cef:LowestPriceOrBidNav" contextRef="C_20220401to20220630" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.75</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104701506_xbrl_20240830104419888" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220401to20220630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">7.14</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104701506_xbrl_20240830104423280" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220401to20220630" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">13.53</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,461,400</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt">March&#160;31, 2022</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104703514_xbrl_20240830104255668" name="cef:HighestPriceOrBid" contextRef="C_20220101to20220331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">16.37</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104703514_xbrl_20240830104407642" name="cef:LowestPriceOrBid" contextRef="C_20220101to20220331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.61</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104703514_xbrl_20240830104411837" name="cef:HighestPriceOrBidNav" contextRef="C_20220101to20220331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">16.71</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right"><ix:nonFraction id="Fxbrl_20240830104703514_xbrl_20240830104415673" name="cef:LowestPriceOrBidNav" contextRef="C_20220101to20220331" unitRef="Usd_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">15.56</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104703514_xbrl_20240830104419888" name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220101to20220331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">2.03</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<ix:nonFraction id="Fxbrl_20240830104703514_xbrl_20240830104423280" name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="C_20220101to20220331" unitRef="Percentage" scale="-2" decimals="4" format="ixt:num-dot-decimal" sign="-">12.53</ix:nonFraction></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,201,000</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  </table> </ix:nonNumeric>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">As of August 6, 2024, the NAV per
common share of the Fund was $14.65 and the market price per common share was $15.09, representing a premium to NAV of 3.00%. Common shares
of the Fund have historically traded at both a premium and discount to NAV.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">As
of August 6, 2024, the Fund has 22,915,000 </span>outstanding common shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Preferred Shares</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter provides that the Board
may authorize and issue preferred shares, with rights as determined by the Board, without the approval of the holders of the common shares.
Common shareholders have no preemptive right to purchase any preferred shares that might be issued. The Fund has $100 million of preferred
shares outstanding. The Fund has authorized and issued 800,000 Series&#160;A MRP Shares for gross proceeds of $20 million, 1,200,000 Series&#160;B
MRP Shares for gross proceeds of $30 million and 2,000,000 Series&#160;C MRP Shares for gross proceeds of $50 million. Each of the MRP
Shares has a liquidation preference of $25.00 per share. The MRP Shares rank, with respect to the rights to the payment of dividends and
the distribution of assets upon the Fund&#8217;s dissolution, liquidation or winding up, (i)&#160;on a parity with each other and any
other class or series of preferred shares and (ii)&#160;senior to the common shares. Holders of MRP Shares do not have any preemptive
rights, or, unless otherwise determined by the Board, other rights to acquire, purchase or subscribe for any preferred shares, common
shares or other securities of the Fund.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Except for matters which do not require
the vote of holders of MRP Shares under the Investment Company Act and except as otherwise provided in the Charter and the Bylaws, (i)&#160;each
holder of MRP Shares is entitled to one vote per share on each matter submitted to a vote of the Fund&#8217;s stockholders, and (ii)&#160;the
holders of MRP Shares, outstanding preferred shares and common shares will vote together as a single class on all matters submitted to
the Fund&#8217;s stockholders; provided, however, that the holders of MRP Shares and outstanding preferred shares will be entitled, as
a class, to the exclusion of the holders of all other classes of stock of the Fund, to elect two directors of the Fund. Holders of preferred
shares, voting as a separate class, are also generally entitled to vote on (i)&#160;certain amendments to the Charter and the Bylaws,
(ii)&#160;the Fund&#8217;s ability to enter into certain agreements, (iii)&#160;the authorization, issuance or reclassification of shares
of the Fund&#8217;s stock that would rank on a parity with or senior to the preferred shares, (iv)&#160;the liquidation or dissolution
of the Fund and (v)&#160;the Fund&#8217;s ability to incur, authorize or guarantee any indebtedness for borrowed money.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Holders
of the MRP Shares are entitled to receive quarterly cumulative cash dividend payments on the first business day following each quarterly
dividend date. </span><span>We generally may not declare or pay, or set apart for payment, any dividend or other distribution on any shares
of our stock ranking junior to the MRP Shares as to dividends or upon liquidation, including our common shares, or on a parity with the
MRP Shares or call for redemption, redeem, purchase or otherwise acquire for consideration, unless (i)&#160;immediately after such transaction,
certain asset coverage would be achieved, (ii)&#160;full, cumulative dividends on the preferred shares have been declared and paid and
(iii)&#160;the Fund has redeemed the full number of MRP Shares required to be redeemed by any provision for mandatory redemption contained
in the terms of the MRP Shares.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The aggregate redemption amount of
the MRP Shares is $100 million. The redemption dates for the Series&#160;A MRP Shares, Series&#160;B MRP Shares and Series&#160;C MRP
Shares are July&#160;15, 2026, September&#160;15, 2026 and September&#160;15, 2028, respectively. The redemption price per share is equal
to the sum of the liquidation preference per share plus any accumulated but unpaid dividends plus, in some cases, an early redemption
premium, which may vary based on the date of redemption.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">13&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
Series&#160;A MRP Shares and the Series&#160;B MRP Shares have a dividend rate of 2.58% per annum, payable quarterly. The Series&#160;C
MRP Shares have a dividend rate of 3.03% per annum, payable quarterly. The weighted average dividend rate for the preferred shares is
2.81% per annum. The MRP Shares are subject to optional and mandatory redemption in certain circumstances. The MRP Shares will be subject
to redemption, at the option of the Fund, in whole or in part, at any time only for the purposes of decreasing leverage of the Fund. The
Fund may be obligated to redeem certain of the MRP Shares if the Fund fails to maintain an asset coverage ratio, calculated in accordance
with the Investment Company Act, greater than or equal to 225%. The Fund is subject to certain restrictions relating to the preferred
shares such as maintaining certain asset coverage ratio requirements. Failure to comply with these restrictions could preclude the Fund
from declaring any dividend to common shareholders and could trigger the mandatory redemption of the MRP Shares. All rights and preferences
of the holders of the MRP Shares of a particular series </span><span>will terminate if no MRP Shares of such series are outstanding. </span>Under
the Investment Company Act, the Fund is not permitted to issue preferred shares unless immediately after such issuance the value of the
Fund&#8217;s total assets is at least 200% of the liquidation value of the outstanding preferred shares (i.e., the liquidation value may
not exceed 50% of the Fund&#8217;s total assets). In addition, the Fund is not permitted to declare any cash dividend or other distribution
on its common shares unless, at the time of such declaration, the value of the Fund&#8217;s total assets is at least 200% of such liquidation
value. Please see &#8220;Description of Shares&#8221; in the SAI for more information.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Authorized Shares</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The following table provides the
Fund&#8217;s authorized shares and common and preferred shares outstanding as of December&#160;31, 2023.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:90%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto">
  <tr style="vertical-align:bottom">
    <td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid">Title of Class</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Authorized</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Held&#160;by<br/>Fund
        or for its<br/>Account</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Amount&#160;Outstanding<br/>Exclusive
        of Amount<br/>held by Fund</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:46%;font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">Common Shares</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">996,000,000</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">&#8212;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right">22,914,939</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;text-indent:-10pt;padding-left:10pt">Preferred Shares</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4,000,000</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">&#8212;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">4,000,000</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td> </tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_008_integixAnchor"></span><strong>THE FUND&#8217;S
INVESTMENTS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Objective and Policies</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please
refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section
of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective,
Policies and Risks,&#8221;</a></span> <span>which is incorporated by reference herein, for a discussion of the Fund&#8217;s investment
objective and policies. The Fund&#8217;s investment objective is non-fundamental and may be changed by the Board without shareholder approval.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>Portfolio Contents and Techniques</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under normal circumstances, the Fund&#8217;s
portfolio is expected to be comprised principally of the following types of investments:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Senior Loans.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Senior loans (&#8220;Senior Loans&#8221;)
generally hold the most senior position in the capital structure of a borrower, are typically secured with specific collateral and have
a claim on the assets and/or stock of the borrower that is senior to that held by unsecured creditors, subordinated debt holders and holders
of equity of the borrower. The majority of loans the Fund may invest in are rated below investment grade. Typically, in order to borrow
money pursuant to a Senior Loan, a borrower will, for the term of the Senior Loan, pledge collateral (subject to typical exceptions),
including but not limited to (i)&#160;working capital assets, such as accounts receivable and inventory; (ii)&#160;tangible fixed assets,
such as real property, buildings and equipment; (iii)&#160;intangible assets, such as trademarks and patent rights; and (iv)&#160;security
interests in shares of stock of subsidiaries or affiliates. In many instances, a Senior Loan may be secured only by shares in the borrower
or its subsidiaries. Collateral may consist of assets that may not be readily liquidated, and there is no assurance that the liquidation
of such assets would satisfy fully a borrower&#8217;s obligations under a Senior Loan.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">14&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Senior Loans typically have rates
of interest that are determined daily, monthly, quarterly or semi-annually by reference to a base lending rate, plus a premium or credit
spread. As a result, as short-term interest rates increase, interest payable to the Fund from its investments in Senior Loans should increase,
and as short-term interest rates decrease, interest payable to the Fund from its investments in Senior Loans should decrease. These base
lending rates are primarily the secured overnight funding rate (&#8220;SOFR&#8221;) or the Euro Interbank Offered Rate (&#8220;Euribor&#8221;)
and secondarily the prime rate offered by one or more major U.S. banks and the certificate of deposit rate or other base lending rates
used by commercial lenders.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">There
may be less readily available information about most Senior Loans and the borrowers thereunder than is the case for many other types of
securities, including securities issued in transactions registered under the </span>Securities Act of 1933, as amended (&#8220;Securities
Act&#8221;) or the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and borrowers subject to the periodic
reporting requirements of Section&#160;13 of the Exchange Act.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">No active trading market may exist
for some Senior Loans, and some loans may be subject to restrictions on resale. Any secondary market for Senior Loans may be subject to
irregular trading activity, wide bid/ask spreads and extended trade settlement periods, which may impair the ability of a seller to realize
full value and thus cause a material decline in the net asset value of the common shares. In addition, the Fund may not be able to readily
dispose of its Senior Loans at prices that approximate those at which the Fund could sell such loans if they were more widely traded and,
as a result of such illiquidity, the Fund may have to sell other investments or engage in borrowing transactions if necessary to raise
cash to meet its obligations. A limited supply or relative illiquidity of Senior Loans may adversely affect the Fund&#8217;s yield.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In the process of buying, selling
and holding Senior Loans, the Fund may receive and/or pay certain fees. These fees are in addition to interest payments received and may
include facility fees, commitment fees, amendment fees, commissions and prepayment penalty fees. On an ongoing basis, the Fund may receive
a commitment fee based on the undrawn portion of the underlying line of credit portion of a Senior Loan. In certain circumstances, the
Fund may receive a prepayment penalty fee upon the prepayment of a Senior Loan by a borrower. Other fees received by the Fund may include
covenant waiver fees, covenant modification fees or other amendment fees.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Direct
Assignments.</i></span>&#160;&#160;The Fund generally will seek to purchase Senior Loans on a direct assignment basis. If the Fund purchases
a Senior Loan on direct assignment, it typically succeeds to all the rights and obligations under the Loan Agreement of the assigning
lender and becomes a lender under the Loan Agreement with the same rights and obligations as the assigning lender.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Loan
Participations.</i></span>&#160;&#160;To a lesser extent than direct assignments, the Fund may transact in participations in Senior Loans.
The participation by the Fund in a lender&#8217;s portion of a Senior Loan typically will result in the Fund&#8217;s having a contractual
relationship only with such lender, not with the borrower. As a result, the Fund may have the right to receive payments of principal,
interest and any fees to which it is entitled only from the lender selling the participation and only upon receipt by such lender of payments
from the borrower. Such indebtedness may be secured or unsecured. In connection with purchasing participations, the Fund generally will
have no right to enforce compliance by the borrower with the terms of the Loan Agreement, nor any rights with respect to any funds acquired
by other investors through set-off against the borrower and the Fund may not directly benefit from the collateral supporting the Senior
Loan in which it has purchased the participation. In the event of the insolvency of the entity selling a participation, the Fund may be
treated as a general creditor of such entity.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Corporate Bonds.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in corporate
bonds that are fixed income securities typically issued by non-investment-grade borrowers, usually at a yield premium to the yield for
investment-grade bonds (&#8220;Corporate Bonds&#8221;). Corporate Bonds generally provide for cash interest payments, but may include
deferred, zero coupon, or payment-in-kind terms. These investments may be acquired during the primary offering process and may also be
purchased in the secondary market as either private securities or publicly registered securities, and typically have multiple institutional
holders.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">15&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Holders of high-yield bonds, as creditors,
have a prior legal claim over common and preferred shareholders as to both income and assets of the issuer for the principal and interest
due them and may have a prior claim over other creditors but are generally subordinate to any senior secured lenders in the issuer&#8217;s
capital structure.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In most cases Corporate Bonds restrict
the borrower&#8217;s ability to incur additional debt and may restrict payments to equity shareholders based upon financial ratios associated
with general credit quality. In addition, Corporate Bonds often limit the borrower&#8217;s ability to repay or amortize its high-yield
bonds, particularly during the initial portion of their contractual tenor. As such, these securities can provide the opportunity for capital
appreciation or yield enhancement, especially when the borrower&#8217;s financial performance is consistent with or superior to expectations,
when conditions are favorable in the borrower&#8217;s industry, or when the general economic environment is positive.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Secured
bonds and notes. </i></span>These bonds and notes generally constitute the senior-most layer of a borrower&#8217;s capital structure and
benefit from a lien on the borrower&#8217;s assets as well as senior ranking in repayment priority. Owing to their claim position and
collateral support, secured bonds and secured notes tend to experience superior recoveries in a bankruptcy as compared to unsecured debt
due to the collateral securing these instruments. Such bonds and notes may rank <i>pari passu</i> in many respects with secured loans.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Unsecured
bonds. </i></span>Dependent upon their terms, these bonds can enjoy a senior ranking or subordinated ranking in repayment priority, but
do not benefit from a lien on a borrower&#8217;s assets. Unsecured bonds typically form a layer between a borrower&#8217;s credit facility
and its equity. Yields tend to reflect a premium in respect of a bond&#8217;s position within a borrower&#8217;s capital structure.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Alternative Credit Instruments.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">These instruments typically include
trust certificates, collateralized debt obligations, collateralized loan obligations (&#8220;CLOs&#8221;), asset-backed securities, credit-linked
notes or other structured finance securities. These securities are generally backed by pools of financials and other assets and tranched
into different asset classes. The structure of these securities may consist of debt rated from AAA to B and equity. These securities typically
make interest and principal payments in order of seniority.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>CLO
Securities</i></span>. A CLO generally holds a portfolio consisting principally of loan obligations. CLOs are created, in part, to reapportion
the risk and return characteristics of a portfolio of underlying assets. The CLO securitizes payment claims arising out of its portfolio
of underlying assets and issues securities with payment characteristics linked to the underlying assets. The redemption of the securities
issued by the CLO typically occurs from the cash flow generated by the portfolio of underlying assets. The vast majority of CLOs are actively
managed by an investment manager that is independent of the CLO and the holders of its securities.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund expects to invest in securities
issued by CLOs (&#8220;CLO Securities&#8221;) that principally hold Senior Loans, diversified by industry and borrower. It is also possible
that the underlying obligations of CLOs in which the Fund invests will include (i)&#160;subordinated loans, (ii)&#160;debt tranches of
other CLOs, and (iii)&#160;equity securities incidental to investments in Senior Loans. The cash flows on the underlying obligations will
primarily determine the payments to holders of CLO Securities. CLO Securities may have floating interest rates, fixed interest rates or,
in the case of subordinated CLO Securities, no set interest rate (but rather participate in residual cash flows of the relevant CLO).
CLOs issue securities in tranches with different payment characteristics and different credit ratings. These tranches are generally categorized
as senior, mezzanine, or subordinated/equity, according to their degree of risk. The key feature of the CLO structure is the prioritization
of the cash flows from a pool of securities among the several tranches of the CLO. As interest payments are received, the CLO makes contractual
interest payments to each tranche of debt based on its seniority. If there are funds remaining after each tranche of debt receives its
contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar covenants), the remaining
funds may be paid to the subordinated (or residual) tranche (often referred to as the &#8220;equity&#8221; tranche). The contractual provisions
setting out this order of payments are set out in detail in the relevant CLO&#8217;s indenture. These provisions are referred to as the
&#8220;priority of payments&#8221; or the &#8220;waterfall&#8221; and determine the terms of payment of any other obligations that may
be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition, for payments to be
made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which are different for
each CLO.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">16&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The tranches of CLO Securities senior
to the subordinated (or residual) tranche (called the &#8220;rated tranches&#8221;) are generally assigned credit ratings by one or more
nationally recognized statistical rating organizations (whether or not such tranches are issued as part of a component of a composite
instrument with one or more other instruments). The &#8220;equity&#8221; tranche does not receive ratings. The transaction documents relating
to the issuance of CLO Securities impose eligibility criteria on the assets of the CLO, restrict the ability of the CLO&#8217;s investment
manager to trade investments and impose certain portfolio-wide asset quality requirements.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">CLO Securities are generally limited
recourse obligations of the CLO payable solely from the underlying assets of the CLO or the proceeds thereof. Consequently, holders of
CLO Securities must rely solely on distributions on the underlying assets or proceeds thereof for payment in respect thereof. The cash
flows generated by the underlying obligations held in a CLO&#8217;s portfolio will generally determine the interest payments on CLO Securities.
Payments to holders of tranched CLO Securities are made in sequential order of priority.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Asset-Backed
Securities</i></span>. Asset-backed securities are debt instruments that are backed by a pool of financial assets, generally consisting
of certain kinds of receivables or loans, including, for example, commercial loans. Such assets are generally securitized through the
use of trusts and special purpose corporations. Payments or distributions of principal and interest may be guaranteed up to certain amounts
and for a certain time period by a letter of credit or a pool insurance policy issued by a financial institution unaffiliated with the
trust or corporation, or other credit enhancements may be present.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Asset-backed securities are often
subject to more rapid repayment than their stated maturity date would indicate as a result of the pass-through of prepayments of principal
on the underlying loans. During periods of declining interest rates, prepayment of loans underlying asset-backed securities can be expected
to accelerate. Accordingly, the Fund&#8217;s ability to maintain positions in such securities will be affected by reductions in the principal
amount of such securities resulting from prepayments, and its ability to reinvest the returns of principal at comparable yields is subject
to generally prevailing interest rates at that time. To the extent that the Fund invests in asset-backed securities, the values of the
Fund&#8217;s portfolio securities will vary with changes in market interest rates generally and the differentials in yields among various
kinds of asset-backed securities. Asset-backed securities also carry credit or default risks. If the issuer of an asset-backed security
defaults on its payment obligations, there is the possibility that, in some cases, the Fund will be unable to possess and sell the underlying
collateral and that the Fund&#8217;s recoveries on repossessed collateral may not be available to support payments on these securities.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Subordinated Loans.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in subordinated
loans. Because subordinated loans are subordinated and thus lower in priority of payment and/or in priority of lien to Senior Loans, they
are subject to the additional risk that the cash flow of the borrower and property securing the loan or debt, if any, may be insufficient
to meet scheduled payments after giving effect to the senior secured obligations of the borrower. This risk is generally higher for subordinated
unsecured loans or debt, which are not backed by a security interest in any specific collateral. Subordinated loans generally have greater
price volatility than Senior Loans and may be less liquid.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Special Situations and Stressed and Distressed
Investments.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in debt securities,
preferred or common shares, or other instruments, of companies that are facing liquidity constraints or are undergoing, or that have recently
completed, bankruptcies, reorganizations, insolvencies, liquidations or other fundamental changes or similar proceedings. These instruments
may be the subject of bankruptcy proceedings or otherwise in default or at risk of being in default as to the repayment of principal and/or
interest at the time of acquisition by the Fund. The repayment of defaulted obligations is subject to significant uncertainties. Defaulted
obligations might be repaid only after lengthy bankruptcy or other reorganization proceedings, during which the issuer might not make
any interest or other payments.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In any investment opportunity involving
any such type of special situation, there also exists the risk that a contemplated transaction either will be unsuccessful, will take
considerable time or will result in a distribution of cash or new securities, the value of which will be less than the purchase price
to the Fund of the securities or other financial instruments in respect of which such distribution is received. Similarly, if an anticipated
transaction does not in fact occur, the Fund may be required to sell its investment at a loss. The consummation of such transactions can
be prevented or delayed by a variety of factors, including but not limited to (i)&#160;market conditions resulting in material changes
in securities prices; (ii)&#160;compliance with any applicable bankruptcy, insolvency or securities laws; and (iii)&#160;other factors
resulting in the inability to obtain adequate financing. Because there is substantial uncertainty concerning the outcome of transactions
involving financially troubled companies in which the Fund intends to invest, there is a potential risk of loss by the Fund of its entire
investment in such companies. Distressed instruments may be highly illiquid and the prices at which they may be sold may represent a substantial
discount to what the Adviser believes to be their ultimate value.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">17&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Equity Securities.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">From time to time, the Fund may invest
in or hold common shares and other equity securities incident to the purchase or ownership of a Senior Loan, Corporate Bond or other instrument
or in connection with a reorganization of a borrower. Investments in equity securities incidental to investment in Senior Loans entail
certain risks in addition to those associated with investments in Senior Loans. Common shares represent an equity ownership interest in
a company. Historical trends would indicate that common shares are subject to higher levels of volatility and market and issuer-specific
risk than debt securities. The value of equity securities may be affected more rapidly, and to a greater extent, by company-specific developments
and general market conditions. These risks may increase fluctuations in the net asset value of the common shares. In addition, the Fund
frequently may possess material non-public information about a borrower. Because of prohibitions on trading in securities while in possession
of material non-public information, the Fund might be unable to enter into a transaction in a security of the borrower when it would otherwise
be advantageous to do so. The equity interests held by the Fund, if any, may not pay dividends or otherwise generate income or appreciate
in value and, in fact, may decline in value. Accordingly, the Fund may not be able to realize gains from its equity investments, and any
gains that the Fund does realize may not be sufficient to contribute materially to the Fund&#8217;s investment objective of seeking current
income. Equity securities held by the Fund may be illiquid.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Short Sales.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may, from time to time,
engage in short sales. A short sale is a transaction in which the Fund sells an instrument that it does not own in anticipation that the
market price will decline. To deliver the securities to the buyer, the Fund arranges through a broker to borrow the securities and, in
so doing, the Fund becomes obligated to replace the securities borrowed at their market price at the time of replacement. When selling
short, the Fund intends to replace the securities at a lower price and therefore profit from the difference between the cost to replace
the securities and the proceeds received from the sale of the securities. When the Fund makes a short sale, the proceeds it receives from
the sale will be held on behalf of a broker until the Fund replaces the borrowed securities. The Fund may have to pay a premium to borrow
the securities and must pay any dividends or interest payable on the securities until they are replaced. The Fund&#8217;s obligation to
replace the securities borrowed in connection with a short sale will be secured by collateral deposited with the broker that consists
of cash and/or liquid securities. Short sales involve certain risks and special considerations. If the Fund incorrectly predicts that
the price of the borrowed security will decline, the Fund will have to replace the securities with securities with a greater value than
the amount received from the sale. As a result, losses from short sales differ from losses that could be incurred from a purchase of a
security because losses from short sales may be theoretically unlimited, whereas losses from purchases can equal only the total amount
invested.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Warrants.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Warrants give holders the right,
but not the obligation, to buy common shares of an issuer at a given price, usually higher than the market price at the time of issuance,
during a specified period. The risk of investing in a warrant is that the warrant may expire prior to the market value of the common shares
exceeding the price fixed by the warrant. Warrants have a subordinate claim on a borrower&#8217;s assets compared with Senior Loans. As
a result, the values of warrants generally are dependent on the financial condition of the borrower and less dependent on fluctuations
in interest rates than are the values of many debt securities. The values of warrants may be more volatile than those of Senior Loans
or Corporate Bonds and this may increase the volatility of the net asset value of the common shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">18&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Non-U.S. Securities.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest a portion of
its capital in non-U.S. securities. Some non-U.S. securities may be less liquid and more volatile than securities of comparable U.S. issuers.
Similarly, there is less volume and liquidity in most foreign financial markets than in the U.S. and, at times, greater price volatility
than in the U.S.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Because evidences of ownership of
such securities usually are held outside the U.S., the Fund will be subject to additional risks, including possible adverse political
and economic developments, seizure or nationalization of foreign deposits and adoption of governmental restrictions that might adversely
affect or restrict the payment of principal and interest on the foreign securities to investors located outside the country of the issuer,
whether from currency blockage or otherwise. Because non-U.S. securities may trade on days when the common shares are not traded on the
NYSE, the market value or net asset value of the common shares can change at times when the common shares cannot be sold.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Foreign Currency Transactions.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may engage in foreign currency
exchange transactions in connection with its investments in foreign securities. The Fund is not required to hedge its currency exposure,
if any, and may choose not to do so. The Fund generally will conduct its foreign currency exchange transactions either on a spot (i.e.,&#160;cash)
basis at the spot rate prevailing in the foreign currency exchange market or through forward contracts to purchase or sell foreign currencies,
including the payment of dividends and the settlement of securities transactions that otherwise might require untimely dispositions of
Fund securities.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A forward foreign currency exchange
contract involves an obligation to purchase or sell a specific currency at a future date, which may be any fixed number of days (usually
less than one year) from the date of the contract agreed upon by the parties, at a price and for an amount set at the time of the contract.
These contracts are traded in the interbank market conducted directly between currency traders (usually large commercial banks) and their
customers. A forward contract generally has a deposit requirement, and no commissions are charged at any stage for trades. Although foreign
exchange dealers do not charge a fee for conversion, they do realize a profit based on the difference (the spread) between the price at
which they are buying and selling various currencies. At the consummation of a forward contract, the Fund may either make delivery of
the foreign currency or terminate its contractual obligation to deliver the foreign currency by purchasing an offsetting contract obligating
it to purchase, at the same maturity date, the same amount of such foreign currency. If the Fund chooses to make delivery of the foreign
currency, it may be required to obtain such currency through the sale of portfolio securities denominated in such currency or through
conversion of other assets of the Fund into such currency. If the Fund engages in an offsetting transaction, the Fund will incur a gain
or loss to the extent that there is a difference between the forward contract price and the offsetting forward contract price.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">It should be noted that this method
of protecting the value of the Fund&#8217;s portfolio securities against a decline in the value of a currency does not eliminate fluctuations
in the underlying prices of the securities. Rather, it simply establishes a rate of exchange that can be achieved at some future point
in time. Additionally, although such contracts tend to minimize the risk of loss due to a decline in the value of the hedged currency,
at the same time they tend to limit any potential gain should the value of the currency increase.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Derivatives.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may use derivatives. Derivatives
are financial instruments the value of which is derived from another security, a commodity (such as gold or oil), a currency or an index
(a measure of value or rates, such as the S&amp;P&#160;500 Index or the prime lending rate). Derivatives may allow the Fund to increase
or decrease the level of risk to which the Fund is exposed more quickly and efficiently than transactions in other types of instruments.
Pursuant to Rule&#160;18f-4 under the Investment Company Act, among other things, the Fund must either limit its derivatives exposure
to no more than 10% of its net assets (the &#8220;Limited Derivatives User Exception&#8221;) or comply with an outer limit based on value-at-risk
as specified in the rule. The Fund is currently relying on the Limited Derivatives User Exception. The Fund may or may not use derivatives
for hedging purposes, as a form of leverage or to seek to enhance returns, including speculation on changes in credit spreads, interest
rates or other characteristics of the market, individual securities or groups of securities. If the Fund invests in a derivative for speculative
purposes, which it initially does not intend to do, the Fund will be fully exposed to the risks of loss of that derivative, which may
sometimes be greater than the derivative&#8217;s cost. The use of derivatives may involve substantial leverage.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">19&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Swap
Agreements.</i></span> The Fund may enter into swap agreements, including interest rate and index swap agreements, for hedging purposes,
as a form of leverage or to seek to obtain a particular desired return at a lower cost to the Fund than if the Fund had invested directly
in an instrument that yielded the desired return. Swap agreements are two-party contracts entered into primarily by institutional investors
for periods ranging from a few weeks to more than one year. In a standard &#8220;swap&#8221; transaction, two parties agree to exchange
the returns (or differentials in rates of return) earned or realized on particular predetermined investments or instruments. The gross
returns to be exchanged or &#8220;swapped&#8221; between the parties are calculated with respect to a &#8220;notional amount&#8221; (i.e.,
the dollar amount invested at a particular interest rate, in a particular foreign currency, or in a &#8220;basket&#8221; of securities
representing a particular index). The &#8220;notional amount&#8221; of the swap agreement is only a basis on which to calculate the obligations
that the parties to a swap agreement have agreed to exchange. The Fund&#8217;s obligations (or rights) under a swap agreement generally
will be equal only to the &#8220;net amount&#8221; to be paid or received under the agreement based on the relative values of the positions
held by each party to the agreement.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may enter into credit default
swap agreements and similar agreements, and may also buy credit-linked securities. Among other purposes, credit default swaps provide
investment exposure to changes in credit spreads and relative interest rates. The credit default swap agreement or similar instrument
may have as reference obligations one or more securities that are not currently held by the Fund (including a &#8220;basket&#8221; of
securities representing an index). The protection &#8220;buyer&#8221; in a credit default contract may be obligated to pay the protection
&#8220;seller&#8221; an upfront payment or a periodic stream of payments over the term of the contract provided generally that no credit
event on a reference obligation has occurred. If a credit event occurs, the seller generally must pay the buyer the &#8220;par value&#8221;
(full notional value) of the swap in exchange for an equal face amount of deliverable obligations of the reference entity described in
the swap, if the swap is physically settled.&#160; If the swap is cash settled, an auction process is used to determine the &#8220;recovery
value&#8221; of the contract, and the seller may be required to deliver the related net cash amount.&#160; The Fund may be either the
buyer or seller in the transaction.&#160; If the Fund is a buyer and no credit event occurs, the Fund recovers nothing if the swap is
held through its termination date.&#160; However, if a credit event occurs and the credit default contract is required to physically settle,
the Fund may elect to receive the full notional value of the swap in exchange for an equal face amount of deliverable obligations of the
reference entity that may have little or no value.&#160; If the credit default contract is required to cash settle, the Fund may elect
to receive a cash amount equal to the &#8220;par value&#8221; (full notional value) of the swap contract minus the &#8220;recovery value&#8221;
as determined by the auction process.&#160; As a seller, the Fund generally receives an upfront payment or a fixed rate of income throughout
the term of the swap, which typically is between six months and three years, provided that there is no credit event. If a credit event
occurs and the credit default contract is required to physically settle, generally the seller must pay the buyer the full notional value
of the swap in exchange for an equal face amount of deliverable obligations of the reference entity that may have little or no value.&#160;
If the credit default contract is required to cash settle, the Fund will be generally obligated to pay the buyer the &#8220;par value&#8221;
(full notional value) of the swap contract minus the &#8220;recovery value&#8221; as determined by the auction process.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may enter into total return
swaps. Total return swaps are used as substitutes for owning a particular physical security, or the securities comprising a given market
index, or to obtain exposure in markets where no physical securities are available such as an interest rate index. Total return refers
to the payment (or receipt) of the total return on the security, index or other instrument underlying the swap, which is then exchanged
for the receipt (or payment) of a floating interest rate. Total return swaps provide the Fund with the additional flexibility of gaining
exposure to a particular security or index by using the most cost-effective vehicle available. Total return swaps provide the Fund with
the opportunity to actively manage the cash maintained by the Fund as a result of not having to purchase the actual securities or other
instruments underlying the swap. Similar to interest rate swaps, the cash backing total return swaps is actively managed to seek to earn
a return in excess of the floating rate paid on the swap.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Swaptions.</i></span>&#160;
The Fund, to the extent permitted under applicable law, may enter into &#8220;swaptions,&#8221; which are options on swap agreements on
either an asset-based or liability-based basis. A swaption is a contract that gives a counterparty the right (but not the obligation)
to enter into a new swap agreement or to shorten, extend, cancel or otherwise modify an existing swap agreement, at some designated future
time on specified terms. The Fund may write (sell) and purchase put and call swaptions. Depending on the terms of the particular option
agreement, the Fund generally will incur a greater degree of risk when it writes a swaption than it will incur when it purchases a swaption.
When the Fund purchases a swaption, it risks losing only the amount of the premium it has paid should it decide to let the option expire
unexercised. When the Fund writes a swaption, upon exercise of the option the Fund will become obligated according to the terms of the
underlying agreement.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">20&#160;</p> </div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p> </div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p> </div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Credit-Linked
Securities.</i></span>&#160; Among the income-producing securities in which the Fund may invest are credit-linked securities, which are
issued by a limited purpose trust or other vehicle that, in turn, invests in a derivative instrument or basket of derivative instruments,
such as credit default swaps, interest rate swaps and other securities, in order to provide exposure to certain fixed income markets.
For instance, the Fund may invest in credit-linked securities as a cash management tool in order to gain exposure to a certain market
and/or to remain fully invested when more traditional income-producing securities are not available.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Indexed
and Inverse Floating Rate Securities.</i></span>&#160;The Fund may invest in securities that provide a potential return based on a particular
index of value or interest rates. To the extent the Fund invests in these types of securities, the Fund&#8217;s return on such securities
will be subject to risk with respect to the value of the particular index: that is, if the value of the index falls, the value of the
indexed securities owned by the Fund will fall. Interest and principal payable on certain securities may also be based on relative changes
among particular indices. The Fund may invest in so-called &#8220;inverse floating obligations&#8221; or &#8220;residual interest bonds&#8221;
on which the interest rates vary inversely with a floating rate (which may be reset periodically by a Dutch auction, a remarketing agent,
or by reference to a short-term tax-exempt interest rate index). The Fund may purchase synthetically-created inverse floating rate bonds
evidenced by custodial or trust receipts. Generally, income on inverse floating rate bonds will decrease when interest rates increase,
and will increase when interest rates decrease.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><strong><i>Repurchase Agreements and Reverse Repurchase
Agreements.</i></strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Subject to its investment objective
and policies, the Fund may invest in repurchase agreements. Repurchase agreements are transactions in which the Fund purchases securities
or other obligations from a bank or securities dealer (or its affiliate) and simultaneously commits to resell them to the counterparty
at an agreed upon date or upon demand and at a price reflecting a market rate of interest unrelated to the coupon rate or maturity of
the purchased obligations. The Fund maintains custody of the underlying obligations prior to their repurchase, either through its regular
custodian or through a special &#8220;triparty&#8221; custodian or sub-custodian that maintains separate accounts for both the Fund and
its counterparty. The obligation of the counterparty to pay the repurchase price on the date agreed to or upon demand is, in effect, secured
by such obligations.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Reverse repurchase agreements involve
the sale of securities held by the Fund subject to the Fund&#8217;s agreement to repurchase the securities at an agreed upon date or upon
demand and at a price reflecting a market rate of interest. Reverse repurchase agreements are a form of effective leverage and may be
subject to the Fund&#8217;s limitation on borrowings and may be entered into only with banks or securities dealers or their affiliates.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_009_integixAnchor"></span><strong>LEVERAGE</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is authorized to utilize
leverage to the maximum extent permitted by law for investment and other general corporate purposes. The Fund currently utilizes leverage
through the issuance of preferred shares and bank borrowings and may obtain additional leverage in the future by issuing preferred shares
and/or notes and borrowing funds from banks and other financial institutions. The Fund may also gain leverage synthetically through swaps
and other derivatives. The use of leverage to purchase additional securities creates an opportunity for increased common share dividends,
but also creates risks for the common shareholders, including increased variability of the Fund&#8217;s net income, distributions, net
asset value and/or market price of its common shares in relation to market changes. Leverage is a speculative technique that exposes the
Fund to greater risk and increased costs than if it were not implemented. Increases and decreases in the value of the Fund&#8217;s portfolio
will be magnified through the use of leverage. In particular, leverage may magnify interest rate risk, which is the risk that the prices
of portfolio securities will fall (or rise) if market interest rates for those types of securities rise (or fall). As a result, leverage
may cause greater changes in the net asset value of the common shares, which will be borne entirely by the common shareholders, and in
the price at which its common shares trade in the secondary market. For example, with respect to the Fund&#8217;s investments in Senior
Loans or other debt instruments that provide an interest rate floor that helps protect the Fund&#8217;s income in falling or flat-rate
environments, if interest rates increase, the Fund may not realize the same extent of additional income compared to any increase in the
Fund&#8217;s cost of financing, which could result in the potential for a decrease in the level of income available for dividends or distributions
made by the Fund. The Fund pays dividends on its preferred shares and interest on borrowings, which increases expenses and may reduce
the Fund&#8217;s return. These dividend payments and interest expenses (which are borne entirely by common shareholders) may be greater
than the Fund&#8217;s return on the underlying investments. The Fund&#8217;s leveraging strategy may not be successful.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">21&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund&#8217;s obligations under
its preferred shares are senior to the common shares, such that holders of preferred shares and Fund indebtedness have priority over the
common shareholders in the distribution of the Fund&#8217;s assets, including dividends, distributions of principal and liquidating distributions.
Preferred shares vote together with the common shareholders on all matters, including the election of directors. Additionally, the holders
of preferred shares have the right separately to elect two directors of the Fund, and vote separately as a class on certain matters which
may at times give holders of preferred shares disproportionate influence over the Fund&#8217;s affairs. Limited term preferred shares
may require the Fund to liquidate its investments and reduce the Fund&#8217;s use of leverage, which could negatively impact common shareholders.
In addition, the Fund&#8217;s ability to make distributions to its common shareholders or to repurchase its share is limited by the asset
coverage requirements and other limitations imposed by the Investment Company Act, Maryland law and the Fund&#8217;s lenders.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund will pay (and common shareholders
will bear) all costs and expenses relating to the issuance and ongoing maintenance of preferred shares and other forms of indebtedness
issued by the Fund, including higher advisory fees. As a result, the Fund cannot assure you that the issuance of preferred shares and/or
notes or other forms of indebtedness will provide a higher yield or return to the holders of the common shares. The costs of any new offers
and/or issuances of preferred shares and/or notes or other forms of indebtedness will be borne immediately by the common shareholders
and result in a reduction of the net asset value of the common shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">So long as the Fund&#8217;s portfolio
provides a higher rate of return, net of expenses, than the interest or dividend rate on borrowed money, the leverage may cause common
shareholders to receive a higher current rate of return than if the Fund were not leveraged. If, however, long-term and/or short-term
rates rise, the interest rate on borrowed money could exceed the rate of return on securities held by the Fund, reducing returns to common
shareholders. Developments in the credit markets may adversely affect the ability of the Fund to borrow for investment purposes and may
increase the costs of such borrowings, which would reduce returns to common shareholders.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">22&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">There is no assurance that a leveraging
strategy will be successful. Leverage involves risks and special considerations for common shareholders, including:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.25in">&#160;</td>
    <td style="width:0.75in"><span>&#9679;</span></td>
    <td style="text-align:justify">the likelihood of greater volatility of net asset value, market price and dividend rate of common shares than
        a comparable portfolio without leverage;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.25in">&#160;</td>
    <td style="width:0.75in"><span>&#9679;</span></td>
    <td style="text-align:justify">the risk that fluctuations in interest rates on borrowings or in dividend payments on, principal proceeds distributed
        to, or redemption of any preferred shares and/or notes or other forms of indebtedness that the Fund has issued will reduce the return
        to the common shareholders;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.25in">&#160;</td>
    <td style="width:0.75in"><span>&#9679;</span></td>
    <td style="text-align:justify">the effect of leverage in a declining market, which is likely to cause a greater decline in the net asset value
        of the common shares than if the Fund were not leveraged, which may result in a greater decline in the market price of the common shares;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.25in">&#160;</td>
    <td style="width:0.75in"><span>&#9679;</span></td>
    <td style="text-align:justify">when the Fund uses financial leverage, the investment advisory fees payable to the Adviser will be higher than
        if the Fund did not use leverage, and may provide a financial incentive to the Adviser to increase the Fund&#8217;s use of leverage and
        create an inherent conflict of interest; and</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.25in">&#160;</td>
    <td style="width:0.75in"><span>&#9679;</span></td>
    <td style="text-align:justify">leverage may increase expenses (which will be borne entirely by common shareholders), which may reduce total
        return.</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The preferred shares and indebtedness
incurred by the Fund impose covenants and other restrictions imposed by its lenders are in addition to, and in certain cases more stringent
than, those imposed by the Investment Company Act. Certain types of borrowings by the Fund may result in the Fund being subject to covenants
relating to asset coverage and portfolio composition requirements. These covenants and restrictions may negatively affect the Fund&#8217;s
ability to achieve its investment objective.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Effects of Leverage</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">As of December&#160;31, 2023, we
had outstanding borrowings of approximately $163 million. In order for us to cover our annual interest payments on our outstanding indebtedness
at December&#160;31, 2023, we must achieve annual returns on our December&#160;31, 2023 total assets of at least 1.29%. The weighted average
stated interest rate charged on our principal amount of outstanding indebtedness as of December&#160;31, 2023 was 4.1%.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The following table illustrates the
effect on return to a common shareholder of the leverage created by our use of borrowing at the weighted average stated interest rate
of 4.1% as of December&#160;31, 2023, together with (a)&#160;our total value of net assets as of December&#160;31, 2023; (b)&#160;approximately
$163 million in aggregate principal amount of indebtedness outstanding as of December&#160;31, 2023; and (c)&#160;hypothetical annual
returns on our portfolio of minus 10% to plus 10%. These numbers are merely estimates used for illustration. Actual leverage expenses
vary frequently and may be significantly higher or lower than the rate estimated above.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:10pt Times New Roman, Times, Serif;width:35%;text-align:justify">Assumed Return on Portfolio (net of expenses)(1)</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">(10.00</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">)%</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">(5.00</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">)%</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">0</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">%</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">5.00</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">%</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">10.00</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">%</td></tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;text-align:justify">Corresponding Return to Common Shareholder(2)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(17.83</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(9.93</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">(2.04</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">)%</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">5.86</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">13.76</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.25in">&#160;</td>
    <td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td>
    <td style="text-align:justify">The assumed portfolio return is required by SEC regulations and is not a prediction of, and does not represent,
        our projected or actual performance. Actual returns may be greater or less than those appearing in the table. Pursuant to SEC regulations,
        this table is calculated as of December&#160;31, 2023. As a result, it has not been updated to take into account any changes in assets
        or leverage since December&#160;31, 2023.</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.25in">&#160;</td>
    <td style="width:0.25in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td>
    <td style="text-align:justify">In order to compute the &#8220;Corresponding Return to Common Shareholder,&#8221; the &#8220;Assumed Return
        on Portfolio&#8221; is multiplied by the total value of our assets at December&#160;31, 2023 to obtain an assumed return to us. From this
        amount, the interest expense (calculated by multiplying the weighted average stated interest rate of 4.1% by the approximately $163 million
        of principal debt outstanding) is subtracted to determine the return available to common shareholders. The return available to common
        shareholders is then divided by the total value of our net assets as of December&#160;31, 2023 to determine the &#8220;Corresponding Return
        to Common Shareholder.&#8221;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">23&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Preferred Shares</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has authorized and issued
800,000 Series&#160;A MRP Shares for gross proceeds of $20 million, 1,200,000 Series&#160;B MRP Shares for gross proceeds of $30 million
and 2,000,000 Series&#160;C MRP Shares for gross proceeds of $50 million. Each of the MRP Shares has a liquidation preference of $25.00
per share. The aggregate redemption amount of the MRP Shares is $100 million.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The redemption dates for the Series&#160;A
MRP Shares, Series&#160;B MRP Shares and Series&#160;C MRP Shares are July&#160;15, 2026, September&#160;15, 2026 and September&#160;15,
2028, respectively. The redemption price per share is equal to the sum of the liquidation preference per share plus any accumulated but
unpaid dividends plus, in some cases, an early redemption premium, which may vary based on the date of redemption.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Series&#160;A MRP Shares and
the Series&#160;B MRP Shares have a dividend rate of 2.58% per annum, payable quarterly. The Series&#160;C MRP Shares have a dividend
rate of 3.03% per annum, payable quarterly. The weighted average dividend rate for the MRP Shares is 2.81% per annum. The MRP Shares are
subject to optional and mandatory redemption in certain circumstances. The MRP Shares will be subject to redemption, at the option of
the Fund, in whole or in part, at any time only for the purposes of decreasing leverage of the Fund. The Fund may be obligated to redeem
certain of the MRP Shares if the Fund fails to maintain an asset coverage ratio, calculated in accordance with the Investment Company
Act, greater than or equal to 225%. The Fund is subject to certain restrictions relating to the preferred shares such as maintaining certain
asset coverage ratio requirements. Failure to comply with these restrictions could preclude the Fund from declaring any dividend to common
shareholders and could trigger the mandatory redemption of the MRP Shares. Additionally, in accordance with the Investment Company Act,
the Fund may not issue additional preferred shares if immediately after such issuance the Fund will not have an asset coverage ratio of
at least 200%. As of December&#160;31, 2023, the Fund was in compliance in all material respects with the terms of the MRP Shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Credit Facility</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under the Investment Company Act,
the Fund is permitted to incur indebtedness, including through the issuance of debt securities or borrowings from a bank, if immediately
thereafter the Fund has asset coverage of at least 300%. In general, the term &#8220;asset coverage&#8221; for this purpose means the
ratio which the value of the total assets of the Fund, less all liabilities and indebtedness not represented by senior securities, bears
to the aggregate amount of senior securities representing indebtedness of the Fund.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is a party to a senior secured
revolving Credit Facility that allows the Fund to borrow up to $212 million at any one time outstanding. The Credit Facility is scheduled
to terminate in 2026 unless extended. Under the Credit Facility, the Fund is required to comply with various covenants, reporting requirements
and other customary requirements for similar revolving credit facilities, including, without limitation, covenants related to: (a)&#160;limitations
on the incurrence of additional indebtedness, including additional mandatory redeemable preferred shares, and liens, (b)&#160;limitations
on certain investments, (c)&#160;limitations on certain restricted payments, and (d)&#160;maintaining a ratio of total assets (less total
liabilities other than senior securities representing indebtedness) to senior securities representing indebtedness plus the involuntary
liquidation preference of the mandatory redeemable preferred shares of the Fund (subject to certain exceptions) of not less than 2:1.0.
These covenants are subject to important limitations and exceptions that are described in the documents governing the Credit Facility.
As of the date of this Prospectus, the Fund was in compliance in all material respects with the terms of the Credit Facility.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_010_integixAnchor"></span><strong>RISKS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please
refer to the&#160;</span><span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">section
of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;Additional Information &#8211; Fund Investment Objective,
Policies and Risks,&#8221;</a></span> <span>which is incorporated by reference herein, for a discussion of the general risks of investing
in the Fund.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">24&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_011_integixAnchor"></span></p></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>HOW THE FUND MANAGES RISK</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Limitations</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has adopted certain investment
limitations designed to limit investment risk. Some of these limitations are fundamental and thus may not be changed without a vote of
the holders of common shares and any preferred shares outstanding. See &#8220;Investment Objective and Policies&#8212;Investment Restrictions&#8221;
in the SAI.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The restrictions and other limitations
set forth throughout this Prospectus and in the SAI apply only at the time of purchase of securities and will not be considered violated
unless an excess or deficiency occurs or exists immediately after and as a result of the acquisition of securities.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Management of Investment Portfolio and Capital Structure to Limit
Leverage Risk</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may take certain actions
if short-term interest rates increase or market conditions otherwise change (or the Fund anticipates such an increase or change) and any
leverage the Fund may have outstanding begins (or is expected) to adversely affect common shareholders. In order to attempt to offset
such a negative impact of any outstanding leverage on common shareholders, the Fund may shorten the average maturity of its investment
portfolio (by investing in short-term securities) or may reduce any indebtedness that it may have incurred. Because of the difficulty
of making such predictions, the Fund may elect not to attempt to manage its capital structure in the manner described in this paragraph.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If market conditions suggest that
employing leverage, or employing additional leverage if the Fund already has outstanding leverage, would be beneficial, the Fund may enter
into one or more credit facilities, increase any existing credit facilities, sell preferred shares or engage in additional leverage transactions
(including through investment in derivatives), subject to the restrictions of the Investment Company Act.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Strategic Transactions</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may use certain strategic
transactions designed to limit the risk of price fluctuations of securities and to preserve capital (&#8220;Strategic Transactions&#8221;).
These Strategic Transactions include using swaps, financial futures contracts, options on financial futures or options based on either
an index of long-term securities, or on securities whose prices, in the opinion of the Adviser, correlate with the prices of the Fund&#8217;s
investments. There can be no assurance that Strategic Transactions will be used or used effectively to limit risk, and Strategic Transactions
may be subject to their own risks.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_012_integixAnchor"></span><strong>MANAGEMENT
OF THE FUND</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Directors and Officers</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
business and affairs of the Fund are overseen by the </span>Board. The Board <span style="font-family:Times New Roman, Times, Serif">performs
the various duties imposed on the directors of investment companies by the Investment Company Act and Maryland law, </span>including supervision
of the duties performed by the Adviser. There are five Directors. A majority of the Directors are not &#8220;interested persons&#8221;
(as defined in the Investment Company Act) of the Fund (the &#8220;Independent Directors&#8221;). The name and business address of the
Directors and officers of the Fund and their principal occupations and other affiliations during the past five years are set forth under
&#8220;Management of the Fund&#8221; in the SAI.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Adviser</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is externally managed by
the Adviser, a subsidiary of Ares, pursuant to an investment advisory and management agreement. The Adviser was registered as an investment
adviser with the SEC under the Investment Advisers Act of 1940 (the &#8220;Advisers Act&#8221;) on June&#160;9, 2011. The Adviser oversees
the management of the Fund&#8217;s activities and is responsible for making investment decisions for the Fund&#8217;s portfolio. Ares
Operations LLC, a subsidiary of Ares, provides certain administrative and other services necessary for the Fund to operate. The Adviser
is located at 1800 Avenue of the Stars, Suite 1400, Los Angeles, CA 90067.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">25&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Portfolio Managers</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The members of the portfolio management
team who are primarily responsible for the day-to-day management of the Fund&#8217;s portfolio are as follows:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Seth
J. Brufsky </i></span>is a Partner, Portfolio Manager and Chairman of Global Liquid Credit in the Ares Credit Group. Seth J. Brufsky also
serves as the Chief Executive Officer, President and is a Director of the Fund. Additionally, Seth J. Brufsky serves as a member of the
Ares Credit Group&#8217;s Liquid Credit Investment Committee. Prior to joining Ares in 1998, Seth J. Brufsky was a member of the Corporate
Strategy and Research Group of Merrill Lynch&#160;&amp; Co., where Seth J. Brufsky focused on analyzing and marketing non-investment grade
securities. Previously, Seth J. Brufsky was a member of the Institutional Sales and Trading Group of the Global Fixed Income Division
at Union Bank of Switzerland. Seth J. Brufsky serves on the Board of Trustees of Choate Rosemary Hall, a private, co-educational, college-preparatory
boarding school, and serves on the Dean&#8217;s Advisory Boards for the College of Arts and Sciences and the College of Agriculture and
Life Sciences of Cornell University. Seth J. Brufsky also serves on the Board of the Luminescence Foundation, a charitable giving organization.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Seth J. Brufsky holds a B.S. from
Cornell University in Applied Economics and Business Management and a M.B.A., with honors, from the University of Southern California&#8217;s
Marshall School of Business in Finance, where Seth J. Brufsky was awarded the Glassick Scholarship for academic achievement.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Keith
Ashton </i></span>is a Partner, Portfolio Manager and Co-Head of Alternative Credit in the Ares Credit Group. Keith Ashton serves as a
Vice President and Portfolio Manager for the Fund. Additionally, Keith Ashton serves as a member of the Ares Credit Group&#8217;s Alternative
Credit, Pathfinder and Pathfinder Core Fund Investment Committees and the Ares Diversity, Equity and Inclusion Council. Prior to joining
Ares in 2011, Keith Ashton was a Partner at Indicus Advisors LLP, where Keith Ashton focused on launching the global structured credit
business in May&#160;2007. Previously, Keith Ashton was a Portfolio Manager and Head of Structured Credit at TIAA-CREF, where Keith Ashton
focused on managing a portfolio of structured credit investments and helped launch TIAA&#8217;s institutional asset management business.
Keith Ashton&#8217;s experience as an investor in alternative fixed income products spans virtually all securitized asset classes, including
CLOs, consumer and commercial receivables, insurance and legal settlements, small business and trade receivables, whole business securitizations,
timeshare and other mortgage-related receivables, and esoteric asset classes such as catastrophe risk and intellectual property.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Keith Ashton holds a B.A. from Brigham
Young University in Economics and a M.B.A. from the University of Rochester William E. Simon School of Business in Finance&#160;&amp;
Accounting.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Charles
Arduini&#160;</i></span>is a Partner and Portfolio Manager in the Ares Credit Group, where Charles Arduini focuses on alternative credit
investments. Charles Arduini serves as a Vice President and Portfolio Manager for the Fund. Additionally, Charles Arduini serves as a
member of the Ares Credit Group&#8217;s Pathfinder Core Fund Investment Committee. Prior to joining Ares in 2011, Charles Arduini was
a Managing Director at Indicus Advisors LLP, where Charles Arduini focused on structured credit investment opportunities. Previously,
Charles Arduini was Director of Structured Credit in the Fixed Income Investment Group and a Manager in the Risk Management Group at TIAA-CREF.
In addition, Charles Arduini worked in the telecommunications and information technology industries in various systems, operations and
management roles.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Charles Arduini holds a B.A. from
Bucknell University in Mathematics and an M.S. from Stevens Institute of Technology in Mathematics. Charles Arduini also holds an M.S.
from Carnegie Mellon University in Computational Finance. Charles Arduini is a CFA&#174; charterholder and a member of the New York Society
of Security Analysts.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Samantha
Milner </i></span><span>is a Partner and U.S. Liquid Credit Portfolio Manager in the Ares Credit Group, where Samantha Milner is primarily
responsible for managing Ares&#8217; U.S. bank loan credit strategies. Samantha Milner serves as a Vice President and Portfolio Manager
for the Fund. Additionally, Samantha Milner serves as a member of the Ares Credit Group&#8217;s U.S. Liquid Credit Investment Committee.
Samantha Milner also serves on the Ares Diversity, Equity and Inclusion Council. Prior to joining Ares in 2004, Samantha Milner was an
Associate in the Financial Restructuring Group at Houlihan Lokey Howard&#160;&amp; Zukin, where Samantha Milner focused on providing advisory
services in connection with restructurings, distressed mergers and acquisitions and private placements. Samantha Milner serves on the
Board of Directors of STEAM:CODERS, a not-for-profit organization focused on underrepresented and underserved students through Science,
Technology, Engineering, Art, and Math (STEAM), in preparation for academic and career opportunities. Samantha Milner holds a B.B.A.,
with distinction, from Emory University&#8217;s Goizueta Business School in Finance and Accounting.</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">26&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The SAI provides additional information
about other accounts managed by the portfolio management team, the compensation of each portfolio manager and the ownership of the Fund&#8217;s
securities by each portfolio manager.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Investment Advisory Agreement</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Pursuant to an investment advisory
and management agreement between the Adviser and the Fund (the &#8220;Investment Advisory Agreement&#8221;), the Fund has agreed to pay
the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund&#8217;s Managed Assets.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A discussion regarding the basis
for the approval of the Investment Advisory Agreement by the Board is available in the Fund&#8217;s Annual Report to shareholders for
the year ended December&#160;31, 2023.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Administration, Accounting Services, Custodian, Transfer Agent
and Other Services</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
Fund has engaged State Street, whose principal business address is One Congress Street, Boston, Massachusetts 02114, to serve as the Fund&#8217;s
administrator, custodian and transfer agent. Under the service agreements between State Street and the Fund, State Street provides certain
administrative services necessary for the operation of the Fund. Such services include maintaining certain Fund books and records, providing
accounting and tax services and preparing certain regulatory filings. State Street also performs custodial, fund accounting and portfolio
accounting services, as well as transfer agency and dividend paying services with respect to the common shares. State Street is entitled
to reasonable compensation for its services and expenses as the Fund&#8217;s aministrator, as agreed upon from time to time between the
Fund and State Street.</span> The total expenses incurred by the Fund under the service agreements with State Street for the year ended
December&#160;31, 2023 were $341,957.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has retained Destra, whose
principal business address is 443 N. Willson Avenue, Bozeman, Montana 59715, to provide investor support services in connection with the
ongoing operations of the Fund. Such services include providing ongoing contact with respect to the Fund and its performance with financial
advisors that are representatives of broker-dealers and other financial intermediaries, communicating with the NYSE specialist for the
Fund&#8217;s common shares and with the closed-end fund analyst community regarding the Fund on a regular basis, and maintaining a website
for the Fund. As compensation for the services provided by Destra pursuant to the Investor Support Services Agreement between the Fund
and Destra, as amended, the Fund pays to Destra a services fee calculated as follows: (1) multiply the end of day AUM balance times (2)
the Applicable Service Rate (the &#8220;ASR&#8221;), as described in the Investor Support Services Agreement between the Fund and Destra,
as amended. The ASR is determined based on the degree of discount or premium the Fund&#8217;s stock price relative to its net asset value
at the end of each day, such fee to be accrued and paid in the same manner, over the same period and paid on the same day as the Adviser&#8217;s
investment advisory fee is paid by the Fund under such investment advisory and management agreement. The total expenses incurred by the
Fund under the agreement with Destra for the year ended December&#160;31, 2023 were $289,508.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Independent Registered Public Accounting Firm</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Ernst&#160;&amp; Young LLP, whose
principal business address is 725 South Figueroa Street, Los Angeles, CA 90017, is the independent registered public accounting firm of
the Fund and is expected to render an opinion annually on the financial statements of the Fund.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_013_integixAnchor"></span><strong>NET ASSET
VALUE</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Effective October&#160;1, 2022, pursuant
to Rule&#160;2a-5 under the Investment Company Act, the Fund&#8217;s Board designated the Fund&#8217;s Adviser as the Fund&#8217;s &#8220;valuation
designee&#8221; to perform the fair value determinations held by the Fund without readily available market quotations, subject to the
oversight of the Board.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund follows ASC 825-10,&#160;<i>Recognition
and Measurement of Financial Assets and Financial Liabilities</i>&#160;(&#8220;ASC 825-10&#8221;), which provides companies the option
to report selected financial assets and liabilities at fair value. ASC 825-10 also establishes presentation and disclosure requirements
designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities
and a better understanding of the effect of the company&#8217;s choice to use fair value on its earnings. ASC 825-10 also requires entities
to display the fair value of the selected assets and liabilities on the face of the balance sheet. The Fund has not elected the ASC 825-10
option to report selected financial assets and liabilities at fair value. With the exception of the line items entitled &#8220;other assets,&#8221;
&#8220;mandatory redeemable preferred shares,&#8221; and &#8220;debt,&#8221; which are reported at amortized cost, the carrying value
of all other assets and liabilities approximate fair value.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">27&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund also follows ASC 820-10,
<i>Fair Value Measurements and Disclosures</i> (&#8220;ASC 820-10&#8221;), which expands the application of fair value accounting. ASC
820-10 defines fair value, establishes a framework for measuring fair value in accordance with U.S. generally accepted accounting principles
(&#8220;GAAP&#8221;) and expands disclosure of fair value measurements. ASC 820-10 determines fair value to be the price that would be
received for an investment in a current sale, which assumes an orderly transaction between market participants on the measurement date.
ASC 820-10 requires the Fund to assume that the portfolio investment is sold in its principal market to market participants or, in the
absence of a principal market, the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers
and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact. In accordance
with ASC 820-10, the Fund has considered its principal market as the market in which the Fund exits its portfolio investments with the
greatest volume and level of activity. ASC 820-10 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation
techniques are observable or unobservable. In accordance with ASC 820-10, these inputs are summarized in the three broad levels listed
below:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>Level 1 &#8212;
Valuations based on quoted prices in active markets for identical assets or liabilities that the Fund has the ability to access.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>Level 2 &#8212;
Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable either directly or
indirectly.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>Level 3 &#8212;
Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In addition to using the above inputs
in investment valuations, the Valuation Designee continues to employ the net asset valuation policy and procedures that have been reviewed
by the Fund&#8217;s Board in connection with their designation of the Adviser as the Fund&#8217;s valuation designee and are consistent
with the provisions of Rule&#160;2a-5 under the Investment Company Act and ASC 820-10. Consistent with its valuation policies and procedures,
the Valuation Designee evaluates the source of inputs, including any markets in which the Fund&#8217;s investments are trading (or any
markets in which securities with similar attributes are trading), in determining fair value. For investments where there is not a readily
available market value, the fair value of these investments must typically be determined using unobservable inputs.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The investments classified as Level
1 or Level 2 are typically valued based on quoted market prices, forward foreign exchange rates, dealer quotations or alternative pricing
sources supported by observable inputs. The Valuation Designee obtains prices from independent pricing services which generally utilize
broker quotes and may use various other pricing techniques which take into account appropriate factors such as yield, quality, coupon
rate, maturity, type of issue, trading characteristics and other data. The Valuation Designee is responsible for all inputs and assumptions
related to the pricing of securities. The Valuation Designee has internal controls in place that support its reliance on information received
from third-party pricing sources. As part of its internal controls, the Valuation Designee obtains, reviews, and tests information to
corroborate prices received from third-party pricing sources. For any security, if market or dealer quotations are not readily available,
or if the Valuation Designee determines that a quotation of a security does not represent a fair value, then the security is valued at
a fair value as determined in good faith by the Valuation Designee subject to the oversight of the Board and will be classified as Level
3. In such instances, the Valuation Designee will use valuation techniques consistent with the market or income approach to measure fair
value and will give consideration to all factors which might reasonably affect the fair value.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Senior
loans and corporate debt</i></span>:&#160;The fair value of Senior Loans and Corporate Bonds is estimated based on quoted market prices,
forward foreign exchange rates, dealer quotations or alternative pricing sources supported by observable inputs and are generally classified
within Level 2 or 3. The Valuation Designee obtains prices from independent pricing services which generally utilize broker quotes and
may use various other pricing techniques which take into account appropriate factors such as yield, quality, coupon rate, maturity, type
of issue, trading characteristics and other data. If the pricing services are only able to obtain a single broker quote or utilize a pricing
model the securities will be classified as Level 3. If the pricing services are unable to provide prices, the Valuation Designee will
attempt to obtain one or more broker quotes directly from a dealer and price such securities at the last bid price obtained; such securities
are classified as Level 3.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">28&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Collateralized
loan obligations</i></span>:&#160;The fair value of CLOs is estimated based on various valuation models from third-party pricing services.
The provided prices are checked using internally developed models. The valuation models generally utilize discounted cash flows and take
into consideration prepayment and loss assumptions, based on historical experience and projected performance, economic factors, the characteristics
and condition of the underlying collateral, comparable yields for similar securities and recent trading activity. These securities are
classified as Level 3.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>Common
shares and warrants</i></span>:&#160;The fair value of common shares and warrants are estimated using either broker quotes or an analysis
of the enterprise value (&#8220;EV&#8221;) of the portfolio company. EV means the entire value of the portfolio company to a market participant,
including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The primary method
for determining EV uses a multiple analysis whereby appropriate multiples are applied to the portfolio company&#8217;s EBITDA (generally
defined as net income before net interest expense, income tax expense, depreciation and amortization). EBITDA multiples are typically
determined based upon review of market comparable transactions and publicly traded comparable companies, if any. The Valuation Designee
may also employ other valuation multiples to determine EV, such as revenues. The second method for determining EV uses a discounted cash
flow analysis whereby future expected cash flows of the portfolio company are discounted to determine a present value using estimated
discount rates (typically a weighted average cost of capital based on costs of debt and equity consistent with current market conditions).
The EV analysis is performed to determine the value of equity investments, the value of debt investments in portfolio companies where
the Fund has control or could gain control through an option or warrant security, and to determine if there is credit impairment for debt
investments. If debt investments are credit impaired, an EV analysis may be used to value such debt investments; however, in addition
to the methods outlined above, other methods such as a liquidation or wind down analysis may be utilized to estimate EV.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_014_integixAnchor"></span><strong>DISTRIBUTIONS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund expects to distribute monthly
all or a portion of its net investment income to common shareholders.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund intends to pay common shareholders
at least annually all or substantially all of its net investment income after the payment of dividends and interest, if any, owed with
respect to any outstanding preferred shares and/or notes or other forms of leverage utilized by the Fund. The Fund intends to pay any
capital gains distributions at least annually. If the Fund makes a long-term capital gain distribution, it will be required to allocate
such gain between the common shares and any preferred shares issued by the Fund in proportion to the total dividends paid to each class
for the year in which the income is realized.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The U.S. federal income tax treatment
and characterization of the Fund&#8217;s distributions may vary significantly from time to time because of the varied nature of the Fund&#8217;s
investments. In light of the Fund&#8217;s investment policies, the Fund anticipates that the Investment Company Act will require it to
accompany each monthly distribution with a statement setting forth the estimated source (as between net income, capital gains and return
of capital) of the distribution made. The Fund will indicate the proportion of its capital gains distributions that constitute long-term
and short-term gains annually. The ultimate U.S. federal income tax characterization of the Fund&#8217;s distributions made in a calendar
or fiscal year cannot finally be determined until after the end of that taxable year. As a result, there is a possibility that the Fund
may make total distributions during a calendar or taxable year in an amount that exceeds the Fund&#8217;s net investment company taxable
income and net capital gains for the relevant taxable year. In such situations, if a distribution exceeds the Fund&#8217;s current and
accumulated earnings and profits (as determined for U.S. federal income tax purposes), a portion of each distribution paid with respect
to such taxable year would generally be treated as a tax-free return of capital reducing the amount of a shareholder&#8217;s tax basis
in such shareholder&#8217;s shares. When a shareholder sells shares in the Fund, the amount, if any, by which the sales price exceeds
the shareholder&#8217;s basis in the Fund&#8217;s shares is gain subject to tax. Because a return of capital reduces a shareholder&#8217;s
basis in the shares, it will increase the amount of such shareholder&#8217;s gain or decrease the amount of such shareholder&#8217;s loss
when such shareholder sells the shares, all other things being equal. To the extent that the amount of any return of capital distribution
exceeds the shareholder&#8217;s basis in such shareholder&#8217;s shares, the excess will be treated as gain from a sale or exchange of
the shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">29&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Various factors will affect the level
of the Fund&#8217;s income, including the asset mix, the average maturity of the Fund&#8217;s portfolio and default rates, the amount
of leverage utilized by the Fund, if any, and any use of hedging activities by the Fund. To permit the Fund to maintain a more stable
monthly distribution, the Fund may from time to time distribute less than the entire amount of income earned in a particular monthly period.
The undistributed income would be available to supplement future distributions. As a result, the distributions paid by the Fund for any
particular monthly period may be more or less than the amount of income actually earned by the Fund during that monthly period. Undistributed
income will add to the Fund&#8217;s net asset value (and indirectly benefits the Adviser by increasing its fees) and, correspondingly,
distributions from undistributed income will reduce the Fund&#8217;s net asset value.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The distributions for any full or
partial year might not be made in equal amounts, and any one distribution may be larger than the other. The Fund will make a distribution
only if authorized by the Board or by the officers of the Fund pursuant to delegated authority granted by the Board, and declared by the
Fund out of assets legally available for these distributions. The Fund may pay a special distribution at the end of each fiscal year if
necessary to maintain the Fund&#8217;s tax treatment as a RIC and/or avoid the imposition of tax on the Fund. This distribution policy
may, under certain circumstances, have certain adverse consequences to the Fund and its shareholders because it may result in a return
of capital to shareholders, which would reduce the Fund&#8217;s net asset value and, over time, potentially increase the Fund&#8217;s
expense ratio. If a distribution constitutes a return of capital, it means that the Fund is returning to shareholders a portion of their
investment rather than making a distribution that is funded from the Fund&#8217;s earned income or other profits. The Board may elect
to change the Fund&#8217;s distribution policy at any time.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Section&#160;19(b)&#160;of the Investment
Company Act and Rule&#160;19b-1 thereunder generally limit the Fund to one long-term capital gain distribution per year, subject to certain
exceptions.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Shareholders will automatically have
all dividends and distributions reinvested in common shares of the Fund in accordance with the Fund&#8217;s dividend reinvestment plan,
unless an election is made to receive cash by contacting the plan administrator at (877) 272-8164. See &#8220;Dividend Reinvestment Plan.&#8221;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_015_integixAnchor"></span><strong>DIVIDEND
REINVESTMENT PLAN</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Please
refer to the section of the Fund&#8217;s most recent annual report on Form&#160;N-CSR&#160;entitled &#8220;<span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">Additional
Information - Dividend Reinvestment Plan</a></span></span>,&#8221; which is incorporated by reference herein, for a discussion of the
Fund&#8217;s dividend reinvestment plan.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_016_integixAnchor"></span><strong>RIGHTS
OFFERINGS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may in the future, and at
its discretion, choose to make offerings of rights to its shareholders to purchase common shares. Rights may be issued independently or
together with any other offered security and may or may not be transferable by the person purchasing or receiving the rights. In connection
with a rights offering to shareholders, we would distribute certificates or other documentation (i.e., rights cards distributed in lieu
of certificates) evidencing the rights and a Prospectus Supplement to our shareholders as of the record date that we set for determining
the shareholders eligible to receive rights in such rights offering. Any such future rights offering will be made in accordance with the
Investment Company Act. Under the laws of Maryland, the Board is authorized to approve rights offerings without obtaining shareholder
approval.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The staff of the SEC has interpreted
the Investment Company Act as not requiring shareholder approval of a transferable rights offering to purchase common shares at a price
below the then current NAV so long as certain conditions are met, including: (i)&#160;a good faith determination by the Fund&#8217;s Board
that such offering would result in a net benefit to existing shareholders; (ii)&#160;the offering fully protects shareholders&#8217; preemptive
rights and does not discriminate among shareholders (except for the possible effect of not offering fractional rights); (iii)&#160;management
uses its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights; and
(iv)&#160;the ratio of a transferable rights offering does not exceed one new share for each three rights held.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">30&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The applicable Prospectus Supplement
would describe the following terms of the rights in respect of which this Prospectus is being delivered:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the period of time the offering would remain open;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the underwriter or distributor, if any, of the rights and any associated underwriting fees or discounts applicable
        to purchases of the rights;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the title of such rights;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the exercise price for such rights (or method of calculation thereof);</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the number of such rights issued in respect of each share;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the number of rights required to purchase a single share;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the extent to which such rights are transferable and the market on which they may be traded if they are transferable;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance
        or exercise of such rights;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the date on which the right to exercise such rights will commence, and the date on which such right will expire
        (subject to any extension);</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the extent to which such rights include an over-subscription privilege with respect to unsubscribed securities
        and the terms of such over-subscription privilege; and</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">termination rights we may have in connection with such rights offering.</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A certain number of rights would
entitle the holder of the right(s)&#160;to purchase for cash such number of common shares at such exercise price as in each case is set
forth in, or be determinable as set forth in, the Prospectus Supplement relating to the rights offered thereby. Rights would be exercisable
at any time up to the close of business on the expiration date for such rights set forth in the applicable Prospectus Supplement. After
the close of business on the expiration date, all unexercised rights would become void. Upon expiration of the rights offering and the
receipt of payment and the rights certificate or other appropriate documentation properly executed and completed and duly executed at
the corporate trust office of the rights agent, or any other office indicated in the applicable Prospectus Supplement, the common shares
purchased as a result of such exercise will be issued as soon as practicable. To the extent permissible under applicable law, we may determine
to offer any unsubscribed offered securities directly to persons other than shareholders, to or through agents, underwriters or dealers
or through a combination of such methods, as set forth in the applicable Prospectus Supplement.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_017_integixAnchor"></span><strong>TAX MATTERS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The
following discussion is a brief summary of certain U.S. federal income tax considerations affecting the Fund and the purchase, ownership
and disposition of the Fund&#8217;s common shares.</span> A more detailed discussion of the tax rules&#160;applicable to the Fund and
its common shareholders can be found in the SAI that is incorporated by reference into this Prospectus. Except as otherwise noted, this
discussion assumes you are a taxable U.S. holder (as defined below) and that you hold your common shares as capital assets for U.S. federal
income tax purposes (generally, assets held for investment). This discussion is based upon current provisions of the Internal Revenue
Code of 1986, as amended (the &#8220;Code&#8221;), the regulations promulgated thereunder and judicial and administrative authorities,
all of which are subject to change or differing interpretations by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;),
possibly with retroactive effect. No attempt is made to present a detailed explanation of all U.S. federal tax concerns affecting the
Fund and its common shareholders. <strong>The discussion set forth herein does not constitute tax advice and potential investors are urged
to consult their own tax advisers to determine the specific U.S. federal, state, local and foreign tax consequences to them of investing
in the Fund.</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">31&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In addition, no attempt is made to
address tax considerations applicable to an investor with a special tax status, such as a financial institution, real estate income trust
(&#8220;REIT&#8221;), insurance company, regulated investment company, individual retirement account, other tax-exempt organization, dealer
in securities or currencies, person holding shares of the Fund as part of a hedging, integrated, conversion or straddle transaction, trader
in securities that has elected the mark-to-market method of accounting for its securities, U.S. holder (as defined below) whose functional
currency is not the U.S. dollar, investor with &#8220;applicable financial statements&#8221; within the meaning of Section&#160;451(b)&#160;of
the Code, or non-U.S. investor. Furthermore, this discussion does not reflect possible application of the alternative minimum tax.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A U.S. holder is a beneficial owner
that is for U.S. federal income tax purposes:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">a citizen or individual resident of the United States (including certain former citizens and former long-term
        residents);</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">a corporation or other entity treated as a corporation for U.S. federal income tax purposes, created or organized
        in or under the laws of the United States or any state thereof or the District of Columbia;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">a trust with respect to which a court within the United States is able to exercise primary supervision over
        its administration and one or more U.S. persons has the authority to control all of its substantial decisions or the trust has made a
        valid election in effect under applicable Treasury regulations to be treated as a U.S. person.</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Taxation of the Fund</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has elected to be treated
as a RIC under Subchapter M of the Code, and operates in a manner so as to qualify for tax treatment applicable to RICs. To qualify for
tax treatment as a RIC, the Fund must, among other things, satisfy certain requirements relating to the sources of its income, diversification
of its assets, and distribution of its income to its shareholders. First, the Fund must derive at least 90% of its annual gross income
from dividends, interest, payments with respect to securities loans, gains from the sale or other disposition of stock or securities or
foreign currencies, or other income (including but not limited to gains from options, futures and forward contracts) derived with respect
to its business of investing in such stock, securities or currencies, or net income derived from interests in &#8220;qualified publicly
traded partnerships&#8221; (as defined in the Code) (the &#8220;90% gross income test&#8221;). Second, the Fund must diversify its holdings
so that, at the close of each quarter of its taxable year, (i)&#160;at least 50% of the value of its total assets consists of cash, cash
items, U.S. Government securities, securities of other RICs and other securities, with such other securities limited in respect of any
one issuer to an amount not greater in value than 5% of the value of the Fund&#8217;s total assets and to not more than 10% of the outstanding
voting securities of such issuer and (ii)&#160;not more than 25% of the market value of the Fund&#8217;s total assets is invested in the
securities (other than U.S. Government securities and securities of other RICs) of any one issuer, any two or more issuers controlled
by the Fund and engaged in the same, similar or related trades or businesses, or any one or more &#8220;qualified publicly traded partnerships.&#8221;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">As long as the Fund qualifies as
a RIC, the Fund will generally not be subject to corporate-level U.S. federal income tax on income and gains that it distributes each
taxable year to its shareholders, provided that in such taxable year it distributes at least 90% of the sum of (i)&#160;its net tax-exempt
interest income, if any, and (ii)&#160;its &#8220;investment company taxable income&#8221; (which includes, among other items, dividends,
taxable interest, taxable original issue discount and market discount income, income from securities lending, net short-term capital gain
in excess of net long-term capital loss, and any other taxable income other than &#8220;net capital gain&#8221; (as defined below) and
is reduced by deductible expenses) determined without regard to the deduction for dividends paid. The Fund may retain for investment its
net capital gain (which consists of the excess of its net long-term capital gain over its net short-term capital loss). However, if the
Fund retains any net capital gain or any investment company taxable income, it will be subject to tax at regular corporate rates on the
amount retained.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Code imposes a 4% nondeductible
excise tax on the Fund to the extent the Fund does not distribute by the end of any calendar year at least the sum of (i)&#160;98% of
its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii)&#160;98.2% of its capital gain in
excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on October&#160;31 of the calendar
year (unless an election is made to use the Fund&#8217;s fiscal year). In addition, the minimum amounts that must be distributed in any
year to avoid the excise tax will be increased or decreased to reflect the total amount of any under-distribution or over-distribution,
as the case may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed any income on
which it paid U.S. federal income tax. While the Fund intends to distribute any income and capital gain in the manner necessary to minimize
imposition of the 4% nondeductible excise tax, there can be no assurance that sufficient amounts of the Fund&#8217;s taxable income and
capital gain will be distributed to entirely avoid the imposition of the excise tax. In that event, the Fund will be liable for the excise
tax only on the amount by which it does not meet the foregoing distribution requirement.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">32&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If in any taxable year the Fund should
fail to qualify under Subchapter M of the Code for tax treatment as a RIC, the Fund would incur a regular corporate U.S. federal income
tax upon all of its taxable income for that year, and all distributions to its shareholders (including distributions of net capital gain)
would be taxable to shareholders as ordinary dividend income for U.S. federal income tax purposes to the extent of the Fund&#8217;s earnings
and profits. Provided that certain holding period and other requirements were met, such dividends would be eligible (i)&#160;to be treated
as qualified dividend income in the case of shareholders taxed as individuals and (ii)&#160;for the dividends received deduction in the
case of corporate shareholders. In addition, to qualify again to be taxed as a RIC in a subsequent year, the Fund would be required to
distribute to shareholders its earnings and profits attributable to non-RIC years. In addition, if the Fund failed to qualify as a RIC
for a period greater than two taxable years, then, in order to qualify as a RIC in a subsequent year, the Fund would be required to elect
to recognize and pay tax on any net built-in gain (the excess of aggregate gain, including items of income, over aggregate loss that would
have been realized if the Fund had been liquidated) or, alternatively, be subject to taxation on such built-in gain recognized for a period
of five years.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The remainder of this discussion
assumes that the Fund qualifies for taxation as a RIC.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt"><i>The
Fund&#8217;s Investments</i></span>. Certain of the Fund&#8217;s investment practices are subject to special and complex U.S. federal
income tax provisions (including mark-to-market, constructive sale, straddle, wash sale, short sale and other rules) that may, among other
things, (i)&#160;disallow, suspend or otherwise limit the allowance of certain losses or deductions, (ii)&#160;convert lower taxed long-term
capital gains or qualified dividend income into higher taxed short-term capital gains or ordinary income, (iii)&#160;convert ordinary
loss or a deduction into capital loss (the deductibility of which is more limited), (iv)&#160;cause the Fund to recognize income or gain
without a corresponding receipt of cash, (v)&#160;adversely affect the time as to when a purchase or sale of shares or securities is deemed
to occur, (vi)&#160;adversely alter the characterization of certain complex financial transactions and (vii)&#160;produce income that
will not be &#8220;qualified&#8221; income for purposes of the 90% annual gross income requirement described above. These U.S. federal
income tax provisions could therefore affect the amount, timing and character of distributions to common shareholders. The Fund monitors
its transactions and may make certain tax elections and may be required to dispose of securities to mitigate the effect of these provisions
and prevent disqualification of the Fund as a RIC. Additionally, the Fund may be required to limit its activities in derivative instruments
in order to enable it to maintain its RIC status.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest a portion of
its net assets in below investment grade securities. Investments in these types of securities may present special tax issues for the Fund.
U.S. federal income tax rules&#160;are not entirely clear about issues such as when the Fund may cease to accrue interest, original issue
discount or market discount, when and to what extent deductions may be taken for bad debts or worthless securities, how payments received
on obligations in default should be allocated between principal and income and whether modifications or exchanges of debt obligations
in a bankruptcy or workout context are taxable. These and other issues could affect the Fund&#8217;s ability to distribute sufficient
income to preserve its status as a RIC or to avoid the imposition of U.S. federal income or excise tax.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Certain debt securities acquired
by the Fund may be treated as debt securities that were originally issued at a discount. Generally, the amount of the original issue discount
is treated as interest income and is included in taxable income (and required to be distributed by the Fund in order to qualify as a RIC
and avoid U.S. federal income tax or the 4% excise tax on undistributed income) over the term of the security, even though payment of
that amount is not received until a later time, usually when the debt security matures.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">33&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If the Fund purchases a debt security
on a secondary market at a price lower than its adjusted issue price, the excess of the adjusted issue price over the purchase price is
&#8220;market discount.&#8221; Unless the Fund makes an election to accrue market discount on a current basis, generally, any gain realized
on the disposition of, and any partial payment of principal on, a debt security having market discount is treated as ordinary income to
the extent the gain, or principal payment, does not exceed the &#8220;accrued market discount&#8221; on the debt security. Market discount
generally accrues in equal daily installments. If the Fund ultimately collects less on the debt instrument than its purchase price plus
the market discount previously included in income, the Fund may not be able to benefit from any offsetting loss deductions.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund may invest in preferred
securities or other securities the U.S. federal income tax treatment of which may not be clear or may be subject to recharacterization
by the IRS. To the extent the tax treatment of such securities or the income from such securities differs from the tax treatment expected
by the Fund, it could affect the timing or character of income recognized by the Fund, potentially requiring the Fund to purchase or sell
securities, or otherwise change its portfolio, in order to comply with the tax rules&#160;applicable to RICs under the Code.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Gain or loss on the sale of securities
by the Fund will generally be long-term capital gain or loss if the securities have been held by the Fund for more than one year. Gain
or loss on the sale of securities held for one year or less will be short-term capital gain or loss.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Because the Fund may invest in foreign
securities, its income from such securities may be subject to non-U.S. taxes. If more than 50% of the Fund&#8217;s total assets at the
close of its taxable year consists of stock or securities of foreign corporations, the Fund may elect for U.S. federal income tax purposes
to treat foreign income taxes paid by it as paid by its shareholders. The Fund may qualify for and make this election in some, but not
necessarily all, of its taxable years. If the Fund were to make such an election, shareholders would be required to take into account
an amount equal to their pro rata portions of such foreign taxes in computing their taxable income and then treat an amount equal to those
foreign taxes as a U.S. federal income tax deduction or as a foreign tax credit against their U.S. federal income tax liability. A taxpayer&#8217;s
ability to use a foreign tax deduction or credit is subject to limitations under the Code. Shortly after any year for which it makes such
an election, the Fund will report to its shareholders the amount per share of such foreign income tax that must be included in each shareholder&#8217;s
gross income and the amount that may be available for the deduction or credit.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Foreign currency gain or loss on
foreign currency exchange contracts, non-U.S. dollar-denominated securities contracts, and non-U.S. dollar-denominated futures contracts,
options and forward contracts that are not section 1256 contracts (as defined below) generally will be treated as ordinary income and
loss.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Income from options on individual
securities written by the Fund will not be recognized by the Fund for tax purposes until an option is exercised, lapses or is subject
to a &#8220;closing transaction&#8221; (as defined by applicable regulations) pursuant to which the Fund&#8217;s obligations with respect
to the option are otherwise terminated. If the option lapses without exercise, the premiums received by the Fund from the writing of such
options will generally be characterized as short-term capital gain. If the Fund enters into a closing transaction, the difference between
the premiums received and the amount paid by the Fund to close out its position will generally be treated as short-term capital gain or
loss. If an option written by the Fund is exercised, thereby requiring the Fund to sell the underlying security, the premium will increase
the amount realized upon the sale of the security, and the character of any gain on such sale of the underlying security as short-term
or long-term capital gain will depend on the holding period of the Fund in the underlying security. Because the Fund will not have control
over the exercise of the options it writes, such exercises or other required sales of the underlying securities may cause the Fund to
realize gains or losses at inopportune times.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Index options that qualify as &#8220;section
1256 contracts&#8221; will generally be treated as &#8220;marked-to-market&#8221; for U.S. federal income tax purposes. As a result, the
Fund will generally recognize gain or loss on the last day of each taxable year equal to the difference between the value of the option
on that date and the adjusted basis of the option. The adjusted basis of the option will consequently be increased by such gain or decreased
by such loss. Any gain or loss with respect to options on indices and sectors that qualify as &#8220;section 1256 contracts&#8221; will
be treated as short-term capital gain or loss to the extent of 40% of such gain or loss and long-term capital gain or loss to the extent
of 60% of such gain or loss. Because the mark-to-market rules&#160;may cause the Fund to recognize gain in advance of the receipt of cash,
the Fund may be required to dispose of investments in order to meet its distribution requirements. &#8220;Mark-to-market&#8221; losses
may be suspended or otherwise limited if such losses are part of a straddle or similar transaction.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">34&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Taxation of Common Shareholders</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund will either distribute or
retain for reinvestment all or part of its net capital gain. If any such gain is retained, the Fund will be subject to a corporate income
tax on such retained amount. In that event, the Fund expects to report the retained amount as undistributed capital gain in a notice to
its common shareholders, each of whom, if subject to U.S. federal income tax on long-term capital gains, (i)&#160;will be required to
include in income for U.S. federal income tax purposes as long-term capital gain its share of such undistributed amounts, (ii)&#160;will
be entitled to credit its proportionate share of the tax paid by the Fund against its U.S. federal income tax liability and to claim refunds
to the extent that the credit exceeds such liability and (iii)&#160;will increase its basis in its common shares by the amount of undistributed
capital gains included in the common shareholder&#8217;s income less the tax deemed paid by the common shareholder under clause (ii).</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Distributions paid to you by the
Fund from its net capital gain, if any, that the Fund properly reports as capital gain dividends (&#8220;capital gain dividends&#8221;)
are taxable as long-term capital gains, regardless of how long you have held your common shares. All other dividends paid to you by the
Fund (including dividends from net short-term capital gains or tax-exempt interest, if any) from its current or accumulated earnings and
profits (&#8220;ordinary income dividends&#8221;) are generally subject to tax as ordinary income. Provided that certain holding period
and other requirements are met, ordinary income dividends (if properly reported by the Fund) may qualify (i)&#160;for the dividends received
deduction in the case of corporate common shareholders to the extent that the Fund&#8217;s income consists of dividend income from U.S.
corporations, (ii)&#160;in the case of individual common shareholders, as &#8220;qualified dividend income&#8221; eligible to be taxed
at long-term capital gains rates to the extent that the Fund receives qualified dividend income and (iii)&#160;in the case of individual
common shareholders, as &#8220;section 199A dividends&#8221; eligible for a 20% &#8220;qualified business income&#8221; deduction in tax
years beginning after December&#160;31, 2017 and before January&#160;1, 2026 to the extent the Fund receives ordinary REIT dividends,
reduced by allocable Fund expenses. Qualified dividend income is, in general, dividend income from taxable domestic corporations and certain
qualified foreign corporations (e.g., generally, foreign corporations incorporated in a possession of the United States or in certain
countries with a qualifying comprehensive tax treaty with the United States, or whose stock with respect to which such dividend is paid
is readily tradable on an established securities market in the United States). There can be no assurance as to what portion, if any, of
the Fund&#8217;s distributions will constitute qualified dividend income or be eligible for the dividends received deduction or &#8220;qualified
business income&#8221; deduction.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Any distributions you receive that
are in excess of the Fund&#8217;s current and accumulated earnings and profits will be treated as a return of capital to the extent of
your adjusted tax basis in your common shares, and thereafter as capital gain from the sale of common shares. The amount of any Fund distribution
that is treated as a return of capital will reduce your adjusted tax basis in your common shares, thereby increasing your potential gain
or reducing your potential loss on any subsequent sale or other disposition of your common shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Common shareholders may be entitled
to offset their capital gain dividends with capital losses. The Code contains a number of statutory provisions affecting when capital
losses may be offset against capital gain, and limiting the use of losses from certain investments and activities. Accordingly, common
shareholders that have capital losses are urged to consult their tax advisers.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Dividends and other taxable distributions
are taxable to you even though they are reinvested in additional common shares of the Fund. Dividends and other distributions paid by
the Fund are generally treated under the Code as received by you at the time the dividend or distribution is made. If, however, the Fund
pays you a dividend in January&#160;that was declared in the previous October, November&#160;or December&#160;to common shareholders of
record on a specified date in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being paid
by the Fund and received by you on December&#160;31 of the year in which the dividend was declared. In addition, certain other distributions
made after the close of the Fund&#8217;s taxable year may be &#8220;spilled back&#8221; and treated as paid by the Fund (except for purposes
of the 4% nondeductible excise tax) during such taxable year. In such case, you will be treated as having received such dividends in the
taxable year in which the distributions were actually made.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">35&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The price of common shares purchased
at any time may reflect the amount of a forthcoming distribution. Those purchasing common shares just prior to the record date of a distribution
will receive a distribution which will be taxable to them even though it represents, economically, a return of invested capital.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund will send you information
after the end of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The sale or other disposition of
common shares will generally result in capital gain or loss to you and will be long-term capital gain or loss if you have held such common
shares for more than one year at the time of sale. Any loss upon the sale or other disposition of common shares held for six months or
less will be treated as long-term capital loss to the extent of any capital gain dividends received (including amounts credited as an
undistributed capital gain dividend) by you with respect to such common shares. Any loss you recognize on a sale or other disposition
of common shares will be disallowed if you acquire other common shares (whether through the automatic reinvestment of dividends or otherwise)
within a 61-day period beginning 30 days before and ending 30 days after your sale or exchange of the common shares. In such case, your
tax basis in the common shares acquired will be adjusted to reflect the disallowed loss.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If the Fund liquidates, common shareholders
generally will realize capital gain or loss upon such liquidation in an amount equal to the difference between the amount of cash or other
property received by the common shareholder (including any property deemed received by reason of its being placed in a liquidating trust)
and the common shareholder&#8217;s adjusted tax basis in its common shares. Any such gain or loss will be long-term if the common shareholder
is treated as having a holding period in the Fund shares of greater than one year, and otherwise will be short-term.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Current U.S. federal income tax law
taxes both long-term and short-term capital gain of corporations at the rates applicable to ordinary income. For non-corporate taxpayers,
short-term capital gain is currently taxed at rates applicable to ordinary income while long-term capital gain generally is taxed at a
reduced maximum rate. The deductibility of capital losses is subject to limitations under the Code.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Certain U.S. holders who are individuals,
estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or a portion of their
&#8220;net investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale or other disposition
of the Fund&#8217;s common shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A common shareholder that is a nonresident
alien individual or a foreign corporation (a &#8220;foreign investor&#8221;) generally will be subject to U.S. federal withholding tax
at the rate of 30% (or possibly a lower rate provided by an applicable tax treaty) on ordinary income dividends (except as discussed below).
In general, U.S. federal withholding tax and U.S. federal income tax will not apply to any gain or income realized by a foreign investor
in respect of any distribution of net capital gain (including amounts credited as an undistributed capital gain dividend) or upon the
sale or other disposition of common shares of the Fund. Different tax consequences may result if the foreign investor is engaged in a
trade or business in the United States or, in the case of an individual, is present in the United States for 183 days or more during a
taxable year and certain other conditions are met. Foreign investors should consult their tax advisers regarding the tax consequences
of investing in the Fund&#8217;s common shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Ordinary income dividends properly
reported by a RIC are generally exempt from U.S. federal withholding tax where they (i)&#160;are paid in respect of the RIC&#8217;s &#8220;qualified
net interest income&#8221; (generally, its U.S.-source interest income, other than certain contingent interest and interest from obligations
of a corporation or partnership in which the RIC is at least a 10% shareholder, reduced by expenses that are allocable to such income)
or (ii)&#160;are paid in respect of the RIC&#8217;s &#8220;qualified short-term capital gains&#8221; (generally, the excess of the RIC&#8217;s
net short-term capital gain over its long-term capital loss for such taxable year). Depending on its circumstances, the Fund may report
all, some or none of its potentially eligible dividends as such qualified net interest income or as qualified short-term capital gains,
and/or treat such dividends, in whole or in part, as ineligible for this exemption from withholding. In order to qualify for this exemption
from withholding, a foreign investor needs to comply with applicable certification requirements relating to its non-U.S. status (including,
in general, furnishing an IRS Form&#160;W-8BEN, W-8BEN-E or substitute Form). In the case of common shares held through an intermediary,
the intermediary may have withheld even if the Fund reported the payment as qualified net interest income or qualified short-term capital
gain. Foreign investors should contact their intermediaries with respect to the application of these rules&#160;to their accounts. There
can be no assurance as to what portion of the Fund&#8217;s distributions would qualify for favorable treatment as qualified net interest
income or qualified short-term capital gains.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">36&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In addition, withholding at a rate
of 30% will apply to dividends paid in respect of common shares of the Fund held by or through certain foreign financial institutions
(including investment funds), unless such institution enters into an agreement with the Treasury to report, on an annual basis, information
with respect to shares in, and accounts maintained by, the institution to the extent such shares or accounts are held by certain U.S.
persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments. Accordingly,
the entity through which common shares of the Fund are held will affect the determination of whether such withholding is required. Similarly,
dividends paid in respect of common shares of the Fund held by an investor that is a non-financial foreign entity that does not qualify
under certain exemptions will be subject to withholding at a rate of 30%, unless such entity either (i)&#160;certifies that such entity
does not have any &#8220;substantial United States owners&#8221; or (ii)&#160;provides certain information regarding the entity&#8217;s
&#8220;substantial United States owners,&#8221; which the Fund or applicable withholding agent will in turn provide to the Secretary of
the Treasury. An intergovernmental agreement between the United States and an applicable foreign country, or future Treasury regulations
or other guidance, may modify these requirements. The Fund will not pay any additional amounts to common shareholders in respect of any
amounts withheld. Foreign investors are encouraged to consult with their tax advisers regarding the possible implications of these rules&#160;on
their investment in the Fund&#8217;s common shares.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">U.S. federal backup withholding tax
may be required on dividends, distributions and sale proceeds payable to certain non-exempt common shareholders who fail to supply their
correct taxpayer identification number (in the case of individuals, generally, their social security number) or to make required certifications,
or who are otherwise subject to backup withholding. Backup withholding is not an additional tax and any amount withheld may be refunded
or credited against your U.S. federal income tax liability, if any, provided that you timely furnish the required information to the IRS.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Ordinary income dividends, capital
gain dividends, and gain from the sale or other disposition of common shares of the Fund also may be subject to state, local, and/or foreign
taxes. Common shareholders are urged to consult their own tax advisers regarding specific questions about U.S. federal, state, local or
foreign tax consequences to them of investing in the Fund.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><strong>The foregoing is a general
and abbreviated summary of certain provisions of the Code and the Treasury regulations currently in effect as they directly govern the
taxation of the Fund and its common shareholders. These provisions are subject to change by legislative or administrative action, and
any such change may be retroactive. A more detailed discussion of the tax rules&#160;applicable to the Fund and its common shareholders
can be found in the SAI that is incorporated by reference into this Prospectus. Common shareholders are urged to consult their tax advisers
regarding specific questions as to U.S. federal, state, local and foreign income or other taxes.</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Please refer to the SAI for more
detailed information. You are urged to consult your tax adviser.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_018_integixAnchor"></span><strong>TAXATION
OF HOLDERS OF RIGHTS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The value of a right will not be
includible in the income of a common shareholder at the time the right is issued.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The basis of a right issued to a
common shareholder will be zero, and the basis of the share with respect to which the subscription right was issued (the old share) will
remain unchanged, unless either (a)&#160;the fair market value of the right on the date of distribution is at least 15% of the fair market
value of the old share, or (b)&#160;such shareholder affirmatively elects (in the manner set out in Treasury regulations under the Code)
to allocate to the subscription right a portion of the basis of the old share. If either (a)&#160;or (b)&#160;applies, then except as
described below such shareholder must allocate basis between the old share and the right in proportion to their fair market values on
the date of distribution.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The basis of a right purchased in
the market will generally be its purchase price.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">37&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The holding period of a right issued
to a common shareholder will include the holding period of the old share. No gain or loss will be recognized by a common shareholder upon
the exercise of a right.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">No loss will be recognized by a common
shareholder if a right distributed to such common shareholder expires unexercised because the basis of the old share may be allocated
to a right only if the right is exercised. If a right that has been purchased in the market expires unexercised, there will be a recognized
loss equal to the basis of the right.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Any gain or loss on the sale of a
right will be a capital gain or loss if the right is held as a capital asset (which in the case of rights issued to common shareholders
will depend on whether the old common shares are held as a capital asset), and will be a long-term capital gain or loss if the holding
period is deemed to exceed one year.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_019_integixAnchor"></span><strong>CERTAIN
PROVISIONS IN THE CHARTER AND BYLAWS</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter and the bylaws of the
Fund (the &#8220;Bylaws&#8221;) contain provisions that could make it more difficult for a potential acquiror to acquire the Fund by means
of a tender offer, proxy contest or otherwise. These provisions are designed to discourage certain coercive takeover practices and inadequate
takeover bids and to encourage persons seeking to acquire control of the Fund to negotiate first with the Board. The Fund believes that
the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other
things, the negotiation of such proposals may improve their terms.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><i>Classified Board</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund&#8217;s Directors (other
than any Directors elected solely by the holders of one or more classes or series of preferred shares in connection with dividend arrearages)
are divided into three classes serving staggered three-year terms. Upon expiration of their current terms, Directors of each class will
be elected to serve until the third successive annual meeting of shareholders after the meeting at which they were elected and until their
successors are duly elected and qualify, and each year one class of Directors will be nominated for election by the shareholders. A classified
board may render a change in control of the Fund or the removal of the Fund&#8217;s incumbent management more difficult. The Fund believes,
however, that the longer time required to elect a majority of a classified board will help to ensure the continuity and stability of the
Fund&#8217;s management and policies.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Election of Directors</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter and the Bylaws provide
that the affirmative vote of the holders of a majority of the shares outstanding and entitled to vote in the election of Directors will
be required to elect a Director. Pursuant to the Charter, the Board may amend the Bylaws from time to time to alter the vote required
to elect a Director.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Number of Directors; Vacancies; Removal</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter provides that the number
of Directors may be increased or decreased only by the Board in accordance with the Bylaws or in accordance with the Charter, but shall
never be less than the minimum required by the Maryland General Corporation Law, which is one. The Bylaws provide that a majority of the
entire Board may at any time establish, increase or decrease the number of Directors. However, unless the Bylaws are amended, the number
of Directors cannot be less than the minimum number required by the Maryland General Corporation Law or more than 10.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund has elected to be subject
to the provision of Subtitle 8 of Title 3 of the Maryland General Corporation Law regarding the filling of vacancies on the Board. For
that reason, except as may be provided by the Board in setting the terms of any class or series of preferred shares, any and all vacancies
on the Board may be filled only by the affirmative vote of a majority of the Directors remaining in office, even if the remaining Directors
do not constitute a quorum, and any Director elected to fill a vacancy will serve for the remainder of the full term of the directorship
in which the vacancy occurred and until a successor is duly elected and qualifies, subject to any applicable requirements of the Investment
Company Act.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">38&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter provides that, subject
to the rights of holders of one or more classes or series of preferred shares, a Director may be removed only for cause, as defined in
the Charter, and then only by the affirmative vote of shareholders entitled to cast at least two-thirds of the votes entitled to be cast
in the election of Directors.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Action by Shareholders</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under the Maryland General Corporation
Law, common shareholders may act only at an annual or special meeting of shareholders or, unless the charter provides for shareholder
action by less than unanimous written consent (which is not the case for the Charter), by unanimous consent in writing or by electronic
transmission in lieu of a meeting. These provisions, combined with the requirements of the Bylaws regarding the calling of a shareholder-requested
special meeting of shareholders discussed below, may have the effect of delaying consideration of a shareholder proposal until the next
annual meeting of shareholders.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Advance Notice Provisions for Shareholder Nominations and Shareholder
Proposals</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Bylaws provide that, with respect
to an annual meeting of shareholders, the nomination of individuals for election as Directors and the proposal of other business to be
considered by the Fund&#8217;s shareholders may be made only (1)&#160;pursuant to the Fund&#8217;s notice of the meeting, (2)&#160;by
or at the direction of the Board or (3)&#160;by a shareholder who (A)&#160;is a shareholder of record both at the time the shareholder
provides the notice required by the Bylaws and at the time of the annual meeting, (B)&#160;is entitled to vote at the meeting in the election
of such individuals as Directors or on such other business and (C)&#160;has complied with the advance notice requirements of, and provided
the information required by, the Bylaws. With respect to special meetings of the Fund&#8217;s shareholders, only the business specified
in the notice of the meeting may be brought before the meeting. Nominations of individuals for election as Directors at a special meeting
of shareholders may be made only (1)&#160;by or at the direction of the Board or (2)&#160;if the special meeting has been called in accordance
with the Bylaws for the purpose of electing Directors, by any shareholder who (A)&#160;is a shareholder of record both at the time the
shareholder provides the notice required by the Bylaws and at the time of the special meeting, (B)&#160;is entitled to vote at the meeting
in the election of each individual so nominated and (C)&#160;has complied with the advance notice requirements of, and provided the information
required by, the Bylaws.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Calling of Special Meetings of Shareholders</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Bylaws provide that special meetings
of the Fund&#8217;s shareholders may be called by the Board, the Chairman of the Board and certain of the Fund&#8217;s officers. The Bylaws
also provide that, subject to the satisfaction of certain procedural and informational requirements by the shareholders requesting the
meeting, a special meeting of shareholders must be called by the secretary of the Fund to act on any matter that may properly be considered
at a meeting of shareholders upon the written request of shareholders entitled to cast not less than a majority of all the votes entitled
to be cast on such matter at such meeting. The Fund&#8217;s secretary will inform the requesting shareholders of the reasonably estimated
cost of preparing and mailing or delivering the notice of meeting (including the Fund&#8217;s proxy materials), and the requesting shareholders
must pay the estimated cost before the secretary may prepare and mail or deliver notice of the special meeting.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Approval of Extraordinary Corporate Action; Amendment of the Charter
and Bylaws</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under Maryland law, a Maryland corporation
generally cannot dissolve, amend its charter, merge, consolidate, convert, sell all or substantially all of its assets or engage in a
statutory stock exchange, unless the action is declared advisable by the corporation&#8217;s board of directors and approved by the affirmative
vote of shareholders entitled to cast at least two-thirds of the votes entitled to be cast on the matter. However, a Maryland corporation
may provide in its charter for approval of these matters by a lesser percentage, but not less than a majority of all of the votes entitled
to be cast on the matter.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">39&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter generally provides for
approval of charter amendments and extraordinary transactions by the shareholders entitled to cast a majority of the votes entitled to
be cast on the matter. However, the Charter provides that the following matters require the approval of shareholders entitled to cast
at least 80 percent of the votes entitled to be cast on such matter:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%">
  <tr style="vertical-align:top;text-align:justify">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">amendments to the provisions of the Charter relating to, or inconsistent with, the classification of the Board,
        the power of the Board to fix the number of Directors and to fill vacancies on the Board, the removal of Directors and, except as otherwise
        provided in the Bylaws, the vote required to elect a Director;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%">
  <tr style="vertical-align:top;text-align:justify">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">charter amendments that would make the Fund&#8217;s common shares redeemable securities (within the meaning
        of the Investment Company Act);</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%">
  <tr style="vertical-align:top;text-align:justify">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the conversion of the Fund, whether by merger or otherwise, from a closed-end investment company into an open-end
        investment company;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%">
  <tr style="vertical-align:top;text-align:justify">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">the liquidation or dissolution of the Fund or charter amendments to effect the liquidation or dissolution of
        the Fund;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%">
  <tr style="vertical-align:top;text-align:justify">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">amendments to the provisions of the Charter relating to, or inconsistent with, the vote required to approve
        charter amendments and extraordinary transactions;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%">
  <tr style="vertical-align:top;text-align:justify">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">any merger, consolidation, stock exchange or sale or exchange of all or substantially all of the Fund&#8217;s
        assets that the Maryland General Corporation Law requires be approved by the Fund&#8217;s shareholders; or</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0;margin-bottom:0;width:100%">
  <tr style="vertical-align:top;text-align:justify">
    <td style="width:0.5in">&#160;</td>
    <td style="width:0.25in;text-align:left"><span style="font-size:10pt">&#9679;</span></td>
    <td style="text-align:justify">any transaction between the Fund, on the one hand, and any person or group of persons acting together that
        is entitled to exercise or direct the exercise, or acquire the right to exercise or direct the exercise, directly or indirectly (other
        than solely by virtue of a revocable proxy), of one-tenth or more of the voting power in the election of Directors generally, or any person
        controlling, controlled by or under common control with any such person or member of such a group (collectively &#8220;Transacting Persons&#8221;),
        on the other hand.</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">However, if such amendment, proposal
or transaction is approved by at least two-thirds of the Fund&#8217;s continuing directors (in addition to approval by the Board), such
amendment, proposal or transaction may instead be approved by the affirmative vote of shareholders entitled to cast a majority of all
the votes entitled to be cast on such amendment, proposal or transaction, provided that any transaction with Transacting Persons that
would not otherwise require shareholder approval under the Maryland General Corporation Law would not require further shareholder approval
unless another provision of the Charter or the Bylaws requires such approval.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The &#8220;continuing directors&#8221;
are defined in the Charter as its current Directors and Directors whose nomination for election by the Fund&#8217;s shareholders or whose
election by the Directors to fill a vacancy on the Board is approved by the current Directors or any successor Directors whose nomination
for election by the shareholders or whose election by the Board to fill vacancies is approved by a majority of the continuing directors
or successor continuing directors then serving on the Board.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter and the Bylaws provide
that the Board has the exclusive power to adopt, alter or repeal any provision of the Bylaws and to make new Bylaws.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Subtitle 8</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Subtitle 8 of Title 3 of the Maryland
General Corporation Law permits a Maryland corporation with a class of equity securities registered under the Exchange Act and at least
three independent directors to elect to be subject, by provision in its charter or bylaws or a resolution of its board of directors and
notwithstanding any contrary provision in the charter or bylaws, to any or all of five provisions of the Maryland General Corporation
Law that provide, respectively, for:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt" width="100%">
  <tr style="vertical-align:top">
    <td style="width:0.75in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td>a classified board;</td></tr>
  <tr style="vertical-align:top">
    <td style="width:0.75in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td>a two-thirds vote requirement for removing a director;</td></tr>
  <tr style="vertical-align:top">
    <td style="width:0.75in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td>a requirement that the number of directors be fixed only by vote of the board of directors;</td></tr>
  <tr style="vertical-align:top">
    <td style="width:0.75in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td>a requirement that a vacancy on the board of directors be filled only by a vote of the remaining directors in office and for the remainder
        of the full term of the class of directors in which the vacancy occurred and until a successor is elected and qualifies; and</td></tr>
  <tr style="vertical-align:top">
    <td style="width:0.75in">&#160;</td>
    <td style="width:0.25in"><span style="font-size:10pt">&#9679;</span></td>
    <td>a majority requirement for the calling of a shareholder-requested special meeting of shareholders.</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">40&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Charter sets forth our election
to be subject to the provisions of Subtitle 8 relating to the filling of vacancies on the Board. Through provisions in the Charter and
the Bylaws unrelated to Subtitle 8, we also (i)&#160;have a classified board, (ii)&#160;require a two-thirds vote to remove a Director,
which removal also requires cause, (iii)&#160;vest in the Board the exclusive power to fix the number of directorships and (iv)&#160;require,
unless called by the Board, the Chairman of the Board or certain of the Fund&#8217;s officers, the written request of shareholders entitled
to cast a majority of all the votes entitled to be cast on any matter that may properly be considered at a meeting of shareholders to
call a special meeting to act on such matter.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Exclusive Forum</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Bylaws provide that, unless we
consent in writing to the selection of an alternative forum, the courts in the State of Maryland or a federal court sitting in the State
of Maryland, will be the sole and exclusive forum for: (i)&#160;any derivative action or proceeding brought on behalf of the Fund, (ii)&#160;any
action asserting a claim of breach of a fiduciary duty owed by any of the Fund&#8217;s Directors, officers or employees to the Fund or
to our shareholders, (iii)&#160;any action asserting a claim against the Fund or any of the Fund&#8217;s Directors, officers or employees
arising pursuant to any provision of the Maryland General Corporation Law or the Charter or the Bylaws, or (iv)&#160;any action otherwise
asserting a claim against the Fund or any of the Fund&#8217;s Directors, officers or employees that is governed by the internal corporate
claims doctrine.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Although we believe that this provision
will benefit us by limiting costly and time-consuming litigation in multiple forums and by providing increased consistency in the application
of applicable law, this provision may limit the ability of a shareholder to bring a claim in a judicial forum that such shareholder finds
favorable for disputes with us or any of our directors, officers or employees, which may discourage such lawsuits against us and our directors,
officers and employees.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><i>Limitation of Liability</i></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">Maryland
law permits a Maryland corporation to include a provision in its charter limiting the liability of its directors and officers to the corporation
and its shareholders for money damages, except for liability resulting from (a)&#160;actual receipt of an improper benefit or profit in
money, property or services or (b)&#160;active and deliberate dishonesty that is established by a final judgment and is material to the
cause of action. The Charter contains a provision that eliminates the Directors&#8217; and officers&#8217; liability for money damages
to the maximum extent permitted by Maryland law and the Investment Company Act. </span>This limitation of liability will be limited to
the extent superseded by applicable federal securities laws.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_020_integixAnchor"></span><strong>CLOSED-END
FUND STRUCTURE</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is a diversified, closed-end
management investment company (commonly referred to as a closed-end fund). Closed-end funds differ from open-end funds (which are generally
referred to as mutual funds) in that closed-end funds generally list their shares for trading on a stock exchange and do not redeem their
shares at the request of the shareholder. This means that if you wish to sell your shares of a closed-end fund, you must sell them to
a third party, generally by trading them on the stock exchange like any other stock at the prevailing market price at that time. In a
mutual fund, if the shareholder wishes to sell shares of the fund, the mutual fund will redeem or buy back the shares at NAV. Also, mutual
funds generally offer new shares on a continuous basis to new investors and closed-end funds generally do not. The continuous inflows
and outflows of assets in a mutual fund can make it difficult to manage the fund&#8217;s investments. By comparison, closed-end funds
are generally able to stay more fully invested in securities that are consistent with their investment objectives and also have greater
flexibility to make certain types of investments and to use certain investment strategies, such as financial leverage and investments
in illiquid securities.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">41&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Shares of closed-end funds frequently
trade at a discount to their NAV. Because of this possibility and the recognition that any such discount may not be in the interest of
shareholders, the Board might consider from time to time engaging in open-market repurchases, tender offers for shares or other programs
intended to reduce the discount. We cannot guarantee or assure, however, that the Board will decide to engage in any of these actions.
Nor is there any guarantee or assurance that such actions, if undertaken, would result in the shares trading at a price equal or close
to the NAV. See &#8220;Repurchase of Common Shares&#8221; below and &#8220;Repurchase of Common Shares&#8221; in the SAI. The Board might
also consider converting the Fund to an open-end mutual fund, which would also require a vote of the shareholders of the Fund.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_021_integixAnchor"></span><strong>REPURCHASE
OF COMMON SHARES</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Because the Fund is a closed-end
management investment company, its shareholders will not have the right to cause the Fund to redeem their common shares. Instead, the
Fund&#8217;s common shares will trade in the open market at a price that will be a function of several direct and indirect factors, including
dividend levels (which are in turn affected by expenses), net asset value, dividend stability, relative demand for and supply of such
shares in the market, general market and economic conditions and other factors. Notice is hereby given in accordance with Section&#160;23(c)&#160;of
the Investment Company Act that the Fund may purchase at market prices from time to time its common shares in the open market but is under
no obligation to do so.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Notwithstanding the foregoing, at
any time if the Fund has preferred shares outstanding, the Fund may not purchase, redeem or otherwise acquire any of its common shares
unless (i)&#160;all accrued preferred share dividends, if any, have been paid and (ii)&#160;at the time of such purchase, redemption or
acquisition, the Fund has an asset coverage of at least 200% after deducting the amount of such purchase, redemption or acquisition, as
applicable. Similarly, if the Fund has outstanding indebtedness, the Fund may not purchase, redeem or acquire its capital stock unless
the Fund has an asset coverage of at least 300% after deducting the amount of such purchase, redemption or acquisition, as applicable.
See &#8220;Leverage&#8221;. Any service fees incurred in connection with any tender offer made by the Fund will be borne by the Fund and
will not reduce the stated consideration to be paid to tendering shareholders.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Subject to its investment restrictions,
the Fund may borrow to finance the repurchase of common shares or to make a tender offer for those shares. Interest on any borrowings
to finance share repurchase transactions or the accumulation of cash by the Fund in anticipation of share repurchases or tenders will
reduce the Fund&#8217;s net income. Any share repurchase, tender offer or borrowing approved by the Board would have to comply with the
NYSE listing requirements and the Exchange Act, the Investment Company Act, and the rules&#160;and regulations thereunder.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">There is no assurance that, if action
is undertaken to repurchase or tender for common shares, such action will result in the Fund&#8217;s common shares trading at a price
that approximates their net asset value. Although share repurchases and tenders could have a favorable effect on the market price of the
Fund&#8217;s common shares, shareholders should be aware that the acquisition of common shares by the Fund will decrease the total net
assets of the Fund and, therefore, may have the effect of increasing the Fund&#8217;s expense ratio and decreasing the asset coverage
with respect to any preferred shares outstanding and any amounts borrowed. For additional information, see &#8220;Repurchase of Common
Shares&#8221; in the SAI.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_022_integixAnchor"></span><strong>PLAN
OF DISTRIBUTION</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">We may sell common shares, including
through a rights offering, through underwriters or dealers, directly to one or more purchasers (including through a rights offering),
through agents, to or through underwriters or dealers, or through a combination of any such methods of sale. The applicable Prospectus
Supplement will identify any underwriter or agent involved in the offer and sale of our common shares, any sales loads, discounts, commissions,
fees or other compensation paid to any underwriter, dealer or agent, the offering price, net proceeds and use of proceeds and the terms
of any sale. In the case of a rights offering, the applicable Prospectus Supplement will set forth the number of our common shares issuable
upon the exercise of each right and the other terms of such rights offering.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The distribution of our common shares
may be effected from time to time in one or more transactions at a fixed price or prices, which may be changed, at prevailing market prices
at the time of sale, at prices related to such prevailing market prices, or at negotiated prices. Sales of our common shares may be made
in transactions that are deemed to be &#8220;at the market&#8221; as defined in Rule&#160;415 under the Securities Act, including sales
made directly on the NYSE or sales made to or through a market maker other than on an exchange.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">42&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">We may sell our common shares directly
to, and solicit offers from, institutional investors or others who may be deemed to be underwriters as defined in the Securities Act for
any resales of the securities. In this case, no underwriters or agents would be involved. We may use electronic media, including the Internet,
to sell offered securities directly.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In connection with the sale of our
common shares, underwriters or agents may receive compensation from us in the form of discounts, concessions or commissions. Underwriters
may sell our common shares to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions
from the underwriters and/or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate
in the distribution of our common shares may be deemed to be underwriters under the Securities Act, and any discounts and commissions
they receive from us and any profit realized by them on the resale of our common shares may be deemed to be underwriting discounts and
commissions under the Securities Act. Any such underwriter or agent will be identified and any such compensation received from us will
be described in the applicable Prospectus Supplement. The maximum amount of compensation to be received by any Financial Industry Regulatory
Authority member or independent broker-dealer will not exceed eight percent for the sale of any securities being offered pursuant to Rule&#160;415
under the Securities Act. We will not pay any compensation to any underwriter or agent in the form of warrants, options, consulting or
structuring fees or similar arrangements. In connection with any rights offering to existing shareholders, we may enter into a standby
underwriting arrangement with one or more underwriters pursuant to which the underwriter(s)&#160;will purchase common shares remaining
unsubscribed after the rights offering.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If a Prospectus Supplement so indicates,
we may grant the underwriters an option to purchase additional common shares at the public offering price, less the underwriting discounts
and commissions, within 45 days from the date of the Prospectus Supplement, to cover any over-allotments.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Under agreements into which we may
enter, underwriters, dealers and agents who participate in the distribution of our common shares may be entitled to indemnification by
us against certain liabilities, including liabilities under the Securities Act. Underwriters, dealers and agents may engage in transactions
with us, or perform services for us, in the ordinary course of business.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If so indicated in the applicable
Prospectus Supplement, we will ourselves, or will authorize underwriters or other persons acting as our agents to solicit offers by certain
institutions to purchase our common shares from us pursuant to contracts providing for payment and delivery on a future date. Institutions
with which such contacts may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational
and charitable institutions and others, but in all cases such institutions must be approved by us. The obligation of any purchaser under
any such contract will be subject to the condition that the purchase of the common shares shall not at the time of delivery be prohibited
under the laws of the jurisdiction to which such purchaser is subject. The underwriters and such other agents will not have any responsibility
in respect of the validity or performance of such contracts. Such contracts will be subject only to those conditions set forth in the
Prospectus Supplement, and the Prospectus Supplement will set forth the commission payable for solicitation of such contracts.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">To the extent permitted under the
Investment Company Act and the rules&#160;and regulations promulgated thereunder, the underwriters may from time to time act as brokers
or dealers and receive fees in connection with the execution of our portfolio transactions after the underwriters have ceased to be underwriters
and, subject to certain restrictions, each may act as a broker while it is an underwriter.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">A Prospectus and accompanying Prospectus
Supplement in electronic form may be made available on the websites maintained by underwriters. The underwriters may agree to allocate
a number of securities for sale to their online brokerage account holders. Such allocations of securities for Internet distributions will
be made on the same basis as other allocations. In addition, securities may be sold by the underwriters to securities dealers who resell
securities to online brokerage account holders.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In order to comply with the securities
laws of certain states, if applicable, our common shares offered hereby will be sold in such jurisdictions only through registered or
licensed brokers or dealers.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">43&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_023_integixAnchor"></span></p></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>INCORPORATION BY REFERENCE</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">This Prospectus is part of a registration
statement that we have filed with the SEC. We are allowed to &#8220;incorporate by reference&#8221; the information that we file with
the SEC, which means that we can disclose important information to you by referring you to those documents. We incorporate by reference
into this Prospectus the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d)&#160;of
the Exchange Act, including any filings on or after the date of this Prospectus from the date of filing (excluding any information furnished,
rather than filed), until we have sold all of the offered securities to which this Prospectus and any accompanying prospectus supplement
relates or the offering is otherwise terminated. The information incorporated by reference is an important part of this Prospectus. Any
statement in a document incorporated by reference into this Prospectus will be deemed to be automatically modified or superseded to the
extent a statement contained in (1)&#160;this Prospectus or (2)&#160;any other subsequently filed document that is incorporated by reference
into this Prospectus modifies or supersedes such statement. The documents incorporated by reference herein include:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr>
    <td style="width:5%">&#160;</td>
    <td style="vertical-align:top;width:3%"><span style="font-size:10pt">&#9679;</span></td>
    <td style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund&#8217;s SAI, dated August 26,
        2024, filed with this Prospectus;</span></td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr>
    <td style="width:5%">&#160;</td>
    <td style="vertical-align:top;width:3%"><span style="font-size:10pt">&#9679;</span></td>
    <td style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">our&#160;<span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract:exhibit">annual
        report</a></span></span>&#160;on Form&#160;N-CSR&#160;for the fiscal year ended December&#160;31, 2023, filed with the SEC on March&#160;6,
        2024;</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr>
    <td style="width:5%">&#160;</td>
    <td style="vertical-align:top;width:3%"><span style="font-size:10pt">&#9679;</span></td>
    <td style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">our&#160;<span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465923097217/tm2318740d1_ncsrs.htm" style="-sec-extract:exhibit">semi-annual
        report</a>&#160;</span></span>on Form&#160;N-CSR&#160;for the fiscal period ended June&#160;30, 2023, filed with the SEC on August&#160;31,
        2023; and</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr>
    <td style="width:5%">&#160;</td>
    <td style="vertical-align:top;width:3%"><span style="font-size:10pt">&#9679;</span></td>
    <td style="vertical-align:top;width:1%">&#160;</td>
    <td style="vertical-align:top"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">the&#160;<span style="color:#0563c1"><a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465912077964/a12-27073_18a12b.htm" style="-sec-extract:exhibit">description
        of the Fund&#8217;s common shares</a></span></span>&#160;contained in our Registration Statement on Form&#160;8-A&#160;(File&#160;No.&#160;811-22535),&#160;filed
        with the SEC on March&#160;22, 2011, including any amendment or report filed for the purpose of updating such description prior to the
        termination of the offering registered hereby.</td></tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Fund will provide without charge
to each person, including any beneficial owner, to whom this Prospectus is delivered, upon written or oral request, a copy of any and
all of the documents that have been or may be incorporated by reference in this Prospectus or the accompanying prospectus supplement.
You should direct requests for documents by calling (888) 818-5298.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.25in">The Fund makes available this Prospectus,
SAI, the Fund&#8217;s proxy voting record and the Fund&#8217;s annual and semi-annual reports, free of charge, at www.arespublicfunds.com.
You may also obtain this Prospectus, the SAI, other documents incorporated by reference and other information the Fund files electronically,
including reports and proxy statements, on the SEC website (http://www.sec.gov) or with the payment of a duplication fee, by electronic
request at publicinfo@sec.gov. Information contained in, or that can be accessed through, the Fund&#8217;s website is not incorporated
by reference into this Prospectus and should not be considered to be part of this Prospectus or the accompanying prospectus supplement.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span id="a_024_integixAnchor"></span><strong>PRIVACY
PRINCIPLES OF THE FUND</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund is committed to maintaining
the privacy of its shareholders and to safeguarding their nonpublic personal information. The following information is provided to help
you understand what personal information the Fund collects, how the Fund protects that information and why, in certain cases, the Fund
may share information with select other parties.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Generally, the Fund will not receive
any non-public personal information about common shareholders of the Fund, although certain shareholders&#8217; non-public information
may become available to the Fund. The non-public personal information that we may receive falls into the following categories:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>Information
the Fund receives from shareholders, whether we receive it orally, in writing or electronically. This includes shareholders&#8217; communications
to the Fund concerning their investment;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>Information
about shareholders&#8217; transactions and history with the Fund; or</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>Other general
information that we may obtain about shareholders, such as demographic and contact information such as address.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">44&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund does not disclose any non-public
personal information about shareholders, except:</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>to the Fund&#8217;s
affiliates (such as our investment adviser) and their employees that have a legitimate business need for the information;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>to the Fund&#8217;s
service providers (such as our administrator, accountants, attorneys, custodians, transfer agent, underwriter and proxy solicitors) and
their employees as is necessary to service shareholder accounts or otherwise provide the applicable service;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>to comply with
court orders, subpoenas, lawful discovery requests, or other legal or regulatory requirements; or</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span>&#9679; </span>as allowed or
required by applicable law or regulation.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">When the Fund shares non-public shareholder
personal information referred to above, the information is made available for limited business purposes and under controlled circumstances
designed to protect our shareholders&#8217; privacy. The Fund does not permit use of shareholder information for any non-business or marketing
purpose, nor does the Fund permit third parties to rent, sell, trade or otherwise release or disclose information to any other party.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">The Fund&#8217;s service providers,
such as its Adviser, administrator, and transfer agent, are required to maintain physical, electronic, and procedural safeguards to protect
shareholder nonpublic personal information; to prevent unauthorized access or use; and to dispose of such information when it is no longer
required.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">Personnel of affiliates may access
shareholder information only for business purposes. The degree of access is based on the sensitivity of the information and on personnel
need for the information to service a shareholder&#8217;s account or comply with legal requirements.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">If a shareholder ceases to be a shareholder,
the Fund will adhere to the privacy policies and practices as described above. The Fund may choose to modify its privacy policies at any
time. Before it does so, it will notify shareholders and provide a description of its privacy policy.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in">In the event of a corporate change
in control resulting from, for example, a sale to, or merger with, another entity, or in the event of a sale of assets, the Fund reserves
the right to transfer shareholders&#8217; non-public personal information to the new party in control or the party acquiring assets.</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="text-align:center;font-size:10pt;margin-top:0pt;margin-bottom:0pt">45&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p></div>


<div style="font:10pt Times New Roman, Times, Serif">


<p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Up to $500,000,000
of Common Stock</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>ARES DYNAMIC CREDIT
ALLOCATION FUND,&#160;INC.</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Common Stock</strong>&#160;</span></p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>Rights to Purchase
Common Stock</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<div style="margin:3pt auto;width:25%">


<div style="font-size:1pt;border-top:Black 1pt solid">&#160;</div></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><span style="font-size:10pt"><strong>PROSPECTUS</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:bold 10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">August 26<span style="font-size:10pt"><strong>,
2024</strong></span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="margin:0pt">&#160;</p></div>


<div style="break-before:page;margin-top:6pt;margin-bottom:12pt">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>&#160;</strong>&#160;</p>


<p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>ARES DYNAMIC CREDIT ALLOCATION FUND, INC. </strong></p>


<p style="font:18pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>Up to $150,000,000 of Common Stock </strong></p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>&#160;</strong></p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>&#160;</strong></p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>&#160;</strong></p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>PROSPECTUS SUPPLEMENT </strong></p>


<p style="font:14pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>&#160;</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"><strong>September 3, 2024</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>&#160;</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>&#160;</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>&#160;</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>&#160;</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0">&#160;</p>


<p style="text-align:justify;font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>Until September 28, 2024 (25 days after the
date of this Prospectus Supplement), all dealers that buy, sell or trade the common shares, whether or not participating in this offering,
may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as underwriters.
</strong></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-indent:0in">&#160;</p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-indent:0in">&#160;</p>


<div style="margin-top:12pt;margin-bottom:6pt;border-bottom:Black 1pt solid">


<p style="margin:0pt">&#160;</p></div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-indent:0in">&#160;</p></div></div>


<div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2416373d6_sai.htm" BannerFilePath="/apps/files/files/jms2files/gofiler/tm2416373-6/tm2416373-6_424b2seq1" --><div>

</div><p style="margin: 0">&#160;&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Ares Dynamic Credit Allocation Fund,&#160;Inc.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>STATEMENT OF ADDITIONAL INFORMATION</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ares
Dynamic Credit Allocation Fund,&#160;Inc. (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company. This Statement
of Additional Information (&#8220;SAI&#8221;) relating to common stock, par value $0.001 per share (&#8220;common shares&#8221;), of
the Fund does not constitute a prospectus, but should be read in conjunction with the prospectus relating thereto dated </span><span style="font-style: normal; font-weight: normal">August
26</span>, 2024 and any related prospectus supplement. This SAI, which is not a prospectus, does not include all information that a prospective
investor should consider before purchasing common shares, and investors should obtain and read the prospectus and any related prospectus
supplement prior to purchasing such shares. A copy of the prospectus and any related prospectus supplement may be obtained without charge
by calling (888) 818-5298. You may also obtain a copy of the prospectus on the Securities and Exchange Commission&#8217;s (the &#8220;SEC&#8221;)
website (http://www.sec.gov). Capitalized terms used but not defined in this SAI have the meanings ascribed to them in the prospectus.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">References
to the Investment Company Act of 1940, as amended</span>, together with the rules&#160;and regulations promulgated thereunder (the &#8220;Investment
Company Act&#8221;), or other applicable law, will include any rules&#160;promulgated thereunder and any guidance, interpretations or
modifications by the SEC, SEC staff or other authority with appropriate jurisdiction, including court interpretations, and exemptive,
no-action or other relief or permission from the SEC, SEC staff or other authority.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_002" style="-sec-extract: exhibit">THE
    FUND</a></span></td>
    <td style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_002" style="-sec-extract: exhibit">1</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_003" style="-sec-extract: exhibit">INVESTMENT
    OBJECTIVE AND POLICIES</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_003" style="-sec-extract: exhibit">1</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_004" style="-sec-extract: exhibit">MANAGEMENT
    OF THE FUND</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_004" style="-sec-extract: exhibit">2</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_005" style="-sec-extract: exhibit">PORTFOLIO
    TRANSACTIONS</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_005" style="-sec-extract: exhibit">9</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_006" style="-sec-extract: exhibit">CONFLICTS
    OF INTEREST</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_006" style="-sec-extract: exhibit">10</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_007" style="-sec-extract: exhibit">DESCRIPTION
    OF SHARES</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_007" style="-sec-extract: exhibit">12</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_008" style="-sec-extract: exhibit">REPURCHASE
    OF COMMON SHARES</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_008" style="-sec-extract: exhibit">12</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_009" style="-sec-extract: exhibit">TAX
    MATTERS</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_009" style="-sec-extract: exhibit">13</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_010" style="-sec-extract: exhibit">INDEPENDENT
    REGISTERED PUBLIC ACCOUNTING FIRM</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_010" style="-sec-extract: exhibit">20</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_011" style="-sec-extract: exhibit">CONTROL
    PERSONS AND PRINCIPAL HOLDERS OF SECURITIES</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_011" style="-sec-extract: exhibit">20</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_012" style="-sec-extract: exhibit">INCORPORATION
    BY REFERENCE</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_012" style="-sec-extract: exhibit">22</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_013" style="-sec-extract: exhibit">FINANCIAL
    STATEMENTS</a></span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sai_013" style="-sec-extract: exhibit">23</a></span></td></tr>
  </table><div>
</div><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>This Statement of Additional Information is
dated August 26, 2024.</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE FUND</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund is a diversified,
closed-end management investment company registered under the Investment Company Act. The Fund was organized as a Maryland corporation
on March&#160;14, 2011, pursuant to the charter of the Fund (the &#8220;Charter&#8221;), which is governed by the laws of the State of
Maryland. The Fund&#8217;s investment adviser is Ares Capital Management II LLC (the &#8220;Adviser&#8221;).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common shares of the Fund are listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;ARDC.&#8221; As of August
6, 2024</span>, the Fund has outstanding 22,915,000 common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INVESTMENT OBJECTIVE
AND POLICIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Restrictions</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following investment
restrictions are fundamental policies of the Fund and may not be changed without the approval of the holders of a majority of the Fund's
outstanding common shares (which for this purpose and under the Investment Company Act means the lesser of (i)&#160;67% of the common
shares represented at a meeting at which more than 50% of the outstanding common shares are represented or (ii)&#160;more than 50% of
the outstanding shares).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to such shareholder
approval, the Fund may not:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">1.</td><td style="text-align: justify">make investments for the purpose
                                            of exercising control or management;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">2.</td><td style="text-align: justify">purchase or sell real estate, commodities
                                            or commodity contracts, except that, to the extent permitted by applicable law, the Fund
                                            may (i)&#160;invest in securities directly or indirectly secured by real estate or interests
                                            therein or issued by entities that invest in real estate or interests therein; (ii)&#160;acquire,
                                            hold and sell real estate acquired through default, liquidation, or other distributions of
                                            an interest in real estate as a result of the Fund's ownership of other assets; (iii)&#160;invest
                                            in instruments directly or indirectly secured by commodities or securities issued by entities
                                            that invest in or hold such commodities and acquire temporarily commodities as a result thereof;
                                            and (iv)&#160;purchase and sell forward contracts, financial futures contracts and options
                                            thereon;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">3.</td><td style="text-align: justify">issue senior securities or borrow
                                            money except as permitted by Section&#160;18 of the Investment Company Act or otherwise as
                                            permitted by applicable law;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">underwrite
                                            securities of other issuers, except insofar as the Fund may be deemed an underwriter under
                                            the </span><span style="font-size: 10pt">Securities Act of 1933, as amended</span>, in selling
                                            its own securities or portfolio securities;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
                                            loans to other persons, except that (i)&#160;the Fund will not be deemed to be making a loan
                                            to the extent that the Fund makes investments in accordance with its stated investment strategies
                                            or otherwise purchases senior loans, subordinated loans, corporate bonds, </span>collateralized
                                            loan obligations (&#8220;CLO&#8221;) securities, debentures or other loans or debt securities
                                            of any type, preferred securities, commercial paper, pass through instruments, loan participation
                                            interests, corporate loans, certificates of deposit, bankers acceptances, repurchase agreements
                                            or any similar instruments; (ii)&#160;the Fund may take short positions in any security or
                                            financial instrument; and (iii)&#160;the Fund may lend its portfolio securities in an amount
                                            not in excess of 33 1/3% of its total assets, taken at market value, provided that such loans
                                            shall be made in accordance with applicable law; and</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">6.</td><td style="text-align: justify">invest more than 25% of its total
                                            assets (taken at market value at the time of each investment) in the securities of issuers
                                            of any one industry; provided that securities issued or guaranteed by the U.S. Government
                                            or its agencies or instrumentalities and tax-exempt securities of governments and their political
                                            subdivisions will not be considered to represent an industry (other than private purpose
                                            industrial development bonds issued on behalf of non-governmental issuers).</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MANAGEMENT OF THE FUND</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Advisory Agreement</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Advisory Services</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ares Capital Management II
LLC serves as the Fund&#8217;s investment adviser and is registered as an investment adviser under the Investment Advisers Act of 1940,
as amended. Subject to the overall supervision of the Board of Directors of the Fund (the &#8220;Board,&#8221; and each member thereof,
a &#8220;Director&#8221;), the Adviser manages the day-to-day operations of, and provides investment advisory and management services
to, the Fund. Under the terms of the investment advisory and management agreement between the Adviser and the Fund (the &#8220;Investment
Advisory Agreement&#8221;), the Adviser:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span>&#160;</td><td style="text-align: justify">obtains
                                            and evaluates pertinent economic, financial, and other information affecting the economy
                                            generally and certain investment assets as such information relates to securities, loans
                                            or other financial instruments, that are purchased for or considered for purchase by the
                                            Fund;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">makes
                                            investment decisions for the Fund (including the exercise or disposition of rights accompanying
                                            portfolio securities, loans or other financial instruments, such as tender offers, exchanges,
                                            amendments, consents, waivers or forbearances, and other attendant rights thereto);</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">places
                                            purchase and sale orders for portfolio transactions on behalf of the Fund and manages otherwise
                                            uninvested cash assets of the Fund;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">arranges
                                            for the pricing of Fund securities, loans or other financial instruments;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">executes
                                            account documentation, agreements, contracts and other documents as may be requested by brokers,
                                            dealers, assignors, assignees, participants, counterparties and other persons in connection
                                            with the Adviser&#8217;s management of the assets of the Fund;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">employs
                                            professional portfolio managers and securities analysts who provide research services to
                                            the Fund;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">engages
                                            certain third-party professionals, consultants, experts or specialists in connection with
                                            the Adviser&#8217;s management of the assets of the Fund; and</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span>&#9679;</span></td><td style="text-align: justify">makes
                                            decisions with respect to the use by the Fund of borrowing for leverage or other investment
                                            purposes.</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Adviser is an affiliate of Ares Management Corporation, a leading global alternative investment manager whose common units are listed
on the NYSE under the symbol &#8220;ARES&#8221; (&#8220;Ares&#8221;), and leverages the Ares investment platform and benefits from the
significant capital markets, trading and research expertise of Ares's investment professionals. Ares Operations LLC, a subsidiary of
</span>Ares, provides certain administrative and other services necessary for the Fund to operate.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Adviser&#8217;s services
to the Fund under the Investment Advisory Agreement are not exclusive. The Adviser may provide investment advisory and administration
services to other entities. Similarly, affiliates of the Adviser may directly or indirectly manage funds or other accounts with investment
objectives similar to those of the Fund. Accordingly, the Fund may compete with these Ares funds or other investment vehicles managed
by the Adviser and its affiliates for capital and investment opportunities. The Adviser endeavors to allocate investment opportunities
in a fair and equitable manner, and in any event consistent with any fiduciary duties owed to the Fund. Nevertheless, it is possible
that the Fund may not be given the opportunity to participate in certain investments made by investment funds or other accounts managed
by the Adviser or its affiliates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Adviser is a wholly owned subsidiary of Ares Management LLC, an SEC-registered investment adviser, and an indirect subsidiary of Ares</span>.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Management Fee</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Investment Advisory Agreement with the Fund and subject to the overall supervision of the Board, the Adviser provides investment
advisory and management services to the Fund. For providing these services, the Adviser receives a monthly fee at the annual rate of
1.00% of the average daily value of the Fund&#8217;s Managed Assets. &#8220;Managed Assets&#8221; means the total assets of the Fund
(including any assets attributable to any preferred shares or to indebtedness)</span><span style="font-size: 10pt">,</span> minus <span style="font-size: 10pt">l</span>iabilities
(other than liabilities relating to indebtedness). Fees for any partial month are appropriately prorated. During periods when the Fund
is using leverage, the fees paid to the Adviser will be higher than if the Fund did not use leverage because the fees paid will be calculated
on the basis of the Fund&#8217;s Managed Assets, which include the assets purchased through leverage.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser may elect from
time to time, in its sole discretion, to waive its right to receive a portion of the advisory fee. If the Adviser elects to waive its
compensation, such action may have a positive effect on the Fund&#8217;s performance or yield. The Adviser is under no obligation to
waive its fees, may elect not to do so, or may decide to waive its compensation periodically.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021, the Fund paid the Adviser advisory
fees of $</span>4.9 million, $5.6 million and $5.3 million, respectively.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Payment of the Fund&#8217;s Expenses and Reimbursement of Certain
Costs of the Adviser and its Affiliates</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The services of all investment
professionals and staff of the Adviser, when and to the extent engaged in providing investment advisory and management services, and
the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by the Adviser.
The Fund bears all other costs and expenses of its operations and transactions, including those relating to: organization; calculation
of its net asset value (including the cost and expenses of any independent valuation firm, agent, or other provider); expenses incurred
by the Adviser payable to third parties, including agents, consultants or other Advisers, in monitoring the financial and legal affairs
of the Fund and in monitoring the Fund&#8217;s investments; interest payable on indebtedness and dividends and distributions on preferred
shares, as applicable, if any, incurred to finance the Fund&#8217;s investments; offerings of the Fund&#8217;s common shares and other
securities (including all fees, costs and expenses related thereto); investment advisory and management fees; fees payable to third parties,
including agents, legal counsel (including, without limitation, any committee formed in accordance with Federal Rule&#160;of Bankruptcy
Procedure 2019 or unsecured committee counsel), consultants or other advisers, relating to, or associated with, evaluating and making
investments; administrator, transfer agent, custodian, investor support services and investor relation fees; federal and state registration
fees; all costs of registration and listing the Fund&#8217;s shares on any securities exchange; federal, state and local taxes; independent
directors&#8217; fees and expenses; costs of preparing and filing reports or other documents required by governmental bodies (including
the SEC), including printing costs; costs of any reports, proxy statements or other notices to shareholders, including printing costs;
insurance premiums for fidelity bond and other insurance coverage, including the Fund&#8217;s allocable portion of the fidelity bond,
directors&#8217; and officers&#8217; errors and omissions liability insurance, and any other insurance premium; direct costs and expenses
of administration, including printing, mailing, long-distance telephone, copying, secretarial and other staff, independent auditors and
outside legal costs; brokerage commissions, assignment fees and other costs in connection with the purchase, holding or sale of securities
and other investment instruments (including, without limitation, security settlement costs); costs incurred to implement and monitor
agreements governing the Fund&#8217;s financing or borrowing facilities and costs associated with issuances of preferred shares and ongoing
related expenses; such unusual, non-recurring or extraordinary expenses as may arise, including those relating to actions, suits or proceedings
to which the Fund is a party and legal obligations that the Fund may have to indemnify the Fund&#8217;s directors, officers and/or employees
or agents with respect to these actions, suits or proceedings; all other expenses incidental to holding meetings of the Fund&#8217;s
shareholders, including proxy solicitations therefor; and all other expenses incurred by the Fund in connection with administering the
Fund&#8217;s business (including the reimbursements contemplated in the following paragraph).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Fund&#8217;s Investment Advisory Agreement,
the Adviser may seek reimbursement from the Fund for certain administrative costs provided to the Fund by the Adviser and its affiliates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Duration, Termination and Amendment</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Investment Advisory Agreement between the
Fund and the Adviser became effective on November&#160;27, 2012. The Investment Advisory Agreement was renewed by the Board on August&#160;14,
2023 and will renew for successive annual periods thereafter if approved annually by the Board or by the affirmative vote of the holders
of a majority of the Fund&#8217;s outstanding voting securities, including, in either case, approval by a majority of the Fund&#8217;s
Directors who are not &#8220;interested persons.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Investment Advisory Agreement will automatically
terminate in the event of its assignment (within the meaning of the Investment Company Act). The Investment Advisory Agreement may be
terminated by either party without penalty upon 60 days&#8217; written notice to the other.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, material changes to the Investment
Advisory Agreement of the Fund must be submitted to the Fund&#8217;s shareholders for approval under the Investment Company Act and the
Fund may from time to time decide it is appropriate to seek shareholder approval to change the terms of the agreement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Indemnification</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Investment Advisory Agreement provides that,
absent willful misfeasance, bad faith or gross negligence in the performance of its duties or by reason of the reckless disregard of
its duties and obligations, the Adviser, its members and their respective officers, managers, partners, agents, employees, controlling
persons, members and any other person or entity affiliated with any of them are entitled to indemnification from the Fund for any damages,
liabilities, costs and expenses (including reasonable attorneys&#8217; fees and amounts reasonably paid in settlement) arising out of
or otherwise based upon the performance of any of the Adviser&#8217;s duties or obligations under the Investment Advisory Agreement or
otherwise as an investment adviser of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Board Approval of Investment Advisory Agreement</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A discussion regarding the basis of the Board&#8217;s
approval of the Investment Advisory Agreement is available in the Fund&#8217;s annual report to shareholders dated December&#160;31,
2023.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Administration and Accounting Services Agreement</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">State Street Bank and Trust
Company (&#8220;State Street&#8221;) provides certain administration and accounting services to the Fund pursuant to an Administration
and Accounting Services Agreement. The table below shows the amounts paid to State Street for such services for the periods indicated:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b>Fiscal&#160;Year&#160;Ended&#160;December&#160;31,</b></p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid&#160;to&#160;State<br/>
    Street</b></span></td>
    <td>&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">341,957</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">358,873</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">515,050</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Destra Capital Advisors LLC
(&#8220;Destra&#8221;) provides investor support services in connection with the ongoing operations of the Fund pursuant to an Investor
Support Services Agreement. The table below shows the amounts paid to Destra for such services for the periods indicated:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b>Fiscal&#160;Year&#160;Ended&#160;December&#160;31,</b></p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid&#160;to
    <br/>
    Destra</b></span></td>
    <td>&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,508</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">328,811</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">342,302</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Biographical Information Pertaining to the Directors</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund&#8217;s business
and affairs are managed under the direction of its Board. The Board of the Fund performs the various duties imposed on the directors
of investment companies by the Investment Company Act and Maryland law. The Board currently consists of five Directors, three of whom
are not &#8220;interested persons&#8221; of the Fund as defined in Section&#160;2(a)(19) of the Investment Company Act. The Fund refers
to these individuals as its &#8220;Independent Directors.&#8221; The Directors of the Fund are divided into three classes, serving staggered
three-year terms. The Board periodically elects the Fund&#8217;s officers, who serve at the discretion of the Board. The Board maintains
an audit committee and a nominating and governance committee and may establish additional committees from time to time as necessary.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s April&#160;9, 2024 definitive proxy statement on Schedule 14A for the annual meeting of the
Fund&#8217;s shareholders entitled: &#8220;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Information
Concerning the Nominees and Members of the Board</a></span>,&#8221; which is incorporated by reference herein, for a discussion of the
Fund&#8217;s Directors, their principal occupations and other affiliates during the past five years, and other information about them.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Qualifications</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s April&#160;9, 2024 definitive proxy statement on Schedule 14A for the annual meeting of the
Fund&#8217;s shareholders entitled: &#8220;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Director
Qualifications</a></span>,&#8221; which is incorporated by reference herein, for a summary of the experience, qualifications, attributes
and skills of each Director that supports the conclusion that each Director should serve as a Director of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Leadership Structure, Composition and Role of the Board of the
Fund in Risk Oversight</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">Please
refer to the sections of the Fund&#8217;s definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s shareholders
entitled: &#8220;</span><span><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Leadership
Structure, Composition and Role of Board of the Fund in Risk Oversight</a>&#8221;&#160;and &#8220;</span><a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Committees
of the Board</a><span>,&#8221; which is incorporated by reference herein, for a discussion of the Board&#8217;s
leadership structure and oversight</span>.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Share Ownership</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Information relating to each Director&#8217;s
share ownership in the Fund as of December&#160;31, 2023 is set out in the chart below:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b>Name
                                    of Director(1)</b></p></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Dollar&#160;Range&#160;of&#160;Equity</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities&#160;in&#160;the&#160;Fund(2)</b></p></td>
    <td>&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent
    Directors</b></span></td>
    <td style="vertical-align: bottom; width: 5%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 43%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elaine
    Orr</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    J. Shaw</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
    $100,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce
    Spector</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Over
    $100,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interested
    Directors</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    A. Sachs</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Over
    $100,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth
    J. Brufsky</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Over
    $100,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All are current Directors.
    </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dollar ranges are as follows:
    None, $1-$10,000, $10,001-$50,000, $50,001-$100,000 or Over $100,000.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation of Directors</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets
forth the compensation paid by the Fund to the Directors during the fiscal year ended December&#160;31, 2023. The Directors who are "interested
persons," as defined in the Investment Company Act, of the Fund and the Fund's officers do not receive compensation from the Fund.
Under the Fund's Investment Advisory Agreement, however, the Adviser may seek reimbursement from the Fund for the costs of certain administrative
services provided to the Fund by the Adviser and its affiliates. The Fund currently pays each Independent Director an annual fee of $50,000.
The Chair of the Nominating and Governance Committee receives an additional annual fee of $5,000. Prior to December&#160;31, 2023, the
Chair of the Audit Committee received an additional annual fee of $5,000. Effective January&#160;1, 2024, the Chair of the Audit Committee
receives an additional annual fee of $10,000. The Nominating and Governance Committee Chair is Bruce H. Spector and the Audit Committee
Chair is Elaine Orr.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b>Name(1)</b></p></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>
    Compensation<br/>
    from the<br/>
    Fund</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pension
                                            or</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Retirement Benefits</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Accrued As Part</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of Fund Expenses</b></p></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Independent
    Directors</b></span></td>
    <td style="vertical-align: bottom; width: 4%">&#160;</td>
    <td style="vertical-align: bottom; width: 3%">&#160;</td>
    <td style="vertical-align: bottom; width: 17%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 20%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elaine
    Orr</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    J. Shaw</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce
    Spector</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,000</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Interested
    Directors</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    </tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    A. Sachs</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth
    J. Brufsky</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
    </tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of </span>August 6, 2024, the Directors and officers of the Fund as a group beneficially owned less than 1% of the Fund&#8217;s outstanding
common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of </span>August 6, 2024, none of the Independent Directors of the Fund or their immediate family members owned beneficially or of record
any securities in the Adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Information Pertaining to the Officers</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#8217;s definitive proxy statement on Schedule 14A for the annual meeting of the Fund&#8217;s shareholders
entitled: &#8220;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">Officers
of the Fund</a></span>,&#8221; which is incorporated by reference herein, for certain biographical and other information relating to
the officers of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Portfolio Management</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Portfolio Manager Assets Under Management</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth information about funds and accounts
other than the Fund for which the portfolio managers are primarily responsible for the day-to-day portfolio management as of December&#160;31,
2023:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of <br/>
    Portfolio <br/>
    Manager</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type
    of <br/>
    Accounts</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    # of <br/>
    Accounts <br/>
    Managed</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Assets <br/>
    (in millions)</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8239;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>#
    of Accounts <br/>
    Managed for <br/>
    which <br/>
    Advisory Fee <br/>
    is Based on<br/>
    Performance</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8239;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Assets <br/>
    for which <br/>
    Advisory Fee <br/>
    is Based on<br/>
    Performance<br/>
    (in millions)</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth J. Brufsky</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered investment companies</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,948</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other pooled investment
    vehicles</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,419</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,846</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,246</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keith Ashton</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered investment companies</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">634</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other pooled investment
    vehicles</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,470</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,890</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,493</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,280</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Arduini</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered investment companies</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">634</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other pooled investment
    vehicles</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,633</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,579</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,296</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Samantha Milner</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered investment companies</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,813</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other pooled investment
    vehicles</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,602</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,931</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,767</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Portfolio Manager Compensation Overview</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The discussion below describes
the portfolio managers&#8217; compensation as of December&#160;31, 2023.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser&#8217;s financial
arrangements with the Portfolio Managers, its competitive compensation and its career path emphasis at all levels reflect the value senior
management places on key resources. Compensation may include a variety of components and may vary from year to year based on a number
of factors. The Portfolio Managers may receive, all or some combination of, salary, an annual bonus and interests in the carried interest
in certain of Ares&#8217;s funds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Base
Compensation.</b></span> Generally, portfolio managers receive base compensation based on their position with the firm.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Discretionary
Incentive Compensation. </b></span>In addition to base compensation, portfolio managers may receive discretionary compensation. Discretionary
compensation may be based on individual seniority and contribution.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Securities Ownership of Portfolio Managers</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets
forth, for each Portfolio Manager, the aggregate dollar range of the Fund&#8217;s equity securities beneficially owned as of December&#160;31,
2023:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio Manager</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dollar Range of Fund
    Shares Beneficially Owned</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seth J. Brufsky</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$500,001 - $1,000,000</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keith Ashton</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$10,001 - $50,000</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Arduini </span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Samantha Milner</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Material Conflicts of Interest</i></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Actual or apparent conflicts
of interest may arise when a Portfolio Manager has day-to-day management responsibilities with respect to more than one fund or other
account.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain inherent conflicts
of interest arise from the fact that the Portfolio Managers, the Adviser and its affiliates provide investment management services both
to the Fund and the other Ares-advised funds, including other funds, as well as client accounts, proprietary accounts and any other investment
vehicles that the Adviser and its affiliates may establish from time to time, managed by the Adviser and its affiliates in which the
Fund will not have an interest. The investment program of the Fund and the other Ares-advised funds or accounts may or may not be substantially
similar. The Portfolio Managers, the Adviser and its affiliates may give advice and recommend securities to the other Ares-advised funds
or accounts that may differ from advice given to, or securities recommended or bought for, the Fund, even though their investment objectives
may be the same or similar to those of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser will seek to
manage potential conflicts of interest in good faith; nonetheless, the portfolio strategies employed by the Portfolio Managers, the Adviser
and its affiliates in managing the other Ares-advised funds could conflict with the transactions and strategies employed by the Portfolio
Managers in managing the Fund and may affect the prices and availability of the securities and instruments in which the Fund invests.
Conversely, participation in specific investment opportunities may be appropriate, at times, for both the Fund and the other Ares-advised
funds or accounts.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser has adopted allocation
procedures that are intended to provide that all investment opportunities will be allocated among the Adviser&#8217;s or its related
parties&#8217; clients on a basis that over a period of time is fair and equitable to each client relative to other clients consistent
with any fiduciary duties owed to clients and in an effort to avoid favoring one client over another, taking into account the terms of
the relevant governing documents and all relevant facts and circumstances, including, but not limited to: (i)&#160;differences with respect
to available capital, size of client, and remaining life of a client; (ii)&#160;differences with respect to investment objectives or
current investment strategies, such as objectives or strategies regarding: (a)&#160;current and total return objectives, (b)&#160;emphasizing
or limiting exposure to specific investments, including, but not limited to, type of security, jurisdiction, industry, or other characteristic
of the investment, (c)&#160;diversification, including industry or company exposure, currency and jurisdiction, or (d)&#160;credit ratings;
(iii)&#160;differences in risk profile at the time an opportunity becomes available; (iv)&#160;the potential transaction and other costs
of allocating an opportunity among various clients; (v)&#160;actual or potential conflicts of interest, including whether multiple clients
directly or indirectly have an existing investment in the security in question or the issuer of such security; (vi)&#160;the nature of
the security or the transaction including size of investment opportunity, minimum investment amounts and the source of the opportunity;
(vii)&#160;current and anticipated market and general economic conditions; and (viii)&#160;prior or existing positions in an issuer/security.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event investment opportunities
are allocated among the Fund and the other Ares-advised funds, the Fund may not be able to structure its investment portfolio in the
manner desired. Although the Adviser endeavors to allocate investment opportunities in a manner that, over a period of time, is fair
and equitable, it is possible that the Fund may not be given the opportunity to participate in certain investments made by the other
Ares-advised funds or portfolio managers affiliated with the Adviser. Furthermore, the Fund and the other Ares-advised funds may make
investments in securities where the prevailing trading activity may make impossible the receipt of the same price or execution on the
entire volume of securities purchased or sold by the Fund and the other Ares-advised funds. When this occurs, the various prices may
be averaged, and the Fund will be charged or credited with the average price. Thus, the effect of the aggregation may operate on some
occasions to the disadvantage of the Fund. In addition, under certain circumstances, the Fund may not be charged the same commission
or commission equivalent rates in connection with a bunched or aggregated order.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is likely that other Ares-advised
funds may make investments in the same or similar securities at different times and on different terms than the Fund. The Fund and the
other Ares-advised funds may make investments at different levels of a borrower&#8217;s capital structure or otherwise in different classes
of a borrower&#8217;s securities. Such investments may inherently give rise to conflicts of interest or perceived conflicts of interest
between or among the various classes of securities that may be held by such entities. Conflicts may also arise because portfolio decisions
regarding the Fund may benefit the other Ares-advised funds. For example, the sale of a long position or establishment of a short position
by the Fund may impair the price of the same security sold short by (and therefore benefit) one or more Ares-advised funds, and the purchase
of a security or covering of a short position in a security by the Fund may increase the price of the same security held by (and therefore
benefit) one or more Ares-advised funds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While these conflicts cannot
be eliminated, the Adviser, when practicable, will cause the Fund and the other Ares-advised funds to hold investments in the same levels
of an issuer&#8217;s capital structure in the same proportion at each level; provided, however, that neither the Fund nor any other Ares-advised
fund will be required to hold an investment if holding such investment would result in a violation of the provisions of the organizational
documents of the Fund or the other Ares-advised fund, as applicable, or constitute a breach of, or default or debt repayment event with
respect to, any credit facility or other debt instrument or obligation.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although the professional
staff of the Adviser will devote as much time to the management of the Fund as the Adviser deems appropriate to perform its obligations,
the professional staff of the Adviser may have conflicts in allocating its time and services among the Fund and the Adviser&#8217;s other
investment vehicles and accounts. The Adviser and its affiliates are not restricted from forming additional investment funds, from entering
into other investment advisory relationships or from engaging in other business activities, even though such activities may be in competition
with the Fund and/or may involve substantial time and resources of the Adviser and its professional staff. These activities could be
viewed as creating a conflict of interest in that the time and effort of the members of the Adviser and their officers and employees
will not be devoted exclusively to the business of the Fund but will be allocated between the business of the Fund and the management
of the monies of other clients of the Adviser.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Codes of Ethics</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund and the Adviser
have each adopted a code of ethics pursuant to Rule&#160;17j-1 under the Investment Company Act that establishes procedures for personal
investments and restricts certain personal securities transactions. Personnel subject to each code may invest in securities for their
personal investment accounts, including securities that may be purchased or held by the Fund, so long as such investments are made in
accordance with the code&#8217;s requirements.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The codes of ethics may be
viewed and copied at the SEC&#8217;s Public Reference Room in Washington, D.C. Information about the SEC&#8217;s Public Reference Room
may be obtained by calling the SEC at (202) 551-8090. The codes of ethics also may be available on the EDGAR Database on the SEC&#8217;s
website, http://www.sec.gov, or be obtained, after paying a duplicating fee, by electronic request to publicinfo@sec.gov, or by writing
to: SEC&#8217;s Public Reference Section, 100 F Street, N.E., Washington, D.C. 20549-0102. This reference to the website does not incorporate
the contents of the website into this SAI.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PORTFOLIO TRANSACTIONS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser is responsible
for decisions to buy and sell securities for the Fund, the selection of brokers and dealers to effect the transactions and the negotiation
of prices and any brokerage commissions. With respect to senior loans and subordinated loans, the Fund generally will engage in privately
negotiated transactions for purchase or sale in which the Adviser will negotiate on behalf of the Fund. Most of these transactions will
be principal transactions at net prices for which the Fund will generally incur little or no brokerage costs. The Fund may be required
to pay fees, or forgo a portion of interest and any fees payable to the Fund, to a lender selling assignment or participations to the
Fund. The Adviser will determine the lenders from whom the Fund will purchase assignments and participations by considering their professional
ability, level of service, relationship with the borrower, financial condition, credit standards and quality of management. Affiliates
of the Adviser may participate in the primary and secondary market for senior loans and subordinated loans. Because of certain limitations
imposed by the Investment Company Act, this may restrict the Fund&#8217;s ability to acquire some senior loans and subordinated loans.
The Adviser does not believe that this will have a material effect on the Fund&#8217;s ability to acquire senior loans and subordinated
loans consistent with its investment policies. Sales to dealers are effected at bid prices. The illiquidity of some senior loans, subordinated
loans and, to a more limited extent, CLOs may restrict the ability of the Adviser to locate in a timely manner persons willing to purchase
the Fund&#8217;s interests in senior loans, subordinated loans or CLOs at a fair price should the Fund desire to sell such interests.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to other types
of securities, the Fund may purchase certain money market instruments directly from an issuer (in which case no commissions or discounts
are paid), may purchase securities in the over-the-counter (OTC) market from an underwriter or dealer serving as market maker for the
securities, in which case the price includes a fixed amount of compensation to the underwriter or dealer, and may purchase and sell listed
securities on an exchange, which are effected through brokers who charge a commission for their services.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser is responsible
for arranging for the execution of the Fund&#8217;s portfolio transactions and will do so in a manner deemed fair and reasonable to the
Fund and in accordance with the Adviser&#8217;s conflicts policy. The primary consideration in all portfolio transactions is prompt execution
of orders in an effective manner at the most favorable price. In selecting broker-dealers and in negotiating prices and any brokerage
commissions on such transactions, the Adviser considers the firm&#8217;s reliability, integrity and financial condition and the firm&#8217;s
execution capability, the size and breadth of the market for the security, the size of and difficulty in executing the order, and the
best net price. There may be instances when, in the judgment of the Adviser, more than one firm can offer comparable execution services.
A commission paid to such brokers may be higher than that which another qualified broker would have charged for effecting the same transaction,
provided that the Adviser determine in good faith that such commission is reasonable in terms either of the transaction or the overall
responsibility of the Adviser to the Fund and its other clients and that the total commissions paid by the Fund will be reasonable in
relation to the benefits to the Fund over the long-term. The advisory fees that the Fund pays to the Adviser will not be reduced if the
Adviser receives brokerage and research services. Commission rates for brokerage transactions on foreign share exchanges are generally
fixed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information about the brokerage
commissions paid by the Fund is set forth in the following tables:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 1pt solid"><b>Fiscal
                                    Year Ended December&#160;31,</b></p></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate&#160;Brokerage<br/>
    Commissions&#160;Paid</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commissions<br/>
    Paid&#160;to&#160;Affiliates</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td></tr>
  <tr>
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span>0</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal year ended
December&#160;31, 2023, the Fund paid no brokerage commissions to affiliates.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table shows
the dollar amount of brokerage commissions paid to brokers for providing third-party research services and the approximate dollar amount
of the transactions involved for the fiscal year ended December&#160;31, 2023. The provision of third-party research services was not
necessarily a factor in the placement of all brokerage business with such brokers.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: auto; margin-right: auto;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: black 1pt solid"><b>Amount&#160;of&#160;Commissions&#160;Paid&#160;to&#160;Brokers&#160;for
                                    Providing<br/>
                                    Research Services</b></p></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount&#160;of&#160;Brokerage&#160;Transactions&#160;Involved</b></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December&#160;31, 2023,
the Fund held no securities of its &#8220;regular brokers or dealers&#8221; (as defined in Rule&#160;10b-1 under the Investment Company
Act) whose shares were purchased during the fiscal year ended December&#160;31, 2023.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONFLICTS OF INTEREST</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund&#8217;s executive
officers and directors, and the employees of the Adviser, serve or may serve as officers, directors or principals of entities that operate
in the same or a related line of business as the Fund or of other Ares-advised funds (&#8220;Other Managed Funds&#8221;). As a result,
they may have obligations to investors in those entities, the fulfillment of which might not be in the best interests of the Fund or
its shareholders. Moreover, notwithstanding the difference in principal investment objectives between the Fund and the Other Managed
Funds, such other Ares-advised funds, including potential new pooled investment vehicles or managed accounts not yet established (whether
managed or sponsored by affiliates or the Adviser), have, and may from time to time have, overlapping investment objectives with the
Fund and, accordingly, invest in, whether principally or secondarily, asset classes similar to those targeted by the Fund. To the extent
the Other Managed Funds have overlapping investment objectives, the scope of opportunities otherwise available to the Fund may be adversely
affected and/or reduced. Additionally, certain employees of the Adviser and its management may face conflicts in their time management
and commitments as well as in the allocation of investment opportunities to other Ares funds.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The results of the Fund&#8217;s
investment activities may differ significantly from the results achieved by Other Managed Funds. It is possible that one or more of such
funds will achieve investment results that are substantially more or less favorable than the results achieved by the Fund. Moreover,
it is possible that the Fund will sustain losses during periods in which one or more affiliates achieve significant profits on their
trading for proprietary or other accounts. The opposite result is also possible. The investment activities of one or more Adviser affiliates
for their proprietary accounts and accounts under their management may also limit the investment opportunities for the Fund in certain
markets.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser may determine
that the Fund should invest on a side-by-side basis with one or more Other Managed Funds. In certain circumstances, negotiated co-investments
may be made only in accordance with the terms of the exemptive order Ares received from the SEC (the &#8220;Order&#8221;). Co-investments
made under the Order are subject to compliance with the conditions and other requirements contained in the Order, which could limit the
Fund&#8217;s ability to participate in a co-investment transaction.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Fund
and the Other Managed Funds may make investments at different levels of an issuer&#8217;s capital structure or otherwise in different
classes of an issuer&#8217;s securities. Such investments may inherently give rise to conflicts of interest or perceived conflicts of
interest between or among the various classes of securities that may be held by such entities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser, its affiliates
and their clients may pursue or enforce rights with respect to an issuer in which the Fund has invested, and those activities may have
an adverse effect on the Fund. As a result, prices, availability, liquidity and terms of the Fund&#8217;s investments may be negatively
impacted by the activities of the Adviser and its affiliates or their clients, and transactions for the Fund may be impaired or effected
at prices or terms that may be less favorable than would otherwise have been the case.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser may enter into
transactions and invest in securities, instruments and currencies on behalf of the Fund in which customers of its affiliates, to the
extent permitted by applicable law, serve as the counterparty, principal or issuer. In such cases, such party&#8217;s interests in the
transaction could be adverse to the interests of the Fund, and such party may have no incentive to assure that the Fund obtains the best
possible prices or terms in connection with the transaction. In addition, the purchase, holding and sale of such investments by the Fund
may enhance the profitability of the Adviser or its affiliates. One or more affiliates may also create, write or issue derivatives for
their customers, the underlying securities, currencies or instruments of which may be those in which the Fund invests or which may be
based on the performance of the Fund. The Fund may, subject to applicable law, purchase investments that are the subject of an underwriting
or other distribution by one or more affiliates of the Adviser and may also enter into transactions with other clients of an affiliate
where such other clients have interests adverse to those of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund will be required
to establish business relationships with its counterparties based on the Fund&#8217;s own credit standing. Neither the Adviser nor any
of its affiliates will have any obligation to allow its credit to be used in connection with the Fund&#8217;s establishment of its business
relationships, nor is it expected that the Fund&#8217;s counterparties will rely on the credit of the Adviser or its affiliates in evaluating
the Fund&#8217;s creditworthiness.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser is paid a fee
based on a percentage of the Fund&#8217;s Managed Assets (as defined above). The participation of the Adviser&#8217;s investment professionals
in the valuation process could therefore result in a conflict of interest. The Adviser also may have a conflict of interest in deciding
whether to cause the Fund to incur leverage or to invest in more speculative investments or financial instruments, thereby potentially
increasing the assets or yield of the Fund and, accordingly, the Management Fees or Incentive Fees received by the Adviser. Certain other
Ares-advised funds pay the Adviser or its affiliates performance-based compensation, which could create an incentive for the Adviser
or affiliate to favor such investment fund or account over the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By reason of the various
activities of the Adviser and its affiliates, the Adviser and such affiliates may acquire confidential or material non-public information
or otherwise be restricted from purchasing certain potential Fund investments that otherwise might have been purchased or be restricted
from selling certain Fund investments that might otherwise have been sold at the time.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Adviser has adopted policies
and procedures designed to prevent conflicts of interest from influencing proxy voting decisions made on behalf of advisory clients,
including the Fund, and to help ensure that such decisions are made in accordance with its fiduciary obligations to clients. Nevertheless,
notwithstanding such proxy voting policies and procedures, actual proxy voting decisions may have the effect of favoring the interests
of other clients, provided that the Adviser believes such voting decisions to be in accordance with its fiduciary obligations. See &#8220;The
Portfolio Managers&#8212;Material Conflicts of Interest&#8221; for further discussion of conflicts of interest relevant to the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DESCRIPTION OF SHARES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Common Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund intends to hold
annual meetings of shareholders so long as the common shares are listed on a national securities exchange and such meetings are required
as a condition to such listing. The Fund will send unaudited reports at least semi-annually and audited annual financial statements to
all of its shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Preferred Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund has authorized and
issued 800,000 shares of Series&#160;A Mandatory Redeemable Preferred Stock, par value $0.001 per share (the &#8220;Series&#160;A MRP
Shares&#8221;), for gross proceeds of $20 million, 1,200,000 shares of Series&#160;B Mandatory Redeemable Preferred Stock, par value
$0.001 per share (the &#8220;Series&#160;B MRP Shares&#8221;), for gross proceeds of $30 million and 2,000,000 shares of Series&#160;C
Mandatory Redeemable Preferred Stock, par value $0.001 per share (the &#8220;Series&#160;C MRP Shares&#8221; and together with the Series&#160;A
MRP Shares and Series&#160;B MRP Shares, the &#8220;preferred shares&#8221;), for gross proceeds of $50 million. Each of the preferred
shares has a liquidation preference of $25.00 per share. The aggregate redemption amount of the preferred shares is $100 million.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The redemption dates for
the Series&#160;A MRP Shares, Series&#160;B MRP Shares and Series&#160;C MRP Shares are July&#160;15, 2026, September&#160;15, 2026 and
September&#160;15, 2028, respectively. The redemption price per share is equal to the sum of the liquidation preference per share plus
any accumulated but unpaid dividends plus, in some cases, an early redemption premium, which may vary based on the date of redemption.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Series&#160;A MRP Shares
and the Series&#160;B MRP Shares have a dividend rate of 2.58% per annum, payable quarterly. The Series&#160;C MRP Shares have a dividend
rate of 3.03% per annum, payable quarterly. The weighted average dividend rate for the preferred shares is 2.81% per annum. Holders of
the preferred shares are entitled to receive quarterly cumulative cash dividend payments on the first business day following each quarterly
dividend date. The preferred shares are subject to optional and mandatory redemption in certain circumstances. The preferred shares will
be subject to redemption, at the option of the Fund, in whole or in part at any time only for the purposes of decreasing leverage of
the Fund. The Fund may be obligated to redeem certain of the preferred shares if the Fund fails to maintain an asset coverage ratio,
calculated in accordance with the Investment Company Act, greater than or equal to 225%. The Fund is subject to certain restrictions
relating to the preferred shares such as maintaining certain asset coverage ratio requirements. Failure to comply with these restrictions
could preclude the Fund from declaring any dividend to common shareholders and could trigger the mandatory redemption of the preferred
shares. Additionally, in accordance with the Investment Company Act, the Fund may not issue additional preferred shares if immediately
after such issuance the Fund will not have an asset coverage ratio of at least 200%. As of December&#160;31, 2023, the Fund was in compliance
in all material respects with the terms of the preferred shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Shares</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board (subject to applicable
law and the Charter) may authorize an offering, without the approval of the common shareholders and, depending on their terms, any preferred
shares outstanding at that time, of other classes of shares, or other classes or series of shares, as it determines to be necessary,
desirable or appropriate, having such terms, rights, preferences, privileges, limitations and restrictions as the Board sees fit. The
Fund currently does not expect to issue any other classes of shares, or series of shares, except for the common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REPURCHASE OF COMMON
SHARES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the Fund is a closed-end
management investment company, its shareholders will not have the right to cause the Fund to redeem their common shares. Instead, the
Fund's common shares will trade in the open market at a price that will be a function of several direct and indirect factors, including
dividend levels (which are in turn affected by expenses), net asset value, dividend stability, relative demand for and supply of such
shares in the market, general market and economic conditions and other factors. Notice is hereby given in accordance with Section&#160;23(c)&#160;of
the Investment Company Act that the Fund may purchase at market prices from time to time its common shares in the open market but is
under no obligation to do so.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
at any time if the Fund has preferred shares outstanding, the Fund may not purchase, redeem or otherwise acquire any of its common shares
unless (i)&#160;all accrued preferred share dividends, if any, have been paid and (ii)&#160;at the time of such purchase, redemption
or acquisition, the Fund has an asset coverage of at least 200% after deducting the amount of such purchase, redemption or acquisition,
as applicable. Similarly, if the Fund has outstanding indebtedness, the Fund may not purchase, redeem or acquire its capital stock unless
the Fund has an asset coverage of at least 300% after deducting the amount of such purchase, redemption or acquisition, as applicable.
See &#8220;Leverage.&#8221; Any service fees incurred in connection with any tender offer made by the Fund will be borne by the Fund
and will not reduce the stated consideration to be paid to tendering shareholders.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to its investment
restrictions, the Fund may borrow to finance the repurchase of common shares or to make a tender offer for those shares. Interest on
any borrowings to finance share repurchase transactions or the accumulation of cash by the Fund in anticipation of share repurchases
or tenders will reduce the Fund's net income. Any share repurchase, tender offer or borrowing approved by the Board would have to comply
with the NYSE listing requirements and the Securities and Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), the Investment Company
Act, and the rules&#160;and regulations thereunder.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is no assurance that,
if action is undertaken to repurchase or tender for common shares, such action will result in the Fund's common shares trading at a price
that approximates their net asset value. Although share repurchases and tenders could have a favorable effect on the market price of
the Fund's common shares, shareholders should be aware that the acquisition of common shares by the Fund will decrease the total net
assets of the Fund and, therefore, may have the effect of increasing the Fund's expense ratio and decreasing the asset coverage with
respect to any preferred shares outstanding and any amounts borrowed.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TAX MATTERS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a description
of certain U.S. federal income tax consequences to a shareholder of acquiring, holding and disposing of common shares of the Fund. Except
as otherwise noted, this discussion assumes you are a taxable U.S. holder (as defined below). This discussion is based upon current provisions
of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the regulations promulgated thereunder and judicial and administrative
authorities, all of which are subject to change or differing interpretations by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;),
possibly with retroactive effect. No attempt is made to present a detailed explanation of all U.S. federal income tax concerns affecting
the Fund and its shareholders, and the discussions set forth here do not constitute tax advice. This discussion assumes that investors
hold common shares of the Fund as capital assets (generally, for investment). The Fund has not sought and will not seek any ruling from
the IRS regarding any matters discussed herein. No assurance can be given that the IRS would not assert, or that a court would not sustain,
a position contrary to those set forth below. This summary does not discuss any aspects of foreign, state or local tax. Prospective investors
must consult their own tax advisers as to the U.S. federal income tax consequences (including the alternative minimum tax consequences)
of acquiring, holding and disposing of the Fund&#8217;s common shares, as well as the effects of state, local and non-U.S. tax laws.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, no attempt is
made to address tax considerations applicable to an investor with a special tax status, such as a financial institution, real estate
income trust (&#8220;REIT&#8221;), insurance company, regulated investment company, individual retirement account, other tax-exempt organization,
dealer in securities or currencies, person holding shares of the Fund as part of a hedging, integrated, conversion or straddle transaction,
trader in securities that has elected the mark-to-market method of accounting for its securities, U.S. holder (as defined below) whose
functional currency is not the U.S. dollar, investor with &#8220;applicable financial statements&#8221; within the meaning of Section&#160;451(b)&#160;of
the Code, or non-U.S. investor. Furthermore, this discussion does not reflect possible application of the alternative minimum tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A U.S. holder is a beneficial
owner that is for U.S. federal income tax purposes:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9679;</span></td><td style="text-align: justify">a
                                            citizen or individual resident of the United States (including certain former citizens and
                                            former long-term residents);</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9679;</span></td><td style="text-align: justify">a
                                            corporation or other entity treated as a corporation for U.S. federal income tax purposes,
                                            created or organized in or under the laws of the United States or any state thereof or the
                                            District of Columbia;</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9679;</span></td><td style="text-align: justify">an
                                            estate, the income of which is subject to U.S. federal income taxation regardless of its
                                            source; or</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span>&#9679;</span></td><td style="text-align: justify">a
                                            trust with respect to which a court within the United States is able to exercise primary
                                            supervision over its administration and one or more U.S. persons have the authority to control
                                            all of its substantial decisions or the trust has made a valid election in effect under applicable
                                            Treasury regulations to be treated as a U.S. person.</td></tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Taxation of the Fund</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has elected to be treated as a registered investment company (&#8220;RIC&#8221;) under Subchapter M of the Code, and operates in
a manner so as to qualify for tax treatment applicable to RICs. To qualify as a RIC, the Fund must, among other things, satisfy certain
requirements relating to the sources of its income, diversification of its assets, and distribution of its income to its shareholders.
First, the Fund must derive at least 90% of its annual gross income from dividends, interest, payments with respect to securities loans,
gains from the sale or other disposition of shares or securities or foreign currencies, or other income (including but not limited to
gains from options, futures and forward contracts) derived with respect to its business of investing in such shares, securities or currencies,
or net income derived from interests in &#8220;qualified publicly traded partnerships&#8221; (as defined in the Code) (the &#8220;90%
gross income test&#8221;). Second, the Fund must diversify its holdings so that, at the close of each quarter of its taxable year, (i)&#160;at
least 50% of the value of its total assets consists of cash, cash items, U.S. Government securities, securities of other RICs and other
securities, with such other securities limited in respect of any one issuer </span>to an amount not greater in value than 5% of the value
of the Fund&#8217;s total assets and to not more than 10% of the outstanding voting securities of such issuer, and (ii)&#160;not more
than 25% of the market value of the Fund&#8217;s total assets is invested in the securities (other than U.S. Government securities and
securities of other RICs) of any one issuer, any two or more issuers controlled by the Fund and engaged in the same, similar or related
trades or businesses, or any one or more &#8220;qualified publicly traded partnerships.&#8221;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As long as the Fund qualifies
as a RIC, the Fund will generally not be subject to corporate-level U.S. federal income tax on income and gains that it distributes each
taxable year to its shareholders, provided that in such taxable year it distributes at least 90% of the sum of (i)&#160;its net tax-exempt
interest income, if any, and (ii)&#160;its &#8220;investment company taxable income&#8221; (which includes, among other items, dividends,
taxable interest, taxable original issue discount and market discount income, income from securities lending, net short-term capital
gain in excess of net long-term capital loss, and any other taxable income other than &#8220;net capital gain&#8221; (as defined below)
and is reduced by deductible expenses) determined without regard to the deduction for dividends paid. The Fund may retain for investment
its net capital gain (which consists of the excess of its net long-term capital gain over its net short-term capital loss). However,
if the Fund retains any net capital gain or any investment company taxable income, it will be subject to tax at regular corporate rates
on the amount retained.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Code imposes a 4% nondeductible
excise tax on the Fund to the extent the Fund does not distribute by the end of any calendar year at least the sum of (i)&#160;98% of
its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii)&#160;98.2% of its capital gain
in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on October&#160;31 of the
calendar year (unless an election is made to use the Fund&#8217;s fiscal year). In addition, the minimum amounts that must be distributed
in any year to avoid the excise tax will be increased or decreased to reflect the total amount of any under-distribution or over-distribution,
as the case may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed any income on
which it paid U.S. federal income tax. While the Fund intends to distribute any income and capital gain in the manner necessary to minimize
imposition of the 4% nondeductible excise tax, there can be no assurance that sufficient amounts of the Fund&#8217;s taxable income and
capital gain will be distributed to entirely avoid the imposition of the excise tax. In that event, the Fund will be liable for the excise
tax only on the amount by which it does not meet the foregoing distribution requirement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If in any taxable year the
Fund should fail to qualify under Subchapter M of the Code for tax treatment as a RIC, the Fund would incur a regular corporate U.S.
federal income tax upon all of its taxable income for that year, and all distributions to its shareholders (including distributions of
net capital gain) would be taxable to shareholders as ordinary dividend income for U.S. federal income tax purposes to the extent of
the Fund&#8217;s earnings and profits. Provided that certain holding period and other requirements were met, such dividends would be
eligible (i)&#160;to be treated as qualified dividend income in the case of shareholders taxed as individuals and (ii)&#160;for the dividends
received deduction in the case of corporate shareholders. In addition, to qualify again to be taxed as a RIC in a subsequent year, the
Fund would be required to distribute to shareholders its earnings and profits attributable to non-RIC years. In addition, if the Fund
failed to qualify as a RIC for a period greater than two taxable years, then, in order to qualify as a RIC in a subsequent year, the
Fund would be required to elect to recognize and pay tax on any net built-in gain (the excess of aggregate gain, including items of income,
over aggregate loss that would have been realized if the Fund had been liquidated) or, alternatively, be subject to taxation on such
built-in gain recognized for a period of five years.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The remainder of this discussion
assumes that the Fund qualifies for taxation as a RIC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The Fund&#8217;s Investments</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the Fund&#8217;s investment practices are subject to special and complex U.S. federal income tax provisions (including mark-to-market,
constructive sale, straddle, wash sale, short sale and other rules) that may, among other things, (i)&#160;disallow, suspend or otherwise
limit the allowance of certain losses or deductions, (ii)&#160;convert lower taxed long-term capital gains or qualified dividend income
into higher taxed short-term capital gains or ordinary income, (iii)&#160;convert ordinary loss or a deduction into capital loss (the
deductibility of which is more limited), (iv)&#160;cause the Fund to recognize income or gain without a corresponding receipt of cash,
(v)&#160;adversely affect the time as to when a purchase or sale of shares or securities is deemed to occur, (vi)&#160;adversely alter
the characterization of certain complex financial transactions and (vii)&#160;produce income that will not be &#8220;qualified&#8221;
income for purposes of the 90% annual gross income requirement described above. These U.S. federal income tax provisions could therefore
affect the amount, timing and character of distributions to common shareholders. The Fund monitors its transactions </span>and may make
certain tax elections and may be required to dispose of securities to mitigate the effect of these provisions and prevent disqualification
of the Fund as a RIC. Additionally, the Fund may be required to limit its activities in derivative instruments in order to enable it
to maintain its RIC status.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund may invest a portion
of its net assets in below investment grade securities, commonly known as &#8220;junk&#8221; securities. Investments in these types of
securities may present special tax issues for the Fund. U.S. federal income tax rules&#160;are not entirely clear about issues such as
when the Fund may cease to accrue interest, original issue discount or market discount, when and to what extent deductions may be taken
for bad debts or worthless securities, how payments received on obligations in default should be allocated between principal and income
and whether modifications or exchanges of debt obligations in a bankruptcy or workout context are taxable. These and other issues could
affect the Fund&#8217;s ability to distribute sufficient income to preserve its status as a RIC or to avoid the imposition of U.S. federal
income or excise tax.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain debt securities acquired
by the Fund may be treated as debt securities that were originally issued at a discount. Generally, the amount of the original issue
discount is treated as interest income and is included in taxable income (and required to be distributed by the Fund in order to qualify
as a RIC and avoid U.S. federal income tax or the 4% excise tax on undistributed income) over the term of the security, even though payment
of that amount is not received until a later time, usually when the debt security matures.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Fund purchases a debt
security on a secondary market at a price lower than its adjusted issue price, the excess of the adjusted issue price over the purchase
price is &#8220;market discount.&#8221; Unless the Fund makes an election to accrue market discount on a current basis, generally, any
gain realized on the disposition of, and any partial payment of principal on, a debt security having market discount is treated as ordinary
income to the extent the gain, or principal payment, does not exceed the &#8220;accrued market discount&#8221; on the debt security.
Market discount generally accrues in equal daily installments. If the Fund ultimately collects less on the debt instrument than its purchase
price, plus the market discount previously included in income, the Fund may not be able to benefit from any offsetting loss deductions.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund may invest in preferred
securities or other securities the U.S. federal income tax treatment of which may not be clear or may be subject to recharacterization
by the IRS. To the extent the tax treatment of such securities or the income from such securities differs from the tax treatment expected
by the Fund, it could affect the timing or character of income recognized by the Fund, potentially requiring the Fund to purchase or
sell securities, or otherwise change its portfolio, in order to comply with the tax rules&#160;applicable to RICs under the Code.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Gain or loss on the sale
of securities by the Fund will generally be long-term capital gain or loss if the securities have been held by the Fund for more than
one year. Gain or loss on the sale of securities held for one year or less will be short-term capital gain or loss.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because the Fund may invest
in foreign securities, its income from such securities may be subject to non-U.S. taxes. If more than 50% of the Fund&#8217;s total assets
at the close of its taxable year consists of stock or securities of foreign corporations, the Fund may elect for U.S. federal income
tax purposes to treat foreign income taxes paid by it as paid by its shareholders. The Fund may qualify for and make this election in
some, but not necessarily all, of its taxable years. If the Fund were to make such an election, shareholders would be required to take
into account an amount equal to their pro rata portions of such foreign taxes in computing their taxable income and then treat an amount
equal to those foreign taxes as a U.S. federal income tax deduction or as a foreign tax credit against their U.S. federal income tax
liability. A taxpayer&#8217;s ability to use a foreign tax deduction or credit is subject to limitations under the Code. Shortly after
any year for which it makes such an election, the Fund will report to its shareholder the amount per share of such foreign income tax
that must be included in each shareholder&#8217;s gross income and the amount that may be available for the deduction or credit.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Foreign currency gain or
loss on foreign currency exchange contracts, non-U.S. dollar-denominated securities contracts, and non-U.S. dollar-denominated futures
contracts, options and forward contracts that are not section 1256 contracts (as defined below) generally will be treated as ordinary
income and loss.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Income from options on individual
securities written by the Fund will generally not be recognized by the Fund for tax purposes until an option is exercised, lapses or
is subject to a &#8220;closing transaction&#8221; (as defined by applicable regulations) pursuant to which the Fund&#8217;s obligations
with respect to the option are otherwise terminated. If the option lapses without exercise, the premiums received by the Fund from the
writing of such options will generally be characterized as short-term capital gain. If the Fund enters into a closing transaction, the
difference between the premiums received and the amount paid by the Fund to close out its position will generally be treated as short-term
capital gain or loss. If an option written by the Fund is exercised, thereby requiring the Fund to sell the underlying security, the
premium will increase the amount realized upon the sale of the security, and the character of any gain on such sale of the underlying
security as short-term or long-term capital gain will depend on the holding period of the Fund in the underlying security. Because the
Fund will not have control over the exercise of the options it writes, such exercises or other required sales of the underlying securities
may cause the Fund to realize gains or losses at inopportune times.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Options on indices of securities
and sectors of securities that qualify as &#8220;section 1256 contracts&#8221; will generally be treated as &#8220;marked-to-market&#8221;
for U.S. federal income tax purposes. As a result, the Fund will generally recognize gain or loss on the last day of each taxable year
equal to the difference between the value of the option on that date and the adjusted basis of the option. The adjusted basis of the
option will consequently be increased by such gain or decreased by such loss. Any gain or loss with respect to options on indices and
sectors that qualify as &#8220;section 1256 contracts&#8221; will be treated as short-term capital gain or loss to the extent of 40%
of such gain or loss and long-term capital gain or loss to the extent of 60% of such gain or loss. Because the mark-to-market rules&#160;may
cause the Fund to recognize gain in advance of the receipt of cash, the Fund may be required to dispose of investments in order to meet
its distribution requirements. &#8220;Mark-to-market&#8221; losses may be suspended or otherwise limited if such losses are part of a
straddle or similar transaction.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Taxation of Common Shareholders</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund will either distribute
or retain for reinvestment all or part of its net capital gain. If any such gain is retained, the Fund will be subject to a corporate
income tax on such retained amount. In that event, the Fund expects to report the retained amount as undistributed capital gain in a
notice to its common shareholders, each of whom, if subject to U.S. federal income tax on long-term capital gains, (i)&#160;will be required
to include in income for U.S. federal income tax purposes as long-term capital gain its share of such undistributed amounts, (ii)&#160;will
be entitled to credit its proportionate share of the tax paid by the Fund against its U.S. federal income tax liability and to claim
refunds to the extent that the credit exceeds such liability and (iii)&#160;will increase its basis in its common shares by the amount
of undistributed capital gains included in the shareholder&#8217;s income, less the tax deemed paid by the shareholder under clause (ii).</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Distributions paid to you
by the Fund from its net capital gain, if any, that the Fund properly reports as capital gain dividends (&#8220;capital gain dividends&#8221;)
are taxable as long-term capital gains, regardless of how long you have held your common shares. All other dividends paid to you by the
Fund (including dividends from net short-term capital gains or tax-exempt interest, if any) from its current or accumulated earnings
and profits (&#8220;ordinary income dividends&#8221;) are generally subject to tax as ordinary income. Provided that certain holding
period and other requirements are met, ordinary income dividends (if properly reported by the Fund) may qualify (i)&#160;for the dividends
received deduction in the case of corporate shareholders to the extent that the Fund&#8217;s income consists of dividend income from
U.S. corporations, and (ii)&#160;in the case of individual shareholders, as &#8220;qualified dividend income&#8221; eligible to be taxed
at long-term capital gains rates to the extent that the Fund receives qualified dividend income. Qualified dividend income is, in general,
dividend income from taxable domestic corporations and certain qualified foreign corporations (e.g., generally, foreign corporations
incorporated in a possession of the United States or in certain countries with a qualifying comprehensive tax treaty with the United
States, or whose stock with respect to which such dividend is paid is readily tradable on an established securities market in the United
States). There can be no assurance as to what portion, if any, of the Fund&#8217;s distributions will constitute qualified dividend income
or be eligible for the dividends received deduction.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any distributions you receive
that are in excess of the Fund&#8217;s current and accumulated earnings and profits will be treated as a return of capital to the extent
of your adjusted tax basis in your common shares, and thereafter as capital gain from the sale of common shares. The amount of any Fund
distribution that is treated as a return of capital will reduce your adjusted tax basis in your common shares, thereby increasing your
potential gain or reducing your potential loss on any subsequent sale or other disposition of your common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Common shareholders may be
entitled to offset their capital gain dividends with capital losses. The Code contains a number of statutory provisions affecting when
capital losses may be offset against capital gain, and limiting the use of losses from certain investments and activities. Accordingly,
common shareholders that have capital losses are urged to consult their tax advisor.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dividends and other taxable
distributions are taxable to you even though they are reinvested in additional common shares of the Fund. Dividends and other distributions
paid by the Fund are generally treated under the Code as received by you at the time the dividend or distribution is made. If, however,
the Fund pays you a dividend in January&#160;that was declared in the previous October, November&#160;or December&#160;to common shareholders
of record on a specified date in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being
paid by the Fund and received by you on December&#160;31 of the year in which the dividend was declared. In addition, certain other distributions
made after the close of the Fund&#8217;s taxable year may be &#8220;spilled back&#8221; and treated as paid by the Fund (except for purposes
of the 4% nondeductible excise tax) during such taxable year. In such case, you will be treated as having received such dividends in
the taxable year in which the distributions were actually made.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The price of common shares
purchased at any time may reflect the amount of a forthcoming distribution. Those purchasing common shares just prior to the record date
for a distribution will receive a distribution which will be taxable to them even though it represents, economically, a return of invested
capital.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund will send you information
after the end of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sale or other disposition
of common shares will generally result in capital gain or loss to you and will be long-term capital gain or loss if you have held such
common shares for more than one year at the time of sale. Any loss upon the sale or other disposition of common shares held for six months
or less will be treated as long-term capital loss to the extent of any capital gain dividends received (including amounts credited as
an undistributed capital gain dividend) by you with respect to such common shares. Any loss you recognize on a sale or other disposition
of common shares will be disallowed if you acquire other common shares (whether through the automatic reinvestment of dividends or otherwise)
within a 61-day period beginning 30 days before and ending 30 days after your sale or exchange of the common shares. In such case, your
tax basis in the common shares acquired will be adjusted to reflect the disallowed loss.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any sales charges paid upon
a purchase of common shares cannot be taken into account for purposes of determining gain or loss on a sale of the common shares before
the 91st day after their purchase to the extent a sales charge is reduced or eliminated in a subsequent acquisition of common shares
of the Fund (or of another fund), during the period beginning on the date of such sale and ending on January&#160;31 of the calendar
year following the calendar year in which such sale was made, pursuant to the reinvestment or exchange privilege. Any disregarded amounts
will result in an adjustment to the shareholder&#8217;s tax basis in some or all of any other shares acquired.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Fund conducts a tender
offer for its shares, a repurchase by the Fund of a shareholder&#8217;s shares pursuant to such tender offer generally will be treated
as a sale or exchange of the shares by a shareholder, provided that either (i)&#160;the shareholder tenders, and the Fund repurchases,
all of such shareholder&#8217;s shares, thereby reducing the shareholder&#8217;s percentage ownership of the Fund, directly and by attribution
under Section&#160;318 of the Code, to 0%, (ii)&#160;the shareholder meets numerical safe harbors under the Code with respect to percentage
voting interest and reduction in ownership of the Fund following completion of the tender offer, or (iii)&#160;the tender offer otherwise
results in a &#8220;meaningful reduction&#8221; of the shareholder&#8217;s ownership percentage interest in the Fund, which determination
depends on a particular shareholder&#8217;s facts and circumstances.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a tendering shareholder&#8217;s
proportionate ownership of the Fund (determined after applying the ownership attribution rules&#160;under Section&#160;318 of the Code)
is not reduced to the extent required under the tests described above, such shareholder will be deemed to receive a distribution from
the Fund under Section&#160;301 of the Code with respect to the shares held (or deemed held under Section&#160;318 of the Code) by the
shareholder after the tender offer (a &#8220;Section&#160;301 distribution&#8221;). The amount of this distribution will equal the price
paid by the Fund to such shareholder for the shares sold, and will be taxable as a dividend, i.e., as ordinary income, to the extent
of the Fund&#8217;s current or accumulated earnings and profits allocable to such distribution, with the excess treated as a return of
capital reducing the shareholder&#8217;s tax basis in the shares held after the tender offer, and thereafter as capital gain. Any Fund
shares held by a shareholder after a tender offer will be subject to basis adjustments in accordance with the provisions of the Code.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Provided that no tendering
shareholder is treated as receiving a Section&#160;301 distribution as a result of selling shares pursuant to a particular tender offer,
shareholders who do not sell shares pursuant to that tender offer will not realize constructive distributions on their shares as a result
of other shareholders selling shares in the tender offer. In the event that any tendering shareholder is deemed to receive a Section&#160;301
distribution, it is possible that shareholders whose proportionate ownership of the Fund increases as a result of that tender offer,
including shareholders who do not tender any shares, will be deemed to receive a constructive distribution under Section&#160;305(c)&#160;of
the Code in an amount equal to the increase in their percentage ownership of the Fund as a result of the tender offer. Such constructive
distribution will be treated as a dividend to the extent of current or accumulated earnings and profits allocable to it.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Use of the Fund&#8217;s cash
to repurchase shares may adversely affect the Fund&#8217;s ability to satisfy the distribution requirements for treatment as a regulated
investment company described above. The Fund may also recognize income in connection with the sale of portfolio securities to fund share
purchases, in which case the Fund would take any such income into account in determining whether such distribution requirements have
been satisfied.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Fund liquidates, shareholders
generally will realize capital gain or loss upon such liquidation in an amount equal to the difference between the amount of cash or
other property received by the shareholder (including any property deemed received by reason of its being placed in a liquidating trust)
and the shareholder&#8217;s adjusted tax basis in its shares. Any such gain or loss will be long-term if the shareholder is treated as
having a holding period in Fund shares of greater than one year, and otherwise will be short-term.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing discussion
does not address the tax treatment of shareholders who do not hold their shares as a capital asset. Such shareholders should consult
their own tax advisers on the specific tax consequences to them of participating or not participating in the tender offer or upon liquidation
of the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Current U.S. federal income
tax law taxes both long-term and short-term capital gain of corporations at the rates applicable to ordinary income. For non-corporate
taxpayers, short-term capital gain is currently taxed at rates applicable to ordinary income while long-term capital gain generally is
taxed at a reduced maximum rate. The deductibility of capital losses is subject to limitations under the Code.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain U.S. holders who
are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or
a portion of their &#8220;net investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale
or other disposition of the Fund&#8217;s common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A common shareholder that
is a nonresident alien individual or a foreign corporation (a &#8220;foreign investor&#8221;) generally will be subject to U.S. federal
withholding tax at the rate of 30% (or possibly a lower rate provided by an applicable tax treaty) on ordinary income dividends (except
as discussed below). In general, U.S. federal withholding tax and U.S. federal income tax will not apply to any gain or income realized
by a foreign investor in respect of any distribution of net capital gain (including amounts credited as an undistributed capital gain
dividend) or upon the sale or other disposition of common shares of the Fund. Different tax consequences may result if the foreign investor
is engaged in a trade or business in the United States or, in the case of an individual, is present in the United States for 183 days
or more during a taxable year and certain other conditions are met. Foreign investors should consult their tax advisor regarding the
tax consequences of investing in the Fund&#8217;s common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ordinary income dividends
properly reported by the RIC are generally exempt from U.S. federal withholding tax where they (i)&#160;are paid in respect of the RIC&#8217;s
&#8220;qualified net interest income&#8221; (generally, its U.S.-source interest income, other than certain contingent interest and interest
from obligations of a corporation or partnership in which the RIC is at least a 10% shareholder, reduced by expenses that are allocable
to such income) or (ii)&#160;are paid in respect of the RIC&#8217;s &#8220;qualified short-term capital gains&#8221; (generally, the
excess of the RIC&#8217;s net short-term capital gain over its long-term capital loss for such taxable year). Depending on its circumstances,
the Fund may report all, some or none of its potentially eligible dividends as such qualified net interest income or as qualified short-term
capital gains, and/or treat such dividends, in whole or in part, as ineligible for this exemption from withholding. In order to qualify
for this exemption from withholding, a foreign investor needs to comply with applicable certification requirements relating to its non-U.S.
status (including, in general, furnishing an IRS Form&#160;W-8BEN, W-8BEN-E, or substitute Form). In the case of common shares held through
an intermediary, the intermediary may have withheld even if the Fund reported the payment as qualified net interest income or qualified
short-term capital gain. Foreign investors should contact their intermediaries with respect to the application of these rules&#160;to
their accounts. There can be no assurance as to what portion of the Fund&#8217;s distributions would qualify for favorable treatment
as qualified net interest income or qualified short-term capital gains.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, withholding
at a rate of 30% will apply to dividends paid in respect of common shares of the Fund held by or through certain foreign financial institutions
(including investment funds), unless such institution enters into an agreement with the Treasury to report, on an annual basis, information
with respect to shares in, and accounts maintained by, the institution to the extent such shares or accounts are held by certain U.S.
persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments. Accordingly,
the entity through which common shares of the Fund are held will affect the determination of whether such withholding is required. Similarly,
dividends paid in respect of common shares of the Fund held by an investor that is a non-financial foreign entity that does not qualify
under certain exemptions will be subject to withholding at a rate of 30%, unless such entity either (i)&#160;certifies that such entity
does not have any &#8220;substantial United States owners&#8221; or (ii)&#160;provides certain information regarding the entity&#8217;s
&#8220;substantial United States owners,&#8221; which the applicable withholding agent will in turn provide to the Secretary of the Treasury.
An intergovernmental agreement between the United States and an applicable foreign country, or future Treasury regulations or other guidance,
may modify these requirements. The Fund will not pay any additional amounts to common shareholders in respect of any amounts withheld.
Foreign investors are encouraged to consult with their tax advisers regarding the possible implications of these rules&#160;on their
investment in the Fund&#8217;s common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S. federal backup withholding
tax may be required on dividends, distributions and sale proceeds payable to certain non-exempt common shareholders who fail to supply
their correct taxpayer identification number (in the case of individuals, generally, their social security number) or to make required
certifications, or who are otherwise subject to backup withholding. Backup withholding is not an additional tax and any amount withheld
may be refunded or credited against your U.S. federal income tax liability, if any, provided that you timely furnish the required information
to the IRS.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ordinary income dividends,
capital gain dividends, and gain from the sale or other disposition of common shares of the Fund also may be subject to state, local,
and/or foreign taxes. Common shareholders are urged to consult their own tax advisers regarding specific questions about U.S. federal,
state, local or foreign tax consequences to them of investing in the Fund.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">***</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing is a general
and abbreviated summary of certain provisions of the Code and the Treasury regulations presently in effect as they directly govern the
taxation of the Fund and its shareholders. For complete provisions, reference should be made to the pertinent Code sections and Treasury
regulations. The Code and the Treasury regulations are subject to change by legislative or administrative action, and any such change
may be retroactive with respect to Fund transactions. Holders of common shares are advised to consult their own tax advisor for more
detailed information concerning the U.S. federal income taxation of the Fund and the income tax consequences to its holders of common
shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>ADMINISTRATIVE, CUSTODIAN,
TRANSFER AGENT AND OTHER SERVICES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The custodian of the assets
of the Fund is State Street, located at One Congress Street, Boston, Massachusetts 02114. The custodian performs custodial, fund accounting
and portfolio accounting services. State Street serves as the Fund&#8217;s transfer agent and dividend paying agent with respect to the
common shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund has engaged State
Street to serve as the Fund's administrator, custodian and transfer agent. Under the service agreements between State Street and the
Fund, State Street provides certain administrative services necessary for the operation of the Fund. Such services include maintaining
certain Fund books and records, providing accounting and tax services and preparing certain regulatory filings. State Street also performs
custodial, fund accounting and portfolio accounting services, as well as transfer agency and dividend paying services with respect to
the common shares. The Fund pays State Street for these services. The total expenses incurred by the Fund under the service agreements
with State Street for the year ended December&#160;31, 2023 were $341,957.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund has retained Destra
to provide investor support services in connection with the on-going operations of the Fund. Such services include providing ongoing
contact with respect to the Fund and its performance with financial advisors that are representatives of broker-dealers and other financial
intermediaries, communicating with the NYSE specialist for the Fund's common shares and with the closed-end fund analyst community regarding
the Fund on a regular basis, and maintaining a website for the Fund. Effective January&#160;1, 2021, the Fund pays Destra a variable
service fee based on the Fund's closing stock price to net asset value at the end of each day. The total expenses incurred by the Fund
under the agreement with Destra for the year ended December&#160;31, 2023 were $289,508.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ernst&#160;&amp;
Young LLP serves as the Fund&#8217;s independent registered public accounting firm. The <a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract: exhibit">financial
statements of the Fund as of December&#160;31, 2023</a></span> have been audited by Ernst&#160;&amp; Young LLP and are incorporated by
reference herein. The principal business address of Ernst&#160;&amp; Young LLP is 725 South Figueroa Street, Los Angeles, California
90017.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONTROL PERSONS AND PRINCIPAL
HOLDERS OF SECURITIES</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A control person includes
a person who beneficially owns more than 25% of the voting securities of a company. Neither the Adviser nor its affiliates own more than
25% of the common shares of the Fund. However, the Adviser may be considered a controlling person of the Fund under the Investment Company
Act to the extent it has the power to exercise a controlling influence over the management or policies of the Fund. The principal executive
offices of the Adviser are located at 1800 Avenue of the Stars, Suite 1400, Los Angeles, California 90067.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is information with respect to persons or organizations that are known to the Fund to be beneficial owners of more than 5%
of the Fund&#8217;s outstanding preferred shares as of </span><span style="font-size: 10pt">August 6</span>, 2024. This information is
based on the Fund&#8217;s records and publicly available information such as Schedule 13D, Schedule 13G and Form&#160;13F disclosures
filed with the SEC.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Name and Address</b></td><td style="padding-bottom: 1pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Preferred
                                            Shares Held</b></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Percentage
                                            of Preferred Shares Held</b></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 72%; font: 10pt Times New Roman, Times, Serif; text-align: left">Thrivent Financial for Lutherans<br/>
    901 Marquette Avenue, Suite&#160;25<br/>
    Minneapolis, Minnesota 55402</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">760,000</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">19.00</td><td style="width: 3%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Athene Annuity and Life Company<br/>
    Athene Annuity&#160;&amp; Life Assurance <br/>
    Company7700 Mills Civic Parkway<br/>
    West Des Moines,&#160;Iowa 50266</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">760,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(a)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sun Life Assurance Company of<br/>
    Canada<br/>
    Sun Life Financial Inc. <br/>
    One York Street<br/> Toronto, Ontario<br/>
    Canada M5J OB6</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">560,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(b)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Principal Life Insurance Company<br/>
    711 High Street <br/>
    Des Moines,&#160;Iowa 50392</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">360,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(c)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Voya Retirement Insurance and Annuity Company <br/>
    5780 Powers Ferry Road, NW <br/>
    Suite&#160;300 <br/>
    Atlanta, Georgia 30327</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">288,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.20</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">The Guardian Life Insurance Company <br/>
    of America <br/>
    10 Hudson Yards<br/>
    New York, New York 10001</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">280,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(d)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Minnesota Life Insurance Company <br/>
    Attn: Securian Asset Management,&#160;Inc. <br/>
    400 Robert Street North <br/>
    St. Paul, Minnesota 55101-2098</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">223,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.58</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<sup>(e)&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Arch Reinsurance Ltd. <br/>
    Waterloo House <br/>
    100 Pitts Bay Road <br/>
    Pembroke HM 08 <br/>
    Bermuda</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">(a)&#160;&#160;Athene Annuity and Life Company
("AAIA") and Athene Annuity&#160;&amp; Life Assurance Company ("AADE") filed their amended Schedule 13G jointly with
the SEC on February&#160;14, 2024 and beneficially owned shares of the Fund in the aggregate amount of 760,000, or 19.00% of the Fund's
outstanding preferred shares. AAIA owned 260,000 Series&#160;A MRP Shares of the Fund with shared voting power and 260,000 Series&#160;A
MRP Shares with shared dispositive power, 160,000 Series&#160;B MRP Shares of the Fund with shared voting power and 160,000 Series&#160;B
MRP Shares with shared dispositive power, and 240,000 Series&#160;C MRP Shares of the Fund with shared voting power and 240,000 Series&#160;C
MRP Shares with shared dispositive power. AADE owned 360,000 Series&#160;A MRP Shares with shared voting power and 360,000 Series&#160;A
MRP Shares with shared dispositive power, 160,000 Series&#160;B MRP Shares with shared voting power and 160,000 Series&#160;B MRP Shares
with shared dispositive power, and 240,000 Series&#160;C MRP Shares with shared voting power and 240,000 Series&#160;C MRP Shares with
shared dispositive power.</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">(b)&#160;&#160;Sun Life Assurance Company of
Canada and Sun Life Financial Inc. filed their amended Schedule 13G jointly with the SEC on February&#160;14, 2022 and beneficially owned
shares of the Fund in the aggregate amount of 560,000, or 14.00% of the Fund's outstanding preferred shares. Sun Life Assurance Company
of Canada owned 240,000 Series&#160;A MRP Shares of the Fund with sole voting power and 240,000 Series&#160;A MRP Shares of the Fund
with sole dispositive power. Sun Life Assurance Company of Canada owned 320,000 Series&#160;C MRP Shares of the Fund with sole voting
power and 320,000 Series&#160;C MRP Shares of the Fund with sole dispositive power. Sun Life Financial Inc. owned 240,000 Series&#160;A
MRP Shares of the Fund with shared voting power and 240,000 Series&#160;A MRP Shares of the Fund with shared dispositive power. Sun Life
Financial Inc. owned 320,000 Series&#160;C MRP Shares of the Fund with shared voting power and 320,000 Series&#160;C MRP Shares of the
Fund with shared dispositive power.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&#160;&#160;Principal Life Insurance Company
filed its Schedule 13G with the SEC on June&#160;16, 2023 and beneficially owned shares of the Fund in the aggregate amount of 360,000,
or 9.00% of the Fund's outstanding preferred shares. Principal Life Insurance Company owned an aggregate amount of 360,000 Series&#160;A
MRP Shares and Series&#160;B MRP Shares with shared voting power and an aggregate amount of 360,000 Series&#160;A MRP Shares and Series&#160;B
MRP Shares with shared dispositive power.</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;&#160;The Guardian Life Insurance Company
of America filed its Schedule 13G with the SEC on February&#160;15, 2022 and beneficially owned shares of the Fund in the aggregate amount
of 280,000, or 7.00% of the Fund's outstanding preferred shares. The Guardian Life Insurance Company of America owned 280,000 Series&#160;C
MRP Shares of the Fund with sole voting power and 280,000 Series&#160;C MRP Shares of the Fund with sole dispositive power.</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e)&#160;&#160;Minnesota Life Insurance Company
filed its Schedule 13G with the SEC on February&#160;14, 2022 and beneficially owned shares of the Fund in the aggregate amount of 223,000,
or 5.58% of the Fund's outstanding preferred shares. Minnesota Life Insurance Company owned 223,000 Series&#160;B MRP Shares of the Fund
with sole voting power and 223,000 Series&#160;B MRP Shares of the Fund with sole dispositive power.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INCORPORATION BY REFERENCE</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">This
SAI is part of a registration statement that we have filed with the SEC. We are allowed to &#8220;incorporate by reference&#8221; the
information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents.
We incorporate by reference into this SAI the documents listed below and any future filings we make with the SEC under Section&#160;13(a),
13(c), 14 or 15(d)&#160;of the Exchange Act, including any filings on or after the date of this SAI from the date of filing (excluding
any information furnished, rather than filed), until we have sold all of the offered securities to which this SAI, the Prospectus and
any accompanying prospectus supplement relates or the offering is otherwise terminated. The information incorporated by reference is
an important part of this SAI. Any statement in a document incorporated by reference into this SAI will be deemed to be automatically
modified or superseded to the extent a statement contained in (1)&#160;this SAI or (2)&#160;any other subsequently filed document that
is incorporated by reference into this SAI modifies or supersedes such statement. The documents incorporated by reference herein include:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Fund&#8217;s Prospectus, dated </span><span style="font-size: 10pt; font-style: normal; font-weight: normal">August 26</span>, 2024,
    filed with this SAI;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our&#160;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract: exhibit">annual
    report</a></span>&#160;on Form&#160;N-CSR&#160;for the fiscal year ended December&#160;31, 2023 filed with the SEC on March&#160;6,
    2024;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our&#160;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465923097217/tm2318740d1_ncsrs.htm" style="-sec-extract: exhibit">semi-annual
    report</a>&#160;</span>on Form&#160;N-CSR&#160;for the fiscal period ended June&#160;30, 2023 filed with the SEC on August&#160;31,
    2023;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Fund&#8217;s&#160;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465924045179/tm2411001d1_def14a.htm" style="-sec-extract: exhibit">definitive
    proxy statement</a></span>&#160;on Schedule 14A, filed with the SEC on April&#160;9, 2024; and</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;  border-collapse: collapse">
  <tr>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 3%; text-align: justify"><span>&#9679;</span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the&#160;<a href="http://www.sec.gov/Archives/edgar/data/1515324/000110465912077964/a12-27073_18a12b.htm" style="-sec-extract: exhibit">description
    of the Fund&#8217;s common shares</a></span>&#160;contained in our Registration Statement on Form&#160;8-A&#160;(File&#160;No.&#160;811-22535)&#160;filed
    with the SEC on March&#160;22, 2011, including any amendment or report filed for the purpose of updating such description prior to
    the termination of the offering registered hereby.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">The
Fund will provide without charge to each person, including any beneficial owner, to whom this SAI is delivered, upon written or oral
request, a copy of any and all of the documents that have been or may be incorporated by reference in this SAI, the Prospectus or the
accompanying prospectus supplement. You should direct requests for documents by calling: (888) 818-5298.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">The
Fund makes available this Prospectus, SAI and the Fund&#8217;s annual and semi-annual reports, free of charge, at www.arespublicfunds.com.
You may also obtain this SAI, the Prospectus, other documents incorporated by reference and other information the Fund files electronically,
including reports and proxy statements, on the SEC&#8217;s website (http://www.sec.gov) or with the payment of a duplication fee, by
electronic request at publicinfo@sec.gov. Information contained in, or that can be accessed through, the Fund&#8217;s website is not
part of this SAI, the Prospectus or the accompanying prospectus supplement.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><div><a id="sai_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FINANCIAL STATEMENTS</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audited financial statements and financial highlights included in the <a href="https://www.sec.gov/Archives/edgar/data/1515324/000110465924031433/tm244051d1_ncsr.htm" style="-sec-extract: exhibit">Annual
Report to the Fund&#8217;s shareholders for the fiscal year ended December&#160;31, 2023</a></span>, together with the report of Ernst&#160;&amp;
Young LLP for the Fund&#8217;s Annual Report are incorporated herein by reference.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>


</div><!-- Field: Page; Sequence: 24; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></span></p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>ck0001515324-20240830.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:ck0001515324="http://www.www.arespublicfunds.com/20240830" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:cef-pre="http://xbrl.sec.gov/cef-pre/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" targetNamespace="http://www.www.arespublicfunds.com/20240830" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://xbrl.sec.gov/cef/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/cef-pre/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/Cover" id="Cover">
        <link:definition>0000 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/FinancialHighlights" id="FinancialHighlights">
        <link:definition>0000 - Disclosure - Senior Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/FeeTable" id="FeeTable">
        <link:definition>0000 - Disclosure - Summary of Fees &amp; Expenses And Example Table</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/GeneralDescriptionOfRegistrant" id="GeneralDescriptionOfRegistrant">
        <link:definition>0000 - Disclosure - General Description of Registrant</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.www.arespublicfunds.com/role/CapitalStockLongTermDebtAndOtherSecurities" id="CapitalStockLongTermDebtAndOtherSecurities">
        <link:definition>0000 - Disclosure - Capital Stock Long Term Debt And Other Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001515324-20240830_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001515324-20240830_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ck0001515324-20240830_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" id="ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AffiliatedTransactionsRestrictionsMember" id="ck0001515324_AffiliatedTransactionsRestrictionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AntiTakeoverProvisionsRiskMember" id="ck0001515324_AntiTakeoverProvisionsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AssetAllocationRiskMember" id="ck0001515324_AssetAllocationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BankLoanRiskMember" id="ck0001515324_BankLoanRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BankObligationsMember" id="ck0001515324_BankObligationsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BorrowingMember" id="ck0001515324_BorrowingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CertificatesOfDepositRiskMember" id="ck0001515324_CertificatesOfDepositRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CollateralizedLoanObligationRiskMember" id="ck0001515324_CollateralizedLoanObligationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommercialMortgageBackedSecuritiesRiskMember" id="ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommercialPaperRiskMember" id="ck0001515324_CommercialPaperRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommodityRelatedInvestmentsRiskMember" id="ck0001515324_CommodityRelatedInvestmentsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommonStocksMember" id="ck0001515324_CommonStocksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConcentrationRiskMember" id="ck0001515324_ConcentrationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConstructionAndDevelopmentRiskMember" id="ck0001515324_ConstructionAndDevelopmentRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleSecuritiesMember" id="ck0001515324_ConvertibleSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ConvertibleSecuritiesRiskMember" id="ck0001515324_ConvertibleSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CorporateBondsRiskMember" id="ck0001515324_CorporateBondsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CorporateLoansRiskMember" id="ck0001515324_CorporateLoansRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CounterpartyRiskMember" id="ck0001515324_CounterpartyRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditDefaultSwapsMember" id="ck0001515324_CreditDefaultSwapsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditFacilityMember" id="ck0001515324_CreditFacilityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditRisksMember" id="ck0001515324_CreditRisksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CurrencyFuturesAndOptionsThereonMember" id="ck0001515324_CurrencyFuturesAndOptionsThereonMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DebtObligationsOfNonUsGovernmentsMember" id="ck0001515324_DebtObligationsOfNonUsGovernmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" id="ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DerivativesRiskMember" id="ck0001515324_DerivativesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DistressedSecuritiesRiskMember" id="ck0001515324_DistressedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DoddFrankActRiskMember" id="ck0001515324_DoddFrankActRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmergingMarketsRiskMember" id="ck0001515324_EmergingMarketsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmergingMarketsSecuritiesMember" id="ck0001515324_EmergingMarketsSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EnvironmentalRiskMember" id="ck0001515324_EnvironmentalRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquitySecuritiesAndRelatedInvestmentsMember" id="ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" id="ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EventLinkedBondsMember" id="ck0001515324_EventLinkedBondsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EventLinkedSwapsMember" id="ck0001515324_EventLinkedSwapsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EventRiskMember" id="ck0001515324_EventRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeTradedNoteRiskMember" id="ck0001515324_ExchangeTradedNoteRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeTradedNotesMember" id="ck0001515324_ExchangeTradedNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeTradedProductRiskMember" id="ck0001515324_ExchangeTradedProductRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExchangeTradedProductsMember" id="ck0001515324_ExchangeTradedProductsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExclusionFromDefinitionOfCommodityPoolOperatorMember" id="ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FloatingRateLoansMember" id="ck0001515324_FloatingRateLoansMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignCurrencyRiskMember" id="ck0001515324_ForeignCurrencyRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignSecuritiesMember" id="ck0001515324_ForeignSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignSecuritiesRiskMember" id="ck0001515324_ForeignSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForwardCurrencyExchangeContractsMember" id="ck0001515324_ForwardCurrencyExchangeContractsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FuturesContractsAndOptionsOnFuturesMember" id="ck0001515324_FuturesContractsAndOptionsOnFuturesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralRiskOfInvestingInFundMember" id="ck0001515324_GeneralRiskOfInvestingInFundMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GoldAndOtherPreciousMetalsRiskMember" id="ck0001515324_GoldAndOtherPreciousMetalsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GovernmentInterventionInFinancialMarketsMember" id="ck0001515324_GovernmentInterventionInFinancialMarketsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GuaranteedMortgagePassThroughSecuritiesMember" id="ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HighYieldJunkSecuritiesRiskMember" id="ck0001515324_HighYieldJunkSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="HybridInstrumentsMember" id="ck0001515324_HybridInstrumentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IlliquidAndRestrictedSecuritiesRiskMember" id="ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncomeAndDistributionRiskMember" id="ck0001515324_IncomeAndDistributionRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InfectiousIllnessRiskMember" id="ck0001515324_InfectiousIllnessRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InflationInterestRateAndBondMarketRiskMember" id="ck0001515324_InflationInterestRateAndBondMarketRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InflationLinkedFixedIncomeSecuritiesMember" id="ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InfrastructureRiskMember" id="ck0001515324_InfrastructureRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InterestRateFuturesContractsAndOptionsThereonMember" id="ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InverseFloatingRateSecuritiesMember" id="ck0001515324_InverseFloatingRateSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestmentGradeCorporateSecuritiesMember" id="ck0001515324_InvestmentGradeCorporateSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestmentGradeSecuritiesRiskMember" id="ck0001515324_InvestmentGradeSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestmentsInDifferentPartsOfCapitalStructureMember" id="ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" id="ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeverageRiskMember" id="ck0001515324_LeverageRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LimitedPartnershipsMember" id="ck0001515324_LimitedPartnershipsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LiquidityRiskMember" id="ck0001515324_LiquidityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LoansOfPortfolioSecuritiesMember" id="ck0001515324_LoansOfPortfolioSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ManagementRiskMember" id="ck0001515324_ManagementRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarketDiscountRiskMember" id="ck0001515324_MarketDiscountRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MasterLimitedPartnershipsMember" id="ck0001515324_MasterLimitedPartnershipsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MasterLimitedPartnershipsRiskMember" id="ck0001515324_MasterLimitedPartnershipsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MortgageAndAssetBackedSecuritiesMember" id="ck0001515324_MortgageAndAssetBackedSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" id="ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NaturalResourcesRiskMember" id="ck0001515324_NaturalResourcesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OptionsMember" id="ck0001515324_OptionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OptionsOnForeignCurrenciesMember" id="ck0001515324_OptionsOnForeignCurrenciesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OptionsOnSecuritiesIndicesMember" id="ck0001515324_OptionsOnSecuritiesIndicesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" id="ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OverCounterTradingRiskMember" id="ck0001515324_OverCounterTradingRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PortfolioTurnoverRiskMember" id="ck0001515324_PortfolioTurnoverRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PotentialConflictsOfInterestRiskMember" id="ck0001515324_PotentialConflictsOfInterestRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreferredSecuritiesRiskMember" id="ck0001515324_PreferredSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreferredStocksMember" id="ck0001515324_PreferredStocksMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrepaymentOrCallRiskMember" id="ck0001515324_PrepaymentOrCallRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivateCompanyLiquidityRiskMember" id="ck0001515324_PrivateCompanyLiquidityRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivateCompanyManagementRiskMember" id="ck0001515324_PrivateCompanyManagementRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivateCompanyValuationRiskMember" id="ck0001515324_PrivateCompanyValuationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrivateInvestmentRiskMember" id="ck0001515324_PrivateInvestmentRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RealEstateInvestmentTrustsMember" id="ck0001515324_RealEstateInvestmentTrustsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RealEstateInvestmentTrustsRiskMember" id="ck0001515324_RealEstateInvestmentTrustsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RealEstateMarketRiskMember" id="ck0001515324_RealEstateMarketRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RecentMarketEconomicAndSocialDevelopmentsRiskMember" id="ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RepurchaseAgreementsRiskMember" id="ck0001515324_RepurchaseAgreementsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ResidentialMortgageBackedSecuritiesRiskMember" id="ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReturnOfCapitalRiskMember" id="ck0001515324_ReturnOfCapitalRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReverseRepurchaseAgreementsRiskMember" id="ck0001515324_ReverseRepurchaseAgreementsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithLongTermObjectiveMember" id="ck0001515324_RisksAssociatedWithLongTermObjectiveMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" id="ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" id="ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" id="ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksOfCurrencyTransactionsMember" id="ck0001515324_RisksOfCurrencyTransactionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" id="ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RisksRelatingToRussiaInvasionOfUkraineMember" id="ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SectorFocusRiskMember" id="ck0001515324_SectorFocusRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecuritiesIndexFuturesContractsAndOptionsThereonMember" id="ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecuritiesLendingRiskMember" id="ck0001515324_SecuritiesLendingRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortSalesRiskMember" id="ck0001515324_ShortSalesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShortTermDebtObligationsRiskMember" id="ck0001515324_ShortTermDebtObligationsRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" id="ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SpecialRisksRelatedToCyberSecurityMember" id="ck0001515324_SpecialRisksRelatedToCyberSecurityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StapledSecuritiesRiskMember" id="ck0001515324_StapledSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StrippedMortgageBackedSecuritiesMember" id="ck0001515324_StrippedMortgageBackedSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StrippedSecuritiesRiskMember" id="ck0001515324_StrippedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StructuredNotesMember" id="ck0001515324_StructuredNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StructuredSecuritiesMember" id="ck0001515324_StructuredSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubordinatedSecuritiesMember" id="ck0001515324_SubordinatedSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubscriptionRightsMember" id="ck0001515324_SubscriptionRightsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SwapAgreementsAndOptionsOnSwapAgreementsMember" id="ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SystemicRiskMember" id="ck0001515324_SystemicRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TemporaryDefensiveStrategiesRiskMember" id="ck0001515324_TemporaryDefensiveStrategiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TrackingRiskMember" id="ck0001515324_TrackingRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnratedSecuritiesRiskMember" id="ck0001515324_UnratedSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UsGovernmentSecuritiesMember" id="ck0001515324_UsGovernmentSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UsGovernmentSecuritiesRiskMember" id="ck0001515324_UsGovernmentSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ValuationRiskMember" id="ck0001515324_ValuationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VariableAndFloatingRateDemandAndMasterDemandNotesMember" id="ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VariableAndFloatingRateSecuritiesRiskMember" id="ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsAndRightsMember" id="ck0001515324_WarrantsAndRightsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ZeroCouponAndPaymentInKindSecuritiesMember" id="ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>ck0001515324-20240830_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#RiskOnly"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#SecurityOnly"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommonStocksMember" xlink:label="loc_ck0001515324_CommonStocksMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SubscriptionRightsMember" xlink:label="loc_ck0001515324_SubscriptionRightsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditFacilityMember" xlink:label="loc_ck0001515324_CreditFacilityMember_1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_PreferredStocksMember_1" order="1" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_CommonStocksMember_2" order="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_SubscriptionRightsMember_7" order="3" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001515324_CreditFacilityMember_1" order="1" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_5"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_6"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_11"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_12"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_13"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_14"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_15"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_16"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_17"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_18"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_19"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_20"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_21"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_22"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_23"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_24"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" xlink:label="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_25"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_26"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_27"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_28"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_29"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_30"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_31"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_32"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_33"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_34"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_35"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_36"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_37"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_38"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_39"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_40"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_41"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_42"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_43"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_44"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_45"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_46"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_47"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_48"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_49"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_50"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_51"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_52"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_53"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_54"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_55"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_56"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_57"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_58"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_59"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_60"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_61"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_62"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_63"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_64"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_65"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_66"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_67"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_68"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_69"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_70"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_71"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_72"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_73"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_74"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_75"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_76"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_77"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_78"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_79"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventLinkedBondsMember" xlink:label="loc_ck0001515324_EventLinkedBondsMember_80"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventLinkedSwapsMember" xlink:label="loc_ck0001515324_EventLinkedSwapsMember_81"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConvertibleSecuritiesMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesMember_82"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedProductsMember" xlink:label="loc_ck0001515324_ExchangeTradedProductsMember_83"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" xlink:label="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_84"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_WarrantsAndRightsMember" xlink:label="loc_ck0001515324_WarrantsAndRightsMember_85"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BorrowingMember" xlink:label="loc_ck0001515324_BorrowingMember_86"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LoansOfPortfolioSecuritiesMember" xlink:label="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_87"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_88"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InverseFloatingRateSecuritiesMember" xlink:label="loc_ck0001515324_InverseFloatingRateSecuritiesMember_89"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_90"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" xlink:label="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_91"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BankObligationsMember" xlink:label="loc_ck0001515324_BankObligationsMember_92"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_93"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CertificatesOfDepositRiskMember" xlink:label="loc_ck0001515324_CertificatesOfDepositRiskMember_94"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_95"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LimitedPartnershipsMember" xlink:label="loc_ck0001515324_LimitedPartnershipsMember_96"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MasterLimitedPartnershipsMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsMember_97"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" xlink:label="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_98"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignSecuritiesMember" xlink:label="loc_ck0001515324_ForeignSecuritiesMember_99"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EmergingMarketsSecuritiesMember" xlink:label="loc_ck0001515324_EmergingMarketsSecuritiesMember_100"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StructuredNotesMember" xlink:label="loc_ck0001515324_StructuredNotesMember_101"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StructuredSecuritiesMember" xlink:label="loc_ck0001515324_StructuredSecuritiesMember_102"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" xlink:label="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_103"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SubordinatedSecuritiesMember" xlink:label="loc_ck0001515324_SubordinatedSecuritiesMember_104"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_FloatingRateLoansMember" xlink:label="loc_ck0001515324_FloatingRateLoansMember_105"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" xlink:label="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_106"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" xlink:label="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_107"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_108"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StrippedMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_109"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_110"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentGradeCorporateSecuritiesMember" xlink:label="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_111"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_HybridInstrumentsMember" xlink:label="loc_ck0001515324_HybridInstrumentsMember_112"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsMember_113"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_114"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EnvironmentalRiskMember" xlink:label="loc_ck0001515324_EnvironmentalRiskMember_115"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedNotesMember" xlink:label="loc_ck0001515324_ExchangeTradedNotesMember_116"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SpecialRisksRelatedToCyberSecurityMember" xlink:label="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_117"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" xlink:label="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_118"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" xlink:label="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_119"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AffiliatedTransactionsRestrictionsMember" xlink:label="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_120"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateInvestmentRiskMember" xlink:label="loc_ck0001515324_PrivateInvestmentRiskMember_121"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyManagementRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyManagementRiskMember_122"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyLiquidityRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_123"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyValuationRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyValuationRiskMember_124"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_125"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GovernmentInterventionInFinancialMarketsMember" xlink:label="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_126"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" xlink:label="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_127"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_128"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_129"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_130"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_131"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_4" order="1" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MarketDiscountRiskMember_5" order="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateMarketRiskMember_6" order="3" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InfrastructureRiskMember_7" order="4" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_NaturalResourcesRiskMember_8" order="5" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SectorFocusRiskMember_9" order="6" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConcentrationRiskMember_10" order="7" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_11" order="8" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DistressedSecuritiesRiskMember_12" order="9" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CollateralizedLoanObligationRiskMember_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_14" order="11" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_15" order="12" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_16" order="13" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrepaymentOrCallRiskMember_17" order="14" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_18" order="15" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_19" order="16" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CorporateBondsRiskMember_20" order="17" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CreditRisksMember_21" order="18" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BankLoanRiskMember_22" order="19" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LeverageRiskMember_23" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PreferredSecuritiesRiskMember_24" order="21" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_25" order="22" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InfectiousIllnessRiskMember_26" order="23" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConvertibleSecuritiesRiskMember_27" order="24" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignSecuritiesRiskMember_28" order="25" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EmergingMarketsRiskMember_29" order="26" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignCurrencyRiskMember_30" order="27" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_31" order="28" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DerivativesRiskMember_32" order="29" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CounterpartyRiskMember_33" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LiquidityRiskMember_34" order="31" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ShortSalesRiskMember_35" order="32" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SecuritiesLendingRiskMember_36" order="33" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RepurchaseAgreementsRiskMember_37" order="34" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_38" order="35" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_39" order="36" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CorporateLoansRiskMember_40" order="37" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_41" order="38" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_42" order="39" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ManagementRiskMember_43" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_44" order="41" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_45" order="42" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UnratedSecuritiesRiskMember_46" order="43" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ValuationRiskMember_47" order="44" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_48" order="45" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedProductRiskMember_49" order="46" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedNoteRiskMember_50" order="47" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PortfolioTurnoverRiskMember_51" order="48" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_52" order="49" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ReturnOfCapitalRiskMember_53" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StapledSecuritiesRiskMember_54" order="51" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_55" order="52" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ShortTermDebtObligationsRiskMember_56" order="53" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_IncomeAndDistributionRiskMember_57" order="54" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_58" order="55" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_59" order="56" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_60" order="57" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DoddFrankActRiskMember_61" order="58" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_TrackingRiskMember_62" order="59" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OverCounterTradingRiskMember_63" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsMember_64" order="61" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_65" order="62" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsOnForeignCurrenciesMember_66" order="63" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_67" order="64" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_68" order="65" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_69" order="66" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_70" order="67" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_71" order="68" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_72" order="69" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_73" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_74" order="71" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksOfCurrencyTransactionsMember_75" order="72" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_76" order="73" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CreditDefaultSwapsMember_77" order="74" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_78" order="75" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_79" order="76" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventLinkedBondsMember_80" order="77" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventLinkedSwapsMember_81" order="78" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConvertibleSecuritiesMember_82" order="79" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedProductsMember_83" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_84" order="81" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_WarrantsAndRightsMember_85" order="82" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BorrowingMember_86" order="83" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_87" order="84" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UsGovernmentSecuritiesMember_88" order="85" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InverseFloatingRateSecuritiesMember_89" order="86" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_90" order="87" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_91" order="88" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BankObligationsMember_92" order="89" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommercialPaperRiskMember_93" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CertificatesOfDepositRiskMember_94" order="91" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_95" order="92" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LimitedPartnershipsMember_96" order="93" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MasterLimitedPartnershipsMember_97" order="94" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_98" order="95" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignSecuritiesMember_99" order="96" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EmergingMarketsSecuritiesMember_100" order="97" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StructuredNotesMember_101" order="98" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StructuredSecuritiesMember_102" order="99" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_103" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SubordinatedSecuritiesMember_104" order="101" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_FloatingRateLoansMember_105" order="102" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_106" order="103" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_107" order="104" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StrippedSecuritiesRiskMember_108" order="105" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_109" order="106" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_110" order="107" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_111" order="108" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_HybridInstrumentsMember_112" order="109" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateInvestmentTrustsMember_113" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_114" order="111" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EnvironmentalRiskMember_115" order="112" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedNotesMember_116" order="113" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_117" order="114" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_118" order="115" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_119" order="116" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_120" order="117" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateInvestmentRiskMember_121" order="118" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyManagementRiskMember_122" order="119" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_123" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyValuationRiskMember_124" order="121" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_125" order="122" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_126" order="123" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_127" order="124" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SystemicRiskMember_128" order="125" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventRiskMember_129" order="126" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AssetAllocationRiskMember_130" order="127" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_131" order="128" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ck0001515324-20240830_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_3"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AffiliatedTransactionsRestrictionsMember" xlink:label="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AffiliatedTransactionsRestrictionsMember" xlink:label="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_5"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_6"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_11"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_12"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_13"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_14"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BankObligationsMember" xlink:label="loc_ck0001515324_BankObligationsMember_15"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BankObligationsMember" xlink:label="loc_ck0001515324_BankObligationsMember_16"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BorrowingMember" xlink:label="loc_ck0001515324_BorrowingMember_17"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BorrowingMember" xlink:label="loc_ck0001515324_BorrowingMember_18"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CertificatesOfDepositRiskMember" xlink:label="loc_ck0001515324_CertificatesOfDepositRiskMember_19"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CertificatesOfDepositRiskMember" xlink:label="loc_ck0001515324_CertificatesOfDepositRiskMember_20"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_21"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_22"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_23"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_24"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_25"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_26"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_27"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_28"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_29"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_30"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_31"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_32"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommonStocksMember" xlink:label="loc_ck0001515324_CommonStocksMember_33"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommonStocksMember" xlink:label="loc_ck0001515324_CommonStocksMember_34"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_35"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_36"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_37"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_38"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_39"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_40"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConvertibleSecuritiesMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesMember_41"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConvertibleSecuritiesMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesMember_42"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_43"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_44"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_45"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_46"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_47"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_48"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_49"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_50"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_51"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_52"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_53"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_54"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_55"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_56"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_57"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditFacilityMember" xlink:label="loc_ck0001515324_CreditFacilityMember_58"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditFacilityMember" xlink:label="loc_ck0001515324_CreditFacilityMember_59"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_60"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_61"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_62"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_63"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_64"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_65"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_66"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_67"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_68"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_69"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_70"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_71"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_72"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_73"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_74"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_75"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_76"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_77"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_78"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_79"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_80"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_81"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_82"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EmergingMarketsSecuritiesMember" xlink:label="loc_ck0001515324_EmergingMarketsSecuritiesMember_83"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EmergingMarketsSecuritiesMember" xlink:label="loc_ck0001515324_EmergingMarketsSecuritiesMember_84"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EnvironmentalRiskMember" xlink:label="loc_ck0001515324_EnvironmentalRiskMember_85"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EnvironmentalRiskMember" xlink:label="loc_ck0001515324_EnvironmentalRiskMember_86"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" xlink:label="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_87"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" xlink:label="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_88"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" xlink:label="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_89"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" xlink:label="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_90"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventLinkedBondsMember" xlink:label="loc_ck0001515324_EventLinkedBondsMember_91"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventLinkedBondsMember" xlink:label="loc_ck0001515324_EventLinkedBondsMember_92"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventLinkedSwapsMember" xlink:label="loc_ck0001515324_EventLinkedSwapsMember_93"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventLinkedSwapsMember" xlink:label="loc_ck0001515324_EventLinkedSwapsMember_94"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_95"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_96"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_97"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_98"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_99"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_100"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedNotesMember" xlink:label="loc_ck0001515324_ExchangeTradedNotesMember_101"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedNotesMember" xlink:label="loc_ck0001515324_ExchangeTradedNotesMember_102"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_103"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_104"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_105"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedProductsMember" xlink:label="loc_ck0001515324_ExchangeTradedProductsMember_106"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedProductsMember" xlink:label="loc_ck0001515324_ExchangeTradedProductsMember_107"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_108"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_109"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_110"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_FloatingRateLoansMember" xlink:label="loc_ck0001515324_FloatingRateLoansMember_111"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_FloatingRateLoansMember" xlink:label="loc_ck0001515324_FloatingRateLoansMember_112"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_113"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_114"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_115"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignSecuritiesMember" xlink:label="loc_ck0001515324_ForeignSecuritiesMember_116"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignSecuritiesMember" xlink:label="loc_ck0001515324_ForeignSecuritiesMember_117"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_118"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_119"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_120"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_121"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_122"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_123"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_124"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_125"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_126"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_127"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_128"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_129"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_130"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_131"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_132"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GovernmentInterventionInFinancialMarketsMember" xlink:label="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_133"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GovernmentInterventionInFinancialMarketsMember" xlink:label="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_134"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" xlink:label="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_135"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" xlink:label="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_136"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_137"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_138"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_139"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_HybridInstrumentsMember" xlink:label="loc_ck0001515324_HybridInstrumentsMember_140"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_HybridInstrumentsMember" xlink:label="loc_ck0001515324_HybridInstrumentsMember_141"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_142"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_143"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_144"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_145"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_146"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_147"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_148"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_149"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_150"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_151"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_152"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_153"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" xlink:label="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_154"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" xlink:label="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_155"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_156"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_157"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_158"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_159"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_160"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_161"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InverseFloatingRateSecuritiesMember" xlink:label="loc_ck0001515324_InverseFloatingRateSecuritiesMember_162"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InverseFloatingRateSecuritiesMember" xlink:label="loc_ck0001515324_InverseFloatingRateSecuritiesMember_163"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentGradeCorporateSecuritiesMember" xlink:label="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_164"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentGradeCorporateSecuritiesMember" xlink:label="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_165"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_166"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_167"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_168"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" xlink:label="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_169"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" xlink:label="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_170"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" xlink:label="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_171"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" xlink:label="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_172"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_173"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_174"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_175"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LimitedPartnershipsMember" xlink:label="loc_ck0001515324_LimitedPartnershipsMember_176"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LimitedPartnershipsMember" xlink:label="loc_ck0001515324_LimitedPartnershipsMember_177"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_178"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_179"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_180"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LoansOfPortfolioSecuritiesMember" xlink:label="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_181"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LoansOfPortfolioSecuritiesMember" xlink:label="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_182"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_183"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_184"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_185"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_186"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_187"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_188"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MasterLimitedPartnershipsMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsMember_189"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MasterLimitedPartnershipsMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsMember_190"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_191"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_192"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_193"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_194"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_195"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_196"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" xlink:label="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_197"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" xlink:label="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_198"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_199"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_200"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_201"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_202"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_203"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_204"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_205"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_206"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_207"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_208"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_209"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_210"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_211"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_212"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_213"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_214"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_215"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_216"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_217"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_218"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_219"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_220"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_221"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_222"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_223"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_224"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_225"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_226"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_227"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_228"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_229"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_230"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyLiquidityRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_231"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyLiquidityRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_232"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyManagementRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyManagementRiskMember_233"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyManagementRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyManagementRiskMember_234"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyValuationRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyValuationRiskMember_235"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyValuationRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyValuationRiskMember_236"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateInvestmentRiskMember" xlink:label="loc_ck0001515324_PrivateInvestmentRiskMember_237"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateInvestmentRiskMember" xlink:label="loc_ck0001515324_PrivateInvestmentRiskMember_238"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsMember_239"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsMember_240"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_241"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_242"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_243"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_244"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_245"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_246"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" xlink:label="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_247"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" xlink:label="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_248"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_249"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_250"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_251"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_252"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_253"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_254"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_255"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_256"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_257"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_258"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_259"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_260"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_261"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_262"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_263"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_264"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_265"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_266"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_267"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_268"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_269"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_270"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_271"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_272"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_273"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_274"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_275"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_276"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_277"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" xlink:label="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_278"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" xlink:label="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_279"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_280"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_281"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_282"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_283"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_284"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_285"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_286"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_287"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_288"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_289"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_290"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_291"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_292"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_293"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_294"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_295"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_296"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_297"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SpecialRisksRelatedToCyberSecurityMember" xlink:label="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_298"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SpecialRisksRelatedToCyberSecurityMember" xlink:label="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_299"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_300"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_301"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_302"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StrippedMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_303"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StrippedMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_304"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_305"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_306"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_307"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StructuredNotesMember" xlink:label="loc_ck0001515324_StructuredNotesMember_308"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StructuredNotesMember" xlink:label="loc_ck0001515324_StructuredNotesMember_309"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StructuredSecuritiesMember" xlink:label="loc_ck0001515324_StructuredSecuritiesMember_310"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StructuredSecuritiesMember" xlink:label="loc_ck0001515324_StructuredSecuritiesMember_311"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SubordinatedSecuritiesMember" xlink:label="loc_ck0001515324_SubordinatedSecuritiesMember_312"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SubordinatedSecuritiesMember" xlink:label="loc_ck0001515324_SubordinatedSecuritiesMember_313"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SubscriptionRightsMember" xlink:label="loc_ck0001515324_SubscriptionRightsMember_314"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SubscriptionRightsMember" xlink:label="loc_ck0001515324_SubscriptionRightsMember_315"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_316"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_317"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_318"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_319"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_320"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_321"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_322"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_323"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_324"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_325"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_326"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_327"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_328"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_329"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_330"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_331"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_332"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_333"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_334"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_335"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_336"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_337"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_338"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_339"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_340"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_341"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_342"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_343"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_344"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_WarrantsAndRightsMember" xlink:label="loc_ck0001515324_WarrantsAndRightsMember_345"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_WarrantsAndRightsMember" xlink:label="loc_ck0001515324_WarrantsAndRightsMember_346"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" xlink:label="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_347"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" xlink:label="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_348"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_349"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_350"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_0" xml:lang="en-US">Additional Risks of Foreign Options, Futures Contracts, Options on Futures Contracts and Forward Contracts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_1" xml:lang="en-US">Additional Risks Of Foreign Options, Futures Contracts, Options On Futures Contracts And Forward Contracts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_2" xml:lang="en-US">It represents additional risks of foreign options, futures contracts, options on futures contracts and forward contracts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_AffiliatedTransactionsRestrictionsMember_0" xml:lang="en-US">Affiliated Transactions Restrictions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_AffiliatedTransactionsRestrictionsMember_1" xml:lang="en-US">It represents risk of affiliated transactions restrictions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_0" xml:lang="en-US">Anti-Takeover Provisions Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_1" xml:lang="en-US">Anti Takeover Provisions Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_2" xml:lang="en-US">It represents as a anti-takeover provisions risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_AssetAllocationRiskMember_0" xml:lang="en-US">It represents as a asset allocation risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_AssetAllocationRiskMember_1" xml:lang="en-US">Asset Allocation Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_AssetAllocationRiskMember_2" xml:lang="en-US">Asset Allocation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_BankLoanRiskMember_0" xml:lang="en-US">Bank Loan Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_BankLoanRiskMember_1" xml:lang="en-US">It represents as a bank loan risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_BankLoanRiskMember_2" xml:lang="en-US">Bank Loan Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_BankObligationsMember_0" xml:lang="en-US">Bank Obligations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_BankObligationsMember_1" xml:lang="en-US">It represents risk of bank obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_BorrowingMember_0" xml:lang="en-US">Borrowing [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_BorrowingMember_1" xml:lang="en-US">It represents risk of borrowing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CertificatesOfDepositRiskMember_0" xml:lang="en-US">This member stands for risk of certificates of deposit risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CertificatesOfDepositRiskMember_1" xml:lang="en-US">Certificates Of Deposit Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CollateralizedLoanObligationRiskMember_0" xml:lang="en-US">Collateralized Loan Obligation ("CLO") Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CollateralizedLoanObligationRiskMember_1" xml:lang="en-US">Collateralized Loan Obligation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CollateralizedLoanObligationRiskMember_2" xml:lang="en-US">Collateralized Loan Obligation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_0" xml:lang="en-US">Commercial Mortgage Backed Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_1" xml:lang="en-US">It represents as a commercial mortgage backed securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_2" xml:lang="en-US">Commercial Mortgage Backed Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CommercialPaperRiskMember_0" xml:lang="en-US">Commercial Paper Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CommercialPaperRiskMember_1" xml:lang="en-US">It represents as a commercial paper risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CommercialPaperRiskMember_2" xml:lang="en-US">Commercial Paper Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_0" xml:lang="en-US">Commodity-Related Investments Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_1" xml:lang="en-US">It represents as a commodity related investments risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_2" xml:lang="en-US">Commodity Related Investments Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CommonStocksMember_0" xml:lang="en-US">Common Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CommonStocksMember_1" xml:lang="en-US">Common Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ConcentrationRiskMember_0" xml:lang="en-US">Concentration Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ConcentrationRiskMember_1" xml:lang="en-US">Concentration Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ConcentrationRiskMember_2" xml:lang="en-US">Concentration Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_0" xml:lang="en-US">It represents as a construction and development risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_1" xml:lang="en-US">Construction And Development Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_2" xml:lang="en-US">Construction and Development Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ConvertibleSecuritiesMember_0" xml:lang="en-US">Convertible Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ConvertibleSecuritiesMember_1" xml:lang="en-US">It represents risk of convertible securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ConvertibleSecuritiesRiskMember_0" xml:lang="en-US">It represents as a convertible securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ConvertibleSecuritiesRiskMember_1" xml:lang="en-US">Convertible Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ConvertibleSecuritiesRiskMember_2" xml:lang="en-US">Convertible Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CorporateBondsRiskMember_0" xml:lang="en-US">Corporate Bonds Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CorporateBondsRiskMember_1" xml:lang="en-US">Corporate Bonds Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CorporateBondsRiskMember_2" xml:lang="en-US">Corporate Bonds Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CorporateLoansRiskMember_0" xml:lang="en-US">Corporate Loans Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_CorporateLoansRiskMember_1" xml:lang="en-US">Corporate Loans Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CorporateLoansRiskMember_2" xml:lang="en-US">Corporate Loans Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CounterpartyRiskMember_0" xml:lang="en-US">It represents as a counterparty risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CounterpartyRiskMember_1" xml:lang="en-US">Counterparty Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CounterpartyRiskMember_2" xml:lang="en-US">Counterparty Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CreditDefaultSwapsMember_0" xml:lang="en-US">It represents credit default swaps.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CreditDefaultSwapsMember_1" xml:lang="en-US">Credit Default Swaps [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CreditDefaultSwapsMember_2" xml:lang="en-US">Credit Default Swaps</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CreditFacilityMember_0" xml:lang="en-US">Credit Facility [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CreditFacilityMember_1" xml:lang="en-US">Represent information about the credit facility.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CreditRisksMember_0" xml:lang="en-US">This member stands for represents as a credit risks.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CreditRisksMember_1" xml:lang="en-US">Credit Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CreditRisksMember_2" xml:lang="en-US">Credit Risks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_0" xml:lang="en-US">Currency Futures And Options Thereon [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_1" xml:lang="en-US">Currency Futures and Options Thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_2" xml:lang="en-US">It represents currency futures and options thereon.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_0" xml:lang="en-US">Debt Obligations of Non-U.S. Governments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_1" xml:lang="en-US">It represents risk of debt obligations of non-U.S. governments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_2" xml:lang="en-US">Debt Obligations Of Non Us Governments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_0" xml:lang="en-US">Debt Securities Issued By Real Estate Investment Trusts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_1" xml:lang="en-US">It represents risk of debt securities issued by real estate investment trusts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_DerivativesRiskMember_0" xml:lang="en-US">Derivatives Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DerivativesRiskMember_1" xml:lang="en-US">It represents derivatives Risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DerivativesRiskMember_2" xml:lang="en-US">Derivatives Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DistressedSecuritiesRiskMember_0" xml:lang="en-US">It represents as a distressed securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_DistressedSecuritiesRiskMember_1" xml:lang="en-US">Distressed Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DistressedSecuritiesRiskMember_2" xml:lang="en-US">Distressed Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_DoddFrankActRiskMember_0" xml:lang="en-US">It represents dodd frank act risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_DoddFrankActRiskMember_1" xml:lang="en-US">Dodd-Frank Act Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_DoddFrankActRiskMember_2" xml:lang="en-US">Dodd Frank Act Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_EmergingMarketsRiskMember_0" xml:lang="en-US">Emerging Markets Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EmergingMarketsRiskMember_1" xml:lang="en-US">Emerging Markets Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EmergingMarketsRiskMember_2" xml:lang="en-US">It represents as a emerging markets risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EmergingMarketsSecuritiesMember_0" xml:lang="en-US">Emerging Markets Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EmergingMarketsSecuritiesMember_1" xml:lang="en-US">It represents risk of eerging markets securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EnvironmentalRiskMember_0" xml:lang="en-US">It represents risk of environmental risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EnvironmentalRiskMember_1" xml:lang="en-US">Environmental Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_0" xml:lang="en-US">Equity Securities And Related Investments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_1" xml:lang="en-US">It represents risk of equity securities and related investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_0" xml:lang="en-US">It represents risk of eurodollar instruments and samurai and yankee bonds.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_1" xml:lang="en-US">Eurodollar Instruments And Samurai And Yankee Bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EventLinkedBondsMember_0" xml:lang="en-US">Event Linked Bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EventLinkedBondsMember_1" xml:lang="en-US">It represents risk of event linked bonds.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EventLinkedSwapsMember_0" xml:lang="en-US">Event Linked Swaps [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EventLinkedSwapsMember_1" xml:lang="en-US">It represents risk of event linked swaps.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_EventRiskMember_0" xml:lang="en-US">Event Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_EventRiskMember_1" xml:lang="en-US">Event Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_EventRiskMember_2" xml:lang="en-US">It represents as a event risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ExchangeTradedNoteRiskMember_0" xml:lang="en-US">Exchange Traded Note Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExchangeTradedNoteRiskMember_1" xml:lang="en-US">Exchange Traded Note Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExchangeTradedNoteRiskMember_2" xml:lang="en-US">Exchange Traded Note Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExchangeTradedNotesMember_0" xml:lang="en-US">Exchange Traded Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExchangeTradedNotesMember_1" xml:lang="en-US">It represents risk of exchange-traded notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExchangeTradedProductRiskMember_0" xml:lang="en-US">Exchange Traded Product Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ExchangeTradedProductRiskMember_1" xml:lang="en-US">Exchange Traded Product Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExchangeTradedProductRiskMember_2" xml:lang="en-US">It represents Exchange-Traded Product Risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExchangeTradedProductsMember_0" xml:lang="en-US">It represents risk of exchange-traded products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExchangeTradedProductsMember_1" xml:lang="en-US">Exchange Traded Products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_0" xml:lang="en-US">Exclusion from Definition of Commodity Pool Operator</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_1" xml:lang="en-US">It represents exclusion from definition of commodity pool operator.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_2" xml:lang="en-US">Exclusion From Definition Of Commodity Pool Operator [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_FloatingRateLoansMember_0" xml:lang="en-US">It represents risk of floating rate loans.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_FloatingRateLoansMember_1" xml:lang="en-US">Floating Rate Loans [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ForeignCurrencyRiskMember_0" xml:lang="en-US">It represents as a foreign currency risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ForeignCurrencyRiskMember_1" xml:lang="en-US">Foreign Currency Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ForeignCurrencyRiskMember_2" xml:lang="en-US">Foreign Currency Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ForeignSecuritiesMember_0" xml:lang="en-US">It represents risk of foreign securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ForeignSecuritiesMember_1" xml:lang="en-US">Foreign Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ForeignSecuritiesRiskMember_0" xml:lang="en-US">It represents as a foreign securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ForeignSecuritiesRiskMember_1" xml:lang="en-US">Foreign Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ForeignSecuritiesRiskMember_2" xml:lang="en-US">Foreign Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_0" xml:lang="en-US">Forward Currency Exchange Contracts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_1" xml:lang="en-US">Forward Currency Exchange Contracts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_2" xml:lang="en-US">It represents forward currency exchange contracts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_0" xml:lang="en-US">It represents futures contracts and options on future.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_1" xml:lang="en-US">Futures Contracts And Options On Futures [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_2" xml:lang="en-US">Futures Contracts and Options on Futures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_0" xml:lang="en-US">General Risk Of Investing In Fund [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_1" xml:lang="en-US">General Risks of Investing in the Fund</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_2" xml:lang="en-US">It represents general risks of investing in the fund.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_0" xml:lang="en-US">Gold and Other Precious Metals Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_1" xml:lang="en-US">Gold And Other Precious Metals Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_2" xml:lang="en-US">It represents as a gold and other precious metals risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_GovernmentInterventionInFinancialMarketsMember_0" xml:lang="en-US">Government Intervention In Financial Markets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_GovernmentInterventionInFinancialMarketsMember_1" xml:lang="en-US">It represents risk of government intervention in financial markets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_0" xml:lang="en-US">Guaranteed Mortgage Pass Through Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_1" xml:lang="en-US">It represents risk of guaranteed mortgage pass-through securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_0" xml:lang="en-US">It represents as a high yield ("Junk") securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_1" xml:lang="en-US">High Yield Junk Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_2" xml:lang="en-US">High Yield ("Junk") Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_HybridInstrumentsMember_0" xml:lang="en-US">It represents risk of hybrid instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_HybridInstrumentsMember_1" xml:lang="en-US">Hybrid Instruments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_0" xml:lang="en-US">It represents as a Illiquid and restricted securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_1" xml:lang="en-US">Illiquid And Restricted Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_2" xml:lang="en-US">Illiquid and Restricted Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_IncomeAndDistributionRiskMember_0" xml:lang="en-US">It represents as a income and distribution risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_IncomeAndDistributionRiskMember_1" xml:lang="en-US">Income and Distribution Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_IncomeAndDistributionRiskMember_2" xml:lang="en-US">Income And Distribution Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InfectiousIllnessRiskMember_0" xml:lang="en-US">Infectious Illness Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_InfectiousIllnessRiskMember_1" xml:lang="en-US">Infectious Illness Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InfectiousIllnessRiskMember_2" xml:lang="en-US">It represents infectious illness risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_0" xml:lang="en-US">It represents as a inflation, interest rate and bond market risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_1" xml:lang="en-US">Inflation Interest Rate And Bond Market Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_2" xml:lang="en-US">Inflation, Interest Rate and Bond Market Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_0" xml:lang="en-US">Inflation Linked Fixed Income Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_1" xml:lang="en-US">It represents risk of inflation-linked fixed-income securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_InfrastructureRiskMember_0" xml:lang="en-US">Infrastructure Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InfrastructureRiskMember_1" xml:lang="en-US">Infrastructure Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InfrastructureRiskMember_2" xml:lang="en-US">Infrastructure Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_0" xml:lang="en-US">Interest Rate Futures Contracts And Options Thereon [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_1" xml:lang="en-US">Interest Rate Futures Contracts and Options Thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_2" xml:lang="en-US">It represents interest rate futures contracts and options thereon.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InverseFloatingRateSecuritiesMember_0" xml:lang="en-US">Inverse Floating Rate Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InverseFloatingRateSecuritiesMember_1" xml:lang="en-US">It represents risk of inverse floating rate securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InvestmentGradeCorporateSecuritiesMember_0" xml:lang="en-US">It represents risk of investment grade corporate securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InvestmentGradeCorporateSecuritiesMember_1" xml:lang="en-US">Investment Grade Corporate Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_0" xml:lang="en-US">Investment Grade Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_1" xml:lang="en-US">Investment Grade Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_2" xml:lang="en-US">Investment Grade Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_0" xml:lang="en-US">Investments In Different Parts Of Capital Structure [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_1" xml:lang="en-US">It represents risk of investments in different parts of capital structure.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_0" xml:lang="en-US">It represents risk of investments where other funds hold related investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_1" xml:lang="en-US">Investments Where Other Funds Hold Related Investments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_LeverageRiskMember_0" xml:lang="en-US">Leverage Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_LeverageRiskMember_1" xml:lang="en-US">Leverage Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_LeverageRiskMember_2" xml:lang="en-US">Leverage Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_LimitedPartnershipsMember_0" xml:lang="en-US">Limited Partnerships [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_LimitedPartnershipsMember_1" xml:lang="en-US">It represents risk of limited partnerships.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_LiquidityRiskMember_0" xml:lang="en-US">Liquidity Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_LiquidityRiskMember_1" xml:lang="en-US">It represents as a liquidity risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_LiquidityRiskMember_2" xml:lang="en-US">Liquidity Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_LoansOfPortfolioSecuritiesMember_0" xml:lang="en-US">It represents risk of loans of portfolio securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_LoansOfPortfolioSecuritiesMember_1" xml:lang="en-US">Loans Of Portfolio Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ManagementRiskMember_0" xml:lang="en-US">Management Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ManagementRiskMember_1" xml:lang="en-US">Management Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ManagementRiskMember_2" xml:lang="en-US">It represents as a management risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_MarketDiscountRiskMember_0" xml:lang="en-US">Market Discount Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MarketDiscountRiskMember_1" xml:lang="en-US">It represents as a market discount risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MarketDiscountRiskMember_2" xml:lang="en-US">Market Discount Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsMember_0" xml:lang="en-US">Master Limited Partnerships [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsMember_1" xml:lang="en-US">It represents risk of master limited partnerships.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_0" xml:lang="en-US">MLP Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_1" xml:lang="en-US">Master Limited Partnerships Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_2" xml:lang="en-US">It represents as a master limited partnerships risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_0" xml:lang="en-US">Mortgage And Asset Backed Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_1" xml:lang="en-US">It represents as a mortgage and asset-backed securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_2" xml:lang="en-US">Mortgage and Asset-Backed Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_0" xml:lang="en-US">Multiple Class Pass Through Securities And Collateralized Mortgage Obligations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_1" xml:lang="en-US">It represents risk of multiple-class pass-through securities and collateralized mortgage obligations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_NaturalResourcesRiskMember_0" xml:lang="en-US">Natural Resources Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_NaturalResourcesRiskMember_1" xml:lang="en-US">Natural Resources Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_NaturalResourcesRiskMember_2" xml:lang="en-US">Natural Resources Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_OptionsMember_0" xml:lang="en-US">Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OptionsMember_1" xml:lang="en-US">Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OptionsMember_2" xml:lang="en-US">It represents options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OptionsOnForeignCurrenciesMember_0" xml:lang="en-US">Options On Foreign Currencies [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OptionsOnForeignCurrenciesMember_1" xml:lang="en-US">It represents options on foreign currencies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_OptionsOnForeignCurrenciesMember_2" xml:lang="en-US">Options on Foreign Currencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_0" xml:lang="en-US">It represents options on securities indice.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_1" xml:lang="en-US">Options On Securities Indices [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_2" xml:lang="en-US">Options on Securities Indices</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_0" xml:lang="en-US">Other Risk Factors Associated With Mortgage Backed Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_1" xml:lang="en-US">It represents risk of other risk factors associated with mortgage-backed securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_OverCounterTradingRiskMember_0" xml:lang="en-US">Over-the-Counter Trading Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_OverCounterTradingRiskMember_1" xml:lang="en-US">Over Counter Trading Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_OverCounterTradingRiskMember_2" xml:lang="en-US">Over Counter Trading Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PortfolioTurnoverRiskMember_0" xml:lang="en-US">It represents as a portfolio turnover risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PortfolioTurnoverRiskMember_1" xml:lang="en-US">Portfolio Turnover Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_PortfolioTurnoverRiskMember_2" xml:lang="en-US">Portfolio Turnover Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_0" xml:lang="en-US">It represents as a potential conflicts of interest risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_1" xml:lang="en-US">Potential Conflicts Of Interest Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_2" xml:lang="en-US">Potential Conflicts of Interest Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PreferredSecuritiesRiskMember_0" xml:lang="en-US">Preferred Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_PreferredSecuritiesRiskMember_1" xml:lang="en-US">Preferred Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PreferredSecuritiesRiskMember_2" xml:lang="en-US">This member stands for Preferred Securities Risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PreferredStocksMember_0" xml:lang="en-US">Preferred Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_PreferredStocksMember_1" xml:lang="en-US">Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PreferredStocksMember_2" xml:lang="en-US">Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_PrepaymentOrCallRiskMember_0" xml:lang="en-US">Prepayment or Call Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrepaymentOrCallRiskMember_1" xml:lang="en-US">Prepayment Or Call Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrepaymentOrCallRiskMember_2" xml:lang="en-US">It represents as a prepayment or call risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrivateCompanyLiquidityRiskMember_0" xml:lang="en-US">Private Company Liquidity Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrivateCompanyLiquidityRiskMember_1" xml:lang="en-US">It represents risk of private xompany liquidity risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrivateCompanyManagementRiskMember_0" xml:lang="en-US">Private Company Management Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrivateCompanyManagementRiskMember_1" xml:lang="en-US">It represents risk of private company management risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrivateCompanyValuationRiskMember_0" xml:lang="en-US">Private Company Valuation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrivateCompanyValuationRiskMember_1" xml:lang="en-US">It represents risk of private company valuation risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_PrivateInvestmentRiskMember_0" xml:lang="en-US">Private Investment Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_PrivateInvestmentRiskMember_1" xml:lang="en-US">It represents risk of private investment risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsMember_0" xml:lang="en-US">Real Estate Investment Trusts [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsMember_1" xml:lang="en-US">It represents risk of real estate investment trusts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_0" xml:lang="en-US">REIT Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_1" xml:lang="en-US">This member stands for real estate investment trusts risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_2" xml:lang="en-US">Real Estate Investment Trusts Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_RealEstateMarketRiskMember_0" xml:lang="en-US">Real Estate Market Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RealEstateMarketRiskMember_1" xml:lang="en-US">It represents as a real estate market risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RealEstateMarketRiskMember_2" xml:lang="en-US">Real Estate Market Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_0" xml:lang="en-US">It represents as a risks of recent market, economic and social developments risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_1" xml:lang="en-US">Recent Market Economic And Social Developments Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RepurchaseAgreementsRiskMember_0" xml:lang="en-US">Repurchase Agreements Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RepurchaseAgreementsRiskMember_1" xml:lang="en-US">It represents as a repurchase agreements risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RepurchaseAgreementsRiskMember_2" xml:lang="en-US">Repurchase Agreements Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_0" xml:lang="en-US">Residential Mortgage Backed Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_1" xml:lang="en-US">Residential Mortgage Backed Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_2" xml:lang="en-US">It represents as a residential mortgage backed securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ReturnOfCapitalRiskMember_0" xml:lang="en-US">Return Of Capital Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ReturnOfCapitalRiskMember_1" xml:lang="en-US">It represents as a return of capital risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ReturnOfCapitalRiskMember_2" xml:lang="en-US">Return of Capital Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_0" xml:lang="en-US">Reverse Repurchase Agreements Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_1" xml:lang="en-US">Reverse Repurchase Agreements Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_2" xml:lang="en-US">It represents as a reverse repurchase agreements risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_0" xml:lang="en-US">Risks Associated With Long Term Objective Not a Complete Investment Program</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_1" xml:lang="en-US">Risks Associated With Long Term Objective [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_2" xml:lang="en-US">Risks Associated With Long Term Objective [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_0" xml:lang="en-US">It represents risk of risks associated with long term objective not a complete investment program.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_1" xml:lang="en-US">Risks Associated With Long Term Objective Not Complete Investment Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_0" xml:lang="en-US">Risks Associated with Position Limits Applicable to Derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_1" xml:lang="en-US">Risks Associated With Position Limits Applicable To Derivatives [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_2" xml:lang="en-US">It represents as a risks associated with position limits applicable to derivatives.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_0" xml:lang="en-US">Risks Associated With Status Regulated Investment Company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_1" xml:lang="en-US">It represents as a risks associated with status as a regulated investment company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_2" xml:lang="en-US">Risks Associated With Status as a Regulated Investment Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_RisksOfCurrencyTransactionsMember_0" xml:lang="en-US">Risks of Currency Transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksOfCurrencyTransactionsMember_1" xml:lang="en-US">It represents risks of currency transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksOfCurrencyTransactionsMember_2" xml:lang="en-US">Risks Of Currency Transactions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_0" xml:lang="en-US">Risks Related to Funds Clearing Broker and Central Clearing Counterparty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_1" xml:lang="en-US">Risks Related To Funds Clearing Broker And Central Clearing Counterparty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_2" xml:lang="en-US">Risks Related to Fund's Clearing Broker and Central Clearing Counterparty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_0" xml:lang="en-US">It represents risk of risks relating to Russia's invasion of Ukraine.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_1" xml:lang="en-US">Risks Relating To Russia Invasion Of Ukraine [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_SectorFocusRiskMember_0" xml:lang="en-US">Sector Focus Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SectorFocusRiskMember_1" xml:lang="en-US">Sector Focus Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SectorFocusRiskMember_2" xml:lang="en-US">It represents as a sector focus risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_0" xml:lang="en-US">Securities Index Futures Contracts and Options Thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_1" xml:lang="en-US">Securities Index Futures Contracts And Options Thereon [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_2" xml:lang="en-US">It represents securities index futures contracts and options thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SecuritiesLendingRiskMember_0" xml:lang="en-US">Securities Lending Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SecuritiesLendingRiskMember_1" xml:lang="en-US">It represents as a securities lending risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SecuritiesLendingRiskMember_2" xml:lang="en-US">Securities Lending Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ShortSalesRiskMember_0" xml:lang="en-US">Short Sales Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ShortSalesRiskMember_1" xml:lang="en-US">Short Sales Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ShortSalesRiskMember_2" xml:lang="en-US">It represents as a short sales risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_ShortTermDebtObligationsRiskMember_0" xml:lang="en-US">Short-term Debt Obligations Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ShortTermDebtObligationsRiskMember_1" xml:lang="en-US">It represents as a short term debt obligations risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ShortTermDebtObligationsRiskMember_2" xml:lang="en-US">Short Term Debt Obligations Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_0" xml:lang="en-US">Special Risk Considerations Relating To Futures And Options Thereon [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_1" xml:lang="en-US">Special Risk Considerations Relating to Futures and Options Thereon</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_2" xml:lang="en-US">It represents special risk considerations relating to futures and options thereon.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_0" xml:lang="en-US">Special Risks Related To Cyber Security [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_1" xml:lang="en-US">It represents risk of special risks related to cyber security.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StapledSecuritiesRiskMember_0" xml:lang="en-US">It represents as a stapled Securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StapledSecuritiesRiskMember_1" xml:lang="en-US">Stapled Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_StapledSecuritiesRiskMember_2" xml:lang="en-US">Stapled Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StrippedMortgageBackedSecuritiesMember_0" xml:lang="en-US">Stripped Mortgage Backed Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StrippedMortgageBackedSecuritiesMember_1" xml:lang="en-US">It represents risk of stripped mortgage-backed securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_StrippedSecuritiesRiskMember_0" xml:lang="en-US">Stripped Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StrippedSecuritiesRiskMember_1" xml:lang="en-US">Stripped Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StrippedSecuritiesRiskMember_2" xml:lang="en-US">It represents as a stripped securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StructuredNotesMember_0" xml:lang="en-US">Structured Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StructuredNotesMember_1" xml:lang="en-US">It represents risk of structured notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_StructuredSecuritiesMember_0" xml:lang="en-US">It represents risk of structured securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_StructuredSecuritiesMember_1" xml:lang="en-US">Structured Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SubordinatedSecuritiesMember_0" xml:lang="en-US">Subordinated Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SubordinatedSecuritiesMember_1" xml:lang="en-US">It represents risk of subordinated securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SubscriptionRightsMember_0" xml:lang="en-US">Subscription Rights [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SubscriptionRightsMember_1" xml:lang="en-US">Subscription Rights [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_0" xml:lang="en-US">Swap Agreements and Options on Swap Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_1" xml:lang="en-US">Swap Agreements And Options On Swap Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_2" xml:lang="en-US">It represents swap agreements and options on swap agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_SystemicRiskMember_0" xml:lang="en-US">Systemic Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_SystemicRiskMember_1" xml:lang="en-US">It represents as a systemic risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_SystemicRiskMember_2" xml:lang="en-US">Systemic Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_0" xml:lang="en-US">It represents temporary defensive strategies risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_1" xml:lang="en-US">Temporary Defensive Strategies Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_2" xml:lang="en-US">Temporary Defensive Strategies Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_TrackingRiskMember_0" xml:lang="en-US">Tracking Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_TrackingRiskMember_1" xml:lang="en-US">Tracking Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_TrackingRiskMember_2" xml:lang="en-US">Tracking Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_UnratedSecuritiesRiskMember_0" xml:lang="en-US">Unrated Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_UnratedSecuritiesRiskMember_1" xml:lang="en-US">Unrated Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_UnratedSecuritiesRiskMember_2" xml:lang="en-US">Unrated Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesMember_0" xml:lang="en-US">U.S. Government Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesMember_1" xml:lang="en-US">Us Government Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesMember_2" xml:lang="en-US">It represents risk of U.S. Government Securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_0" xml:lang="en-US">It represents as a U.S. government securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_1" xml:lang="en-US">U.S. Government Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_2" xml:lang="en-US">Us Government Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ValuationRiskMember_0" xml:lang="en-US">Valuation Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ValuationRiskMember_1" xml:lang="en-US">It represents as a valuation risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_ValuationRiskMember_2" xml:lang="en-US">Valuation Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_0" xml:lang="en-US">It represents risk of variable and floating rate demand and master demand notes.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_1" xml:lang="en-US">Variable And Floating Rate Demand And Master Demand Notes [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_0" xml:lang="en-US">It represents as a variable and floating rate securities risk.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_1" xml:lang="en-US">Variable And Floating Rate Securities Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_2" xml:lang="en-US">Variable and Floating Rate Securities Risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_WarrantsAndRightsMember_0" xml:lang="en-US">Warrants And Rights [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_WarrantsAndRightsMember_1" xml:lang="en-US">It represents risk of warrants and rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_0" xml:lang="en-US">It represents risk of zero coupon and payment in-kind securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_1" xml:lang="en-US">Zero Coupon And Payment In Kind Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain_0" xml:lang="en-US">Class of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_0" xml:lang="en-US">Debt Instrument Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_1" xlink:to="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_2" xlink:to="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_3" xlink:to="lab_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_4" xlink:to="lab_ck0001515324_AffiliatedTransactionsRestrictionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_5" xlink:to="lab_ck0001515324_AffiliatedTransactionsRestrictionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_6" xlink:to="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_7" xlink:to="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_8" xlink:to="lab_ck0001515324_AntiTakeoverProvisionsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AssetAllocationRiskMember_9" xlink:to="lab_ck0001515324_AssetAllocationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AssetAllocationRiskMember_10" xlink:to="lab_ck0001515324_AssetAllocationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_AssetAllocationRiskMember_11" xlink:to="lab_ck0001515324_AssetAllocationRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankLoanRiskMember_12" xlink:to="lab_ck0001515324_BankLoanRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankLoanRiskMember_13" xlink:to="lab_ck0001515324_BankLoanRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankLoanRiskMember_14" xlink:to="lab_ck0001515324_BankLoanRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankObligationsMember_15" xlink:to="lab_ck0001515324_BankObligationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BankObligationsMember_16" xlink:to="lab_ck0001515324_BankObligationsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BorrowingMember_17" xlink:to="lab_ck0001515324_BorrowingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_BorrowingMember_18" xlink:to="lab_ck0001515324_BorrowingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CertificatesOfDepositRiskMember_19" xlink:to="lab_ck0001515324_CertificatesOfDepositRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CertificatesOfDepositRiskMember_20" xlink:to="lab_ck0001515324_CertificatesOfDepositRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CollateralizedLoanObligationRiskMember_21" xlink:to="lab_ck0001515324_CollateralizedLoanObligationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CollateralizedLoanObligationRiskMember_22" xlink:to="lab_ck0001515324_CollateralizedLoanObligationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CollateralizedLoanObligationRiskMember_23" xlink:to="lab_ck0001515324_CollateralizedLoanObligationRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_24" xlink:to="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_25" xlink:to="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_26" xlink:to="lab_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialPaperRiskMember_27" xlink:to="lab_ck0001515324_CommercialPaperRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialPaperRiskMember_28" xlink:to="lab_ck0001515324_CommercialPaperRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommercialPaperRiskMember_29" xlink:to="lab_ck0001515324_CommercialPaperRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_30" xlink:to="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_31" xlink:to="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_32" xlink:to="lab_ck0001515324_CommodityRelatedInvestmentsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommonStocksMember_33" xlink:to="lab_ck0001515324_CommonStocksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CommonStocksMember_34" xlink:to="lab_ck0001515324_CommonStocksMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConcentrationRiskMember_35" xlink:to="lab_ck0001515324_ConcentrationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConcentrationRiskMember_36" xlink:to="lab_ck0001515324_ConcentrationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConcentrationRiskMember_37" xlink:to="lab_ck0001515324_ConcentrationRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_38" xlink:to="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_39" xlink:to="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_40" xlink:to="lab_ck0001515324_ConstructionAndDevelopmentRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesMember_41" xlink:to="lab_ck0001515324_ConvertibleSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesMember_42" xlink:to="lab_ck0001515324_ConvertibleSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesRiskMember_43" xlink:to="lab_ck0001515324_ConvertibleSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesRiskMember_44" xlink:to="lab_ck0001515324_ConvertibleSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ConvertibleSecuritiesRiskMember_45" xlink:to="lab_ck0001515324_ConvertibleSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateBondsRiskMember_46" xlink:to="lab_ck0001515324_CorporateBondsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateBondsRiskMember_47" xlink:to="lab_ck0001515324_CorporateBondsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateBondsRiskMember_48" xlink:to="lab_ck0001515324_CorporateBondsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateLoansRiskMember_49" xlink:to="lab_ck0001515324_CorporateLoansRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateLoansRiskMember_50" xlink:to="lab_ck0001515324_CorporateLoansRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CorporateLoansRiskMember_51" xlink:to="lab_ck0001515324_CorporateLoansRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CounterpartyRiskMember_52" xlink:to="lab_ck0001515324_CounterpartyRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CounterpartyRiskMember_53" xlink:to="lab_ck0001515324_CounterpartyRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CounterpartyRiskMember_54" xlink:to="lab_ck0001515324_CounterpartyRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditDefaultSwapsMember_55" xlink:to="lab_ck0001515324_CreditDefaultSwapsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditDefaultSwapsMember_56" xlink:to="lab_ck0001515324_CreditDefaultSwapsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditDefaultSwapsMember_57" xlink:to="lab_ck0001515324_CreditDefaultSwapsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditFacilityMember_58" xlink:to="lab_ck0001515324_CreditFacilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditFacilityMember_59" xlink:to="lab_ck0001515324_CreditFacilityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditRisksMember_60" xlink:to="lab_ck0001515324_CreditRisksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditRisksMember_61" xlink:to="lab_ck0001515324_CreditRisksMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CreditRisksMember_62" xlink:to="lab_ck0001515324_CreditRisksMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_63" xlink:to="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_64" xlink:to="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_65" xlink:to="lab_ck0001515324_CurrencyFuturesAndOptionsThereonMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_66" xlink:to="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_67" xlink:to="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_68" xlink:to="lab_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_69" xlink:to="lab_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_70" xlink:to="lab_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DerivativesRiskMember_71" xlink:to="lab_ck0001515324_DerivativesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DerivativesRiskMember_72" xlink:to="lab_ck0001515324_DerivativesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DerivativesRiskMember_73" xlink:to="lab_ck0001515324_DerivativesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DistressedSecuritiesRiskMember_74" xlink:to="lab_ck0001515324_DistressedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DistressedSecuritiesRiskMember_75" xlink:to="lab_ck0001515324_DistressedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DistressedSecuritiesRiskMember_76" xlink:to="lab_ck0001515324_DistressedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DoddFrankActRiskMember_77" xlink:to="lab_ck0001515324_DoddFrankActRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DoddFrankActRiskMember_78" xlink:to="lab_ck0001515324_DoddFrankActRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_DoddFrankActRiskMember_79" xlink:to="lab_ck0001515324_DoddFrankActRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsRiskMember_80" xlink:to="lab_ck0001515324_EmergingMarketsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsRiskMember_81" xlink:to="lab_ck0001515324_EmergingMarketsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsRiskMember_82" xlink:to="lab_ck0001515324_EmergingMarketsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsSecuritiesMember_83" xlink:to="lab_ck0001515324_EmergingMarketsSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EmergingMarketsSecuritiesMember_84" xlink:to="lab_ck0001515324_EmergingMarketsSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EnvironmentalRiskMember_85" xlink:to="lab_ck0001515324_EnvironmentalRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EnvironmentalRiskMember_86" xlink:to="lab_ck0001515324_EnvironmentalRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_87" xlink:to="lab_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_88" xlink:to="lab_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_89" xlink:to="lab_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_90" xlink:to="lab_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventLinkedBondsMember_91" xlink:to="lab_ck0001515324_EventLinkedBondsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventLinkedBondsMember_92" xlink:to="lab_ck0001515324_EventLinkedBondsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventLinkedSwapsMember_93" xlink:to="lab_ck0001515324_EventLinkedSwapsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventLinkedSwapsMember_94" xlink:to="lab_ck0001515324_EventLinkedSwapsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventRiskMember_95" xlink:to="lab_ck0001515324_EventRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventRiskMember_96" xlink:to="lab_ck0001515324_EventRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_EventRiskMember_97" xlink:to="lab_ck0001515324_EventRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNoteRiskMember_98" xlink:to="lab_ck0001515324_ExchangeTradedNoteRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNoteRiskMember_99" xlink:to="lab_ck0001515324_ExchangeTradedNoteRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNoteRiskMember_100" xlink:to="lab_ck0001515324_ExchangeTradedNoteRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNotesMember_101" xlink:to="lab_ck0001515324_ExchangeTradedNotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedNotesMember_102" xlink:to="lab_ck0001515324_ExchangeTradedNotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductRiskMember_103" xlink:to="lab_ck0001515324_ExchangeTradedProductRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductRiskMember_104" xlink:to="lab_ck0001515324_ExchangeTradedProductRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductRiskMember_105" xlink:to="lab_ck0001515324_ExchangeTradedProductRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductsMember_106" xlink:to="lab_ck0001515324_ExchangeTradedProductsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExchangeTradedProductsMember_107" xlink:to="lab_ck0001515324_ExchangeTradedProductsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_108" xlink:to="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_109" xlink:to="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_110" xlink:to="lab_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FloatingRateLoansMember_111" xlink:to="lab_ck0001515324_FloatingRateLoansMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FloatingRateLoansMember_112" xlink:to="lab_ck0001515324_FloatingRateLoansMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignCurrencyRiskMember_113" xlink:to="lab_ck0001515324_ForeignCurrencyRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignCurrencyRiskMember_114" xlink:to="lab_ck0001515324_ForeignCurrencyRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignCurrencyRiskMember_115" xlink:to="lab_ck0001515324_ForeignCurrencyRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesMember_116" xlink:to="lab_ck0001515324_ForeignSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesMember_117" xlink:to="lab_ck0001515324_ForeignSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesRiskMember_118" xlink:to="lab_ck0001515324_ForeignSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesRiskMember_119" xlink:to="lab_ck0001515324_ForeignSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForeignSecuritiesRiskMember_120" xlink:to="lab_ck0001515324_ForeignSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_121" xlink:to="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_122" xlink:to="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_123" xlink:to="lab_ck0001515324_ForwardCurrencyExchangeContractsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_124" xlink:to="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_125" xlink:to="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_126" xlink:to="lab_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_127" xlink:to="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_128" xlink:to="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_129" xlink:to="lab_ck0001515324_GeneralRiskOfInvestingInFundMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_130" xlink:to="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_131" xlink:to="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_132" xlink:to="lab_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_133" xlink:to="lab_ck0001515324_GovernmentInterventionInFinancialMarketsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_134" xlink:to="lab_ck0001515324_GovernmentInterventionInFinancialMarketsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_135" xlink:to="lab_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_136" xlink:to="lab_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_137" xlink:to="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_138" xlink:to="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_139" xlink:to="lab_ck0001515324_HighYieldJunkSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HybridInstrumentsMember_140" xlink:to="lab_ck0001515324_HybridInstrumentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_HybridInstrumentsMember_141" xlink:to="lab_ck0001515324_HybridInstrumentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_142" xlink:to="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_143" xlink:to="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_144" xlink:to="lab_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IncomeAndDistributionRiskMember_145" xlink:to="lab_ck0001515324_IncomeAndDistributionRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IncomeAndDistributionRiskMember_146" xlink:to="lab_ck0001515324_IncomeAndDistributionRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_IncomeAndDistributionRiskMember_147" xlink:to="lab_ck0001515324_IncomeAndDistributionRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfectiousIllnessRiskMember_148" xlink:to="lab_ck0001515324_InfectiousIllnessRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfectiousIllnessRiskMember_149" xlink:to="lab_ck0001515324_InfectiousIllnessRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfectiousIllnessRiskMember_150" xlink:to="lab_ck0001515324_InfectiousIllnessRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_151" xlink:to="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_152" xlink:to="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_153" xlink:to="lab_ck0001515324_InflationInterestRateAndBondMarketRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_154" xlink:to="lab_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_155" xlink:to="lab_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfrastructureRiskMember_156" xlink:to="lab_ck0001515324_InfrastructureRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfrastructureRiskMember_157" xlink:to="lab_ck0001515324_InfrastructureRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InfrastructureRiskMember_158" xlink:to="lab_ck0001515324_InfrastructureRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_159" xlink:to="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_160" xlink:to="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_161" xlink:to="lab_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InverseFloatingRateSecuritiesMember_162" xlink:to="lab_ck0001515324_InverseFloatingRateSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InverseFloatingRateSecuritiesMember_163" xlink:to="lab_ck0001515324_InverseFloatingRateSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_164" xlink:to="lab_ck0001515324_InvestmentGradeCorporateSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_165" xlink:to="lab_ck0001515324_InvestmentGradeCorporateSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_166" xlink:to="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_167" xlink:to="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_168" xlink:to="lab_ck0001515324_InvestmentGradeSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_169" xlink:to="lab_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_170" xlink:to="lab_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_171" xlink:to="lab_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_172" xlink:to="lab_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LeverageRiskMember_173" xlink:to="lab_ck0001515324_LeverageRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LeverageRiskMember_174" xlink:to="lab_ck0001515324_LeverageRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LeverageRiskMember_175" xlink:to="lab_ck0001515324_LeverageRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LimitedPartnershipsMember_176" xlink:to="lab_ck0001515324_LimitedPartnershipsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LimitedPartnershipsMember_177" xlink:to="lab_ck0001515324_LimitedPartnershipsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LiquidityRiskMember_178" xlink:to="lab_ck0001515324_LiquidityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LiquidityRiskMember_179" xlink:to="lab_ck0001515324_LiquidityRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LiquidityRiskMember_180" xlink:to="lab_ck0001515324_LiquidityRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_181" xlink:to="lab_ck0001515324_LoansOfPortfolioSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_182" xlink:to="lab_ck0001515324_LoansOfPortfolioSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ManagementRiskMember_183" xlink:to="lab_ck0001515324_ManagementRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ManagementRiskMember_184" xlink:to="lab_ck0001515324_ManagementRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ManagementRiskMember_185" xlink:to="lab_ck0001515324_ManagementRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MarketDiscountRiskMember_186" xlink:to="lab_ck0001515324_MarketDiscountRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MarketDiscountRiskMember_187" xlink:to="lab_ck0001515324_MarketDiscountRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MarketDiscountRiskMember_188" xlink:to="lab_ck0001515324_MarketDiscountRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsMember_189" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsMember_190" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_191" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_192" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_193" xlink:to="lab_ck0001515324_MasterLimitedPartnershipsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_194" xlink:to="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_195" xlink:to="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_196" xlink:to="lab_ck0001515324_MortgageAndAssetBackedSecuritiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_197" xlink:to="lab_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_198" xlink:to="lab_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_NaturalResourcesRiskMember_199" xlink:to="lab_ck0001515324_NaturalResourcesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_NaturalResourcesRiskMember_200" xlink:to="lab_ck0001515324_NaturalResourcesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_NaturalResourcesRiskMember_201" xlink:to="lab_ck0001515324_NaturalResourcesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsMember_202" xlink:to="lab_ck0001515324_OptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsMember_203" xlink:to="lab_ck0001515324_OptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsMember_204" xlink:to="lab_ck0001515324_OptionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnForeignCurrenciesMember_205" xlink:to="lab_ck0001515324_OptionsOnForeignCurrenciesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnForeignCurrenciesMember_206" xlink:to="lab_ck0001515324_OptionsOnForeignCurrenciesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnForeignCurrenciesMember_207" xlink:to="lab_ck0001515324_OptionsOnForeignCurrenciesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_208" xlink:to="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_209" xlink:to="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_210" xlink:to="lab_ck0001515324_OptionsOnSecuritiesIndicesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_211" xlink:to="lab_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_212" xlink:to="lab_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OverCounterTradingRiskMember_213" xlink:to="lab_ck0001515324_OverCounterTradingRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OverCounterTradingRiskMember_214" xlink:to="lab_ck0001515324_OverCounterTradingRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_OverCounterTradingRiskMember_215" xlink:to="lab_ck0001515324_OverCounterTradingRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PortfolioTurnoverRiskMember_216" xlink:to="lab_ck0001515324_PortfolioTurnoverRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PortfolioTurnoverRiskMember_217" xlink:to="lab_ck0001515324_PortfolioTurnoverRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PortfolioTurnoverRiskMember_218" xlink:to="lab_ck0001515324_PortfolioTurnoverRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_219" xlink:to="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_220" xlink:to="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_221" xlink:to="lab_ck0001515324_PotentialConflictsOfInterestRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredSecuritiesRiskMember_222" xlink:to="lab_ck0001515324_PreferredSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredSecuritiesRiskMember_223" xlink:to="lab_ck0001515324_PreferredSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredSecuritiesRiskMember_224" xlink:to="lab_ck0001515324_PreferredSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredStocksMember_225" xlink:to="lab_ck0001515324_PreferredStocksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredStocksMember_226" xlink:to="lab_ck0001515324_PreferredStocksMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PreferredStocksMember_227" xlink:to="lab_ck0001515324_PreferredStocksMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrepaymentOrCallRiskMember_228" xlink:to="lab_ck0001515324_PrepaymentOrCallRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrepaymentOrCallRiskMember_229" xlink:to="lab_ck0001515324_PrepaymentOrCallRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrepaymentOrCallRiskMember_230" xlink:to="lab_ck0001515324_PrepaymentOrCallRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_231" xlink:to="lab_ck0001515324_PrivateCompanyLiquidityRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_232" xlink:to="lab_ck0001515324_PrivateCompanyLiquidityRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyManagementRiskMember_233" xlink:to="lab_ck0001515324_PrivateCompanyManagementRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyManagementRiskMember_234" xlink:to="lab_ck0001515324_PrivateCompanyManagementRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyValuationRiskMember_235" xlink:to="lab_ck0001515324_PrivateCompanyValuationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateCompanyValuationRiskMember_236" xlink:to="lab_ck0001515324_PrivateCompanyValuationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateInvestmentRiskMember_237" xlink:to="lab_ck0001515324_PrivateInvestmentRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_PrivateInvestmentRiskMember_238" xlink:to="lab_ck0001515324_PrivateInvestmentRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsMember_239" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsMember_240" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_241" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_242" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_243" xlink:to="lab_ck0001515324_RealEstateInvestmentTrustsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateMarketRiskMember_244" xlink:to="lab_ck0001515324_RealEstateMarketRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateMarketRiskMember_245" xlink:to="lab_ck0001515324_RealEstateMarketRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RealEstateMarketRiskMember_246" xlink:to="lab_ck0001515324_RealEstateMarketRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_247" xlink:to="lab_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_248" xlink:to="lab_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RepurchaseAgreementsRiskMember_249" xlink:to="lab_ck0001515324_RepurchaseAgreementsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RepurchaseAgreementsRiskMember_250" xlink:to="lab_ck0001515324_RepurchaseAgreementsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RepurchaseAgreementsRiskMember_251" xlink:to="lab_ck0001515324_RepurchaseAgreementsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_252" xlink:to="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_253" xlink:to="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_254" xlink:to="lab_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReturnOfCapitalRiskMember_255" xlink:to="lab_ck0001515324_ReturnOfCapitalRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReturnOfCapitalRiskMember_256" xlink:to="lab_ck0001515324_ReturnOfCapitalRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReturnOfCapitalRiskMember_257" xlink:to="lab_ck0001515324_ReturnOfCapitalRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_258" xlink:to="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_259" xlink:to="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_260" xlink:to="lab_ck0001515324_ReverseRepurchaseAgreementsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_261" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_262" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_263" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_264" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_265" xlink:to="lab_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_266" xlink:to="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_267" xlink:to="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_268" xlink:to="lab_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_269" xlink:to="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_270" xlink:to="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_271" xlink:to="lab_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksOfCurrencyTransactionsMember_272" xlink:to="lab_ck0001515324_RisksOfCurrencyTransactionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksOfCurrencyTransactionsMember_273" xlink:to="lab_ck0001515324_RisksOfCurrencyTransactionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksOfCurrencyTransactionsMember_274" xlink:to="lab_ck0001515324_RisksOfCurrencyTransactionsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_275" xlink:to="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_276" xlink:to="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_277" xlink:to="lab_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_278" xlink:to="lab_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_279" xlink:to="lab_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SectorFocusRiskMember_280" xlink:to="lab_ck0001515324_SectorFocusRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SectorFocusRiskMember_281" xlink:to="lab_ck0001515324_SectorFocusRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SectorFocusRiskMember_282" xlink:to="lab_ck0001515324_SectorFocusRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_283" xlink:to="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_284" xlink:to="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_285" xlink:to="lab_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesLendingRiskMember_286" xlink:to="lab_ck0001515324_SecuritiesLendingRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesLendingRiskMember_287" xlink:to="lab_ck0001515324_SecuritiesLendingRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SecuritiesLendingRiskMember_288" xlink:to="lab_ck0001515324_SecuritiesLendingRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortSalesRiskMember_289" xlink:to="lab_ck0001515324_ShortSalesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortSalesRiskMember_290" xlink:to="lab_ck0001515324_ShortSalesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortSalesRiskMember_291" xlink:to="lab_ck0001515324_ShortSalesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortTermDebtObligationsRiskMember_292" xlink:to="lab_ck0001515324_ShortTermDebtObligationsRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortTermDebtObligationsRiskMember_293" xlink:to="lab_ck0001515324_ShortTermDebtObligationsRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ShortTermDebtObligationsRiskMember_294" xlink:to="lab_ck0001515324_ShortTermDebtObligationsRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_295" xlink:to="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_296" xlink:to="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_297" xlink:to="lab_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_298" xlink:to="lab_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_299" xlink:to="lab_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StapledSecuritiesRiskMember_300" xlink:to="lab_ck0001515324_StapledSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StapledSecuritiesRiskMember_301" xlink:to="lab_ck0001515324_StapledSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StapledSecuritiesRiskMember_302" xlink:to="lab_ck0001515324_StapledSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_303" xlink:to="lab_ck0001515324_StrippedMortgageBackedSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_304" xlink:to="lab_ck0001515324_StrippedMortgageBackedSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedSecuritiesRiskMember_305" xlink:to="lab_ck0001515324_StrippedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedSecuritiesRiskMember_306" xlink:to="lab_ck0001515324_StrippedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StrippedSecuritiesRiskMember_307" xlink:to="lab_ck0001515324_StrippedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StructuredNotesMember_308" xlink:to="lab_ck0001515324_StructuredNotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StructuredNotesMember_309" xlink:to="lab_ck0001515324_StructuredNotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StructuredSecuritiesMember_310" xlink:to="lab_ck0001515324_StructuredSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_StructuredSecuritiesMember_311" xlink:to="lab_ck0001515324_StructuredSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SubordinatedSecuritiesMember_312" xlink:to="lab_ck0001515324_SubordinatedSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SubordinatedSecuritiesMember_313" xlink:to="lab_ck0001515324_SubordinatedSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SubscriptionRightsMember_314" xlink:to="lab_ck0001515324_SubscriptionRightsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SubscriptionRightsMember_315" xlink:to="lab_ck0001515324_SubscriptionRightsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_316" xlink:to="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_317" xlink:to="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_318" xlink:to="lab_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SystemicRiskMember_319" xlink:to="lab_ck0001515324_SystemicRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SystemicRiskMember_320" xlink:to="lab_ck0001515324_SystemicRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_SystemicRiskMember_321" xlink:to="lab_ck0001515324_SystemicRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_322" xlink:to="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_323" xlink:to="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_324" xlink:to="lab_ck0001515324_TemporaryDefensiveStrategiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TrackingRiskMember_325" xlink:to="lab_ck0001515324_TrackingRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TrackingRiskMember_326" xlink:to="lab_ck0001515324_TrackingRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_TrackingRiskMember_327" xlink:to="lab_ck0001515324_TrackingRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UnratedSecuritiesRiskMember_328" xlink:to="lab_ck0001515324_UnratedSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UnratedSecuritiesRiskMember_329" xlink:to="lab_ck0001515324_UnratedSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UnratedSecuritiesRiskMember_330" xlink:to="lab_ck0001515324_UnratedSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesMember_331" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesMember_332" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesMember_333" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_334" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_335" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_336" xlink:to="lab_ck0001515324_UsGovernmentSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ValuationRiskMember_337" xlink:to="lab_ck0001515324_ValuationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ValuationRiskMember_338" xlink:to="lab_ck0001515324_ValuationRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ValuationRiskMember_339" xlink:to="lab_ck0001515324_ValuationRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_340" xlink:to="lab_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_341" xlink:to="lab_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_342" xlink:to="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_343" xlink:to="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_344" xlink:to="lab_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_WarrantsAndRightsMember_345" xlink:to="lab_ck0001515324_WarrantsAndRightsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_WarrantsAndRightsMember_346" xlink:to="lab_ck0001515324_WarrantsAndRightsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_347" xlink:to="lab_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_348" xlink:to="lab_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain_349" xlink:to="lab_us-gaap_ClassOfStockDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_350" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ck0001515324-20240830_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2"/>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredStocksMember" xlink:label="loc_ck0001515324_PreferredStocksMember_1"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommonStocksMember" xlink:label="loc_ck0001515324_CommonStocksMember_2"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SubscriptionRightsMember" xlink:label="loc_ck0001515324_SubscriptionRightsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditFacilityMember" xlink:label="loc_ck0001515324_CreditFacilityMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_0"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GeneralRiskOfInvestingInFundMember" xlink:label="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_4"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MarketDiscountRiskMember" xlink:label="loc_ck0001515324_MarketDiscountRiskMember_5"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateMarketRiskMember" xlink:label="loc_ck0001515324_RealEstateMarketRiskMember_6"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfrastructureRiskMember" xlink:label="loc_ck0001515324_InfrastructureRiskMember_7"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_NaturalResourcesRiskMember" xlink:label="loc_ck0001515324_NaturalResourcesRiskMember_8"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SectorFocusRiskMember" xlink:label="loc_ck0001515324_SectorFocusRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConcentrationRiskMember" xlink:label="loc_ck0001515324_ConcentrationRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_HighYieldJunkSecuritiesRiskMember" xlink:label="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_11"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DistressedSecuritiesRiskMember" xlink:label="loc_ck0001515324_DistressedSecuritiesRiskMember_12"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CollateralizedLoanObligationRiskMember" xlink:label="loc_ck0001515324_CollateralizedLoanObligationRiskMember_13"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MortgageAndAssetBackedSecuritiesMember" xlink:label="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_14"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_15"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialMortgageBackedSecuritiesRiskMember" xlink:label="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_16"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrepaymentOrCallRiskMember" xlink:label="loc_ck0001515324_PrepaymentOrCallRiskMember_17"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InflationInterestRateAndBondMarketRiskMember" xlink:label="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_18"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_VariableAndFloatingRateSecuritiesRiskMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_19"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateBondsRiskMember" xlink:label="loc_ck0001515324_CorporateBondsRiskMember_20"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditRisksMember" xlink:label="loc_ck0001515324_CreditRisksMember_21"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BankLoanRiskMember" xlink:label="loc_ck0001515324_BankLoanRiskMember_22"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LeverageRiskMember" xlink:label="loc_ck0001515324_LeverageRiskMember_23"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PreferredSecuritiesRiskMember" xlink:label="loc_ck0001515324_PreferredSecuritiesRiskMember_24"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember" xlink:label="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_25"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InfectiousIllnessRiskMember" xlink:label="loc_ck0001515324_InfectiousIllnessRiskMember_26"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConvertibleSecuritiesRiskMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesRiskMember_27"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignSecuritiesRiskMember" xlink:label="loc_ck0001515324_ForeignSecuritiesRiskMember_28"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EmergingMarketsRiskMember" xlink:label="loc_ck0001515324_EmergingMarketsRiskMember_29"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignCurrencyRiskMember" xlink:label="loc_ck0001515324_ForeignCurrencyRiskMember_30"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateInvestmentTrustsRiskMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_31"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DerivativesRiskMember" xlink:label="loc_ck0001515324_DerivativesRiskMember_32"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CounterpartyRiskMember" xlink:label="loc_ck0001515324_CounterpartyRiskMember_33"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LiquidityRiskMember" xlink:label="loc_ck0001515324_LiquidityRiskMember_34"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortSalesRiskMember" xlink:label="loc_ck0001515324_ShortSalesRiskMember_35"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesLendingRiskMember" xlink:label="loc_ck0001515324_SecuritiesLendingRiskMember_36"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_RepurchaseAgreementsRiskMember_37"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReverseRepurchaseAgreementsRiskMember" xlink:label="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_38"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember" xlink:label="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_39"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CorporateLoansRiskMember" xlink:label="loc_ck0001515324_CorporateLoansRiskMember_40"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesRiskMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_41"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_42"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ManagementRiskMember" xlink:label="loc_ck0001515324_ManagementRiskMember_43"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PotentialConflictsOfInterestRiskMember" xlink:label="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_44"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AntiTakeoverProvisionsRiskMember" xlink:label="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_45"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UnratedSecuritiesRiskMember" xlink:label="loc_ck0001515324_UnratedSecuritiesRiskMember_46"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ValuationRiskMember" xlink:label="loc_ck0001515324_ValuationRiskMember_47"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember" xlink:label="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_48"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedProductRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedProductRiskMember_49"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedNoteRiskMember" xlink:label="loc_ck0001515324_ExchangeTradedNoteRiskMember_50"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PortfolioTurnoverRiskMember" xlink:label="loc_ck0001515324_PortfolioTurnoverRiskMember_51"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MasterLimitedPartnershipsRiskMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_52"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ReturnOfCapitalRiskMember" xlink:label="loc_ck0001515324_ReturnOfCapitalRiskMember_53"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StapledSecuritiesRiskMember" xlink:label="loc_ck0001515324_StapledSecuritiesRiskMember_54"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentGradeSecuritiesRiskMember" xlink:label="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_55"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ShortTermDebtObligationsRiskMember" xlink:label="loc_ck0001515324_ShortTermDebtObligationsRiskMember_56"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_IncomeAndDistributionRiskMember" xlink:label="loc_ck0001515324_IncomeAndDistributionRiskMember_57"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommodityRelatedInvestmentsRiskMember" xlink:label="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_58"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GoldAndOtherPreciousMetalsRiskMember" xlink:label="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_59"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TemporaryDefensiveStrategiesRiskMember" xlink:label="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_60"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DoddFrankActRiskMember" xlink:label="loc_ck0001515324_DoddFrankActRiskMember_61"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_TrackingRiskMember" xlink:label="loc_ck0001515324_TrackingRiskMember_62"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OverCounterTradingRiskMember" xlink:label="loc_ck0001515324_OverCounterTradingRiskMember_63"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsMember" xlink:label="loc_ck0001515324_OptionsMember_64"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnSecuritiesIndicesMember" xlink:label="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_65"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OptionsOnForeignCurrenciesMember" xlink:label="loc_ck0001515324_OptionsOnForeignCurrenciesMember_66"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_FuturesContractsAndOptionsOnFuturesMember" xlink:label="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_67"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_68"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CurrencyFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_69"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember" xlink:label="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_70"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForwardCurrencyExchangeContractsMember" xlink:label="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_71"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember" xlink:label="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_72"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember" xlink:label="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_73"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember" xlink:label="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_74"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksOfCurrencyTransactionsMember" xlink:label="loc_ck0001515324_RisksOfCurrencyTransactionsMember_75"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember" xlink:label="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_76"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CreditDefaultSwapsMember" xlink:label="loc_ck0001515324_CreditDefaultSwapsMember_77"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember" xlink:label="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_78"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember" xlink:label="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_79"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventLinkedBondsMember" xlink:label="loc_ck0001515324_EventLinkedBondsMember_80"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventLinkedSwapsMember" xlink:label="loc_ck0001515324_EventLinkedSwapsMember_81"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConvertibleSecuritiesMember" xlink:label="loc_ck0001515324_ConvertibleSecuritiesMember_82"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedProductsMember" xlink:label="loc_ck0001515324_ExchangeTradedProductsMember_83"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember" xlink:label="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_84"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_WarrantsAndRightsMember" xlink:label="loc_ck0001515324_WarrantsAndRightsMember_85"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BorrowingMember" xlink:label="loc_ck0001515324_BorrowingMember_86"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LoansOfPortfolioSecuritiesMember" xlink:label="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_87"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_UsGovernmentSecuritiesMember" xlink:label="loc_ck0001515324_UsGovernmentSecuritiesMember_88"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InverseFloatingRateSecuritiesMember" xlink:label="loc_ck0001515324_InverseFloatingRateSecuritiesMember_89"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DebtObligationsOfNonUsGovernmentsMember" xlink:label="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_90"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember" xlink:label="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_91"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_BankObligationsMember" xlink:label="loc_ck0001515324_BankObligationsMember_92"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CommercialPaperRiskMember" xlink:label="loc_ck0001515324_CommercialPaperRiskMember_93"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_CertificatesOfDepositRiskMember" xlink:label="loc_ck0001515324_CertificatesOfDepositRiskMember_94"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember" xlink:label="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_95"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_LimitedPartnershipsMember" xlink:label="loc_ck0001515324_LimitedPartnershipsMember_96"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MasterLimitedPartnershipsMember" xlink:label="loc_ck0001515324_MasterLimitedPartnershipsMember_97"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember" xlink:label="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_98"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ForeignSecuritiesMember" xlink:label="loc_ck0001515324_ForeignSecuritiesMember_99"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EmergingMarketsSecuritiesMember" xlink:label="loc_ck0001515324_EmergingMarketsSecuritiesMember_100"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StructuredNotesMember" xlink:label="loc_ck0001515324_StructuredNotesMember_101"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StructuredSecuritiesMember" xlink:label="loc_ck0001515324_StructuredSecuritiesMember_102"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InflationLinkedFixedIncomeSecuritiesMember" xlink:label="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_103"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SubordinatedSecuritiesMember" xlink:label="loc_ck0001515324_SubordinatedSecuritiesMember_104"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_FloatingRateLoansMember" xlink:label="loc_ck0001515324_FloatingRateLoansMember_105"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember" xlink:label="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_106"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember" xlink:label="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_107"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StrippedSecuritiesRiskMember" xlink:label="loc_ck0001515324_StrippedSecuritiesRiskMember_108"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_StrippedMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_109"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember" xlink:label="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_110"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentGradeCorporateSecuritiesMember" xlink:label="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_111"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_HybridInstrumentsMember" xlink:label="loc_ck0001515324_HybridInstrumentsMember_112"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_RealEstateInvestmentTrustsMember_113"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember" xlink:label="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_114"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EnvironmentalRiskMember" xlink:label="loc_ck0001515324_EnvironmentalRiskMember_115"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ExchangeTradedNotesMember" xlink:label="loc_ck0001515324_ExchangeTradedNotesMember_116"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SpecialRisksRelatedToCyberSecurityMember" xlink:label="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_117"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember" xlink:label="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_118"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember" xlink:label="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_119"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AffiliatedTransactionsRestrictionsMember" xlink:label="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_120"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateInvestmentRiskMember" xlink:label="loc_ck0001515324_PrivateInvestmentRiskMember_121"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyManagementRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyManagementRiskMember_122"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyLiquidityRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_123"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_PrivateCompanyValuationRiskMember" xlink:label="loc_ck0001515324_PrivateCompanyValuationRiskMember_124"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember" xlink:label="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_125"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_GovernmentInterventionInFinancialMarketsMember" xlink:label="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_126"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember" xlink:label="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_127"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_SystemicRiskMember" xlink:label="loc_ck0001515324_SystemicRiskMember_128"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_EventRiskMember" xlink:label="loc_ck0001515324_EventRiskMember_129"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_AssetAllocationRiskMember" xlink:label="loc_ck0001515324_AssetAllocationRiskMember_130"/>
    <loc xlink:type="locator" xlink:href="ck0001515324-20240830.xsd#ck0001515324_ConstructionAndDevelopmentRiskMember" xlink:label="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_131"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_PreferredStocksMember_1" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_CommonStocksMember_2" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_0" xlink:to="loc_ck0001515324_SubscriptionRightsMember_7" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0" xlink:to="loc_ck0001515324_CreditFacilityMember_1" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GeneralRiskOfInvestingInFundMember_4" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MarketDiscountRiskMember_5" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateMarketRiskMember_6" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InfrastructureRiskMember_7" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_NaturalResourcesRiskMember_8" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SectorFocusRiskMember_9" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConcentrationRiskMember_10" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_HighYieldJunkSecuritiesRiskMember_11" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DistressedSecuritiesRiskMember_12" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CollateralizedLoanObligationRiskMember_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MortgageAndAssetBackedSecuritiesMember_14" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember_15" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommercialMortgageBackedSecuritiesRiskMember_16" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrepaymentOrCallRiskMember_17" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InflationInterestRateAndBondMarketRiskMember_18" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_VariableAndFloatingRateSecuritiesRiskMember_19" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CorporateBondsRiskMember_20" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CreditRisksMember_21" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BankLoanRiskMember_22" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LeverageRiskMember_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PreferredSecuritiesRiskMember_24" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember_25" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InfectiousIllnessRiskMember_26" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConvertibleSecuritiesRiskMember_27" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignSecuritiesRiskMember_28" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EmergingMarketsRiskMember_29" order="26" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignCurrencyRiskMember_30" order="27" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateInvestmentTrustsRiskMember_31" order="28" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DerivativesRiskMember_32" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CounterpartyRiskMember_33" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LiquidityRiskMember_34" order="31" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ShortSalesRiskMember_35" order="32" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SecuritiesLendingRiskMember_36" order="33" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RepurchaseAgreementsRiskMember_37" order="34" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ReverseRepurchaseAgreementsRiskMember_38" order="35" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember_39" order="36" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CorporateLoansRiskMember_40" order="37" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UsGovernmentSecuritiesRiskMember_41" order="38" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveMember_42" order="39" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ManagementRiskMember_43" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PotentialConflictsOfInterestRiskMember_44" order="41" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AntiTakeoverProvisionsRiskMember_45" order="42" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UnratedSecuritiesRiskMember_46" order="43" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ValuationRiskMember_47" order="44" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember_48" order="45" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedProductRiskMember_49" order="46" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedNoteRiskMember_50" order="47" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PortfolioTurnoverRiskMember_51" order="48" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MasterLimitedPartnershipsRiskMember_52" order="49" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ReturnOfCapitalRiskMember_53" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StapledSecuritiesRiskMember_54" order="51" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentGradeSecuritiesRiskMember_55" order="52" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ShortTermDebtObligationsRiskMember_56" order="53" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_IncomeAndDistributionRiskMember_57" order="54" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommodityRelatedInvestmentsRiskMember_58" order="55" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GoldAndOtherPreciousMetalsRiskMember_59" order="56" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_TemporaryDefensiveStrategiesRiskMember_60" order="57" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DoddFrankActRiskMember_61" order="58" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_TrackingRiskMember_62" order="59" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OverCounterTradingRiskMember_63" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsMember_64" order="61" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsOnSecuritiesIndicesMember_65" order="62" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OptionsOnForeignCurrenciesMember_66" order="63" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_FuturesContractsAndOptionsOnFuturesMember_67" order="64" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember_68" order="65" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CurrencyFuturesAndOptionsThereonMember_69" order="66" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember_70" order="67" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForwardCurrencyExchangeContractsMember_71" order="68" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember_72" order="69" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember_73" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember_74" order="71" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksOfCurrencyTransactionsMember_75" order="72" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember_76" order="73" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CreditDefaultSwapsMember_77" order="74" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember_78" order="75" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember_79" order="76" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventLinkedBondsMember_80" order="77" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventLinkedSwapsMember_81" order="78" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConvertibleSecuritiesMember_82" order="79" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedProductsMember_83" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember_84" order="81" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_WarrantsAndRightsMember_85" order="82" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BorrowingMember_86" order="83" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LoansOfPortfolioSecuritiesMember_87" order="84" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_UsGovernmentSecuritiesMember_88" order="85" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InverseFloatingRateSecuritiesMember_89" order="86" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DebtObligationsOfNonUsGovernmentsMember_90" order="87" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember_91" order="88" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_BankObligationsMember_92" order="89" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CommercialPaperRiskMember_93" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_CertificatesOfDepositRiskMember_94" order="91" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember_95" order="92" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_LimitedPartnershipsMember_96" order="93" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MasterLimitedPartnershipsMember_97" order="94" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember_98" order="95" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ForeignSecuritiesMember_99" order="96" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EmergingMarketsSecuritiesMember_100" order="97" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StructuredNotesMember_101" order="98" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StructuredSecuritiesMember_102" order="99" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InflationLinkedFixedIncomeSecuritiesMember_103" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SubordinatedSecuritiesMember_104" order="101" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_FloatingRateLoansMember_105" order="102" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember_106" order="103" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember_107" order="104" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StrippedSecuritiesRiskMember_108" order="105" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_StrippedMortgageBackedSecuritiesMember_109" order="106" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember_110" order="107" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentGradeCorporateSecuritiesMember_111" order="108" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_HybridInstrumentsMember_112" order="109" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RealEstateInvestmentTrustsMember_113" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember_114" order="111" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EnvironmentalRiskMember_115" order="112" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ExchangeTradedNotesMember_116" order="113" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SpecialRisksRelatedToCyberSecurityMember_117" order="114" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember_118" order="115" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember_119" order="116" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AffiliatedTransactionsRestrictionsMember_120" order="117" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateInvestmentRiskMember_121" order="118" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyManagementRiskMember_122" order="119" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyLiquidityRiskMember_123" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_PrivateCompanyValuationRiskMember_124" order="121" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember_125" order="122" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_GovernmentInterventionInFinancialMarketsMember_126" order="123" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember_127" order="124" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_SystemicRiskMember_128" order="125" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_EventRiskMember_129" order="126" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_AssetAllocationRiskMember_130" order="127" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cef_AllRisksMember_0" xlink:to="loc_ck0001515324_ConstructionAndDevelopmentRiskMember_131" order="128" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140456423188944">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="10">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 30, 2024</div></th>
<th class="th"><div>Aug. 26, 2024</div></th>
<th class="th"><div>Aug. 23, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0001515324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">424B2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARES
DYNAMIC CREDIT ALLOCATION FUND, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:bold 10pt Times New Roman, Times, Serif">Shareholder Transaction Expenses</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;width:88%;text-align:left">Sales load paid by you (<span style="font-size:10pt;font-family:Times New Roman">as
        a percentage of offering price</span>)</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right">1.00</td>
    <td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Offering expenses borne by the Fund (as a percentage
        of offering price) (1)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">0.17</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Dividend reinvestment plan fees(2)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">None</span></td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td> </tr>
  </table>


<div>&#160;</div>


<div>


<table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse">
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;width:4%;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(1)</span></td>
    <td style="font-size:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The percentage reflects
        estimated offering expenses of approximately $250,000 for the estimated duration of this offering and assumes we sell all $150,000,000
        of common shares under this Prospectus Supplement and the accompanying Prospectus. There is no guarantee that there will be any sales
        of our common shares pursuant to this Prospectus Supplement and the accompanying Prospectus. Actual sales of the Fund's common shares
        under this Prospectus Supplement and the accompanying Prospectus, if any, may be less than as set forth under &#8220;Capitalization&#8221;
        below. In addition, the price per share of any such sale may be greater than or less than the price set forth under &#8220;Capitalization&#8221;
        below, depending on market price of the Fund's common shares at the time of any such sale.</span></td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify">&#160;</td>
    <td style="font-size:10pt;text-align:justify">&#160;</td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(2)</span></td>
    <td style="font-size:10pt;text-align:justify"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The plan administrator's
        service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders
        with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or
        in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's
        open-market purchases in connection with the reinvestment of dividends and distributions.</span></td> </tr>
  </table> </div> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in">
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:bold 10pt Times New Roman, Times, serif;text-align:left;width:88%">Annual Expenses (as a percentage of net assets attributable
        to common shares)</td>
    <td style="font-size:10pt;width:1%">&#160;</td>
    <td style="font-size:10pt;text-align:right;width:10%">&#160;</td>
    <td style="font-size:10pt;text-align:left;width:1%">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Advisory Fees(3)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">1.67</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Interest payments on borrowed funds(4)</td>
    <td style="font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:right">2.56</td>
    <td style="font:10pt Times New Roman, Times, Serif;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Other Expenses(5)</td>
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right">0.76</td>
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left">%</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left">Total Annual Fund Operating Expenses</td>
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt">&#160;</td>
    <td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right">4.99</td>
    <td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1.5pt;text-align:left">%</td> </tr>
  </table>


<table cellpadding="0" cellspacing="0" style="width:100%">
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%">&#160;</td>
    <td style="font-size:10pt;text-align:justify;width:96%">&#160;</td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(3)</span></td>
    <td style="font-size:10pt;text-align:justify;width:96%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">The Fund currently
        pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders
        bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable
        to common shares than if the Fund did not use leverage.&#160;&#160;The advisory fee shown in the table assumes an <span>amount of leverage
        of </span>36<span>% of the Fund&#8217;s Managed Assets.&#160;&#160;Based on the same assumptions, leverage would equal </span>56<span>%
        of the Fund&#8217;s net assets.</span></span></td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%">&#160;</td>
    <td style="font-size:10pt;text-align:justify;width:96%">&#160;</td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(4)</span></td>
    <td style="font-size:10pt;text-align:justify;width:96%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Interest
        payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for the six months ended June&#160;30,
        2024.&#160;&#160;We had outstanding borrowings of approximately $190 million (with a carrying value of approximately $189) as of June&#160;30,
        2024. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at
        leverage of 36% of the Fund&#8217;s Managed Assets <span>and </span>56<span>% of the Fund&#8217;s net assets</span>) to those prior to
        such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s
        and the Board of Directors of the Fund's assessment of market and other factors at the time of any proposed borrowing. </span></td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%">&#160;</td>
    <td style="font-size:10pt;text-align:justify;width:96%">&#160;</td> </tr>
  <tr style="font-size:10pt;vertical-align:top">
    <td style="font-size:10pt;text-align:justify;width:4%"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">(5)</span></td>
    <td style="font-size:10pt;text-align:justify;width:96%"> <span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Other
        Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred
        by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221;
        are based on estimated amounts for the current fiscal year.</span> </td> </tr>
  </table> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">1.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">2.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">0.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">


<div>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"><span style="font-size:10pt">The
following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (i)&#160;total annual
expenses of 4.99% of net assets attributable to common shares in 2024 and thereafter, and (ii)&#160;a 5% annual return:</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in">
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">One&#160;Year</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Three&#160;Years</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Five&#160;Years</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid">Ten&#160;Years</td>
    <td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt">Total expenses incurred</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">62</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">163</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">264</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">$</td>
    <td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right">515</td>
    <td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left">&#160;</td> </tr>
  </table>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><span style="font-size:10pt">&#160;</span></p>


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt"><strong>The example should
not be considered a representation of future expenses. The example assumes that the estimated &#8220;Other expenses&#8221; set forth in
the Estimated Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be
greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return
shown in the example.</strong></span></p> </div> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">


<p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"><span style="font-size:10pt">The following table and
example are intended to assist you in understanding the various costs and expenses directly or indirectly associated with investing in
our common shares.</span></p> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman">as
        a percentage of offering price</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-family:Times New Roman, Times, Serif;font-size:10pt">&#8220;Other
        Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred
        by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221;
        are based on estimated amounts for the current fiscal year.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">
  <tr style="vertical-align:bottom">
    <td style="padding-bottom:1pt;vertical-align:bottom;font:10pt Times New Roman, Times, Serif;text-align:left">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>&#160;</strong></p> </td>
    <td style="padding-bottom:1pt">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">NYSE&#160;Market&#160;Price<br/>Per&#160;Common
        Share</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">NAV per Common<br/>Share on&#160;Date&#160;of<br/>Market&#160;Price</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="border-bottom:Black 1pt solid;padding-bottom:1pt;font-size:10pt;font-weight:bold;text-align:center">Premium/(Discount)&#160;on<br/>Date&#160;of<br/>Market&#160;Price</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font-size:10pt;font-weight:bold;text-align:center">Trading</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="padding-bottom:1pt;font-size:10pt"><strong>During Quarter Ended</strong></td>
    <td style="padding-bottom:1pt">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Volume</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:15%;font-size:10pt;text-indent:-10pt;padding-left:10pt">June 30, 2024</td>
    <td style="width:1%">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:9%;font-size:10pt;text-align:right">14.89</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:9%;font-size:10pt;text-align:right">13.79</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:9%;font-size:10pt;text-align:right">14.81</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:9%;font-size:10pt;text-align:right">14.50</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:9%;font-size:10pt;text-align:right">0.54</td>
    <td style="width:1%;font-size:10pt;text-align:left">%</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:9%;font-size:10pt;text-align:right">(4.90</td>
    <td style="width:1%;font-size:10pt;text-align:left">)%</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:9%;font-size:10pt;text-align:right">5,985,800</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">March 31, 2024</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.29</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.41</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.69</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.46</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(2.72</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(7.26</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,951,700</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">December&#160;31, 2023</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.86</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.88</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.51</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.76</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(4.48</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(13.66</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,020,500</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">September&#160;30, 2023</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.93</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.10</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.25</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.75</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(9.26</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(12.00</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,500,400</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">June&#160;30, 2023</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.33</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.61</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.87</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.58</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(11.10</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(14.51</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,473,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">March&#160;31, 2023</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.85</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.42</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.12</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.37</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(8.99</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(14.58</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">7,627,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">December&#160;31, 2022</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.31</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.27</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.73</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.17</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(10.34</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(14.43</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,699,200</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">September&#160;30, 2022</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.45</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.65</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.77</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.33</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(8.94</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(12.60</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">4,773,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">June&#160;30, 2022</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.82</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.89</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">15.96</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.75</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(7.14</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(13.53</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,461,400</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt;text-indent:-10pt;padding-left:10pt">March&#160;31, 2022</td>
    <td>&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">16.37</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.61</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">16.71</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">15.56</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(2.03</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(<span style="font-size:10pt;font-family:Times New Roman">12.53</span></td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,201,000</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  </table> <span></span>
</td>
<td class="text">


<table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif">
  <tr style="vertical-align:bottom">
    <td style="font:10pt Times New Roman, Times, serif;border-bottom:1pt solid black">
        <p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"><strong>During Quarter Ended</strong></p> </td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="font-size:10pt;font-weight:bold;text-align:center;border-bottom:Black 1pt solid">NYSE&#160;Market&#160;Price<br/>Per&#160;Common
        Share</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="font-size:10pt;font-weight:bold;text-align:center;border-bottom:Black 1pt solid">NAV per<br/>Common<br/>Share on&#160;Date&#160;of<br/>Market&#160;Price</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="6" style="font-size:10pt;font-weight:bold;text-align:center;border-bottom:Black 1pt solid">Premium/(Discount)&#160;on<br/>Date&#160;of<br/>Market&#160;Price</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold;padding-bottom:1pt">&#160;</td>
    <td colspan="2" style="font-size:10pt;font-weight:bold;text-align:center">Trading</td>
    <td style="padding-bottom:1pt;font-size:10pt;font-weight:bold">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">High</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Low</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td>
    <td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center">Volume</td>
    <td style="font-size:10pt;font-weight:bold">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="width:30%;font-size:10pt">March 31, 2024</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:7%;font-size:10pt;text-align:right">14.29</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:7%;font-size:10pt;text-align:right">13.41</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:7%;font-size:10pt;text-align:right">14.69</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">$</td>
    <td style="width:7%;font-size:10pt;text-align:right">14.46</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:7%;font-size:10pt;text-align:right">(2.72</td>
    <td style="width:1%;font-size:10pt;text-align:left">)%</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:7%;font-size:10pt;text-align:right">(7.26</td>
    <td style="width:1%;font-size:10pt;text-align:left">)%</td>
    <td style="width:1%;font-size:10pt">&#160;</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td>
    <td style="width:7%;font-size:10pt;text-align:right">6,951,700</td>
    <td style="width:1%;font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">December&#160;31, 2023</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.86</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.88</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.51</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.76</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(4.48</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(13.66</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,020,500</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt">September&#160;30, 2023</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.93</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.10</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.25</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.75</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(9.26</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(12.00</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,500,400</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">June&#160;30, 2023</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.33</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.61</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.87</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.58</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(11.10</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(14.51</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,473,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt">March&#160;31, 2023</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.85</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.42</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.12</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.37</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(8.99</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(14.58</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">7,627,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">December&#160;31, 2022</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">12.31</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.27</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.73</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.17</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(10.34</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(14.43</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,699,200</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt">September&#160;30, 2022</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.45</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.65</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.77</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.33</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(8.94</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(12.60</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">4,773,900</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom">
    <td style="font-size:10pt">June&#160;30, 2022</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">14.82</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">11.89</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">15.96</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.75</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(7.14</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(13.53</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">5,461,400</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  <tr style="vertical-align:bottom;background-color:rgb(204,238,255)">
    <td style="font-size:10pt">March&#160;31, 2022</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">16.37</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">13.61</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">16.71</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">$</td>
    <td style="font-size:10pt;text-align:right">15.56</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(2.03</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">(12.53</td>
    <td style="font-size:10pt;text-align:left">)%</td>
    <td style="font-size:10pt">&#160;</td>
    <td style="font-size:10pt;text-align:left">&#160;</td>
    <td style="font-size:10pt;text-align:right">6,201,000</td>
    <td style="font-size:10pt;text-align:left">&#160;</td> </tr>
  </table> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.79<span></span>
</td>
<td class="nump">$ 13.41<span></span>
</td>
<td class="nump">$ 11.88<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 11.61<span></span>
</td>
<td class="nump">$ 11.42<span></span>
</td>
<td class="nump">$ 11.27<span></span>
</td>
<td class="nump">$ 11.65<span></span>
</td>
<td class="nump">$ 11.89<span></span>
</td>
<td class="nump">$ 13.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.89<span></span>
</td>
<td class="nump">14.29<span></span>
</td>
<td class="nump">13.86<span></span>
</td>
<td class="nump">12.93<span></span>
</td>
<td class="nump">12.33<span></span>
</td>
<td class="nump">12.85<span></span>
</td>
<td class="nump">12.31<span></span>
</td>
<td class="nump">13.45<span></span>
</td>
<td class="nump">14.82<span></span>
</td>
<td class="nump">16.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidNav', window );">Lowest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
<td class="nump">14.46<span></span>
</td>
<td class="nump">13.76<span></span>
</td>
<td class="nump">13.75<span></span>
</td>
<td class="nump">13.58<span></span>
</td>
<td class="nump">13.37<span></span>
</td>
<td class="nump">13.17<span></span>
</td>
<td class="nump">13.33<span></span>
</td>
<td class="nump">13.75<span></span>
</td>
<td class="nump">15.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidNav', window );">Highest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.81<span></span>
</td>
<td class="nump">$ 14.69<span></span>
</td>
<td class="nump">$ 14.51<span></span>
</td>
<td class="nump">$ 14.25<span></span>
</td>
<td class="nump">$ 13.87<span></span>
</td>
<td class="nump">$ 14.12<span></span>
</td>
<td class="nump">$ 13.73<span></span>
</td>
<td class="nump">$ 14.77<span></span>
</td>
<td class="nump">$ 15.96<span></span>
</td>
<td class="nump">$ 16.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.54%<span></span>
</td>
<td class="num">(2.72%)<span></span>
</td>
<td class="num">(4.48%)<span></span>
</td>
<td class="num">(9.26%)<span></span>
</td>
<td class="num">(11.10%)<span></span>
</td>
<td class="num">(8.99%)<span></span>
</td>
<td class="num">(10.34%)<span></span>
</td>
<td class="num">(8.94%)<span></span>
</td>
<td class="num">(7.14%)<span></span>
</td>
<td class="num">(2.03%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.90%)<span></span>
</td>
<td class="num">(7.26%)<span></span>
</td>
<td class="num">(13.66%)<span></span>
</td>
<td class="num">(12.00%)<span></span>
</td>
<td class="num">(14.51%)<span></span>
</td>
<td class="num">(14.58%)<span></span>
</td>
<td class="num">(14.43%)<span></span>
</td>
<td class="num">(12.60%)<span></span>
</td>
<td class="num">(13.53%)<span></span>
</td>
<td class="num">(12.53%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LatestPremiumDiscountToNavPercent', window );">Latest Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.87%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The percentage reflects estimated offering expenses of approximately $250,000 for the estimated duration of this offering and assumes we sell all $150,000,000 of common shares under this Prospectus Supplement and the accompanying Prospectus. There is no guarantee that there will be any sales of our common shares pursuant to this Prospectus Supplement and the accompanying Prospectus. Actual sales of the Fund's common shares under this Prospectus Supplement and the accompanying Prospectus, if any, may be less than as set forth under &#8220;Capitalization&#8221; below. In addition, the price per share of any such sale may be greater than or less than the price set forth under &#8220;Capitalization&#8221; below, depending on market price of the Fund's common shares at the time of any such sale.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#8217;s use of leverage in the form of higher fees as a percentage of the Fund&#8217;s net assets attributable to common shares than if the Fund did not use leverage. The advisory fee shown in the table assumes an amount of leverage of 36% of the Fund&#8217;s Managed Assets. Based on the same assumptions, leverage would equal 56% of the Fund&#8217;s net assets.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">&#8220;Interest payments on borrowed funds&#8221; represents our actual interest and credit facility expenses incurred for the six months ended June 30, 2024. We had outstanding borrowings of approximately $190 million (with a carrying value of approximately $189) as of June 30, 2024. This item is based on the assumption that the Fund&#8217;s borrowings and interest costs after an offering will remain similar (at leverage of 36% of the Fund&#8217;s Managed Assets and 56% of the Fund&#8217;s net assets) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#8217;s and the Board of Directors of the Fund's assessment of market and other factors at the time of any proposed borrowing.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">&#8220;Other Expenses&#8221; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#8220;Other Expenses&#8221; are based on estimated amounts for the current fiscal year.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LatestPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LatestPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 54B<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 59<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-59<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #5B2-9)/<N::87  !'P   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;.V=6W/;-A;'W_4I,-YD:\\HLDC=T\0SCJW[+9NXW>EX^D!+L,4)16IYL>/]
M](L#D*)(0;2<_F?;A\ZTL2WA_' [. 1Q<( /3Y[_+5AQ'K+O:\<-/IZLPG#S
M_OP\6*SXV@HJWH:[XIM[SU];H?C3?S@/-CZWEE)H[9R;U6KS?&W9[LG%!_G9
M9__B@Q>%CNWRSSX+HO7:\I\_<<=[^GABG"0??+$?5B%]<'[Q86,]\*\\_&7S
MV1=_G6\I2WO-W<#V7.;S^X\GE\;[>;U* C+%KS9_"G9^9U25.\_[1G\,EQ]/
MJE0B[O!%2 A+_'CD5]QQB"3*\9\8>K+-DP1W?T_H/5EY49D[*^!7GO-O>QFN
M/IZT3]B2WUN1$W[QG@8\KE"#> O/">2_["E.6SUABR@(O74L+$JPMEWUT_H>
M-\2.@%$[(&#& F9.X& .M5B@=JQ /1:HYXM4/R#0B 4:>8'& 8%F+- \-H=6
M+- Z5J ="[2/%>C$ IUC!8QJTG/5HT6VG;W7VP=%DNXV\OU]6"3I<"/?XX=%
MDBXWCNYS(^ETI?#G2N/E<+FV0NOB@^\],9_2"Q[](L><E!>CQ';)/'P-??&M
M+>3"B]D[D[UCOWR]9J=OSCZ<AP))7YPO8O&>$C</B-?8U'/#5<"Z[I(OL_+G
MHBC;\IA)>:[,0N!E]%!AM6J9F56SKBG/]1'B9O.@>/<8\=I!\5ZQ^"AR"PO?
M+Q:?6KX0-PZ*#XK%K_EB*U[3B ^+Q;_RS;;P.O'1\777B8^/K[M.?')\W4V-
M^/3XNNO$9\?772<^/[[N9L$8JFW'=$WR:@=X5]XC]]GMY5T0^N+Q^[NF1%>*
M4-<3:$[R/MA8"_[Q1$PZ NX_\I.+?_[#:%9_UHU))*R+A/60L#X2-D#"ADC8
M" D;(V$3)&R*A,V0L#D(EK$=]:WMJ!?1+[IN:(?/[(J[PG8X;"@>Z]_9F#_K
M;$@QJ5JM&@VC4=,_Q@ME7VLRD+ >$M9'P@9(V! )&R%A8R1L@H1-D; 9$C8'
MP3(FH[$U&8W"@7ZYYNY2_!^RGF,]Z Q%L?R]Y01<9R,*Q5YK(Y"P'A+61\(&
M2-@0"1LA86,D;(*$39&P&1(V!\$R-J*YM1'-PC%^[2TB:2)NGC>ZL7Y5+%XW
MZY]T+U;7A6*O-1%(6 \)ZR-A R1LB(2-D+ Q$C9!PJ9(V P)FX-@&1/1VIJ(
MUC%O'E_X@TWK%L)6S*RUUE84<RZ_=+^6KG^;74Z'5^SJ2_=Z>,,N)Y/YU>7-
M<#YCO5]FUV4VG%U5=/:D$/U:>X*$]9"P/A(V0,*&2-@("1LC81,D;(J$S9"P
M.0B6L2?MK3UI%ZZ"]CAG-]:=PU]8"6TC5T*1L"X2UD/"^DC8  D;(F$C)&R,
MA$V0L"D2-D/"YB!8QGYTMO:C4SB/^+JR?+[RG"7WV8V8CP26VM#0_;[A;L #
M=JNLRPW_'K)/CK?XIC4O?RR3TE?+$5DYGK5D&\M>LKMG]NQ%[)190<EB&^XO
MQ%N5]<"9=R_^N^>^[3ZPC6\O.#,JU2I[6YHGG_*DX'>>[W(BA2O.>I&[9*=6
MP'9II3W:&3LUSEBU8K0$\MI^M)=<R/G<=A]Y$,I7NXUCN>R>\^#4/&,SS^4E
M$KD1>>P4T^?WM#,D* DI>VV%?)EFM"V@R-W:;'SONTSA/+,W9J-:KHKJW'N^
M+'4JO8Q\2S:9$ I7=I#B+%% *PC$>V? GC@+N.,P2_S_QE P^I\JNO#6:R$?
M4%<$3#0']Q7IL^\%&U'8*&!?H\W&X;*:A*4B6 LAN+'<9\HK35JA&ON<"7G7
M8P^115-9\2@*5U9(<N*K)UN4XDX0W&<64/_*YH[\7$DVD1]$- \.O3]4GDOQ
MPW)43JJ55*__%&0S+/W1JI>9?4^5*K.U]4P5%!D&5'%7](-H_Y"Z+US%3?S/
M?[1-L_KSE;6Q0\NQ_RM[47YH_%RZHWU+%384DLNE3=^49<Y*LX4^J3)+3:%6
MC!8K6<$DYP>?"^WP5>9"9]*2I)37%ZC,EERHZ)*J+9IM;?G?!$/1"AJ6J9YG
M0F7W2UPIT7"1HX3&C[5<VZY\ 0H]_Z>@1%:-\&)<I<U+_; =+#0D$BFE^&$"
M2Q1-6@Y*MS/F$SU-T@AEO?.];]RG4;H0Y7X0;*%Y06JA@M*3+5I+U(CZF[[,
M5M,6@XU&I.V+K\6HW;4PTL"(1)$34A,L8PL24.<LJ;[V743M+=3>>I9VE=LT
M6ICMYG+Q_!)]9@6K"AMX3_R1^V7&+=&<&\L/[86]H3$CJR509-9\[YUH3BM5
MF9V*"K0HMLS8=A>1[XL*Y&L9'NH<VJ3W+M&"R!>M1ATB2^RZ\?XW"2-"QE9F
MFH"Z,],&VE?3P@?):Z>62%@/">LC80,D;(B$C9"P,1(V0<*F2-@,"9N#8)FI
MI5%-=]U5B^=]\F$\H6G=[6<U.]+.'F-,0V)HJ^_C1;52-3Z</^Z:AN+,7FL;
MH+0>E-:'T@90VA!*&T%I8RAM J5-H;09E#9'T;)F8F=SKE'L-DM>M+[L3AYH
MOG EYC_L<SSG8#WQUJ4I_J<7\+>&WN@HJ>:NT<E;G$+PJRT.DM:#TOI0V@!*
M&T)I(RAM#*5-H+0IE#:#TN8H6M;BF*G%,0M7S>?RI4N_WE6XC!YS0>OH4%H7
M2NM!:7TH;0"E#:&T$90VAM(F4-H42IM!:7,4+6M?TM $HW#W<J%]*7@1^O0"
M]M;4&R4EU<J^/E6-5GXZ XU@@-)Z4%H?2AM :4,H;02EC:&T"90VA=)F4-H<
M1<N:FS2:P2C<^7QQZ;KD^WBES^Z5T+SWC%9W71Z2\XF'M/JO5G8IYU)^T?RL
M=+E\M //?Y8O<:>U,V94FN1D&[HA%PE"6L6FU[Z 7 YWGB_:@"_9?>0N@]/Z
M&3,KC29Y^:1=38ITVB!?78N^N/%"4=:XR'(I?BY*:H7D*-C6H%[I=$1:ROTF
M6;&7B^%NZ#R71 $"N80MBRJRL=C:<D5%Y=OH/>?DX*#E<96)@,LF(/_CV\0O
M8CVJ!?>E93O/[-%RHKS+9"J12W8I6ZW"KG::*?$_W'$K]O_MN H3!KEJC-;/
M 8L"R79XG*>MO#X42T^?K^P':BOR5#)-S^WACNU*Y5^R4P);VDOF>J$L4%(:
MZ7=A5M+IU'K!RGMRDU)*]M9O2:VZ]B+E,4@0Y"Y\JRUJO@T_60$Y6!4YL-8Q
M>".]#.6TA9Z\R%DR_A_JOK>EXD:HE$CM8F=9HJ2EPTH:>]"8S^4(EVDBG\X%
MH-SL1,MI46/A\Z4M-,I:V [M!=SV\M8UD_A_ _L[6ZO(8TZ1QVP4N9Q",$L4
M.UMA_^9L98F:1V$06LIAITHE?M/YEXU.E:UMQZ$)R:ETV5AL8?F^]'!NM34O
MU.Z<D0:);W+9WY /U0[YFMS =[N=D+;_UB.<;>B=8E*3;-MGX06D@/?DU22?
M9N+EEHXNG]-)$*)51!W$"#FUPM*V;T7I:LUCU$7FIT^8]GZ)3$O<^=+FE!(C
MDO2SZ"LG6G+5RQ2)NN)6ZJXLQ]_+C06)SFQ;2"J&(^RR' 0;ST\\^UL.E=&3
MMFY/.4IWS^R2QF%LX,BG-YE<T< 2']#HITQMTK\[QWZ(4R1.;[[KW9,'5SSX
M7%DXJ0_DWE8=(@8]#=/O7 RPW99@N98HD;=Q6[5TQX(:T,%6EV-#R^[M8"%&
MQ+.P<5H'8/%3Z=635"2M!Z7UH;0!E#:$TD90VAA*FT!I4RAM!J7-4;3L)#6-
MGS.* ^"FZ62*YH OO @7LVYK^AEM0_<B;#3W7H2A,7=06@]*ZT-I RAM"*6-
MH+0QE#:!TJ90V@Q*FZ-H61N3QM\9Q1%TV[?)[3N?F)-\2N>:Q3:GF'U;U]N<
MIL[FF(UFWN9 @_B@M!Z4UH?2!E#:$$H;06EC*&T"I4VAM!F4-D?1LC8G#>@S
M6D?X$O>6X(K=B,CXHVLHK0NE]:"T/I0V@-*&4-H(2AM#:1,H;0JES:"T.8J6
M-2UI;)]1&/ISR+043F**B;<-O3UJ:SV(K;U)##3R#TKK06E]*&T I0VAM!&4
M-H;2)E#:%$J;06ES%"UK:=(H0*,X0B_C/SO*TES%Q)S-J'<Z>9L!#>F TGI0
M6A]*&T!I0RAM!*6-H;0)E#:%TF90VAQ%RQYAG$9WF,71';&9$.;"6F_H (*C
M=AV\ +U9\=*]YSARP8;Q&&T[3B1=5CS(.L:E=Y%"A95OET+AR*G%WA@RD'9G
M.WD^PJZLG)24RZE]QD)I )5OO[3K=Z=- V\+]CIH @1=>;1Q$D?J<^G.5'ZU
M4UOD9;'&V^TV AY&OON^-'<Y^XW\_C<KGZM? ]:S'Y-?;[BK?HNW.NP[C=^P
MIBG^,9HU\:_9K(M_&T9#^N&39@Q6U$HE<M;?452@&]A+3K)6ZK?>AAG?1Z)D
M:5-7,J3$<[_U[J:.OXRSD.?<IFDTJNV62*Z[E<L_?.(M KX,Q(WD=@O5HK0-
MPW&*(@NE5!*)2-4+V>SRUVV,\+;M5!AM*0FCS470>D%2SV6%33V?>S((<\]M
M'/OXDPTAJD?S(;I[T;FKYPUY>$.;O*%"'Y18*;-+(FYMK9^T>!R]]K$*I?6@
MM#Z4-H#2AE#:"$H;0VD3*&T*I<V@M#F*EGVLIM%09G&X4NZQ6E:/!8J&U#Q,
M]V.8FF9N_EV<W:L-!32("4KK0VD#*&T(I8V@M#&4-H'2IE#:#$J;HVA90V&F
MAJ(PB$%O* )FT(Q4=[G$5<QK[U@+,5O,FPMH3!*4UH/2^E#: $H;0FDC*&T,
MI4V@M"F4-H/2YBA:UERD,4EF<?!0D;EH:,U%;<]<B-?*O+F QA1!:3THK0^E
M#:"T(90V@M+&4-H$2IM":3,H;8ZB9<U%&E-D%FX'+3071E5K+^I[+R,-HY&W
M%\@MK5THK0>E]:&T 90VA-)&4-H82IM :5,H;0:ES5&TK+U(MW>;Q5NR/T?^
MQE,A:>F9Q&4V\T+R#+S@$RA&W\BPML0G$*\+N\O2=C&:#J)T0Q4B)<R3%01V
MH-P"MJM"7[;Q4;2L^FCYMA<%2;#1[C&#VU/]/#J3;_N7('H+6RY3RS 9M;(L
M VW<TMZ9EOKU6NB><RBM!Z7UH;0!E#:$TD90VAA*FT!I4RAM!J7-4;2LX4OW
MG)O%^\(_68$\CS=SW -%N!QK_(KQ+YZ K#4VT,WF4%H/2NM#:0,H;0BEC:"T
M,90V@=*F4-H,2INC:%ECDVXV-XNO?<F&X!YK88J9?\<Y_QEQSL6=\FH3#=VT
M#Z7UH;0!E#:$TD90VAA*FT!I4RAM!J7-4;2LB4XW[9O%-_+TN<OI4N%K'BQ\
M>Y/8O)T;OXIC@TSH53U06A=*ZT%I?2AM *4-H;01E#:&TB90VA1*FT%I<Q0M
M:V;2'?OF$7?JL,_R5HXC=][^P';AV6]?NVRJ[GY0><TN?Y4WD\0'5WWV^=J.
MUN>GUV*^0S.A,YH>B5=AFA.6KB/YGOJOR/)I$V17KM -[(<5FXCZ[O_RJ^=$
M:UY*SAE2^VC?,*->:7?H9ZW2ZL1_&^IGH\JJE4:=O66G]4JGRL[>LD:YTVZ4
MV]5J211\L6(U8Q=DQJ!Z#&C&P'J3G9J5EDF$TU;%;-(OS7*G891; G7-%WQ]
M)^H0TVJ*TF[23Z/2;L?%,>)B-JD\];:DB;^;,:YJ5LL-@?O*-V',JZ8\L]*)
M?QK5N+2-F-=@IYVX4*?B^VI<4\$JUP5OM\5B1*VFBM:,B]1NJ9^-MB 8E(-D
MR3)+5KU5*W?RK1;#V@T%JYNJ7(:I8+46.VW3L6H)2]:X56Z:+<G*-YL9E\U0
M.#,N4RMN3D/@C&JE5D]X]9HJ6[/3*9NZ=HO+48_+UVRH\K5BL&@$*E\]:;>F
MK'6]W(KKNMMN<=7:9MRE4C$:E4XS[8)6Q:@G7=J(BU9O&K(+,LVF=F)3\TA9
MU0?-2LM0S(94MJHDG%*#*%A3U%%M7-<^RG]@_&H'X.%!73R:7QZX?P^XOP?<
M7W_ '3?>NC\RW@HFN]!0,RAM *4-H;01E#:&TB90VA1*FT%I<Q0M,]FMI:%F
MM>*H,/&(H5-]U,/*\]DG>ZF;X1937OOJ#*5UH;1>3.OL;N6ER7%VMTU?GZR>
MNUEIH$M&C]ALLF&<C&Z+2=.)1V<VV4A/:^:2C?7)ZKGPA8D^F9D[TFUZ(-/<
M]J/9@9KFVFVN;[>=*F3U.(WMJ!7'=M!\Z2A%1NY3OX;2NE!:+Z;1?2!I4]?W
M>J1_()W9R:NR+AU-&_.ZK$M'T\&\,NO3U6IY;=:G:S?RZGR 9^3U65^/^IY"
M'V@_,Z_1NG0T7SJ@TFD40JTX"D%CFLOT/J%5:^CM*5!:%TKKQ32ZAF*W6QIY
MK3:UO5=OYK5:EXY>>O):?2!=(Z_5^G2-=EZK]>EJK;Q6Z]/E;Z"8'N+5\EI]
M7#WFVG0TVS^@U>EF^5KQ9GF=H3ZLULA]O]=06A=*Z\6T3L[8&'FUUB9K[MEJ
M;;*&D5=J;3)S3Z<UR>@E/*_26IJQ-^W0TEJUO$)K::U67I\UR>A%-Z_.FF3T
M#GM F].]W+7BO=QZ;8X7>]C.8D_HR:6@PG-?BO-ZM;9#]X-#:;V8EC\5JU'/
MJWMQZ\M5KK=GNA?OER1I14LK.7Q)DM:NM)*CER3E4I56=/R2*"U,:24G+V9*
M:U!:T>D1F>HE9R])TN*25G+^<H]6:WG)[-A,]TW7BC<W:^=//SHTD?LJKZ&T
M+I36>Z%1I2](V[7]ER1;AP;.X"5)N>I\8+2^)$H+S >&ZTNB],0\,%R/$-6;
ME\D1HO6]$1"/UY?KVM37=79$"S?TN<Z/R'5?-#MDTQV_M>(MN3NN5^TH1&XX
MO(;2NC$M-Q')OT7WH)GVH;0!E#:$TD90VAA*FT!I4RAM!J7-4;2L>4CWZ-:*
M]]/28UH\I9DT$UH# 3W]&4KKQK3\"XV9-Q#0':)0V@!*&T)I(RAM#*5-H+0I
ME#:#TN8H6M9 I#M$:\6',$_H',/PAR?YT/VA4%JWICU'NI9?A.E!<^U#:0,H
M;0BEC:"T,90V@=*F4-H,2INC:%GS03L_,Y_44_=XO=@]?FO\3C'2&X<NTDSC
M7CS_IX!1_K2T<,]YF:[MM-SG<C;FF2)7$BD55Q@F,'GMXIWXP[+5K91WS]OS
M+^6!H.(]*$GC>NS.][ZIZQ@78N[S0(=X>IFK357PC6B4#5^$FI-3@R#BRS0(
M>R<W=8>I2!0Y\I;0]/1/4:KLX9\;ZUENA^6VC./)'_RJ0KO9P@I6%3;PGK@\
MU9-;BY60]$-[86\L&28DJD7GR5ILXWOO1'-:"D"Y[U14H$6Q9<;;HUCSM0P/
M=8XGNN#=6NW$VT2^:#45 D5GL[I<A9)*&!&2 TUE%%.F"?8.0*W<FDHCTKA1
MG]\[@ACLA"YMXTAWS[O-W?YI-JIR@U02WI1*+R-_>U9LN)(AL#'.DMVE#HA]
MXD(#14O2B:UO# 630"&5[98D=$N0/ON>;+LH8%^CS<91@5OQ>;IT'*RW%GTD
M;RU-DR;Z*.2%*CY$%L5:<+X]HG9'584L"RQ'57@O?)]Z(HA(!V37_7AYXN-F
MMSGM7 .,K7HZL.-39].C9JU@Y\Q=E4\<Y79E;>S0<NS_REY,XOWNN.,]5=B0
M='5ITS?JQ%L9:BSWB&X'@6S%2 P;JF#^O%N9^=ZAMXKR^@*5V9(+%95QAAZ=
MK:M&C%HS+6C8^'!BH;+[):[<UG[?OP::_66N@69_I6N@]VWU_^L:Z.-O]OVQ
MBZ ;!]@[5T'?UG_/701=<%OY__<B:/;G7@3-_BH70?^ NLC\7N[],_44H*-M
MA+VA_O"4#4F*%.OXON)F*BSM(U]O'.]9&9#G>+8140VD@9)54W:.D=D52#)W
M<A(CG@VBB<J[ABD]?SQ^.'SR+)\>ZNQ:SI\\/__0H0H%03)]B(UH&H(M]% *
M:8RFT ,ZW&>9=E?EMO%[4;CTGQ<XSOYB@>,,%CBNW@[.@Q7GX;68CUY\6',Q
MR[X2\RMZ\ D:O2+L?$J3/KK[Y?TG\^1\[_.>\7YN:#Z_K'7>S\3KB.:;>O7]
M3+R+B&_.TZPO/FR$ND_%A-\6#>GP>U&,:J75.&&^>/AL_PB]S<<3XT2H4!AZ
M:_DK=27W*8'X_M[SPN0/RN#)\[_)JE[\#U!+ P04    " #5B2-9*BY>8#L#
M  #($P  #0   'AL+W-T>6QE<RYX;6S=6-%.VS 4_97(;!-($VF;-32CK;15
M0IJT34CPL#?D-DYJR;$SQV4M7S_?.$W3XHL8#UM9*AK['I]SC^T;8AA79B/8
MS9(Q$ZP+(:L)61I3?@S#:K%D!:W.5<FD13*E"VIL5^=A56I&TPI(A0@'O5X<
M%I1+,AW+57%5F"I8J)4T$Q*WH<#=OJ03TH\_D,#)S53*)N3D_<E)[^W=V>6I
M:YV1T$L;[M/N3M_]7"ES^29P]YIL50[C3A43C3U>SGL=.]#!R!?/<&3YJ"F+
M8=*C9TD_H8P))]X)=Z9;$\-F)Z?C3,G=AD;$!:PR+5AP3\6$S*C@<\V!E=&"
MBXT+#R"P4$+IP-A*LJGZ$*D>'-QW/2BR1J?@4NDZM\O@ON?-\ -@VP.#7(C6
MX("XP'1<4F.8EE>V4P^N@X^@H&G?;DKK,-=TTQ\,R8Y0WVR2N=(ITVV:/MF&
MIF/!,K"C>;Z$NU%E"* QJK"-E--<25I[V#*:AI5=,"%NX G\D>UIK[/.GO5@
MQV3;M(::II-Q'=#OJCGMKFST(MV@Y/?*?%[9Z<BZ#T7&KC7+^+KNK[/6 *;>
MQ]5I68K-)\%S63 W^6<GG([IEA<LE>8/-AN4RL(&F";!/=.&+[J17YJ6MVQM
MMN6TSG#/@U?H^>^N<\XDTU1T3=O:/^95?K'CYI7U+SS7OU8.'2,FAZ_!9'S\
M)J.+X_?8'#Z.W>3H^$U&R?%[;(YM1V<R; X9G9/,WCFFC09P7IR0[W#R%+ND
MP7S%A>&RZ2UYFC+YZ#ACY0V=VS]3]O3M^)1E="7,;0M.R*[]C:5\523MJ&M8
MB&;4KOT5IM>/V\.JS<5ERM8LG35=G<_K9F ;-FMS >$0N:HO/X)Q'.9' ,/R
M8 XPCF-A>?ZG^8S0^3@,\S;R(B.4,T(YCN5#9O4'R^/G)/;RSS1)HBB.L16=
MS;P.9MBZQ3'\^-4P;\# \D"F/UMK?+?Q"GFZ#K ]?:I"L)GBE8C-%%]K0/SK
M!HPD\>\VE@<8V"Y@M0/Y_7F@IOR<*()=Q;QA3S".) F&0"WZ:S2.D=6)X>/?
M'^PIB:(D\2. ^1U$$8; TX@CF /P@"%15+\'#]Y'X?8]%>[^=S?]#5!+ P04
M    " #5B2-9EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_
MQ=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+
MJ1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D
M5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@
M2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/
M['X 4$L#!!0    ( -6)(UFV0E<F,@$  " "   /    >&PO=V]R:V)O;VLN
M>&ULC5'12L- $/R5<.^:6K1@:?IB40M2BY6^7Y)-L_3N-NQM6NW7NTD(%GSQ
M:6]GEF%F;G$F/N9$Q^3+NQ S4XLT\S2-10W>QEMJ("A3$7LKNO(AC0V#+6,-
M(-ZET\EDEGJ+P2P7H]:6T^N%! I!"@IVP![A''_Y;DU.&#%'A_*=F?[MP"0>
M WJ\0)F9B4EB3>=78KQ0$.MV!9-SF;D;B#VP8/$'WG4F/VT>>T1L_F'52&9F
M$Q6LD*/T%[V^58\GT.-A:X6>T0GPR@J\,+4-AD,GHRG2JQA]#^,<2ISS?VJD
MJL("5E2T'H(,/3*XSF"(-3;1),%ZR,SF9MJE4?EU.203M735$\]1"5Z7@[G1
M40D5!B@W*A(5UW:*+2?=Z'6F]P]WC]I"Z]R38N_AC6PY!AP_9_D#4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( -6)(UD'04UB@0   +$    0
M          "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ U8DC
M65YG#(CO    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N
M>&UL4$L! A0#%     @ U8DC69E<G",0!@  G"<  !,              ( !
MS0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #5B2-9)/<N::87
M  !'P   &               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N
M>&UL4$L! A0#%     @ U8DC62HN7F [ P  R!,   T              ( !
MZA\  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #5B2-9EXJ[',     3 @
M"P              @ %0(P  7W)E;',O+G)E;'-02P$"% ,4    " #5B2-9
MMD)7)C(!   @ @  #P              @ $Y)   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ U8DC620>FZ*M    ^ $  !H              ( !F"4
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ U8DC6660
M>9(9 0  SP,  !,              ( !?28  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  QR<

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>14</ContextCount>
  <ElementCount>31</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2416373d6_424b2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ck0001515324-20240830.xsd</File>
    <File>ck0001515324-20240830_def.xml</File>
    <File>ck0001515324-20240830_lab.xml</File>
    <File>ck0001515324-20240830_pre.xml</File>
    <File doctype="424B2" isUsgaap="true" original="tm2416373d6_424b2.htm">tm2416373d6_424b2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="134">http://xbrl.sec.gov/cef/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2416373d6_424b2.htm": {
   "nsprefix": "ck0001515324",
   "nsuri": "http://www.www.arespublicfunds.com/20240830",
   "dts": {
    "schema": {
     "local": [
      "ck0001515324-20240830.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ck0001515324-20240830_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ck0001515324-20240830_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ck0001515324-20240830_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2416373d6_424b2.htm"
     ]
    }
   },
   "keyStandard": 31,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 14,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 329,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2023": 134,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://fasb.org/us-gaap/2023": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20240830to20240830",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2416373d6_424b2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20240830to20240830",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "strong",
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2416373d6_424b2.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ck0001515324_AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "AdditionalRisksOfForeignOptionsFuturesContractsOptionsOnFuturesContractsAndForwardContractsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Risks of Foreign Options, Futures Contracts, Options on Futures Contracts and Forward Contracts",
        "label": "Additional Risks Of Foreign Options, Futures Contracts, Options On Futures Contracts And Forward Contracts [Member]",
        "documentation": "It represents additional risks of foreign options, futures contracts, options on futures contracts and forward contracts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_AffiliatedTransactionsRestrictionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "AffiliatedTransactionsRestrictionsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Transactions Restrictions [Member]",
        "documentation": "It represents risk of affiliated transactions restrictions."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ck0001515324_AntiTakeoverProvisionsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "AntiTakeoverProvisionsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-Takeover Provisions Risk",
        "label": "Anti Takeover Provisions Risk [Member]",
        "documentation": "It represents as a anti-takeover provisions risk."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_AssetAllocationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "AssetAllocationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a asset allocation risk.",
        "verboseLabel": "Asset Allocation Risk",
        "label": "Asset Allocation Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_BankLoanRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "BankLoanRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Loan Risk",
        "documentation": "It represents as a bank loan risk.",
        "label": "Bank Loan Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_BankObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "BankObligationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank Obligations [Member]",
        "documentation": "It represents risk of bank obligations."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_BorrowingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "BorrowingMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowing [Member]",
        "documentation": "It represents risk of borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ck0001515324_CertificatesOfDepositRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CertificatesOfDepositRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for risk of certificates of deposit risk.",
        "label": "Certificates Of Deposit Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r73",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r174",
      "r175",
      "r177"
     ]
    },
    "ck0001515324_CollateralizedLoanObligationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CollateralizedLoanObligationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Collateralized Loan Obligation (\"CLO\") Risk",
        "documentation": "Collateralized Loan Obligation Risk [Member]",
        "label": "Collateralized Loan Obligation Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CommercialMortgageBackedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CommercialMortgageBackedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial Mortgage Backed Securities Risk",
        "documentation": "It represents as a commercial mortgage backed securities risk.",
        "label": "Commercial Mortgage Backed Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CommercialPaperRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CommercialPaperRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Paper Risk [Member]",
        "documentation": "It represents as a commercial paper risk.",
        "verboseLabel": "Commercial Paper Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CommodityRelatedInvestmentsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CommodityRelatedInvestmentsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commodity-Related Investments Risk",
        "documentation": "It represents as a commodity related investments risk.",
        "label": "Commodity Related Investments Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CommonStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CommonStocksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stocks [Member]",
        "documentation": "Common Stocks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ConcentrationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Member]",
        "documentation": "Concentration Risk [Member]",
        "verboseLabel": "Concentration Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ConstructionAndDevelopmentRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ConstructionAndDevelopmentRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a construction and development risk.",
        "label": "Construction And Development Risk [Member]",
        "verboseLabel": "Construction and Development Risk"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ConvertibleSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ConvertibleSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Securities [Member]",
        "documentation": "It represents risk of convertible securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ConvertibleSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ConvertibleSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a convertible securities risk.",
        "terseLabel": "Convertible Securities Risk",
        "label": "Convertible Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CorporateBondsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CorporateBondsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Bonds Risk [Member]",
        "verboseLabel": "Corporate Bonds Risk",
        "documentation": "Corporate Bonds Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CorporateLoansRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CorporateLoansRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Loans Risk [Member]",
        "verboseLabel": "Corporate Loans Risk",
        "documentation": "Corporate Loans Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CounterpartyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CounterpartyRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a counterparty risk.",
        "terseLabel": "Counterparty Risk",
        "label": "Counterparty Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CreditDefaultSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CreditDefaultSwapsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents credit default swaps.",
        "label": "Credit Default Swaps [Member]",
        "terseLabel": "Credit Default Swaps"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CreditFacilityMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Member]",
        "documentation": "Represent information about the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CreditRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CreditRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for represents as a credit risks.",
        "terseLabel": "Credit Risk",
        "label": "Credit Risks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_CurrencyFuturesAndOptionsThereonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "CurrencyFuturesAndOptionsThereonMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency Futures And Options Thereon [Member]",
        "terseLabel": "Currency Futures and Options Thereon",
        "documentation": "It represents currency futures and options thereon."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r7",
      "r8",
      "r10",
      "r11",
      "r17",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r53",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r176"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r17",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r53",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r176"
     ]
    },
    "ck0001515324_DebtObligationsOfNonUsGovernmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "DebtObligationsOfNonUsGovernmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Debt Obligations of Non-U.S. Governments [Member]",
        "documentation": "It represents risk of debt obligations of non-U.S. governments.",
        "label": "Debt Obligations Of Non Us Governments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "DebtSecuritiesIssuedByRealEstateInvestmentTrustsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities Issued By Real Estate Investment Trusts [Member]",
        "documentation": "It represents risk of debt securities issued by real estate investment trusts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r161"
     ]
    },
    "ck0001515324_DerivativesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "DerivativesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives Risk",
        "documentation": "It represents derivatives Risk.",
        "label": "Derivatives Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_DistressedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "DistressedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a distressed securities risk.",
        "terseLabel": "Distressed Securities Risk",
        "label": "Distressed Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r161"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_DoddFrankActRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "DoddFrankActRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents dodd frank act risk.",
        "terseLabel": "Dodd-Frank Act Risk",
        "label": "Dodd Frank Act Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ck0001515324_EmergingMarketsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "EmergingMarketsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Emerging Markets Risk",
        "label": "Emerging Markets Risk [Member]",
        "documentation": "It represents as a emerging markets risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EmergingMarketsSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "EmergingMarketsSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Emerging Markets Securities [Member]",
        "documentation": "It represents risk of eerging markets securities."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ck0001515324_EnvironmentalRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "EnvironmentalRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of environmental risk.",
        "label": "Environmental Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EquitySecuritiesAndRelatedInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "EquitySecuritiesAndRelatedInvestmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities And Related Investments [Member]",
        "documentation": "It represents risk of equity securities and related investments."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EurodollarInstrumentsAndSamuraiAndYankeeBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "EurodollarInstrumentsAndSamuraiAndYankeeBondsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of eurodollar instruments and samurai and yankee bonds.",
        "label": "Eurodollar Instruments And Samurai And Yankee Bonds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EventLinkedBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "EventLinkedBondsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event Linked Bonds [Member]",
        "documentation": "It represents risk of event linked bonds."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EventLinkedSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "EventLinkedSwapsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event Linked Swaps [Member]",
        "documentation": "It represents risk of event linked swaps."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_EventRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "EventRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Event Risk [Member]",
        "terseLabel": "Event Risk",
        "documentation": "It represents as a event risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExchangeTradedNoteRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ExchangeTradedNoteRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exchange Traded Note Risk",
        "documentation": "Exchange Traded Note Risk [Member]",
        "label": "Exchange Traded Note Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExchangeTradedNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ExchangeTradedNotesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange Traded Notes [Member]",
        "documentation": "It represents risk of exchange-traded notes."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExchangeTradedProductRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ExchangeTradedProductRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange Traded Product Risk [Member]",
        "terseLabel": "Exchange Traded Product Risk",
        "documentation": "It represents Exchange-Traded Product Risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExchangeTradedProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ExchangeTradedProductsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of exchange-traded products.",
        "label": "Exchange Traded Products [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ExclusionFromDefinitionOfCommodityPoolOperatorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ExclusionFromDefinitionOfCommodityPoolOperatorMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exclusion from Definition of Commodity Pool Operator",
        "documentation": "It represents exclusion from definition of commodity pool operator.",
        "label": "Exclusion From Definition Of Commodity Pool Operator [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ck0001515324_FloatingRateLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "FloatingRateLoansMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of floating rate loans.",
        "label": "Floating Rate Loans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ForeignCurrencyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ForeignCurrencyRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a foreign currency risk.",
        "terseLabel": "Foreign Currency Risk",
        "label": "Foreign Currency Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ForeignSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ForeignSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of foreign securities.",
        "label": "Foreign Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ForeignSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ForeignSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a foreign securities risk.",
        "label": "Foreign Securities Risk [Member]",
        "terseLabel": "Foreign Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ForwardCurrencyExchangeContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ForwardCurrencyExchangeContractsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forward Currency Exchange Contracts",
        "label": "Forward Currency Exchange Contracts [Member]",
        "documentation": "It represents forward currency exchange contracts."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_FuturesContractsAndOptionsOnFuturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "FuturesContractsAndOptionsOnFuturesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents futures contracts and options on future.",
        "label": "Futures Contracts And Options On Futures [Member]",
        "verboseLabel": "Futures Contracts and Options on Futures"
       }
      }
     },
     "auth_ref": []
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ck0001515324_GeneralRiskOfInvestingInFundMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "GeneralRiskOfInvestingInFundMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Risk Of Investing In Fund [Member]",
        "verboseLabel": "General Risks of Investing in the Fund",
        "documentation": "It represents general risks of investing in the fund."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_GoldAndOtherPreciousMetalsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "GoldAndOtherPreciousMetalsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gold and Other Precious Metals Risk",
        "label": "Gold And Other Precious Metals Risk [Member]",
        "documentation": "It represents as a gold and other precious metals risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_GovernmentInterventionInFinancialMarketsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "GovernmentInterventionInFinancialMarketsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Government Intervention In Financial Markets [Member]",
        "documentation": "It represents risk of government intervention in financial markets."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_GuaranteedMortgagePassThroughSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "GuaranteedMortgagePassThroughSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guaranteed Mortgage Pass Through Securities [Member]",
        "documentation": "It represents risk of guaranteed mortgage pass-through securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_HighYieldJunkSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "HighYieldJunkSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a high yield (\"Junk\") securities risk.",
        "label": "High Yield Junk Securities Risk [Member]",
        "terseLabel": "High Yield (\"Junk\") Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ck0001515324_HybridInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "HybridInstrumentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of hybrid instruments.",
        "label": "Hybrid Instruments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_IlliquidAndRestrictedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "IlliquidAndRestrictedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a Illiquid and restricted securities risk.",
        "label": "Illiquid And Restricted Securities Risk [Member]",
        "terseLabel": "Illiquid and Restricted Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ck0001515324_IncomeAndDistributionRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "IncomeAndDistributionRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a income and distribution risk.",
        "verboseLabel": "Income and Distribution Risk",
        "label": "Income And Distribution Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InfectiousIllnessRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InfectiousIllnessRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Infectious Illness Risk [Member]",
        "terseLabel": "Infectious Illness Risk",
        "documentation": "It represents infectious illness risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InflationInterestRateAndBondMarketRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InflationInterestRateAndBondMarketRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a inflation, interest rate and bond market risk.",
        "label": "Inflation Interest Rate And Bond Market Risk [Member]",
        "terseLabel": "Inflation, Interest Rate and Bond Market Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InflationLinkedFixedIncomeSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InflationLinkedFixedIncomeSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inflation Linked Fixed Income Securities [Member]",
        "documentation": "It represents risk of inflation-linked fixed-income securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InfrastructureRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InfrastructureRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Infrastructure Risk",
        "documentation": "Infrastructure Risk [Member]",
        "label": "Infrastructure Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ck0001515324_InterestRateFuturesContractsAndOptionsThereonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InterestRateFuturesContractsAndOptionsThereonMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Futures Contracts And Options Thereon [Member]",
        "verboseLabel": "Interest Rate Futures Contracts and Options Thereon",
        "documentation": "It represents interest rate futures contracts and options thereon."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]",
        "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability."
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ck0001515324_InverseFloatingRateSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InverseFloatingRateSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inverse Floating Rate Securities [Member]",
        "documentation": "It represents risk of inverse floating rate securities."
       }
      }
     },
     "auth_ref": []
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r158",
      "r159",
      "r160"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ck0001515324_InvestmentGradeCorporateSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InvestmentGradeCorporateSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of investment grade corporate securities.",
        "label": "Investment Grade Corporate Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InvestmentGradeSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InvestmentGradeSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Grade Securities Risk [Member]",
        "verboseLabel": "Investment Grade Securities Risk",
        "label": "Investment Grade Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ck0001515324_InvestmentsInDifferentPartsOfCapitalStructureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InvestmentsInDifferentPartsOfCapitalStructureMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments In Different Parts Of Capital Structure [Member]",
        "documentation": "It represents risk of investments in different parts of capital structure."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "InvestmentsWhereOtherFundsHoldRelatedInvestmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of investments where other funds hold related investments.",
        "label": "Investments Where Other Funds Hold Related Investments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_LatestNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_LatestSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestSharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ck0001515324_LeverageRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "LeverageRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Risk [Member]",
        "verboseLabel": "Leverage Risk",
        "label": "Leverage Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_LimitedPartnershipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "LimitedPartnershipsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Limited Partnerships [Member]",
        "documentation": "It represents risk of limited partnerships."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_LiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "LiquidityRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity Risk [Member]",
        "documentation": "It represents as a liquidity risk.",
        "terseLabel": "Liquidity Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ck0001515324_LoansOfPortfolioSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "LoansOfPortfolioSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of loans of portfolio securities.",
        "label": "Loans Of Portfolio Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ck0001515324_ManagementRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ManagementRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management Risk",
        "label": "Management Risk [Member]",
        "documentation": "It represents as a management risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MarketDiscountRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "MarketDiscountRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Discount Risk",
        "documentation": "It represents as a market discount risk.",
        "label": "Market Discount Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MasterLimitedPartnershipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "MasterLimitedPartnershipsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Master Limited Partnerships [Member]",
        "documentation": "It represents risk of master limited partnerships."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MasterLimitedPartnershipsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "MasterLimitedPartnershipsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "MLP Risk",
        "label": "Master Limited Partnerships Risk [Member]",
        "documentation": "It represents as a master limited partnerships risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MortgageAndAssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "MortgageAndAssetBackedSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mortgage And Asset Backed Securities [Member]",
        "documentation": "It represents as a mortgage and asset-backed securities.",
        "terseLabel": "Mortgage and Asset-Backed Securities"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "MultipleClassPassThroughSecuritiesAndCollateralizedMortgageObligationsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Multiple Class Pass Through Securities And Collateralized Mortgage Obligations [Member]",
        "documentation": "It represents risk of multiple-class pass-through securities and collateralized mortgage obligations."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_NaturalResourcesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "NaturalResourcesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Natural Resources Risk",
        "label": "Natural Resources Risk [Member]",
        "documentation": "Natural Resources Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share",
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r61",
      "r68",
      "r69",
      "r71",
      "r72",
      "r75",
      "r85"
     ]
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r158",
      "r159",
      "r160"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ck0001515324_OptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "OptionsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options",
        "label": "Options [Member]",
        "documentation": "It represents options."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_OptionsOnForeignCurrenciesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "OptionsOnForeignCurrenciesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options On Foreign Currencies [Member]",
        "documentation": "It represents options on foreign currencies.",
        "terseLabel": "Options on Foreign Currencies"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_OptionsOnSecuritiesIndicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "OptionsOnSecuritiesIndicesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents options on securities indice.",
        "label": "Options On Securities Indices [Member]",
        "terseLabel": "Options on Securities Indices"
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ck0001515324_OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "OtherRiskFactorsAssociatedWithMortgageBackedSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Risk Factors Associated With Mortgage Backed Securities [Member]",
        "documentation": "It represents risk of other risk factors associated with mortgage-backed securities."
       }
      }
     },
     "auth_ref": []
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ck0001515324_OverCounterTradingRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "OverCounterTradingRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Over-the-Counter Trading Risk",
        "label": "Over Counter Trading Risk [Member]",
        "documentation": "Over Counter Trading Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PortfolioTurnoverRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "PortfolioTurnoverRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a portfolio turnover risk.",
        "label": "Portfolio Turnover Risk [Member]",
        "verboseLabel": "Portfolio Turnover Risk"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ck0001515324_PotentialConflictsOfInterestRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "PotentialConflictsOfInterestRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a potential conflicts of interest risk.",
        "label": "Potential Conflicts Of Interest Risk [Member]",
        "terseLabel": "Potential Conflicts of Interest Risk"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ck0001515324_PreferredSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "PreferredSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Securities Risk [Member]",
        "verboseLabel": "Preferred Securities Risk",
        "documentation": "This member stands for Preferred Securities Risk."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r9",
      "r175",
      "r178"
     ]
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ck0001515324_PreferredStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "PreferredStocksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stocks [Member]",
        "terseLabel": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PrepaymentOrCallRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "PrepaymentOrCallRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment or Call Risk",
        "label": "Prepayment Or Call Risk [Member]",
        "documentation": "It represents as a prepayment or call risk."
       }
      }
     },
     "auth_ref": []
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ck0001515324_PrivateCompanyLiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "PrivateCompanyLiquidityRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Company Liquidity Risk [Member]",
        "documentation": "It represents risk of private xompany liquidity risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PrivateCompanyManagementRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "PrivateCompanyManagementRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Company Management Risk [Member]",
        "documentation": "It represents risk of private company management risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PrivateCompanyValuationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "PrivateCompanyValuationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Company Valuation Risk [Member]",
        "documentation": "It represents risk of private company valuation risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_PrivateInvestmentRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "PrivateInvestmentRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Investment Risk [Member]",
        "documentation": "It represents risk of private investment risk."
       }
      }
     },
     "auth_ref": []
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "ck0001515324_RealEstateInvestmentTrustsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RealEstateInvestmentTrustsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate Investment Trusts [Member]",
        "documentation": "It represents risk of real estate investment trusts."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RealEstateInvestmentTrustsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RealEstateInvestmentTrustsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REIT Risk",
        "documentation": "This member stands for real estate investment trusts risk.",
        "label": "Real Estate Investment Trusts Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RealEstateMarketRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RealEstateMarketRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Real Estate Market Risk",
        "documentation": "It represents as a real estate market risk.",
        "label": "Real Estate Market Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RecentMarketEconomicAndSocialDevelopmentsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RecentMarketEconomicAndSocialDevelopmentsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a risks of recent market, economic and social developments risk.",
        "label": "Recent Market Economic And Social Developments Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ck0001515324_RepurchaseAgreementsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RepurchaseAgreementsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase Agreements Risk",
        "documentation": "It represents as a repurchase agreements risk.",
        "label": "Repurchase Agreements Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ResidentialMortgageBackedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ResidentialMortgageBackedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Residential Mortgage Backed Securities Risk",
        "label": "Residential Mortgage Backed Securities Risk [Member]",
        "documentation": "It represents as a residential mortgage backed securities risk."
       }
      }
     },
     "auth_ref": []
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ck0001515324_ReturnOfCapitalRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ReturnOfCapitalRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return Of Capital Risk [Member]",
        "documentation": "It represents as a return of capital risk.",
        "verboseLabel": "Return of Capital Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ReverseRepurchaseAgreementsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ReverseRepurchaseAgreementsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Repurchase Agreements Risk [Member]",
        "terseLabel": "Reverse Repurchase Agreements Risk",
        "documentation": "It represents as a reverse repurchase agreements risk."
       }
      }
     },
     "auth_ref": []
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksAssociatedWithLongTermObjectiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RisksAssociatedWithLongTermObjectiveMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Risks Associated With Long Term Objective Not a Complete Investment Program",
        "documentation": "Risks Associated With Long Term Objective [Member]",
        "label": "Risks Associated With Long Term Objective [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RisksAssociatedWithLongTermObjectiveNotCompleteInvestmentProgramMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of risks associated with long term objective not a complete investment program.",
        "label": "Risks Associated With Long Term Objective Not Complete Investment Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksAssociatedWithPositionLimitsApplicableToDerivativesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RisksAssociatedWithPositionLimitsApplicableToDerivativesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risks Associated with Position Limits Applicable to Derivatives",
        "label": "Risks Associated With Position Limits Applicable To Derivatives [Member]",
        "documentation": "It represents as a risks associated with position limits applicable to derivatives."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksAssociatedWithStatusRegulatedInvestmentCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RisksAssociatedWithStatusRegulatedInvestmentCompanyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks Associated With Status Regulated Investment Company [Member]",
        "documentation": "It represents as a risks associated with status as a regulated investment company.",
        "terseLabel": "Risks Associated With Status as a Regulated Investment Company"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksOfCurrencyTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RisksOfCurrencyTransactionsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risks of Currency Transactions",
        "documentation": "It represents risks of currency transactions.",
        "label": "Risks Of Currency Transactions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RisksRelatedToFundsClearingBrokerAndCentralClearingCounterpartyMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risks Related to Funds Clearing Broker and Central Clearing Counterparty [Member]",
        "label": "Risks Related To Funds Clearing Broker And Central Clearing Counterparty [Member]",
        "verboseLabel": "Risks Related to Fund's Clearing Broker and Central Clearing Counterparty"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_RisksRelatingToRussiaInvasionOfUkraineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "RisksRelatingToRussiaInvasionOfUkraineMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of risks relating to Russia's invasion of Ukraine.",
        "label": "Risks Relating To Russia Invasion Of Ukraine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ck0001515324_SectorFocusRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "SectorFocusRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sector Focus Risk",
        "label": "Sector Focus Risk [Member]",
        "documentation": "It represents as a sector focus risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SecuritiesIndexFuturesContractsAndOptionsThereonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "SecuritiesIndexFuturesContractsAndOptionsThereonMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Index Futures Contracts and Options Thereon",
        "label": "Securities Index Futures Contracts And Options Thereon [Member]",
        "documentation": "It represents securities index futures contracts and options thereon"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SecuritiesLendingRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "SecuritiesLendingRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Lending Risk [Member]",
        "documentation": "It represents as a securities lending risk.",
        "terseLabel": "Securities Lending Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "cef_SeniorSecuritiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r133",
      "r140"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r134",
      "r140"
     ]
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r132",
      "r140"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ck0001515324_ShortSalesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ShortSalesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short Sales Risk [Member]",
        "terseLabel": "Short Sales Risk",
        "documentation": "It represents as a short sales risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ShortTermDebtObligationsRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ShortTermDebtObligationsRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Short-term Debt Obligations Risk",
        "documentation": "It represents as a short term debt obligations risk.",
        "label": "Short Term Debt Obligations Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "SpecialRiskConsiderationsRelatingToFuturesAndOptionsThereonMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Special Risk Considerations Relating To Futures And Options Thereon [Member]",
        "terseLabel": "Special Risk Considerations Relating to Futures and Options Thereon",
        "documentation": "It represents special risk considerations relating to futures and options thereon."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SpecialRisksRelatedToCyberSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "SpecialRisksRelatedToCyberSecurityMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Special Risks Related To Cyber Security [Member]",
        "documentation": "It represents risk of special risks related to cyber security."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_StapledSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "StapledSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a stapled Securities risk.",
        "label": "Stapled Securities Risk [Member]",
        "verboseLabel": "Stapled Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r73",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r174",
      "r175",
      "r177"
     ]
    },
    "ck0001515324_StrippedMortgageBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "StrippedMortgageBackedSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stripped Mortgage Backed Securities [Member]",
        "documentation": "It represents risk of stripped mortgage-backed securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_StrippedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "StrippedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stripped Securities Risk",
        "label": "Stripped Securities Risk [Member]",
        "documentation": "It represents as a stripped securities risk."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_StructuredNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "StructuredNotesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Structured Notes [Member]",
        "documentation": "It represents risk of structured notes."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_StructuredSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "StructuredSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of structured securities.",
        "label": "Structured Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SubordinatedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "SubordinatedSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subordinated Securities [Member]",
        "documentation": "It represents risk of subordinated securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SubscriptionRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "SubscriptionRightsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Rights [Member]",
        "documentation": "Subscription Rights [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SwapAgreementsAndOptionsOnSwapAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "SwapAgreementsAndOptionsOnSwapAgreementsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Swap Agreements and Options on Swap Agreements",
        "label": "Swap Agreements And Options On Swap Agreements [Member]",
        "documentation": "It represents swap agreements and options on swap agreements."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_SystemicRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "SystemicRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Systemic Risk [Member]",
        "documentation": "It represents as a systemic risk.",
        "terseLabel": "Systemic Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_TemporaryDefensiveStrategiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "TemporaryDefensiveStrategiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents temporary defensive strategies risk",
        "label": "Temporary Defensive Strategies Risk [Member]",
        "terseLabel": "Temporary Defensive Strategies Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ck0001515324_TrackingRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "TrackingRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tracking Risk",
        "label": "Tracking Risk [Member]",
        "documentation": "Tracking Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ck0001515324_UnratedSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "UnratedSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrated Securities Risk [Member]",
        "documentation": "Unrated Securities Risk [Member]",
        "verboseLabel": "Unrated Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_UsGovernmentSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "UsGovernmentSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "U.S. Government Securities [Member]",
        "label": "Us Government Securities [Member]",
        "documentation": "It represents risk of U.S. Government Securities."
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_UsGovernmentSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "UsGovernmentSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a U.S. government securities risk.",
        "terseLabel": "U.S. Government Securities Risk",
        "label": "Us Government Securities Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_ValuationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ValuationRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Risk [Member]",
        "documentation": "It represents as a valuation risk.",
        "terseLabel": "Valuation Risk"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_VariableAndFloatingRateDemandAndMasterDemandNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "VariableAndFloatingRateDemandAndMasterDemandNotesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of variable and floating rate demand and master demand notes.",
        "label": "Variable And Floating Rate Demand And Master Demand Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001515324_VariableAndFloatingRateSecuritiesRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "VariableAndFloatingRateSecuritiesRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents as a variable and floating rate securities risk.",
        "label": "Variable And Floating Rate Securities Risk [Member]",
        "terseLabel": "Variable and Floating Rate Securities Risk"
       }
      }
     },
     "auth_ref": []
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ck0001515324_WarrantsAndRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "WarrantsAndRightsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants And Rights [Member]",
        "documentation": "It represents risk of warrants and rights."
       }
      }
     },
     "auth_ref": []
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ck0001515324_ZeroCouponAndPaymentInKindSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.www.arespublicfunds.com/20240830",
     "localname": "ZeroCouponAndPaymentInKindSecuritiesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents risk of zero coupon and payment in-kind securities.",
        "label": "Zero Coupon And Payment In Kind Securities [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "59",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "4",
   "Subparagraph": "Instruction 3"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-24-096442-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-096442-xbrl.zip
M4$L#!!0    ( -6)(UD0_;S]'PP  )^)   9    8VLP,# Q-3$U,S(T+3(P
M,C0P.#,P+GAS9.U=6W?;N!%^WU_!ZJ%OBNQXLV?CVMGC:]:M8_G8RB;;EST0
M"4JH08 !2%_VUW>&%TFV!1!4TG9\F@<?B^(W WRXS@PNVOOE/I/1+3=6:+4_
MV'ZU-8BXBG4BU&Q_4!;I\.?!+^]^V+/QG&<L K"RN_'-UM;6]IOM-SNO?]P?
MS(LBWQV-[N[N7N$?,]SFY52*."U58E_%.AN]WGK]X];/.Z"[4O!89N>5-C.
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M]<W LBOWRT KUS,#ZX>&P*1; 4SS37!JSUOINN2L"UXU6/RP28(K+7VS1/\
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M*=&:,Z+W/RQ_;?YSSQ/Q_G]02P,$%     @ U8DC62%KEN+_.@  IVT# !T
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MHYSFF:6Y5EKF/R!%FX-B0(I&!\6 $ZE.Z6TY.AHR6WS.LR_%)WF0+JL7INU
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M[!$25KPN*Y[UEY]=S-<("E.QHC6"J5BQ&L%4K+A;YR-YZJAIH41 P(JM!X2
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MF8N4U>M+\4GF)<TDZW"=BYADA<$X,0[18)QXAF@P3NQ2%^K@QH"\,!PG7AW
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M/<[*=$"47M28WGX=U9^'LL6EPZ%T+ 4.SRUP1F*6#@E0E6&NL;K[,K3.L(%
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MXJ3+OWN[ #?3&C==P0"_)&O*QY:9>8]>,!PGWH)DYD)ZP7#<<PL2P(?T@@%
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MI]E 1F>U5#@^.,4"<!6E5#@^-\4"\!.UE'\L:_(HCW/-^ E)TTGG 8B)7C0
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M+>6[%758S/Q.+15JNYCYFD;*/Y8AWP;]9OV0'9"%>T>U 7CI;K5AIG@[J@W
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MO&Y+#I&RFX \ST3,Q7TA$S4P^ R&C:;D$"=B?J89#+97?,&A/=[ C"D!GO?
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M =?@CVEDN;!E<5^#"M>/8>\;LR$;.?CFQ(L1D2#+7)!/@PA)/,#UNE<3.E
MV'L'3AE;N+CG;-?/S!+P=TYT4[7_".X$Z(<56SA E+$3QF[?'>/.HV7!4# K
MB*,=0*>3,)ZQ4!@:P*:)7;\_">'8R*TRGD:< $BPHW@)=-8;!PE"$,,YT"?A
M1H/A"*%P_5N0?K0?4RA <J9PL IG-9N[>\TIG$44H,7Y2!= 2T0@=0:W+C 8
MX&CD^( . @TX#=D>E^O[*'Y@M80U, 1J;]1N<6X9@0/'A1%O'6^2W4A?:,@!
M&0(Q"+-#@XJ*GZZ$(T\%XP!18^ &KN]] .D6T=B>D'.Z+ O(CH#O;]QK9!2
M.V(V,PZMHN%\H)9#0,$Z&>G$<#E^)JGC)B, D0:P3V("2$%#^P@X S 9A/>$
MO>@FN/,5E#RV.LT0JR/4-5,+@L_-W3>%P&:Q^ E8;( B#)^,G)$<>DQ\4TF&
MO LF'@B)?Y" [2EC)XA8A>%:S;V#(H:3PO@8SDY 8HS<AGP5(=!701C"E@5A
MA-JKDM"A&,.3_ R<I0Z?>JX: +='G]6YH=-W/3>^3_A%;UJE7T3N#QMH&-^
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M_;P@;I$S&=^C(AF[0Q>M*UR+*/30'1[_=YJ1LB]_3,9]EYHP#07L:3<8Y*&
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MHO+#<F+9=*KQ(M:W9<*?#)X(74R<@E'# 2;J)MDC0(.1UE9F8K"2#J2F!1'
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M\YODAJ\W]/VONB;8A6]F7AQD+I,3.,PI[=2UM;Z0"(7S?>=*@%TCWN.N_&#
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M0( B2%<UZ8K"Z4(/K.KA+-ON6Z:,+#!'YKQEFMAX(_MF1LQA@6_1)U53:2[
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MU:(J8JEHKL>L$O4T"K/E6X@SA%][72S*=GYQ=MCM'CV->FROA7=_AL*[*^0
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M5&4#XHT#NI#HVCP85NS42SR2?$:Q<]7FY7%Z"8&.5Y5HCHQI0X5:,HVE9#(
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M!@P@%)P4H%4M9#@'_KX"=2(YRUX.UYP*E\_N]#TA'NQ:[!\FRI(Z >1]"!T
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MG*47:)?4C'-%!YXK5DD<(#)D674 1-2A"UWNQ0H?>QP@J Z,,)'J,DQ;GB#
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M:=F$UV5XXX"IG$W@;XP 4*$[%;W]E'66?ED9A:QCP=:7+G=[)!P_4K<)&!&
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MA<1?];C0CHPT.]#W&U+D%E]KIS3PBXDGU.M7.W4S4T+>$WOW[#]/)67AR;*
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M2#V[3=Q^2IM8=X7*-->;[D=5,7JZH&)$<40.Z&%4U$(Z8JF01:;(J=YU^DS
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M >Y8GF;$^4W>"@/,3*-755$W$OL$QO8,,5>*T_CMVW?NT\'D1"+(]!FTR\#
M,/)+@ 9S.[7W=YI!CNX9Y&<PR,--#/)N :;XR3-K_OWX5?S;Z_C=^]]>O'KU
M<LM8]BU'L@H"#60\0@]*;OLSA^$BCXBMB8T6F/E2[&6;A*?@5H0GNG2X5C6+
MD8F Q<3_S'P>68R-=S#CL)$\@7.?8*GA+?Z$=N;!&01K[)EEN;*8[E$PL=A-
M#!_%EX.<D ;=Q]S=R6P?M[ZT?5_"+;9I&ZQL$YYTT%M!KM:S:*8YEW0P2 8$
MHJ*&!LUG6>7<==?O+B&HK@JN'[!M'RXZ$R(I2MTG1'G:+<Y]B SVX5A _[5O
M0%>G=Z<4('8N8<7E1)H!"]9^6A/L(!U[_DEV<A"_DR<H=<0/D40Y@>C;#S@C
MRNUQ'V42[* %-Z09G1*R9MA\'!Y&=<5C3YI787J9EB=$.<CCBKNB<J),T!;[
MSO*5?M;^Z!+=]\//KPB[9ON9I\M.I9;<(*Q >8,;A>VU/=!L9+)2>YJ!^)8A
M)HFCO\& [22#.6/5:5I0GR'*$/TEK=9SRHCS;4:1<\#OQS-I17"01'N@SH8]
M10FB%E@R6L>VC\P+_IUM48(+Y:Z]GL/,TW.7XLI8T?"#3F;0!:0%!E/@A9M'
MW%X&Q^3F6^0?&#T9#N.CLZSPJ;@P*M8<':_ 1HA'!\-A$K\M42L]S>9X?B^.
MXJ= =H\3UZ0$&&JVG&$SA6)%;6_@&SM/GCQY$#\9/=D]W'OZ9"O!H1Y?<K->
MOCI^\?[-NP]O?OL5 :*.?\:VLG?XFGF]*H">O<,SOB)C"!I6$+*<HG=JF48$
M(B:FT@:1>B;+QJ*BA@V0@AX@[?8RJV59!#W%+7!YO'%*D;0=.2L;_@@59'#!
MQ2R;MU^=E.2VY HUS"U;$JHH5DH0^RL+;6WH$(@K-M=[H=\"E3#2,CW?Z3S,
MM:\1\S,KM&PE+8(\W<2):P8-I5H:?*8HBUW.PJ0AMY:LO+SQC13Q7#2=:I%E
M6#E91PC0;0^M+IUJU$6M#GM+I-BNCW%EC3*3?9+&0 R!3?W$^%NB=4HK19)$
M3K^+-&-WSGTZVJW0:DRT717J_6$'A>G[6&>+?-=WS<3K((]J^^H^?Q&W<]1>
MFJUVIUMZ\K\7"(7(=4J9M%2H RV#?D. B::F@^\J]I3)BU6YJ@FX' &532=+
M>4A:)T@I#%Y A5&,WU-G*JYIL_N)&+L9YJ-R^=G):AVE'I6X70+&P-WZX7F5
MI9,U,1@V1^RXZ+*':0'5GC ./Y?*<2%R*C5@02,4+<4]S^ML$!U?'^^_)*1.
M3^Y]\/^,Q7_5;T3AF1#CG*S(8".@4C9E!)I_8KYH6P' )_FP^$7IY25OTI"=
MUUL3CIY+K[;&(=2'!4_A>4G4)"^F<VH&1^H>W>4+$/_Q^E\!Z7\#PG\;W!_^
M#R]P/[Y_'W3_9LS_CMC!;@*10OUOAOBG!=\LN#_LZKH428@7LRI1$78S]'.]
MO*/$Q9TD',PLK*I-2EIM1I'%@8'XCWH@_O\DM'^7MBZ"]"_Q F+:<.3P_&W)
MPP4-"SRN-\'Y7JG)@<_^9T/CZ,WVBHB.H64KF#JGR[:24::2GH,B6:&67H!]
MKIH66I(G\WP\9U9.@XHN0>H>,Z5.RRH"D+Z@9953$XR$0;I'VB4=A:7425KG
M$@]O@UF3(DT![L3%-.!"H$%K@* 3F@C=#BDG0ZX)_^3QD;.[,OHZ6 8VX+.;
MY9&-<8[MO[H_@L:\0( ;OI:*<!&1*X\ZG,@W)F)'DRXN[(%<23+'L$F+!9Y(
MYW5I5L^V!1O!'0]L]W@B$3 <+Z+#1@:I._<-AG7V_%SC+QK7B6\AL!/_F'_Z
M :RA7U<+>&Y,CH77GTZJ^;_VAGL'PR?[P]&3@\<'H[V])]^!';# .&HV_8&8
M)76'^H T]@&V]?F\''_\CB08_/0>(ZLO9)"]1TVI__HNSNIQNL2SJ%;9=S=>
M+4!H0E</#=T.KEQ->QX2IB/)^ 1)],9:7GN7R4N^J?\?7\WX%<:' \])?!5<
M4/KQ/*.""4S\_?R,YD>;@$([0W]V$C-R)/XV=RKC?Q,A_GA2/?SIG0;"6_V^
MB%ZOAT?:F?5GX&O?\<UDN40;Q_M%_SQF9 W)%G\)<D=;W=*?NQM_OZW!MKYC
MB?YPYZ4(<VT5S-O[E6[H1G3@RS<4-%6VZ&]CX?&?PP^]%JS^%8^B9^\NQ]S\
MS)W]&?YZ<S.^ZZM]6YY_.XN]/]JO=K'W1_O5+O8?Y1Q,K3\]YRN+M>O7U^V+
M(65%(*4.Q))E>H5JFBN*SPWO?%[YRN.+7I<B%;%V7U?2C:?'W!T>P*8\>A28
MNS^S/XBTL]^JYZ#E]=FYH^%([-S]_=%W,>9'T9]_KR?_ CW[7Z18 V7!$65D
MT4ZR<;Y(YS41''=L_._O\D_-#\5JL3LIFUUYX+N?1@>#O:<_/@QGWX^7<N6]
M_/SSV*(S/!@^?G2P9\_P+?GQ_L(CW!\<C.Z/\#..<#1ZLO_XPFOX:WKV%]S$
M1_<W\;..\?#1X_V+;N)?<XH'C[Z24[QTC*L<Y<X5S_+IDR<72T;Q?JCOXT,)
MI_N.H2H_ZY#?.7A+=\*[>_:(#RX^8NH(">]@8Y+'>S=\U ^^_[J/>6]_[\GP
MHBM[]T[Y\6#OIB_TUI[RH^3IX2AY/.QOLW*=N=R@%VU3P=JE!M'GV'M7%'4W
M(^$>'3QZ,AK]ZV;,B/W14.[*_FCO%G30)U>\)7^"4+?[V*YE.=SNJ8T&3Y[<
MG]K%IW9=8^%V3^Y@<'A%F^\;/KGKV0>WS2@?;Q6CO-:KGZ44;CR^&S8)-I_K
MS2F+8/W=$$/=H"-^%2=[PU; ESA8N+>/;NC>WNV3?90,]X;)X085_S8T^^OV
M2+2;=9PM&ZO\#[\&Y?_I\.:4_^%CO2+#I_O#&Y9I>X.G^]LDT_Z"8[N>\G_+
MIS8:WI_:Q:=V;>7_5D_N8+!W>']REYS<-97_6STX4/ZWZN"^A(JXX?AN6OG?
M>*XWIR,^O;*G>+M5Q#]WLC>M_'^!@P51.;PA47FW3_80%?_DX LJ_Y>K]O^S
MTH8!7X56?SAZ<GAS6OV!H_U'MZ ?[M]K]1<?VS6U^ML\M='@T;UC^))3N[Y6
M?YLGMS]X\OC^Y"XYN>MJ];=[<(=;%47[ KK?IN.[<:U^T[G>H/(WNC$_R=U6
M_O[<T=ZX6O\%3O;F@JAW^V0/DX/'^\G3+?/I&S3!KR*9Y_!@?__IC6G^(W<]
M;CZ'=6_P9*O<5'_!L5U3\[_-4QL-#JZ8COKMGMKU-?_;/+F#P>C^Y"X[N>MJ
M_K=Y</N#_:TRV;Z$>KCA^&Y<\]]TKC>G'SX9/+UB0<YVJX=_[F1O7/&__8-%
MQ?^;2--ZG#S:>_Q%%?]KINGW=R?<&I'UZ/'>_@UI]GLNF6WO%K)/]P;[]][A
MBX_M6IK][9[::+"W56K&7W%JU]7L;_?D]@>/[V-HEYW<]33[VSZXT59=N2^A
M_VTXOAO6[#>?ZPTJ@,/!_L&WH #^N:.]8=7^BYSLP>#@ACCNW3[9P^31TZ?)
MWI;Y]/OS]+=<^W\"_W=3VK_+9MN[E?33@WN__L7'=CWM_U9/;31X=']JEYS:
MM;7_6SVY@\'CK5(B_Y*3NZ;V?\N,<KM2'[^$BKCA^&Y:^]]XKC?JU[]7_B\]
MV9M6_K_ P8[V!H^^B52M@^3Q%T[HN4:>_E9K]4"LA\-'-Z;5'SC:O_GTTX/!
MD_OL@8N/[9I:_6V>VFCPY(:"RU_OJ5U?J[_-DSL</-TJ!)>_Y.2NJ]7?YL'=
M5]]>^?AN7*O?=*XWB=,XNM?J+SW9&]?J;_]@L;[F&W'I'SP:?='JV]M)T]]R
MQ7__<'1P8XK_R%V/F\\^?;1EV:=_P;%=4_&_S5/;OR_0O?34KJ_XW^Y]>WQ_
M<I>=W'45_]L\N,/!X599;%]"/=QP?#>N^&\ZUYN$X1]^$^KAGSO9&U?\;_]@
M1WO?B.+_*('M3(8WJ?@_I-;'^(N@#?-V]IL_PO[P\='J%!Z)'W&+L,1V0(^"
M#NC2Q)RZNI^G=?PW;*USZ!JCVW[FW?;I_,+A8/@TB:ML664U3 2['Z>VHSIU
MAY_&^X/A\/M!_,*V.H_LYV?I&793KYNR0N-KOM9&Z&D3@PDV,Z/B]+1+NWSB
M=GJ@?XD3^Q';W04$/$T7^7S]P\5?:M_'(]K-OH.7W:WCO;WDZ>@0+P_0.G[U
MIW+5U WL)AY:T(3^#FZG[[$-['>:5160!FDZ==!?^VY-^HHT\ &.Z<6,6X8O
MJ_(LG\#XS0PH'P_P>9E6DVB1KN-TU<S@>OR1T17(ZWJ5X:60W>"C2^+S'&X+
M\<LZAF.?9##L(B_@B9.U'Y"? PJ@7Z5+_&XZ5XXP*^>3K*KUQY X(GN+]4FZ
MOT6)\\D6RR:'GV@.>$&7JVH,%(C37G<FS M=T+,G&:]J,H@_6-+]VPB(%F[%
M'(4YS,F-$<D8AI);K[H]F_A-F\1/AD.Z"'AD6<TG?A3_\OZ=T!3*W?BT*NL:
M#V2<91/:B[_MN6DD\0AS2CNC/(\N'V7?+P;GM(>#= 9Z<87I'+J!!O&K=#S3
M\X(W(WF3]B">Y_]9Y9.4E"'>O*P89[PDX.!#XNZTE[Q]YM-56GQ4HLKJ93:F
M(\6O"(W)3\MTO0":QC$G.9)P 9.$Y47X1V#7396?K!HYP+2N,WAUM80?E4G]
MG_]ZLC=Z_*S&A^MR3L\FP<QA$\YS9E>K91+OY*ZM-TJ'M,J;-4\TH[V @2O:
M8""[B'\:S^'+.$Y-.QW0DM(COK&3Z]@@U')X7A897H3X9W]-S(Y-2K@(#=\(
MH7BY$A%O60(S2$ /G&<X&9S8>0ZW8^--Y;G[[4['L"=5EOB+A2M:G=1CV..,
MB*7OIB4R?7=I*AFYSL8KV#S9$#V/.R@$KLA/7WT:9_ X[@,HSPV>T/DL!Y*0
MDZDRVC^BS+.RH7LPZSU*V ;8'WSN37$&1@!1.+"_)>[O$5P%)):,/Y?:LQ0V
M#@R'"5S9NZI6S]?S]+PV-(PD&_$D6G/(ZQ@5JV8.H\'AEX5,VEU9^!53/"\6
M*6&1P[_H\=2ML'//0-<:?Y1U)RVRAX>CWBU)+*_MOSS!)8$+.9_S')KR-.,[
MB2RIAO?GF=Y(N,'PF)Z674%TX;R?N9U.X C/L[.L2KSH[#]4G..%BZ IPT72
M;8?-J:.4IYHH*X!3GZ]JX6>MC^%:#,/A>T73M@=!0V5SXJCG);"]"OY95N$E
MM#RF+?82W%?2N&E#,V"!:9/I/)$RP(PLX].LR"I2J2T=,5D4G@+'6=6D0*Y@
M]Q83)'3'VC<0;Q202WA&Z4D^1W:,*\2NRW /X)_N$Z?($O$3> ."451>I\S^
M45ZG)*J  6:TLGP*!H(*DJXE$9()T\)YN9I/2)+%'5E!PL#R^"[;W,G/S Q;
M$LE(J\"@H?MT=H7]R0O@OHE1[E#6K^ H8=]8@"!W.X';4*"\0*YV4E85$/LD
MAGN6K;>74=^0\2-7)/+:C[OJ5180/9!0AJKI?U9$T7 EQJO%:IZ2OCI.ZYG3
M752?(=Z$HT[S"DRK$[CR= P3T,>GY7Q>GN,%)/;K!HW<($ FH%&)N46K_>F?
MF;F0J-6C1)H@:5=T]/#=A(D21 H0*LLQF4U"]."&=Q(\U*\*>LI?C7)5R6W
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M$&KYDAR<0$W-BE.>%)3N&XR:'=Y'S3Z?WQCTO!E(VEV^X729R1WL4R<B0<H
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M]BMQ#&3CV:3 ]"=*9O6]PR6U/^JY:\JIVCU"N\8R 1)8+<ZK@R'SZN)TNN[
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MD-_K&)2B/[(*S:4N6<D9BVG&-B"\\Z&"VY6Q2^?%K$1GSWNPX2C;]6>@EH2
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M]_Z%^ZUL1G?7\@]& 3!;*M$6:C('N]VO'FSO)IH*&+94-<:5GI1GRB>CH)V
M9\L"J.SV&'WQY%:B(&)>(+N&01D6F!X-8Q[\TA+Q^M>245".L\FJ4G9!F,\G
MJ.-@$5%VCBS8^YY:SK'^N&A>.:]9%SJTUUGF9Z9>,A;<E8#9@R0HFL@@C99G
M@H.%986?Y^GC#&(GG@:8UB)?X!6@J&YME8)T^<WB1H\]QY#QJZ+BU>6J8I6+
MCS5HO%:L'=OIJ VF/-A4$E<$?$QO[Y!.NXXZ(UA$5UR.^EZ,2\:,P[G?JEV'
MAL  VPJ%N@HEYC?TOSF[+%)U0T8=-Z38'[W>DSH+!EZL$.=ZO41A-B<=TT0#
M^88$+(-W<WMYP(=9N'ZJ.T95CK1DXJC1" 6/"C,Z,K<_M).3CCA3 T @?$%H
M88$%_C>#^:#/A^'W";,_B3D-P'B+\8.VJ!,'PJPDIN):\R(X3-@]#?)G]5R)
M\@2#\[5*6TJSL?$?^8Q)%R)"]N;FJ@&-Y8\LXO0%7FTM 4[&A-9R/W8$Z8!&
MA97;A8T-"+Y<#%=V#L'S[!SBB@TM_E[GV7R28!]P[B$);RQ!,:X([T8Q^1-R
M:M(-QP[$B;N@6)4& P*%U*[$CJ>'?<,V;E8/#B *054SB@F;BPS['/FND,X*
M%F>IQ2':\*D9M=9C5$?&G"[GQ$BHWH7%@:;"Y-R"DCOPD4#W19AJ9T=2]YU7
MDUUN*NI.E@F(LC#P+[Z10>OK&Z6;T% B4DD2/]!<JL."T#)":.KRA("AE.2\
M)^#2&;YFOJK[MZ:^NG*QJ&=*^\ZHLMB)QB01<L_IIA49CP:K17Y0-M%U!O&D
MS%J];M&/8SP\\ 5)+]!7\EIY1-I$:> X"A(MX+!/RY+:J8.H$$'?,]D69'Y_
M%,DWHL$F-#T<;9],1<E8D,;U&T^<!EI9D]3>YW%+:!L3G&0652W3Y<:D#G2.
ML.I(6Q')5NAT3ZF"7>Q\I:.8=4]F">+^H"6[;$37/B24<-LKE6X2,@\[ID98
MBZEMX@6KC3I:F[+2'WB9'SI* @\1OW5#.+@WH#9T(F(2 "QEP?T%+Q2%T4V)
MPOAJHM!IKUZ&^?M >BQ</!7M\*7]6Y>=<4=V1G^![(S[9&?T^;+SS300=S[_
M%ZUP:IPE+C_>/F2F\-P\W 7R8\GNI$[76903.!7#3%F1WLC4\.PNFLZJT+EH
MFJFJ9Q?PO<CV&^(EV'XKX5DZ)X-T@Q=:E@)6C#:N0K- G$)S!.@^R?4I_DXV
M>=9^/B(SK'?EWUX,[<E]#.TOA+LIYZCN F-#WS%)%R!;^'XJO6XNERJ(6[5!
M<B@?]/H&\8+Z J51+CIU??$)Q,*KZ=K,LO%'9\*JN@MW=8(WJ$1,,/X("X#.
MI[M\7'-@,2J>UK-X2A%)+A;YF'%OIE"5H9J1M8-3G)>8PN=MB,3OP"S'O%YR
M*%M<,79\_)LS#DP*>A)G@O^D[%]B]"'WCEC^2ULKU1C)33-?<_J['FLBB2?$
M,DF$A/DCK3X]T@U9I8:/D7P@!X-]NLJB+\C"MNU:89I^9-/TTZK"\-U5;E1/
MDK^\33? 7S2^ ^(9#T48QV>Y!B"OM5L'\6BX3&(#9"YX_NH?'I._#90M*4&#
M^-4_4.<O:AT*I&28O]-YAY3^GBAJ$MG^8A2^TC%H0/)"HEK+,6Z&VC#$1W@.
M>"VYE13>XM;RR/Q;ECE'IC%GG_D!@Z"L82'-K)Q018-UU<$2"8LKU5* S.TA
MN^I -[5*FC[%)Y,*"JOZ#MK;X5R0KYZ_^?#R*-YQS"@R$=V"@IYD;K'4D]](
M>TC),$_T&:QH<[^;H#T[SGV6FF3\T"\>#/3#X;2=%RSJ% RPBDD.@K@T'?4<
M2PD:A1%?HWQC#O)/*-'(/>O2W<@#0"35KZ.3(LT9>.QU9TW5\'(W?\PITTG#
MZ25.7:XR*E,2,5 C7YW(J<>;3[TE"R*4!5T*X&YA/F':B(V--X'"]G[T8-ZI
M9A?*=9)[K?<\<E4:W!ITQ[LML38'36BD'*DDQ\PNXB+29LW)(OQ#[\5J6_Z:
MQ;%H]T_D9FRX76Y+<MO[)UB4N\Q4",)?,@[:)'R YF3]M^@T:VTBMU2#(_"I
MZY).@)XN:FQ*B2JG*4=1Z+<*Y$*I["PN*^6GQB4E3>K\]-G-Q%YYA8>#2>05
M%_<3!9VTX/G>]*PC]=T<^7VL5(+)V$V4)!#E:KPI1,CMX9[%L_(<.S8FMHUC
M) R'R9N:4<Z9FV#\*U'H3OFKWI TGA,T4NIV)<>T5NS9UID9JTHT.R5+6,$=
M%_7].?X'E^3XOWQS_.']F^>_?WCSVZ_'VY_A[_+MF%LQQ\2"78I<@59<-#,,
M-<WI C$,KRB56M\59'FQS"E[&_QN_R8A:5"J((%[]"T2*]SF&1KZKB)&]@X[
M 378>MG_\J(]Y![@)"S$EJ!Z/*[W5EQ&EODJ+^$FGTM3^L@4M;;;(W=ZO\+O
M'\($"]4,I4*5RM>QFZ6V@'77W,2G34YU:W,P5JI"YI1<:HZN6!MH;Y1SZTCS
MT8\D<GTO33M8,%:"[9/58R0)?Q-Q*%,7).X=3>_9.LFN(HU;U=D><I6%!2&$
MWE7J71#VRA5^_HBH?A Y(CK$R1:*@@*^( 0MIT[!*+:VM_NZ4/[J-$.;>&Y5
MT09S[A8*(>(-US^"U(4@(!^2#8J<,U3130*+NN):4 )!\VQT-L I%FDC2;#M
M[[1D=0'BS\1;-J0(N&P%D\-HVZN[A+ -J1%$M4*R2,4-XT#P T0XPH&#76 ]
M+/6E=03O3;D$_X^]MVUNVTK61;_C5^#Z[-21JB!9+[9CQS.IJ\ARHEV.["LI
MF3.?ID 2I# A 1X E,S]Z^_JU]4+ $7)L3VBHUVU)Y9$ NNE5Z]^>?II[/6'
MSHZZ@0R)@%:((OW>ATCB\(R2E^_6"%LX\M_4ZPL&,7,&O#G^.!7 7,&)$]1(
MZ[JX31]0C4NI]*=Z\ F\ZGNKRT!%:\ (P.!'JV.5W'V2I(TRQBVG4W>BTPKR
MBV-G;+M'XPEVL@=90J@)Z0%1.#&8&C7.-<\D$>E'BKBXIV".%D =M9M$XJU*
MN&OK.A?LH$46H@,$"E)UCATWMX3TPP:=;M^(DRK ]P.G 9\,U2G9J <HU+J<
MU'&GQT5R6;FYP2?#_15M5V7N"D&<63!MR4S6>:-0*[C(0BE;.3)Q0R"SXL[,
M8L9%^U)R)&&T,0C>5IB%A9&MDI3YHH+&J="W/#!WJ%C=#@T5O*60 $,;IQ2L
M-L'C?6 1 /2(/*:.BO#AG3&@<>G<6>>L@@X_BE:C_:)4M3<Y=$%@\$22E<O*
M]GQ*Z%_^ 2GLX$$($*_UUO-< HEYO;<UW'WHKZ\:6R=17H-W#+VPOA'@&'N)
MM_3"I;O:YL#3C[OQ3ZS1TU4KA09#SRNCX)5<(J5&@]M[R#!GK45>N8(X-G3P
M[O<]B -'-[#L[8_PRMO!^2(K2%U.0'6CTP_Y/:?R2JXI0Z]<=8.1D&+9LTA6
M>B-[L&[=IC6BE&AY6^WS=D; <;DX4P9B DNGV6"N,V>A_.MEMUY].]FMWO'?
M\:%/OIIM^COGG!1G @)K4"58"Q'U&WUD+X6A:6X?DW]D)<FNDB3<U[5^A(A*
M-D[=S2_ "'^.HW6^E]?%XKNPO7N5C28F/V.:>[/+AI7PL]S4*F U$Y'Z0'0;
MPLI8Q99%?0:HL7;!%.D:WR:$, 6]T  )M<D+>$W%-R_<V@2/2CD3@)Q#\G)B
M=Z'XHGNK/ET;[$@-FJG-Q\MX/I\RWR8%90-3J6MZM4RI#@7,F$' *X<H(3%<
M0:@."6;?F78ZY#Y /'_[+FWM[;1[:QV H<^O@5AA),LC33!T##G#Q.,L(O1C
M%<LP</8)FDH6.CY8RNV(V=0&&9)J+"V$S&%%P$DX#-#Y(EP[%(K^O2*G!R[L
MM>/<;"^XM2*,=!PO,")$0B2^!$'=P)T Z6'7 Z][EIK:'W. IK1<,10Z)XX3
MM!A8W-" :+MHZ#>$1G:$$!Y0)HO&^5E6SS"_>B4_]_:NM[1=HPP:3N'=3P]S
M2G "T?36,Q-6?D,WZ!8-$I)!*V4!]J\*2#?8KZ@[I_G2*B6,00EC6KA</2Q4
MUJW+QY'GHK2*L2.L042#K/GSTV,)J*7794[4 OG,N10^&^^^5196'U_E=<NU
MP'H1\/,2KJ\0^LEA7CE?1[&<6#WB^XAC.W3THIWH4+?-/EJ[@-!6 B5Y@^M&
MVI T<2<2T&;#E3I54K]W/-.D/HB^*X<K=5Z"'4N!T< :#^(SG,6,$66!P<*6
MJ^B#!W6?CX 6OV2H;9T>!MW@PZAN6W2_@0_80*V-Y0RK4K;1TT*ZQ[<&A:]R
M;P#2/8^';BV0WGZH'S4$R]XK"3:=1-@AY*( 7Y.-Z%OC&%IZU*#JP%3WQNK4
M"RI\8A:B5UN#;?IGAP0Z:M<?^9JE_5>#G7T*L]#)\I[Y-&_;1*!I[Q"!AGL9
M=4= _R.$MTK]L<$ID M[)LC06#B/(VTXTPQZ"+-$88HBO "KC(Y.QH5L-OQN
M[Y,>/H0>&6?J6WDHA6.G;K+1HIA27T,Z*K!!.<?SD-(%:Q,H+3]8"AFH6/3P
MB#B@2X:SL_7R^^^WXX/O#W9>[K]X!LV*E;_QC8SDW([D@WO,+J-F'O:N]^=!
MGZ_-@_Y^^N;D[$UT?G)Z]OO)Q>6O)V>7\8=W1V>;GQ3]3$BO#Y#? E8,8&WF
M:[AF>>SS"Y&$@2%VTA2 Z(?<%]Z6U8Q6XFSG&!A#X9]MXJ!@X,-R6E8__*^]
MYR\.A_MN4FE\Y8;R]R=733.O?WCZ].;F9M<-9W=27C\]JH97P%G[U'F.:?44
M0-]/]Y_O/S\\>/9T;V]O?W_OV8OGKPZ>[1WN/SL\?-K,#IX]VWN^/]K_5S&L
MJ]VK9O9$7KOCGKGCUA3"[3]D'Z_R0>[6PG=OBDY-]=!.O/KT_.UIJD)'_VG1
M%^7DE'.1 MJ0N-8(H@3]#JV-T.BV705HY:,[*I,'KK'[S^Z+-6?W_/3G7RXO
MHO=OWYZ<GY[]_"W!&, ^8DN=/'[VFIH([%X0 V?J802#Z=30OO\#'1OLV(0W
M$71@)2Q$QUJ&[/;"G9:T[C"JG].WV!GCM+&I'2%:@J:<$!L()?$*@:_A "!=
M)R5E4FZ)'=B6XAH*#3QZ0M(;QPT,C! :%[6[YVM.;C6:$29=? %YQ'E$GJXL
M08^1+P$6$]<!ZP;SKP%J8%0Z[T2)\+;RW6PWD></G0%KC%.R J9YMD 'PSQN
M.\[P/ [#T=-.QA^J$K,MBQH)D3F^ \;:HFK9[FI6$/,_T@.117X#JKAI0_W:
M.0MGF3O)RSF:)(8#CT9"XZW5VXV/H)H1"8TIYM1>7@F2:X*Q:^M$_?EBVYIA
MFA*>\%?GI4Y3R=+X%B?>E0<D!+9+Z0RE5FI+*D9!C+V??B1=5AZX%ERC&)RS
M/!Z+)%R<'/LZW+E3!M#Q8'6"/I5"4$C1MY8G:$*3AB>SYTCUJPV&(D/FC*AW
M"$L":2+)<)X=_1[7)?HAV");(@$*O$04X0Q8HS0X_8,[>^P<I;;B-* ZC5<2
M341<B^R$V(LM^_@^/ !^/<<-$>CR$3O/!6M4OW8#D9%P (D>!U$P0-LXWW_8
M4K+28W(.)-AS* >,C ;0ZES4YCE.!D.KK3?'6^1X:1Z:\NE3RVD)C_$CJ@BI
M#'87OFX;!R^C]]S>$<*!<VR& I#K,< NB :DP)I7]" @>-=X_@C/5V4T&@P-
M8B]N(X*AWUR5;IY$4?D1>KS7F54V2.P8;>779F$Q+'('2=3EHP0@NKB%.W#4
MRAT&A $Q(HCB+P,C[E\O.W>X]^UDY[ZFODU]TX/>NSIB6X+[')"QADR/5 ?+
MN$-S3+#M#@$:W1\$=N!N.?/\7'+D(W=G7X,I]65(S!HJ5LBFTSD K(O)WY_L
M/<&?G8T]E)\_Z86W"*.[J$?-U=^?[._M?>=D*([_UE3RDFLPG8;IE'?'/00_
M 9\9R6?PZ[)),J%FM/)S!RL<8>/>,BN5NF@]3^O*S),?V6"%7!EL,F8-[;T@
MU\P,81;.=*:!NO^I<-Y/<0,>]_4A[BL&5&^<]Y(AZ$Q-?23%%(SRN&/20_V+
M]#8>^8?@G9R1=R$U+K71+C@J^#]C7+4TQZ/L;(SL8"1+ 52/V[=AVZ=F*H$
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M:H$T1N/<]_H3#V:"+8JXUD*Q-?!!J4X?W74GF%[/RG4DQX"K=SD?+O>(2KN
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MP"U^X(EX:^-3]OW2F18:T75)=>[!S*G-,@T2'N;KWL-G'OBA<;CMCB/,I?.
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MEJO,OP0:PF-DV,G_),-*)/C[#N+Q21KCWZ!R >TH&^ 'KBDNO\//)6:^0@J
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MY@KKY4%2J[+(AQ&V2YSE!.-T'YSFV8)O9YII-Q*.JS? 4ZCV>-\MQ-9I:.(
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M\[22--TLS:?LE#E?);_.*O&2_+4J"VGX33J223 F>%/E=K[>]G4A*\8:H1
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MNY$QC]ZQ,\AVS6X,+:LYQAR/LXQZ&Z*T]+3 1&DW!BNQ)YO2$U7VSH4KPK]
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M&+($>3GBML.Z<CETMH,_BQM*HC"&5\W37$U!D0V$X3OS[BJ?Z/!SDYX=N:^
M!0CA%(V8#+)A"K\(GRR/&J;3X0)["XI7/4CKO+Z#X"@E(O=8,R$\C^.1XC(9
MS8:I[7ORFUF?RUGL3MU K"#" A;82O=?+$+&>LC2G8M17@^KC$(D[@,(UL"_
M(A*#ZBM0'4"32V?'&S6E^L?MZ6Y\&CI]^/(Z>&2$OE=1<T"&L"<4SX7A8@/%
ME,O=W#\SA)X)'V(@!DZ6$20&MIT[#TLPG$)?*N>&VDX8PU[<D9_A&)-L?J5
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M'MRC3V,OVN]=>W-_-O/@KAC3PPW&E#"F!QN,Z0^+\KU*"\+4XY4$R]"VT/G
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M\.#=SG-8,[[91+H_W2#=">E^N$&Z_["0ZHG;VLJ)!:TWV.R35T*?A3<VN@R
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MVX%_6L]S0_/N>E?49WJM*EI]92[8,CCGC0C+^W2%(V_&X[((17NM[&=RP;X
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M MJ,JQ06E!<U\.K+!!V<>ESL-77V%E9X4<93U^J]<2M)C.ANX#K@;_P'7S@
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M\_WFXI("!T0M,1Q@7\@NB6==QD!@I)LME+@<^N:P!\QBSN$FEZOP\$S*U6X
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MTL>4:.WETW #$'?*N^M'T_Q%/3QA/'AY4HQX8:<U7,2*T?,/:15WC ]W<:>
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M0N@S(+S 5RP4>3(F%/>-5V@W?"71&X3"B3I*X"Y>;$ 1< O)[=:%(Q8W7,R
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MRVY$_QNEO"D +\&)R!0#I=E*5=]6X2#'# ^86":D^]0,#1ACJ?O.[ =IS>,
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M>[-1(U4KITE%DV75.K'4$UZQ0,-/:++Y1<@I<DG5@A+IZ%&4-IP94F$(Y)]
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MLC-34HG$J!69/YZ>?;)"(\W-==0 D,@0OX:P#0_EY!6;$X:@%L--TV<CB4/
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MP'9&4J%>_(83Q,E$(=;\J^ A[33C842:"6\LR$QY:9:2A,9&#^#8<3411Z*
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MG-M.<)0ZU);IYO)3U90J$""LB%B>R7=';GYG$",![](IUQ^)PX/'&/FVQ!C
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MD;GR[H(J9'I-SXE*X?Y_SC'-.#;1RW_-\\\:=[,/[+JZB-A3R L7,[JB+BR
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ML^VF5YGBSE!!!K)X,%9&D>=$<4!F-O(1A>ENLAMUH*2B=GQ\:51^"9S+;^U
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MP=#-DHNTPE]=LN-YA AA[)Y"GVC3-=5TN 0'/6RUG+HL8L;Y-]TBG'MEVZ[
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M[I0!UT9CF['_NIB9^>PO&X]<(S#J\Z?/GK\PCHL[CMZ_K]DNGZ+GO?G2 B=
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M9BYX;6Q02P$"% ,4    " #5B2-9(6N6XO\Z  "G;0, '0
M@ $2'0  8VLP,# Q-3$U,S(T+3(P,C0P.#,P7VQA8BYX;6Q02P$"% ,4
M" #5B2-942VK<H02  !/^   '0              @ %,6   8VLP,# Q-3$U
M,S(T+3(P,C0P.#,P7W!R92YX;6Q02P$"% ,4    " #5B2-9R1$J/*'+ 0#%
M,@L %0              @ $+:P  =&TR-#$V,S<S9#9?-#(T8C(N:'1M4$L%
3!@     %  4 :P$  -\V @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm2416373d6_424b2_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0001515324-20240830.xsd" xlink:type="simple"/>
    <context id="C_20240830to20240830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2024-08-30</startDate>
            <endDate>2024-08-30</endDate>
        </period>
    </context>
    <context id="C_20240401to20240630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="C_20240101to20240331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_20231001to20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230701to20230930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_20230401to20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230101to20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_20221001to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220701to20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20240823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <instant>2024-08-23</instant>
        </period>
    </context>
    <context id="C_20240823to20240823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2024-08-23</startDate>
            <endDate>2024-08-23</endDate>
        </period>
    </context>
    <context id="C_20240826to20240826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001515324</identifier>
        </entity>
        <period>
            <startDate>2024-08-26</startDate>
            <endDate>2024-08-26</endDate>
        </period>
    </context>
    <unit id="Percentage">
        <measure>pure</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Usd_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="C_20240830to20240830"
      id="Fdei_EntityCentralIndexKey20240830100824006">0001515324</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20240830to20240830"
      id="Fdei_AmendmentFlag20240830100847280">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_20240830to20240830"
      id="Fdei_DocumentType20240830111654741">424B2</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="C_20240830to20240830"
      id="Fxbrl_20240830101439415">ARES DYNAMIC CREDIT ALLOCATION FUND, INC.</dei:EntityRegistrantName>
    <cef:PurposeOfFeeTableNoteTextBlock
      contextRef="C_20240830to20240830"
      id="Fxbrl_20240830180654210">


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;The following table and
example are intended to assist you in understanding the various costs and expenses directly or indirectly associated with investing in
our common shares.&lt;/span&gt;&lt;/p&gt; </cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock
      contextRef="C_20240830to20240830"
      id="Fxbrl_20240830175521162">


&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in"&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif"&gt;Shareholder Transaction Expenses&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;width:88%;text-align:left"&gt;Sales load paid by you (&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as
        a percentage of offering price&lt;/span&gt;)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;1.00&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left"&gt;Offering expenses borne by the Fund (as a percentage
        of offering price) (1)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.17&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left"&gt;Dividend reinvestment plan fees(2)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;None&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;div&gt;&#160;&lt;/div&gt;


&lt;div&gt;


&lt;table cellpadding="0" cellspacing="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse"&gt;
  &lt;tr style="font-size:10pt;vertical-align:top"&gt;
    &lt;td style="font-size:10pt;width:4%;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The percentage reflects
        estimated offering expenses of approximately $250,000 for the estimated duration of this offering and assumes we sell all $150,000,000
        of common shares under this Prospectus Supplement and the accompanying Prospectus. There is no guarantee that there will be any sales
        of our common shares pursuant to this Prospectus Supplement and the accompanying Prospectus. Actual sales of the Fund's common shares
        under this Prospectus Supplement and the accompanying Prospectus, if any, may be less than as set forth under &#x201c;Capitalization&#x201d;
        below. In addition, the price per share of any such sale may be greater than or less than the price set forth under &#x201c;Capitalization&#x201d;
        below, depending on market price of the Fund's common shares at the time of any such sale.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-size:10pt;vertical-align:top"&gt;
    &lt;td style="font-size:10pt;text-align:justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-size:10pt;vertical-align:top"&gt;
    &lt;td style="font-size:10pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The plan administrator's
        service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders
        with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or
        in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's
        open-market purchases in connection with the reinvestment of dividends and distributions.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock
      contextRef="C_20240830to20240830"
      id="Fxbrl_20240830180724459">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as
        a percentage of offering price&lt;/span&gt;</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="C_20240830to20240830"
      decimals="4"
      id="Fxbrl_20240830180153949"
      unitRef="Percentage">0.01</cef:SalesLoadPercent>
    <cef:OtherTransactionExpensesPercent
      contextRef="C_20240830to20240830"
      decimals="4"
      id="Fxbrl_20240830180159779"
      unitRef="Percentage">0.0017</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="C_20240830to20240830"
      decimals="0"
      id="Fxbrl_20240830180202468"
      unitRef="USD">0</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock
      contextRef="C_20240830to20240830"
      id="Fxbrl_20240830175537024">


&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in"&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, serif;text-align:left;width:88%"&gt;Annual Expenses (as a percentage of net assets attributable
        to common shares)&lt;/td&gt;
    &lt;td style="font-size:10pt;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right;width:10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left;width:1%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left"&gt;Advisory Fees(3)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.67&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left"&gt;Interest payments on borrowed funds(4)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;2.56&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left"&gt;Other Expenses(5)&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom:Black 1pt solid;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.76&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom:2.5pt;font:10pt Times New Roman, Times, Serif;padding-left:0.25in;text-align:left"&gt;Total Annual Fund Operating Expenses&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom:Black 2.5pt double;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4.99&lt;/td&gt;
    &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1.5pt;text-align:left"&gt;%&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;table cellpadding="0" cellspacing="0" style="width:100%"&gt;
  &lt;tr style="font-size:10pt;vertical-align:top"&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:96%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-size:10pt;vertical-align:top"&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:4%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:96%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;The Fund currently
        pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders
        bear the expenses of the Fund&#x2019;s use of leverage in the form of higher fees as a percentage of the Fund&#x2019;s net assets attributable
        to common shares than if the Fund did not use leverage.&#160;&#160;The advisory fee shown in the table assumes an &lt;span&gt;amount of leverage
        of &lt;/span&gt;36&lt;span&gt;% of the Fund&#x2019;s Managed Assets.&#160;&#160;Based on the same assumptions, leverage would equal &lt;/span&gt;56&lt;span&gt;%
        of the Fund&#x2019;s net assets.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-size:10pt;vertical-align:top"&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:96%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-size:10pt;vertical-align:top"&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:4%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(4)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:96%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&#x201c;Interest
        payments on borrowed funds&#x201d; represents our actual interest and credit facility expenses incurred for the six months ended June&#160;30,
        2024.&#160;&#160;We had outstanding borrowings of approximately $190 million (with a carrying value of approximately $189) as of June&#160;30,
        2024. This item is based on the assumption that the Fund&#x2019;s borrowings and interest costs after an offering will remain similar (at
        leverage of 36% of the Fund&#x2019;s Managed Assets &lt;span&gt;and &lt;/span&gt;56&lt;span&gt;% of the Fund&#x2019;s net assets&lt;/span&gt;) to those prior to
        such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#x2019;s
        and the Board of Directors of the Fund's assessment of market and other factors at the time of any proposed borrowing. &lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-size:10pt;vertical-align:top"&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:96%"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="font-size:10pt;vertical-align:top"&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:4%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:justify;width:96%"&gt; &lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&#x201c;Other
        Expenses&#x201d; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred
        by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#x201c;Other Expenses&#x201d;
        are based on estimated amounts for the current fiscal year.&lt;/span&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="C_20240830to20240830"
      decimals="4"
      id="Fxbrl_20240830180256967"
      unitRef="Percentage">0.0167</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="C_20240830to20240830"
      decimals="4"
      id="Fxbrl_20240830180259813"
      unitRef="Percentage">0.0256</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="C_20240830to20240830"
      decimals="4"
      id="Fxbrl_20240830180302941"
      unitRef="Percentage">0.0076</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="C_20240830to20240830"
      decimals="4"
      id="Fxbrl_20240830180306076"
      unitRef="Percentage">0.0499</cef:TotalAnnualExpensesPercent>
    <cef:OtherExpensesNoteTextBlock
      contextRef="C_20240830to20240830"
      id="Fxbrl_20240830181905930">&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&#x201c;Other
        Expenses&#x201d; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred
        by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#x201c;Other Expenses&#x201d;
        are based on estimated amounts for the current fiscal year.&lt;/span&gt;</cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock
      contextRef="C_20240830to20240830"
      id="Fxbrl_20240830175850525">


&lt;div&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify;text-indent:0.5in"&gt;&lt;span style="font-size:10pt"&gt;The
following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (i)&#160;total annual
expenses of 4.99% of net assets attributable to common shares in 2024 and thereafter, and (ii)&#160;a 5% annual return:&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="font-size:10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:95%;font:10pt Times New Roman, Times, Serif;margin-left:0.25in"&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;One&#160;Year&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Three&#160;Years&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Five&#160;Years&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Ten&#160;Years&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="width:48%;font:10pt Times New Roman, Times, Serif;text-align:left;text-indent:-10pt;padding-left:10pt"&gt;Total expenses incurred&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;62&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;163&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;264&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;515&lt;/td&gt;
    &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="font-size:10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;strong&gt;The example should
not be considered a representation of future expenses. The example assumes that the estimated &#x201c;Other expenses&#x201d; set forth in
the Estimated Annual Expenses table are accurate and that all dividends and distributions are reinvested at NAV. Actual expenses may be
greater or less than those assumed. Moreover, the Fund&#x2019;s actual rate of return may be greater or less than the hypothetical 5% return
shown in the example.&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt; </cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="C_20240830to20240830"
      decimals="0"
      id="Fxbrl_20240830180528618"
      unitRef="USD">62</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="C_20240830to20240830"
      decimals="0"
      id="Fxbrl_20240830180534041"
      unitRef="USD">163</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="C_20240830to20240830"
      decimals="0"
      id="Fxbrl_20240830180549809"
      unitRef="USD">264</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="C_20240830to20240830"
      decimals="0"
      id="Fxbrl_20240830180553938"
      unitRef="USD">515</cef:ExpenseExampleYears1to10>
    <cef:SharePriceTableTextBlock
      contextRef="C_20240830to20240830"
      id="Fxbrl_20240830180020628">


&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="padding-bottom:1pt;vertical-align:bottom;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&#160;&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;NYSE&#160;Market&#160;Price&lt;br/&gt;Per&#160;Common
        Share&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;NAV per Common&lt;br/&gt;Share on&#160;Date&#160;of&lt;br/&gt;Market&#160;Price&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom:Black 1pt solid;padding-bottom:1pt;font-size:10pt;font-weight:bold;text-align:center"&gt;Premium/(Discount)&#160;on&lt;br/&gt;Date&#160;of&lt;br/&gt;Market&#160;Price&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size:10pt;font-weight:bold;text-align:center"&gt;Trading&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt"&gt;&lt;strong&gt;During Quarter Ended&lt;/strong&gt;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;High&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;Low&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;High&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;Low&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;High&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;Low&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;Volume&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="width:15%;font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;June 30, 2024&lt;/td&gt;
    &lt;td style="width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:9%;font-size:10pt;text-align:right"&gt;14.89&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:9%;font-size:10pt;text-align:right"&gt;13.79&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:9%;font-size:10pt;text-align:right"&gt;14.81&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:9%;font-size:10pt;text-align:right"&gt;14.50&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:9%;font-size:10pt;text-align:right"&gt;0.54&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;%&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:9%;font-size:10pt;text-align:right"&gt;(4.90&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:9%;font-size:10pt;text-align:right"&gt;5,985,800&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;March 31, 2024&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.29&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.41&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.69&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.46&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(2.72&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(7.26&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;6,951,700&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;December&#160;31, 2023&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.86&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.88&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.51&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.76&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(4.48&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(13.66&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;6,020,500&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;September&#160;30, 2023&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.93&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.10&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.25&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.75&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(9.26&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(12.00&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;5,500,400&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;June&#160;30, 2023&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.33&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.61&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.87&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.58&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(11.10&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(14.51&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;5,473,900&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;March&#160;31, 2023&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.85&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.42&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.12&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.37&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(8.99&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(14.58&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;7,627,900&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;December&#160;31, 2022&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.31&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.27&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.73&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.17&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(10.34&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(14.43&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;5,699,200&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;September&#160;30, 2022&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.45&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.65&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.77&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.33&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(8.94&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(12.60&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;4,773,900&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;June&#160;30, 2022&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.82&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.89&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;15.96&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.75&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(7.14&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(13.53&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;5,461,400&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt;text-indent:-10pt;padding-left:10pt"&gt;March&#160;31, 2022&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;16.37&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.61&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;16.71&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;15.56&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(2.03&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;12.53&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;6,201,000&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="C_20240401to20240630"
      decimals="2"
      id="Fxbrl_20240830181013582"
      unitRef="Usd_per_Share">14.89</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240401to20240630"
      decimals="2"
      id="Fxbrl_20240830181022795"
      unitRef="Usd_per_Share">13.79</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240401to20240630"
      decimals="2"
      id="Fxbrl_20240830181026051"
      unitRef="Usd_per_Share">14.81</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240401to20240630"
      decimals="2"
      id="Fxbrl_20240830181029025"
      unitRef="Usd_per_Share">14.5</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240401to20240630"
      decimals="4"
      id="Fxbrl_20240830181032041"
      unitRef="Percentage">0.0054</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240401to20240630"
      decimals="4"
      id="Fxbrl_20240830181035961"
      unitRef="Percentage">-0.049</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240101to20240331"
      decimals="2"
      id="Fxbrl_20240830181153539_4_3"
      unitRef="Usd_per_Share">14.29</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240101to20240331"
      decimals="2"
      id="Fxbrl_20240830181153539_8_3"
      unitRef="Usd_per_Share">13.41</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240101to20240331"
      decimals="2"
      id="Fxbrl_20240830181153539_12_3"
      unitRef="Usd_per_Share">14.69</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240101to20240331"
      decimals="2"
      id="Fxbrl_20240830181153539_16_3"
      unitRef="Usd_per_Share">14.46</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240101to20240331"
      decimals="4"
      id="Fxbrl_20240830181153539_20_3"
      unitRef="Percentage">-0.0272</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240101to20240331"
      decimals="4"
      id="Fxbrl_20240830181153539_24_3"
      unitRef="Percentage">-0.0726</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20231001to20231231"
      decimals="2"
      id="Fxbrl_20240830181153539_4_4"
      unitRef="Usd_per_Share">13.86</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20231001to20231231"
      decimals="2"
      id="Fxbrl_20240830181153539_8_4"
      unitRef="Usd_per_Share">11.88</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20231001to20231231"
      decimals="2"
      id="Fxbrl_20240830181153539_12_4"
      unitRef="Usd_per_Share">14.51</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20231001to20231231"
      decimals="2"
      id="Fxbrl_20240830181153539_16_4"
      unitRef="Usd_per_Share">13.76</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231001to20231231"
      decimals="4"
      id="Fxbrl_20240830181153539_20_4"
      unitRef="Percentage">-0.0448</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231001to20231231"
      decimals="4"
      id="Fxbrl_20240830181153539_24_4"
      unitRef="Percentage">-0.1366</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230701to20230930"
      decimals="2"
      id="Fxbrl_20240830181153539_4_5"
      unitRef="Usd_per_Share">12.93</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230701to20230930"
      decimals="2"
      id="Fxbrl_20240830181153539_8_5"
      unitRef="Usd_per_Share">12.1</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20230701to20230930"
      decimals="2"
      id="Fxbrl_20240830181153539_12_5"
      unitRef="Usd_per_Share">14.25</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20230701to20230930"
      decimals="2"
      id="Fxbrl_20240830181153539_16_5"
      unitRef="Usd_per_Share">13.75</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230701to20230930"
      decimals="4"
      id="Fxbrl_20240830181153539_20_5"
      unitRef="Percentage">-0.0926</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230701to20230930"
      decimals="4"
      id="Fxbrl_20240830181153539_24_5"
      unitRef="Percentage">-0.12</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20240830181153539_4_6"
      unitRef="Usd_per_Share">12.33</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20240830181153539_8_6"
      unitRef="Usd_per_Share">11.61</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20240830181153539_12_6"
      unitRef="Usd_per_Share">13.87</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20240830181153539_16_6"
      unitRef="Usd_per_Share">13.58</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230401to20230630"
      decimals="4"
      id="Fxbrl_20240830181153539_20_6"
      unitRef="Percentage">-0.111</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230401to20230630"
      decimals="4"
      id="Fxbrl_20240830181153539_24_6"
      unitRef="Percentage">-0.1451</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230101to20230331"
      decimals="2"
      id="Fxbrl_20240830181153539_4_7"
      unitRef="Usd_per_Share">12.85</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230101to20230331"
      decimals="2"
      id="Fxbrl_20240830181153539_8_7"
      unitRef="Usd_per_Share">11.42</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20230101to20230331"
      decimals="2"
      id="Fxbrl_20240830181153539_12_7"
      unitRef="Usd_per_Share">14.12</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20230101to20230331"
      decimals="2"
      id="Fxbrl_20240830181153539_16_7"
      unitRef="Usd_per_Share">13.37</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230101to20230331"
      decimals="4"
      id="Fxbrl_20240830181153539_20_7"
      unitRef="Percentage">-0.0899</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230101to20230331"
      decimals="4"
      id="Fxbrl_20240830181153539_24_7"
      unitRef="Percentage">-0.1458</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20221001to20221231"
      decimals="2"
      id="Fxbrl_20240830181153539_4_8"
      unitRef="Usd_per_Share">12.31</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20221001to20221231"
      decimals="2"
      id="Fxbrl_20240830181153539_8_8"
      unitRef="Usd_per_Share">11.27</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20221001to20221231"
      decimals="2"
      id="Fxbrl_20240830181153539_12_8"
      unitRef="Usd_per_Share">13.73</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20221001to20221231"
      decimals="2"
      id="Fxbrl_20240830181153539_16_8"
      unitRef="Usd_per_Share">13.17</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20221001to20221231"
      decimals="4"
      id="Fxbrl_20240830181153539_20_8"
      unitRef="Percentage">-0.1034</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20221001to20221231"
      decimals="4"
      id="Fxbrl_20240830181153539_24_8"
      unitRef="Percentage">-0.1443</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20220701to20220930"
      decimals="2"
      id="Fxbrl_20240830181153539_4_9"
      unitRef="Usd_per_Share">13.45</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20220701to20220930"
      decimals="2"
      id="Fxbrl_20240830181153539_8_9"
      unitRef="Usd_per_Share">11.65</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20220701to20220930"
      decimals="2"
      id="Fxbrl_20240830181153539_12_9"
      unitRef="Usd_per_Share">14.77</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20220701to20220930"
      decimals="2"
      id="Fxbrl_20240830181153539_16_9"
      unitRef="Usd_per_Share">13.33</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220701to20220930"
      decimals="4"
      id="Fxbrl_20240830181153539_20_9"
      unitRef="Percentage">-0.0894</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220701to20220930"
      decimals="4"
      id="Fxbrl_20240830181153539_24_9"
      unitRef="Percentage">-0.126</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_20240830181153539_4_10"
      unitRef="Usd_per_Share">14.82</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_20240830181153539_8_10"
      unitRef="Usd_per_Share">11.89</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_20240830181153539_12_10"
      unitRef="Usd_per_Share">15.96</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_20240830181153539_16_10"
      unitRef="Usd_per_Share">13.75</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220401to20220630"
      decimals="4"
      id="Fxbrl_20240830181153539_20_10"
      unitRef="Percentage">-0.0714</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220401to20220630"
      decimals="4"
      id="Fxbrl_20240830181153539_24_10"
      unitRef="Percentage">-0.1353</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20220101to20220331"
      decimals="2"
      id="Fxbrl_20240830181153539_4_11"
      unitRef="Usd_per_Share">16.37</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20220101to20220331"
      decimals="2"
      id="Fxbrl_20240830181153539_8_11"
      unitRef="Usd_per_Share">13.61</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20220101to20220331"
      decimals="2"
      id="Fxbrl_20240830181153539_12_11"
      unitRef="Usd_per_Share">16.71</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20220101to20220331"
      decimals="2"
      id="Fxbrl_20240830181153539_16_11"
      unitRef="Usd_per_Share">15.56</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220101to20220331"
      decimals="4"
      id="Fxbrl_20240830181153539_20_11"
      unitRef="Percentage">-0.0203</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220101to20220331"
      decimals="4"
      id="Fxbrl_20240830181153539_24_11"
      unitRef="Percentage">-0.1253</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20240823"
      decimals="2"
      id="Fxbrl_20240830184026160"
      unitRef="Usd_per_Share">14.72</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="C_20240823"
      decimals="2"
      id="Fxbrl_20240830184032957"
      unitRef="Usd_per_Share">15.29</us-gaap:SharePrice>
    <cef:LatestPremiumDiscountToNavPercent
      contextRef="C_20240823to20240823"
      decimals="4"
      id="Fxbrl_20240830184048799"
      unitRef="Percentage">0.0387</cef:LatestPremiumDiscountToNavPercent>
    <cef:SharePriceTableTextBlock
      contextRef="C_20240826to20240826"
      id="Fxbrl_20240830184741228">


&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font:10pt Times New Roman, Times, serif;border-bottom:1pt solid black"&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;During Quarter Ended&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size:10pt;font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;NYSE&#160;Market&#160;Price&lt;br/&gt;Per&#160;Common
        Share&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size:10pt;font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;NAV per&lt;br/&gt;Common&lt;br/&gt;Share on&#160;Date&#160;of&lt;br/&gt;Market&#160;Price&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size:10pt;font-weight:bold;text-align:center;border-bottom:Black 1pt solid"&gt;Premium/(Discount)&#160;on&lt;br/&gt;Date&#160;of&lt;br/&gt;Market&#160;Price&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size:10pt;font-weight:bold;text-align:center"&gt;Trading&lt;/td&gt;
    &lt;td style="padding-bottom:1pt;font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;High&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;Low&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;High&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;Low&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;High&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;Low&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom:Black 1pt solid;font-size:10pt;font-weight:bold;text-align:center"&gt;Volume&lt;/td&gt;
    &lt;td style="font-size:10pt;font-weight:bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="width:30%;font-size:10pt"&gt;March 31, 2024&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:7%;font-size:10pt;text-align:right"&gt;14.29&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:7%;font-size:10pt;text-align:right"&gt;13.41&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:7%;font-size:10pt;text-align:right"&gt;14.69&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="width:7%;font-size:10pt;text-align:right"&gt;14.46&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:7%;font-size:10pt;text-align:right"&gt;(2.72&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:7%;font-size:10pt;text-align:right"&gt;(7.26&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width:7%;font-size:10pt;text-align:right"&gt;6,951,700&lt;/td&gt;
    &lt;td style="width:1%;font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt"&gt;December&#160;31, 2023&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.86&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.88&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.51&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.76&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(4.48&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(13.66&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;6,020,500&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font-size:10pt"&gt;September&#160;30, 2023&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.93&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.10&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.25&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.75&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(9.26&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(12.00&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;5,500,400&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt"&gt;June&#160;30, 2023&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.33&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.61&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.87&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.58&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(11.10&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(14.51&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;5,473,900&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font-size:10pt"&gt;March&#160;31, 2023&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.85&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.42&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.12&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.37&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(8.99&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(14.58&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;7,627,900&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt"&gt;December&#160;31, 2022&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;12.31&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.27&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.73&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.17&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(10.34&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(14.43&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;5,699,200&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font-size:10pt"&gt;September&#160;30, 2022&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.45&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.65&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.77&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.33&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(8.94&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(12.60&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;4,773,900&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom"&gt;
    &lt;td style="font-size:10pt"&gt;June&#160;30, 2022&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;14.82&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;11.89&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;15.96&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.75&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(7.14&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(13.53&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;5,461,400&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
    &lt;td style="font-size:10pt"&gt;March&#160;31, 2022&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;16.37&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;13.61&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;16.71&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;$&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;15.56&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(2.03&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;(12.53&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;)%&lt;/td&gt;
    &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:right"&gt;6,201,000&lt;/td&gt;
    &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; </cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="C_20240101to20240331"
      decimals="2"
      id="Fxbrl_20240830104255668"
      unitRef="Usd_per_Share">14.29</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240101to20240331"
      decimals="2"
      id="Fxbrl_20240830104407642"
      unitRef="Usd_per_Share">13.41</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240101to20240331"
      decimals="2"
      id="Fxbrl_20240830104411837"
      unitRef="Usd_per_Share">14.69</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240101to20240331"
      decimals="2"
      id="Fxbrl_20240830104415673"
      unitRef="Usd_per_Share">14.46</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240101to20240331"
      decimals="4"
      id="Fxbrl_20240830104419888"
      unitRef="Percentage">-0.0272</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240101to20240331"
      decimals="4"
      id="Fxbrl_20240830104423280"
      unitRef="Percentage">-0.0726</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20231001to20231231"
      decimals="2"
      id="Fxbrl_20240830104646811_xbrl_20240830104255668"
      unitRef="Usd_per_Share">13.86</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20231001to20231231"
      decimals="2"
      id="Fxbrl_20240830104646811_xbrl_20240830104407642"
      unitRef="Usd_per_Share">11.88</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20231001to20231231"
      decimals="2"
      id="Fxbrl_20240830104646811_xbrl_20240830104411837"
      unitRef="Usd_per_Share">14.51</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20231001to20231231"
      decimals="2"
      id="Fxbrl_20240830104646811_xbrl_20240830104415673"
      unitRef="Usd_per_Share">13.76</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231001to20231231"
      decimals="4"
      id="Fxbrl_20240830104646811_xbrl_20240830104419888"
      unitRef="Percentage">-0.0448</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231001to20231231"
      decimals="4"
      id="Fxbrl_20240830104646811_xbrl_20240830104423280"
      unitRef="Percentage">-0.1366</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230701to20230930"
      decimals="2"
      id="Fxbrl_20240830104649011_xbrl_20240830104255668"
      unitRef="Usd_per_Share">12.93</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230701to20230930"
      decimals="2"
      id="Fxbrl_20240830104649011_xbrl_20240830104407642"
      unitRef="Usd_per_Share">12.1</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20230701to20230930"
      decimals="2"
      id="Fxbrl_20240830104649011_xbrl_20240830104411837"
      unitRef="Usd_per_Share">14.25</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20230701to20230930"
      decimals="2"
      id="Fxbrl_20240830104649011_xbrl_20240830104415673"
      unitRef="Usd_per_Share">13.75</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230701to20230930"
      decimals="4"
      id="Fxbrl_20240830104649011_xbrl_20240830104419888"
      unitRef="Percentage">-0.0926</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230701to20230930"
      decimals="4"
      id="Fxbrl_20240830104649011_xbrl_20240830104423280"
      unitRef="Percentage">-0.12</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20240830104651851_xbrl_20240830104255668"
      unitRef="Usd_per_Share">12.33</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20240830104651851_xbrl_20240830104407642"
      unitRef="Usd_per_Share">11.61</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20240830104651851_xbrl_20240830104411837"
      unitRef="Usd_per_Share">13.87</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20240830104651851_xbrl_20240830104415673"
      unitRef="Usd_per_Share">13.58</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230401to20230630"
      decimals="4"
      id="Fxbrl_20240830104651851_xbrl_20240830104419888"
      unitRef="Percentage">-0.111</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230401to20230630"
      decimals="4"
      id="Fxbrl_20240830104651851_xbrl_20240830104423280"
      unitRef="Percentage">-0.1451</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20230101to20230331"
      decimals="2"
      id="Fxbrl_20240830104654339_xbrl_20240830104255668"
      unitRef="Usd_per_Share">12.85</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20230101to20230331"
      decimals="2"
      id="Fxbrl_20240830104654339_xbrl_20240830104407642"
      unitRef="Usd_per_Share">11.42</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20230101to20230331"
      decimals="2"
      id="Fxbrl_20240830104654339_xbrl_20240830104411837"
      unitRef="Usd_per_Share">14.12</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20230101to20230331"
      decimals="2"
      id="Fxbrl_20240830104654339_xbrl_20240830104415673"
      unitRef="Usd_per_Share">13.37</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230101to20230331"
      decimals="4"
      id="Fxbrl_20240830104654339_xbrl_20240830104419888"
      unitRef="Percentage">-0.0899</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20230101to20230331"
      decimals="4"
      id="Fxbrl_20240830104654339_xbrl_20240830104423280"
      unitRef="Percentage">-0.1458</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20221001to20221231"
      decimals="2"
      id="Fxbrl_20240830104656723_xbrl_20240830104255668"
      unitRef="Usd_per_Share">12.31</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20221001to20221231"
      decimals="2"
      id="Fxbrl_20240830104656723_xbrl_20240830104407642"
      unitRef="Usd_per_Share">11.27</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20221001to20221231"
      decimals="2"
      id="Fxbrl_20240830104656723_xbrl_20240830104411837"
      unitRef="Usd_per_Share">13.73</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20221001to20221231"
      decimals="2"
      id="Fxbrl_20240830104656723_xbrl_20240830104415673"
      unitRef="Usd_per_Share">13.17</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20221001to20221231"
      decimals="4"
      id="Fxbrl_20240830104656723_xbrl_20240830104419888"
      unitRef="Percentage">-0.1034</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20221001to20221231"
      decimals="4"
      id="Fxbrl_20240830104656723_xbrl_20240830104423280"
      unitRef="Percentage">-0.1443</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20220701to20220930"
      decimals="2"
      id="Fxbrl_20240830104658658_xbrl_20240830104255668"
      unitRef="Usd_per_Share">13.45</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20220701to20220930"
      decimals="2"
      id="Fxbrl_20240830104658658_xbrl_20240830104407642"
      unitRef="Usd_per_Share">11.65</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20220701to20220930"
      decimals="2"
      id="Fxbrl_20240830104658658_xbrl_20240830104411837"
      unitRef="Usd_per_Share">14.77</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20220701to20220930"
      decimals="2"
      id="Fxbrl_20240830104658658_xbrl_20240830104415673"
      unitRef="Usd_per_Share">13.33</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220701to20220930"
      decimals="4"
      id="Fxbrl_20240830104658658_xbrl_20240830104419888"
      unitRef="Percentage">-0.0894</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220701to20220930"
      decimals="4"
      id="Fxbrl_20240830104658658_xbrl_20240830104423280"
      unitRef="Percentage">-0.126</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_20240830104701506_xbrl_20240830104255668"
      unitRef="Usd_per_Share">14.82</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_20240830104701506_xbrl_20240830104407642"
      unitRef="Usd_per_Share">11.89</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_20240830104701506_xbrl_20240830104411837"
      unitRef="Usd_per_Share">15.96</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_20240830104701506_xbrl_20240830104415673"
      unitRef="Usd_per_Share">13.75</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220401to20220630"
      decimals="4"
      id="Fxbrl_20240830104701506_xbrl_20240830104419888"
      unitRef="Percentage">-0.0714</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220401to20220630"
      decimals="4"
      id="Fxbrl_20240830104701506_xbrl_20240830104423280"
      unitRef="Percentage">-0.1353</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20220101to20220331"
      decimals="2"
      id="Fxbrl_20240830104703514_xbrl_20240830104255668"
      unitRef="Usd_per_Share">16.37</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20220101to20220331"
      decimals="2"
      id="Fxbrl_20240830104703514_xbrl_20240830104407642"
      unitRef="Usd_per_Share">13.61</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20220101to20220331"
      decimals="2"
      id="Fxbrl_20240830104703514_xbrl_20240830104411837"
      unitRef="Usd_per_Share">16.71</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20220101to20220331"
      decimals="2"
      id="Fxbrl_20240830104703514_xbrl_20240830104415673"
      unitRef="Usd_per_Share">15.56</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220101to20220331"
      decimals="4"
      id="Fxbrl_20240830104703514_xbrl_20240830104419888"
      unitRef="Percentage">-0.0203</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20220101to20220331"
      decimals="4"
      id="Fxbrl_20240830104703514_xbrl_20240830104423280"
      unitRef="Percentage">-0.1253</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20240830180159779"
          xlink:label="Fxbrl_20240830180159779"
          xlink:type="locator"/>
        <link:footnote id="FN20240830180412881" xlink:label="FN20240830180412881" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The percentage reflects estimated offering expenses of approximately $250,000 for the estimated duration of this offering and assumes we sell all $150,000,000 of common shares under this Prospectus Supplement and the accompanying Prospectus. There is no guarantee that there will be any sales of our common shares pursuant to this Prospectus Supplement and the accompanying Prospectus. Actual sales of the Fund's common shares under this Prospectus Supplement and the accompanying Prospectus, if any, may be less than as set forth under &#x201c;Capitalization&#x201d; below. In addition, the price per share of any such sale may be greater than or less than the price set forth under &#x201c;Capitalization&#x201d; below, depending on market price of the Fund's common shares at the time of any such sale.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240830180159779"
          xlink:to="FN20240830180412881"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240830180202468"
          xlink:label="Fxbrl_20240830180202468"
          xlink:type="locator"/>
        <link:footnote id="FN20240830180423289" xlink:label="FN20240830180423289" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The plan administrator's service fee, if any, and expenses for administering the plan will be paid for by the Fund. There will be no brokerage charges to shareholders with respect to common shares issued directly by the Fund as a result of dividends or distributions payable either in common shares or in cash. However, each participant will pay a pro-rata share of brokerage commissions incurred with respect to the plan administrator's open-market purchases in connection with the reinvestment of dividends and distributions.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240830180202468"
          xlink:to="FN20240830180423289"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240830180256967"
          xlink:label="Fxbrl_20240830180256967"
          xlink:type="locator"/>
        <link:footnote id="FN20240830180433673" xlink:label="FN20240830180433673" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund currently pays the Adviser a management fee at an annual rate of 1.00% of the average daily value of the Fund's Managed Assets. Common shareholders bear the expenses of the Fund&#x2019;s use of leverage in the form of higher fees as a percentage of the Fund&#x2019;s net assets attributable to common shares than if the Fund did not use leverage. The advisory fee shown in the table assumes an amount of leverage of 36% of the Fund&#x2019;s Managed Assets. Based on the same assumptions, leverage would equal 56% of the Fund&#x2019;s net assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240830180256967"
          xlink:to="FN20240830180433673"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240830180259813"
          xlink:label="Fxbrl_20240830180259813"
          xlink:type="locator"/>
        <link:footnote id="FN20240830180443793" xlink:label="FN20240830180443793" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Interest payments on borrowed funds&#x201d; represents our actual interest and credit facility expenses incurred for the six months ended June 30, 2024. We had outstanding borrowings of approximately $190 million (with a carrying value of approximately $189) as of June 30, 2024. This item is based on the assumption that the Fund&#x2019;s borrowings and interest costs after an offering will remain similar (at leverage of 36% of the Fund&#x2019;s Managed Assets and 56% of the Fund&#x2019;s net assets) to those prior to such offering. The amount of leverage that the Fund may employ at any particular time will depend on, among other things, the Adviser&#x2019;s and the Board of Directors of the Fund's assessment of market and other factors at the time of any proposed borrowing.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240830180259813"
          xlink:to="FN20240830180443793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20240830180302941"
          xlink:label="Fxbrl_20240830180302941"
          xlink:type="locator"/>
        <link:footnote id="FN20240830180453153" xlink:label="FN20240830180453153" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Other Expenses&#x201d; includes our overhead expenses, including payments based on our allocable portion of overhead and other expenses incurred by Ares Operations LLC in performing its obligations under the administration agreement with us, and income taxes. &#x201c;Other Expenses&#x201d; are based on estimated amounts for the current fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20240830180302941"
          xlink:to="FN20240830180453153"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
